Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FGFBP1,Fibroblast growth factor-binding protein 1,40411,0.127056950866887,0.00290865239575316,0.121355992171211,0.132757909562563,0
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GCG,Pro-glucagon,39980,-0.473873088624773,0.011508550073008,-0.496429846767869,-0.451316330481678,0
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IGSF9,Protein turtle homolog A,37990,-0.302465435889798,0.00730692818703387,-0.316787015136385,-0.288143856643212,0
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LDLR,Low-density lipoprotein receptor,40356,-0.222471792860074,0.00478155292463417,-0.231843636592357,-0.213099949127791,0
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MFGE8,Lactadherin,40332,-0.17947349416849,0.00384639714304758,-0.187012432568864,-0.171934555768117,0
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PON3,Serum paraoxonase/lactonase 3,40422,0.105422220006076,0.00253197957658439,0.100459540035971,0.110384899976181,0
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRAP1,Proline-rich acidic protein 1,37998,-0.173605853134954,0.00384263401913627,-0.181137415812461,-0.166074290457447,0
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRSS8,Prostasin,40293,-0.149044721271044,0.00374178128726685,-0.156378612594087,-0.141710829948001,0
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ASGR1,Asialoglycoprotein receptor 1,40228,-0.104071516259002,0.00272799203442502,-0.109418380646475,-0.0987246518715287,1.11026565451636e-304
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PLA2G7,Platelet-activating factor acetylhydrolase,40332,0.111269351038395,0.00292325752070575,0.105539766297811,0.116998935778978,1.84322075318542e-303
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NPY,Pro-neuropeptide Y,40489,-0.233274570855676,0.00620778693187347,-0.245441833242148,-0.221107308469204,2.95489665721013e-296
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AGRP,Agouti-related protein,40516,-0.181536789296564,0.0049916281125672,-0.191320380397196,-0.171753198195932,2.29505116662575e-278
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADIPOQ,Adiponectin,38013,0.224971082846379,0.00619216366171002,0.212834442069427,0.23710772362333,6.8650252311995e-276
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LPL,Lipoprotein lipase,40359,0.142791276966369,0.00431495787787783,0.134333959525729,0.15124859440701,2.68113574380854e-232
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TMPRSS15,Enteropeptidase,40305,-0.279838405004995,0.00867133720400495,-0.296834225924845,-0.262842584085145,2.36994977005598e-221
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OXT,Oxytocin-neurophysin 1,40471,-0.400920828657988,0.0124549600985138,-0.425332550451075,-0.376509106864901,2.41463689158809e-220
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,APOF,Apolipoprotein F,37987,0.0725199795783744,0.00227484739095341,0.0680612786921058,0.0769786804646431,4.21556177241107e-215
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,INHBC,Inhibin beta C chain,40332,-0.126743920454187,0.00401650502548857,-0.134616270304145,-0.11887157060423,4.96898605164558e-212
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GPR37,Prosaposin receptor GPR37,40042,-0.198441532267109,0.00634091439751183,-0.210869724486233,-0.186013340047986,1.43799742062853e-208
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MAMDC4,Apical endosomal glycoprotein,37900,-0.161074229554651,0.00513435406790834,-0.171137563527752,-0.151010895581551,1.45878141969692e-208
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PYY,Peptide YY,37562,-0.279580086502407,0.0089315524741419,-0.297085929351725,-0.262074243653089,1.68432228691314e-207
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IGFBP1,Insulin-like growth factor-binding protein 1,40500,0.344688314826595,0.0110852894195293,0.322961147564318,0.366415482088873,3.58168644300337e-206
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLC39A5,Zinc transporter ZIP5,40341,-0.155165752622776,0.00505511462075396,-0.165073777279453,-0.145257727966098,4.71266469357876e-201
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CES1,Liver carboxylesterase 1,40352,-0.214586463167266,0.00720540557919262,-0.228709058102484,-0.200463868232049,1.06025879277447e-189
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PLTP,Phospholipid transfer protein,40461,0.0960263311739522,0.00324070139893712,0.0896745564320355,0.102378105915869,6.71683821892568e-188
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EPHA1,Ephrin type-A receptor 1,40400,-0.0948786572877046,0.00323496807488865,-0.101219194714486,-0.0885381198609229,3.31022381838615e-184
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FURIN,Furin,40411,-0.0933968448899966,0.00318681254971454,-0.0996429974874371,-0.0871506922925561,6.02891048476965e-184
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCN1,CCN family member 1,40280,-0.214489843956394,0.00738735749622044,-0.228969064648986,-0.200010623263802,1.25860083255955e-180
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CPM,Carboxypeptidase M,40415,-0.0938058875994222,0.00324238936342088,-0.100160970751727,-0.0874508044471173,2.00380651203101e-179
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SERPINF1,Pigment epithelium-derived factor,37790,-0.070842414902913,0.00245636856104679,-0.0756568972825647,-0.0660279325232613,1.76767424623976e-177
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RARRES2,Retinoic acid receptor responder protein 2,40424,-0.123038023751813,0.00438185933234632,-0.131626468043212,-0.114449579460414,2.23913493925256e-169
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FGF21,Fibroblast growth factor 21,40453,-0.307468030724679,0.0111083087150602,-0.329240315806197,-0.285695745643162,9.2424537618795e-165
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RTN4R,Reticulon-4 receptor,40489,-0.0885453050411099,0.00321486637869348,-0.0948464431433491,-0.0822441669388707,3.33936687186292e-163
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GHR,Growth hormone receptor,37671,-0.0754883552909632,0.00273893383357153,-0.0808566656047634,-0.070120044977163,1.22719279198197e-162
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NTRK3,NT-3 growth factor receptor,40471,0.0565634975450861,0.00207459783400015,0.0524972857904458,0.0606297092997264,4.87983850683012e-160
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MXRA8,Matrix remodeling-associated protein 8,37671,0.0791241479125176,0.0028980938486341,0.0734438839691948,0.0848044118558405,1.03067745921893e-159
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MCAM,Cell surface glycoprotein MUC18,40403,0.0877880478246964,0.00323986781513326,0.0814379069070352,0.0941381887423576,4.0585488598354e-158
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,C9,Complement component C9,37987,0.125066127947215,0.00463121151606551,0.115988953375726,0.134143302518703,1.74019371400351e-156
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,APOM,Apolipoprotein M,40372,0.0685302649561467,0.00254880417642752,0.0635346087703488,0.0735259211419447,9.13324738132203e-156
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DSG2,Desmoglein-2,40332,0.0681448745165592,0.00256317738122572,0.0631210468493568,0.0731687021837616,2.08800252548577e-152
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NRP1,Neuropilin-1,40424,0.0710530233733454,0.00268464469299536,0.0657911197750745,0.0763149269716163,4.19864366797538e-151
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLUL1,Clusterin-like protein 1,40338,0.114685759380861,0.00433440287231236,0.106190329751129,0.123181189010593,5.22159208805998e-151
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL1RN,Interleukin-1 receptor antagonist protein,40313,-0.138634368241483,0.00524148283233846,-0.148907674592867,-0.1283610618901,6.80035755084549e-151
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CA14,Carbonic anhydrase 14,40489,0.0868922519287294,0.00328562131703174,0.0804524341473472,0.0933320697101116,6.8142586053933e-151
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,F9,Coagulation factor IX,40372,-0.045016210520368,0.0017132932976741,-0.0483742653838092,-0.0416581556569268,5.50763405885919e-149
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL17RB,Interleukin-17 receptor B,40126,0.132927139806351,0.00508459989125178,0.122961324019498,0.142892955593205,1.68334848849022e-147
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ACY1,Aminoacylase-1,40359,-0.14795731348349,0.00566437879742235,-0.159059495926438,-0.136855131040542,2.66476740687804e-147
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD300LG,CMRF35-like molecule 9,40332,0.0934972599559218,0.00358913295339089,0.0864625593672757,0.100531960544568,1.57926558378442e-146
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AMBP,Protein AMBP,40470,-0.0489470449130271,0.00190547101435462,-0.0526817681011622,-0.045212321724892,1.22286066712419e-142
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,40228,-0.0779138063807592,0.00305040879909119,-0.0838926076269779,-0.0719350051345404,4.86674251879444e-141
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NOTCH3,Neurogenic locus notch homolog protein 3,40536,0.0840264132540677,0.00330172265404511,0.0775550368521393,0.0904977896559961,4.20035259884969e-140
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCL16,C-C motif chemokine 16,40536,-0.127392310544407,0.00504943830588852,-0.137289209623949,-0.117495411464866,9.07238145593448e-138
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NHLRC3,NHL repeat-containing protein 3,37370,-0.0767769940127194,0.00304898270164867,-0.0827530001079508,-0.070800987917488,1.2357518856221e-136
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTH,Parathyroid hormone,37572,-0.185372296958812,0.007523237015276,-0.200117841508753,-0.170626752408871,4.39200865463341e-131
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IGFBP2,Insulin-like growth factor-binding protein 2,40497,0.148940533473723,0.00606968827939467,0.13704394444611,0.160837122501337,1.45002691693407e-130
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HHEX,Hematopoietically-expressed homeobox protein HHEX,37942,-0.173942317092569,0.00718832381264197,-0.188031431765347,-0.15985320241979,1.15014114458058e-126
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,F7,Coagulation factor VII,40376,-0.0688272602167136,0.00286276481239749,-0.0744382792490127,-0.0632162411844146,1.71780689095098e-125
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADGRG2,Adhesion G-protein coupled receptor G2,40359,0.0610969910644422,0.00257093314209333,0.0560579621059393,0.0661360200229451,1.0596612997371e-122
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GUSB,Beta-glucuronidase,40419,-0.132576473921638,0.0055862427686607,-0.143525509748213,-0.121627438095063,2.1634402145296e-122
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,UPB1,Beta-ureidopropionase,37990,-0.206128494292166,0.00872294488329592,-0.223225466263426,-0.189031522320906,5.17907140170983e-121
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SIT1,Signaling threshold-regulating transmembrane adapter 1,40044,-0.125289281611389,0.0053269774550267,-0.135730157423241,-0.114848405799536,3.14512929306222e-120
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MVK,Mevalonate kinase,40044,-0.172282126899436,0.00732856282465421,-0.186646110035758,-0.157918143763114,4.08186230561628e-120
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VMO1,Vitelline membrane outer layer protein 1 homolog,40305,-0.151290987054554,0.00645439488900419,-0.163941601037002,-0.138640373072106,1.78471553091384e-119
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,40411,-0.077280573134602,0.00329921895134225,-0.0837470422792329,-0.0708141039899712,2.4947972563234e-119
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GLA,Alpha-galactosidase A,37642,-0.0803268790765409,0.00346439260185004,-0.0871170885761669,-0.0735366695769148,1.31932993027667e-116
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD4,T-cell surface glycoprotein CD4,40309,-0.067423760424826,0.00291844134106305,-0.0731439054533096,-0.0617036153963424,3.5797010348498e-116
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SHBG,Sex hormone-binding globulin,37987,0.118831326836166,0.00516564510756362,0.108706662425341,0.12895599124699,6.67918696172014e-115
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LGALS4,Galectin-4,40357,-0.115380397836967,0.00506152898065493,-0.125300994639051,-0.105459801034884,3.28430491355463e-113
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,40042,-0.183623509718406,0.00805550863564965,-0.199412306644279,-0.167834712792533,3.62908581227686e-113
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VPS37A,Vacuolar protein sorting-associated protein 37A,40305,-0.171946656729689,0.00756971962475489,-0.186783307194208,-0.157110006265169,1.96838982187568e-112
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SMOC1,SPARC-related modular calcium-binding protein 1,40489,-0.071410996638806,0.0031537756762802,-0.0775923969643151,-0.0652295963132968,9.18055842880855e-112
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MET,Hepatocyte growth factor receptor,40375,0.0435089284849366,0.00192792078972728,0.0397302037370711,0.047287653232802,4.92055599745734e-111
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KIT,Mast/stem cell growth factor receptor Kit,40372,0.0639865932280609,0.00284537407897857,0.0584096600332629,0.0695635264228589,2.82506140827041e-110
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,APOD,Apolipoprotein D,37345,0.0961434487556677,0.00427174926532331,0.087770820195634,0.104516077315701,4.63087989440322e-110
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CRELD1,Protein disulfide isomerase CRELD1,37671,-0.080713081850058,0.00360796498729354,-0.0877846932251533,-0.0736414704749626,7.83575498228424e-109
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RBP5,Retinol-binding protein 5,40305,-0.117943498466036,0.00529870290233673,-0.128328956154616,-0.107558040777456,4.16307488333706e-108
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GSTA1,Glutathione S-transferase A1,40333,-0.17608881103703,0.00792061094248453,-0.191613208484299,-0.16056441358976,7.44850897910435e-108
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IGFBP4,Insulin-like growth factor-binding protein 4,40063,-0.0902693225716867,0.00406167372511045,-0.0982302030729032,-0.0823084420704702,9.24894762373479e-108
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CKB,Creatine kinase B-type,37998,0.128160740253658,0.00579442622677715,0.116803664849175,0.139517815658141,1.61488877292833e-106
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IGSF8,Immunoglobulin superfamily member 8,40359,-0.0631629811863074,0.00286277968063392,-0.0687740293603499,-0.0575519330122649,2.76778436142443e-106
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CTSD,Cathepsin D,39243,-0.0843068333485608,0.0038199329006044,-0.0917939018337455,-0.0768197648633762,3.14158028429748e-106
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NOS3,"Nitric oxide synthase, endothelial",39961,-0.115479677943129,0.00524555786286578,-0.125760971354346,-0.105198384531912,8.62168721447025e-106
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,UMOD,Uromodulin,40502,0.113498318434692,0.00519629692799057,0.103313576455831,0.123683060413554,3.02962441663549e-104
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NOMO1,Nodal modulator 1,40332,-0.0494920276949888,0.00226783267836553,-0.0539369797445852,-0.0450470756453923,4.67153717818764e-104
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,40160,-0.0960362002668696,0.0044011937719272,-0.104662540059847,-0.0874098604738923,5.17044630348231e-104
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HGF,Hepatocyte growth factor,40516,-0.0714913151933568,0.0032819274935099,-0.0779238930806362,-0.0650587373060774,1.05300325351617e-103
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AFM,Afamin,38013,-0.0389609803839054,0.00178886628054661,-0.0424671582937768,-0.0354548024740341,2.11846484039098e-103
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VWA1,von Willebrand factor A domain-containing protein 1,40453,-0.0868384568394397,0.0040180325609438,-0.0947138006588895,-0.0789631130199898,3.964615940209e-102
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DEFB4A_DEFB4B,Beta-defensin 4A,40141,-0.306685262721138,0.0141943838745483,-0.334506255115252,-0.278864270327023,4.81074268581868e-102
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HJV,Hemojuvelin,37959,-0.0953777481091286,0.00441926008506334,-0.104039497875853,-0.0867159983424044,1.35855408714265e-101
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCL23,C-C motif chemokine 23,40422,-0.0841469881275371,0.00393079012848078,-0.0918513367793595,-0.0764426394757148,2.92712775518784e-100
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PSRC1,Proline/serine-rich coiled-coil protein 1,39980,-0.120072558147037,0.00561660532153431,-0.131081104577244,-0.10906401171683,5.86235412386294e-100
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ACE2,Angiotensin-converting enzyme 2,40042,-0.0995231177113195,0.00469334929599048,-0.108722082331461,-0.0903241530911781,2.09106685343662e-98
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,40305,-0.0843259185564716,0.00398163752746106,-0.0921299281102952,-0.0765219090026479,3.42675925149291e-98
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDKN1A,Cyclin-dependent kinase inhibitor 1,40305,-0.211897834316008,0.0100537357957875,-0.231603156475752,-0.192192512156265,2.81039912462787e-97
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,F11R,Junctional adhesion molecule A,40332,-0.113620794541837,0.0054196420846504,-0.124243293027752,-0.102998296055922,2.77104303265654e-96
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRCP,Lysosomal Pro-X carboxypeptidase,40443,-0.0620518330737613,0.00296168932915639,-0.0678567441589078,-0.0562469219886148,3.55097671617568e-96
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GSTA3,Glutathione S-transferase A3,39980,-0.151965886937277,0.00725703304089967,-0.16618967169744,-0.137742102177114,4.84924845681404e-96
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AGR3,Anterior gradient protein 3,39963,-0.119241678295735,0.00570762924070343,-0.130428631607514,-0.108054724983957,1.31768408959485e-95
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NCAM2,Neural cell adhesion molecule 2,40332,0.0539941615490199,0.00259288732522575,0.0489121023915774,0.0590762207064624,4.87388335398114e-95
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PPY,Pancreatic prohormone,40337,-0.200899297115855,0.00967551890683846,-0.219863314173259,-0.181935280058452,1.65443444488109e-94
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AMOT,Angiomotin,37671,-0.0832640181875395,0.00401251599373602,-0.0911285495352621,-0.075399486839817,3.77033672091472e-94
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FETUB,Fetuin-B,40372,-0.0669217026817852,0.00324815455452371,-0.0732880856086517,-0.0605553197549187,4.21473207154605e-93
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TTR,Transthyretin,37871,-0.0505901654018042,0.00245410760446924,-0.0554002163065639,-0.0457801144970445,5.57552886711696e-93
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PGF,Placenta growth factor,40516,-0.0517786814569302,0.00252100878948149,-0.0567198586843139,-0.0468375042295465,1.49112956829973e-92
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BPIFB1,BPI fold-containing family B member 1,40261,0.121547252265606,0.00591848543746343,0.109947020808178,0.133147483723034,1.62055325517622e-92
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MUC13,Mucin-13,39961,-0.0983504786460563,0.00482452620161625,-0.107806550001224,-0.0888944072908884,3.5106385458532e-91
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SMAD1,Mothers against decapentaplegic homolog 1,39980,-0.155959192939663,0.00771558500650062,-0.171081739552405,-0.140836646326922,1.0582854515487e-89
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ANGPTL7,Angiopoietin-related protein 7,40489,-0.0717197960127533,0.00355183173957209,-0.0786813862223146,-0.064758205803192,1.48029139943168e-89
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,40042,-0.105637688832607,0.00523414927284454,-0.115896621407382,-0.0953787562578312,1.93571425737069e-89
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,40516,-0.0738250779682526,0.003664938337122,-0.0810083571090117,-0.0666417988274934,3.85331294927545e-89
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CTBS,Di-N-acetylchitobiase,37819,-0.0523718264705369,0.00260520997805364,-0.057478038027522,-0.0472656149135518,1.41570807012892e-88
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DNAJB1,DnaJ homolog subfamily B member 1,40305,-0.168921303352699,0.0084309462683272,-0.185445958038621,-0.152396648666778,3.30508906693797e-88
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,39980,-0.118535075899163,0.00591757758981363,-0.130133527975198,-0.106936623823128,3.82719838998165e-88
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FAM20A,Pseudokinase FAM20A,37990,-0.0544555536369647,0.00271681239095803,-0.0597805059232425,-0.049130601350687,4.30446523895916e-88
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,40489,-0.0666437322600922,0.00332990077851938,-0.0731703377859902,-0.0601171267341942,4.95623612794659e-88
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,40403,0.0722965357166388,0.0036123225558957,0.0652163835070832,0.0793766879261944,5.00832407697681e-88
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FTCD,Formimidoyltransferase-cyclodeaminase,37920,-0.160065109418673,0.00798973142071392,-0.175724983003272,-0.144405235834074,5.3167967055753e-88
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,40305,-0.0589360345808104,0.0029556883249118,-0.0647291836976375,-0.0531428854639833,2.15794292385949e-87
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MTSS1,Protein MTSS 1,37901,-0.21190222911968,0.0106336100350687,-0.232744104788414,-0.191060353450945,4.21860469754898e-87
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CTSO,Cathepsin O,40516,-0.0572044476145907,0.00289011333826435,-0.0628690697575888,-0.0515398254715926,3.62104638767432e-86
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CTSZ,Cathepsin Z,40345,-0.0586763205675265,0.00298989212251638,-0.0645365091276586,-0.0528161320073944,9.53049358237346e-85
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CNTN1,Contactin-1,40536,0.0521254439324831,0.00265829506859555,0.0469151855980359,0.0573357022669304,1.26863066641152e-84
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OMD,Osteomodulin,40422,0.0833710875926332,0.00426558044256529,0.0750105499252052,0.0917316252600612,4.35595145256988e-84
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,40471,-0.097762577735266,0.00501041368939967,-0.107582988566489,-0.0879421669040426,8.16291727231391e-84
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CTSB,Cathepsin B,40353,0.101249602713721,0.00519636224256075,0.0910647327183019,0.11143447270914,1.39389661125496e-83
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SERPIND1,Heparin cofactor 2,37981,-0.0511675210734358,0.00263446095700175,-0.0563310645491593,-0.0460039775977124,6.68970177026402e-83
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCLY,Selenocysteine lyase,40434,-0.0884660802872371,0.00457551969930082,-0.0974340988978667,-0.0794980616766075,2.39005036531439e-82
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KRT18,"Keratin, type I cytoskeletal 18",40305,-0.142778234811466,0.00740481601481018,-0.157291674200494,-0.128264795422438,6.60749616345979e-82
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCL27,C-C motif chemokine 27,40359,-0.109896970142843,0.00571854511459498,-0.121105318567449,-0.0986886217182369,2.20038653395542e-81
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GIP,Gastric inhibitory polypeptide,37628,-0.0951007252161235,0.00497719869171967,-0.104856034651894,-0.085345415780353,2.66729215344437e-80
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CHL1,Neural cell adhesion molecule L1-like protein,40379,0.0580155172464145,0.00305342769112119,0.0520307989718169,0.064000235521012,1.29078443240866e-79
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CHI3L1,Chitinase-3-like protein 1,40054,-0.135975218413779,0.00716410039217696,-0.150016855182446,-0.121933581645112,1.9540678312064e-79
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,37990,-0.132438795883528,0.00698574448922258,-0.146130855082405,-0.118746736684652,3.97301995812144e-79
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,COL18A1,Collagen alpha-1(XVIII) chain,40391,-0.0419316522403824,0.00222937997454955,-0.0463012369904995,-0.0375620674902653,4.48708292559315e-78
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CANT1,Soluble calcium-activated nucleotidase 1,40312,-0.036650007747051,0.00195691672258097,-0.0404855645233097,-0.0328144509707923,1.98405926773487e-77
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,40044,-0.0790413242304219,0.00422298803068221,-0.087318380770559,-0.0707642676902848,2.53287753058372e-77
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TFF3,Trefoil factor 3,40309,-0.0951700694936194,0.00515189221721261,-0.105267778239356,-0.0850723607478827,2.10989602043185e-75
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FGFR2,Fibroblast growth factor receptor 2,40411,-0.0378227698570673,0.00205612975313858,-0.0418527841732189,-0.0337927555409157,8.51564627456326e-75
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MME,Neprilysin,40305,-0.143386870647509,0.00782952992668731,-0.158732749303816,-0.128040991991202,3.74585440766104e-74
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NECTIN2,Nectin-2,40330,-0.0509870441097301,0.00278413597722592,-0.0564439506250929,-0.0455301375943673,3.74785263786966e-74
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",37628,-0.100246677811569,0.00551252589322986,-0.111051228562299,-0.089442127060838,5.26439337691253e-73
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GRP,Gastrin-releasing peptide,37628,-0.0953773107282015,0.00524507925375204,-0.105657666065556,-0.0850969553908475,5.36867481097762e-73
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL18R1,Interleukin-18 receptor 1,40516,-0.0566765691028003,0.00313372920710876,-0.0628186783487335,-0.0505344598568672,2.14631191409792e-72
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GDF15,Growth/differentiation factor 15,40536,-0.0747473144612945,0.0041485808637415,-0.0828785329542278,-0.0666160959683612,7.2136761210684e-72
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CRIP2,Cysteine-rich protein 2,40228,-0.0625356901058222,0.00347694821715198,-0.0693505086114401,-0.0557208716002043,1.30568649338809e-71
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,APOC1,Apolipoprotein C-I,37981,0.0629216909948463,0.00349775860863044,0.0560660841219306,0.0697772978677619,1.61102105312605e-71
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCG2,Secretogranin-2,40392,-0.0555866719219256,0.00310229544255157,-0.0616671709893266,-0.0495061728545245,4.25524938929326e-71
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CFI,Complement factor I,38013,-0.0346522745380871,0.00193858784045298,-0.0384519067053749,-0.0308526423707993,1.1916315111998e-70
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ERP44,Endoplasmic reticulum resident protein 44,40280,-0.0439616636693186,0.00246611596840096,-0.0487952509673844,-0.0391280763712527,2.15370379373686e-70
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KLRB1,Killer cell lectin-like receptor subfamily B member 1,40516,-0.064075226264228,0.00359562824222738,-0.0711226576189937,-0.0570277949094624,2.33669604844407e-70
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SNAPIN,SNARE-associated protein Snapin,37959,-0.0985144967937231,0.00552655675130338,-0.109346548026278,-0.0876824455611685,2.84628493929634e-70
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SERPINA5,Plasma serine protease inhibitor,37835,-0.0566057887097003,0.00317659904048795,-0.0628319228290567,-0.0503796545903439,3.21653003629306e-70
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CXCL6,C-X-C motif chemokine 6,40516,-0.132498559794106,0.00748210140837446,-0.14716347855452,-0.117833641033692,1.64250302510826e-69
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SKAP1,Src kinase-associated phosphoprotein 1,40192,-0.124435535889087,0.00705750521307814,-0.13826824610672,-0.110602825671454,6.46764871710992e-69
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MEGF9,Multiple epidermal growth factor-like domains protein 9,40490,-0.035489212087771,0.00202058196741143,-0.0394495527438974,-0.0315288714316446,2.0352155841059e-68
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,POSTN,Periostin,37998,0.0637227611974121,0.00365043049533489,0.0565679174265558,0.0708776049682685,1.68869850615592e-67
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,40379,-0.0499710085097504,0.00286849847442327,-0.05559326551962,-0.0443487514998808,2.42183196567373e-67
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DPY30,Protein dpy-30 homolog,40414,-0.0992889141661212,0.00571898122495329,-0.11049811736703,-0.0880797109652127,6.66726250565453e-67
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NPPC,C-type natriuretic peptide,40341,-0.071793526466943,0.0041518720827206,-0.0799311957490754,-0.0636558571848106,2.19450550767072e-66
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD74,HLA class II histocompatibility antigen gamma chain,40471,-0.0578944290319157,0.00334848760663156,-0.0644574647409136,-0.0513313933229179,2.24980956879637e-66
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADGRG1,Adhesion G-protein coupled receptor G1,40305,-0.0912177488798072,0.0052775439247149,-0.101561734972248,-0.080873762787366,2.51041905306572e-66
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PLAT,Tissue-type plasminogen activator,40490,-0.081636464308202,0.0047236151737528,-0.0908947500487575,-0.0723781785676466,2.5348269361245e-66
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IDUA,Alpha-L-iduronidase,40489,-0.075139261506786,0.00435273847169168,-0.0836706289113017,-0.0666078941022703,3.56849915697323e-66
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MEP1A,Meprin A subunit alpha,37901,-0.114026659926041,0.00659999061711466,-0.126962641535586,-0.101090678316496,3.63785688929433e-66
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SELPLG,P-selectin glycoprotein ligand 1,40341,-0.0459784802800732,0.00266390139986009,-0.051199727023799,-0.0407572335363474,3.78359877474861e-66
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL10RB,Interleukin-10 receptor subunit beta,40422,-0.0474001896796786,0.00274642909863538,-0.0527831907130039,-0.0420171886463533,3.82080061896101e-66
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LBR,Delta(14)-sterol reductase LBR,40471,-0.108915949517349,0.0063138081247058,-0.121291013441772,-0.0965408855929252,4.38927363825123e-66
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CNTN3,Contactin-3,40332,-0.0579712405525032,0.00336804617594624,-0.0645726110573578,-0.0513698700476486,8.50979402222133e-66
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ERBB4,Receptor tyrosine-protein kinase erbB-4,40411,0.040367129346151,0.00234672073731322,0.0357675567010171,0.0449667019912849,1.01203337342016e-65
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VEGFA,Vascular endothelial growth factor A,40456,-0.0968674518618169,0.00565756344529103,-0.107956276214587,-0.0857786275090465,3.88261772688623e-65
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CA5A,"Carbonic anhydrase 5A, mitochondrial",40042,-0.15131286799607,0.0088523544615911,-0.168663482740788,-0.133962253251351,6.53355726758386e-65
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SEMA3F,Semaphorin-3F,40359,-0.0425386001382175,0.00249290460188848,-0.0474246931579189,-0.0376525071185161,1.03764417954928e-64
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CPA2,Carboxypeptidase A2,40398,-0.105383891302506,0.00617909726577398,-0.117494921943423,-0.0932728606615887,1.20265160911648e-64
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NCAM1,Neural cell adhesion molecule 1,40403,0.0455206481342554,0.00266964255694877,0.0402881487226358,0.050753147545875,1.27898597977822e-64
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CPB1,Carboxypeptidase B,40536,-0.0924679353673066,0.00543541869588202,-0.103121356011235,-0.0818145147233778,2.43944792870476e-64
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BTN3A2,Butyrophilin subfamily 3 member A2,40341,-0.0617926984424178,0.00363607078716565,-0.0689193971852624,-0.0546659996995731,3.33637157607703e-64
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,40228,-0.0897015832569518,0.0052954955510561,-0.100080754537022,-0.0793224119768819,8.46574498363915e-64
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,37562,-0.110322414937004,0.00655964482667646,-0.123179318797289,-0.0974655110767177,8.1447949895323e-63
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TIMP4,Metalloproteinase inhibitor 4,40332,0.065689622939369,0.00391837613062571,0.0580096057233426,0.0733696401553953,1.52994402264086e-62
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FABP4,"Fatty acid-binding protein, adipocyte",40536,-0.0791298434165626,0.00473521373966926,-0.0884108623463143,-0.0698488244868108,3.6476665265643e-62
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,F10,Coagulation factor X,37987,-0.0419222865210349,0.00250731164596906,-0.0468366173471343,-0.0370079556949356,3.93166061097442e-62
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,37671,-0.0783526421982255,0.00469350731295147,-0.0875519165316104,-0.0691533678648407,6.25078203692846e-62
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SELE,E-selectin,40536,-0.080339828472278,0.00482327570829023,-0.0897934488605268,-0.0708862080840291,8.90657746573589e-62
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD2AP,CD2-associated protein,40359,-0.102327136397548,0.0061650185256613,-0.114410572707844,-0.0902437000872519,2.36219062318614e-61
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KHK,Ketohexokinase,37628,-0.103267571295513,0.00622210680968445,-0.115462900642495,-0.0910722419485318,3.06817550310665e-61
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RNASET2,Ribonuclease T2,40465,-0.0420545668198302,0.0025504182004665,-0.0470533864927445,-0.0370557471469158,1.38322935195397e-60
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GPD1,Glycerol-3-phosphate dehydrogenase,37900,-0.0812525611717518,0.00492830830818847,-0.0909120454558013,-0.0715930768877024,1.78485539832369e-60
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CXCL13,C-X-C motif chemokine 13,40471,-0.100633944160745,0.00610892609687751,-0.112607439310625,-0.0886604490108652,1.79422414669221e-60
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LCAT,Phosphatidylcholine-sterol acyltransferase,37987,-0.0353689005063701,0.00214796160877247,-0.0395789052595641,-0.031158895753176,2.47280696465934e-60
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",40411,-0.0551154319470475,0.00335021634853262,-0.0616818559901715,-0.0485490079039236,2.57426320048364e-60
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCL15,C-C motif chemokine 15,40536,-0.070679449999693,0.00429688622314944,-0.0791013469970659,-0.0622575530023201,2.64938840460234e-60
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LGALS9,Galectin-9,40350,-0.0506586385716603,0.00310230508225781,-0.0567391565328856,-0.0445781206104349,1.85926426937898e-59
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KYNU,Kynureninase,40516,-0.0701653597314669,0.00429972499721454,-0.0785928207260074,-0.0617378987369264,2.18719809568207e-59
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLEC4M,C-type lectin domain family 4 member M,37969,0.0763179907482048,0.00467817210552275,0.0671487734213802,0.0854872080750294,2.90498051939515e-59
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NUCB2,Nucleobindin-2,40447,-0.0582991106171592,0.00357735418451455,-0.0653107248188077,-0.0512874964155107,3.1243699060645e-59
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TGFB1,Transforming growth factor beta-1 proprotein,40502,-0.0592967940281682,0.00365416781052311,-0.0664589629367935,-0.0521346251195429,9.50935199549767e-59
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LSP1,Lymphocyte-specific protein 1,40341,-0.0624285579823101,0.00385245879938633,-0.0699793772291074,-0.0548777387355129,1.37391709872419e-58
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADAMTSL2,ADAMTS-like protein 2,37998,-0.0481069328886157,0.00298310743971866,-0.0539538234704643,-0.0422600423067671,5.75817600995651e-58
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GLB1,Beta-galactosidase,40228,-0.0633146526347214,0.00393536355393395,-0.0710279652004319,-0.0556013400690108,8.83224553131743e-58
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OCLN,Occludin,37959,-0.0677760394754383,0.00421309791455195,-0.0760337113879601,-0.0595183675629164,1.08074152622369e-57
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD5,T-cell surface glycoprotein CD5,40470,-0.0515353177116917,0.00322139878045144,-0.0578492593213765,-0.0452213761020069,3.66839143312798e-57
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,40341,0.0595008922892468,0.00373925136114248,0.0521719596214075,0.066829824957086,1.41903774078004e-56
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FAM3B,Protein FAM3B,40305,-0.0553010022566931,0.00348724868836927,-0.0621360096858969,-0.0484659948274893,3.34359854396095e-56
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SRP14,Signal recognition particle 14 kDa protein,40305,-0.0906711086323505,0.00572778970328174,-0.101897576450783,-0.0794446408139183,5.18570355492068e-56
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FAM3C,Protein FAM3C,40330,-0.0452142683857776,0.00286597559815463,-0.0508315805581607,-0.0395969562133945,1.20002005520604e-55
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CREG1,Protein CREG1,40145,-0.0545209327730512,0.0034687328622668,-0.0613196491830941,-0.0477222163630083,3.01200603059828e-55
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CNTN5,Contactin-5,40367,0.0561016900862932,0.00357649306790674,0.049091763673196,0.0631116164993904,4.8535634109697e-55
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LRP11,Low-density lipoprotein receptor-related protein 11,40359,-0.0534534901884859,0.00340970997005688,-0.0601365217297974,-0.0467704586471744,5.61650379998377e-55
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EGLN1,Egl nine homolog 1,40341,-0.080223330519681,0.00511929784153872,-0.0902571542890969,-0.0701895067502651,6.17756403275951e-55
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MENT,Protein MENT,37671,0.0328092623767556,0.00209954608872181,0.0286941520428608,0.0369243727106503,1.46957935022894e-54
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CES3,Carboxylesterase 3,40305,-0.103118040056565,0.00662478196149533,-0.116102612701096,-0.0901334674120343,3.14634095270552e-54
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LTBP2,Latent-transforming growth factor beta-binding protein 2,40536,0.0475034006687189,0.0030539064778709,0.0415177439720919,0.0534890573653458,3.65205299294671e-54
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PCSK9,Proprotein convertase subtilisin/kexin type 9,40536,-0.0587199064553323,0.00377880298811409,-0.0661263603120359,-0.0513134525986287,4.64766785100946e-54
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,37663,-0.0683848547012545,0.00440263299635294,-0.0770140153741062,-0.0597556940284027,6.24274730362872e-54
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SMAD2,Mothers against decapentaplegic homolog 2,37900,-0.101610834688419,0.00655278009362864,-0.114454283671931,-0.0887673857049065,9.14613091109233e-54
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,40228,-0.110576695689176,0.00713646590594861,-0.124564168864835,-0.0965892225135166,9.3898804185796e-54
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",40305,-0.0655319202561296,0.00423355847622461,-0.0738296948695299,-0.0572341456427294,1.184411481869e-53
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ITGA11,Integrin alpha-11,40341,0.0508471913615061,0.00328975034274199,0.0443992806897318,0.0572951020332804,1.67833083410173e-53
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CST3,Cystatin-C,40372,-0.0419378599950066,0.00271511284698694,-0.047259481175101,-0.0366162388149122,1.95701160527905e-53
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CFH,Complement factor H,37301,-0.0346797095984686,0.00224340829782266,-0.039076789862201,-0.0302826293347362,1.99990750882819e-53
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DNER,Delta and Notch-like epidermal growth factor-related receptor,40319,0.0366557875331793,0.00237481582591913,0.0320011485143778,0.0413104265519808,2.31735389848216e-53
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PSIP1,PC4 and SFRS1-interacting protein,40341,-0.0923202870374378,0.00598282180169746,-0.104046617768765,-0.0805939563061108,2.47229680730457e-53
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HAO1,Hydroxyacid oxidase 1,40489,-0.193875960680796,0.0125746619088892,-0.218522298022219,-0.169229623339373,2.98622292883984e-53
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EFNA4,Ephrin-A4,40203,-0.0437733100470746,0.0028441912511136,-0.0493479248992572,-0.0381986951948919,4.61741775141472e-53
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DMP1,Dentin matrix acidic phosphoprotein 1,37628,0.0947164616224751,0.00615078901226228,0.082660915158441,0.106772008086509,4.80750609782132e-53
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MLN,Promotilin,40341,-0.131687660569613,0.00856167767200644,-0.148468548806746,-0.11490677233248,5.28448837894039e-53
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,39980,-0.0999764933911586,0.00650202165767636,-0.112720455840204,-0.0872325309421129,5.80464594490636e-53
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,40228,-0.0556067418852751,0.00362058842274861,-0.0627030951938624,-0.0485103885766878,7.49560318039905e-53
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",40379,0.0507557744832041,0.00331883202362461,0.0442508637168999,0.0572606852495083,1.99894259275045e-52
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRSS2,Trypsin-2,40403,-0.0741321448201704,0.00485299633837243,-0.0836440176433803,-0.0646202719969604,2.61025750664275e-52
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SNAP29,Synaptosomal-associated protein 29,40411,-0.133647032615322,0.00879442164990045,-0.150884099049127,-0.116409966181517,8.55611236460495e-52
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ABL1,Tyrosine-protein kinase ABL1,40305,-0.0996512535699359,0.00656032235724215,-0.11250948539013,-0.0867930217497412,9.53036643612677e-52
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SERPINA4,Kallistatin,37781,-0.0352575158777128,0.00232039876552311,-0.0398054974581381,-0.0307095342972875,1.04073449798907e-51
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SERPINE1,Plasminogen activator inhibitor 1,40536,-0.0989551324355116,0.00652464914825445,-0.11174344476609,-0.0861668201049329,1.34344783039859e-51
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL16,Pro-interleukin-16,40516,-0.0590801362785869,0.00389659074565203,-0.0667174541400649,-0.0514428184171089,1.43549022756206e-51
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FLI1,Friend leukemia integration 1 transcription factor,39980,-0.159079737514879,0.0104917816341767,-0.179643629517866,-0.138515845511893,1.4694957593138e-51
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EGFR,Epidermal growth factor receptor,40536,0.0239970589935716,0.0015831058019886,0.0208941716216739,0.0270999463654692,1.51802174449342e-51
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AGRN,Agrin,40422,-0.0485821490245599,0.00320594545203395,-0.0548658021105465,-0.0422984959385734,1.6322596357829e-51
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ITGAV,Integrin alpha-V,40489,0.0239364347675257,0.00158095263528603,0.020837767602365,0.0270351019326863,1.9844091927596e-51
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NUMB,Protein numb homolog,37598,-0.121985398761812,0.0080545179123745,-0.137772253870066,-0.106198543653558,2.21825316568157e-51
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LATS1,Serine/threonine-protein kinase LATS1,37598,-0.123259436527965,0.00814183244861531,-0.139217428127251,-0.107301444928679,2.4240962086441e-51
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TXLNA,Alpha-taxilin,40228,-0.130093782549206,0.00860081059597444,-0.146951371317316,-0.113236193781096,2.50874844185272e-51
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PSME1,Proteasome activator complex subunit 1,40216,-0.0550301642878271,0.00363834044421155,-0.0621613115584818,-0.0478990170171725,2.53621539928957e-51
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EFCAB14,EF-hand calcium-binding domain-containing protein 14,37901,-0.0393898307569917,0.00260555044268406,-0.0444967096246524,-0.0342829518893309,3.26246214877514e-51
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SEZ6L2,Seizure 6-like protein 2,40305,0.0346937847767021,0.00229696372351393,0.0301917358786148,0.0391958336747894,3.4504714299907e-51
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CES2,Cocaine esterase,40305,-0.0780289828827624,0.00517046874206049,-0.0881631016172009,-0.0678948641483238,4.18528279318758e-51
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FYB1,FYN-binding protein 1,40311,-0.132975737780253,0.00881676556060832,-0.150256598279045,-0.11569487728146,4.79560521986908e-51
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,40332,-0.0421187243457441,0.00279477351399006,-0.0475964804331646,-0.0366409682583236,5.6973107417301e-51
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TGFA,Protransforming growth factor alpha,40341,-0.0695331110368082,0.00462841748458931,-0.0786048093066033,-0.0604614127670131,1.15480260184105e-50
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CXADR,Coxsackievirus and adenovirus receptor,40341,-0.0770025042038126,0.00512734499374188,-0.0870521003915467,-0.0669529080160785,1.24541451344623e-50
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADM,Pro-adrenomedullin,40489,-0.0389923629923437,0.00259980711729539,-0.0440879849422427,-0.0338967410424448,1.66024069314608e-50
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LECT2,Leukocyte cell-derived chemotaxin-2,37990,-0.0944224620431479,0.00630881573519113,-0.106787740884123,-0.0820571832021733,3.05300432860511e-50
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MYH9,Myosin-9,37998,-0.162080924792078,0.0108441188054877,-0.183335397650834,-0.140826451933322,4.11975099878603e-50
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TFPI,Tissue factor pathway inhibitor,40309,0.0449577594750996,0.00300997143999686,0.0390582154527058,0.0508573034974935,4.19313842299942e-50
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BECN1,Beclin-1,37628,-0.0880560066730798,0.00589914615506103,-0.0996183331369995,-0.0764936802091602,5.63742828676397e-50
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CHMP6,Charged multivesicular body protein 6,37990,-0.0803930930133506,0.00538811811900364,-0.0909538045265978,-0.0698323815001035,6.0492968755739e-50
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CRHBP,Corticotropin-releasing factor-binding protein,40357,-0.0403679280884118,0.00271254508679373,-0.0456845164585275,-0.0350513397182961,9.3334698351474e-50
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AREG,Amphiregulin,40305,-0.071159051005816,0.00478921596695826,-0.0805459143010542,-0.0617721877105778,1.32771227060582e-49
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SORD,Sorbitol dehydrogenase,40417,-0.0954792872606306,0.0064478000706552,-0.108116975399115,-0.0828415991221464,2.75959484367943e-49
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NFASC,Neurofascin,40516,-0.0389338411579623,0.00263108478410993,-0.0440907673348178,-0.0337769149811068,3.19979698096631e-49
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTS,6-pyruvoyl tetrahydrobiopterin synthase,39886,-0.0784954028594401,0.0053081182921628,-0.0888993147120792,-0.068091491006801,3.80906898557905e-49
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CPA1,Carboxypeptidase A1,40536,-0.0817366247195079,0.00553225808918729,-0.092579850574315,-0.0708933988647008,4.48393214232161e-49
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SMNDC1,Survival of motor neuron-related-splicing factor 30,37901,-0.0823210974859234,0.00558568715671558,-0.0932690443130859,-0.0713731506587608,8.83949051684071e-49
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RELT,Tumor necrosis factor receptor superfamily member 19L,40332,-0.0388648327433806,0.00264177779342673,-0.044042717218497,-0.0336869482682642,1.13515023572241e-48
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD209,CD209 antigen,40382,0.0552429056498268,0.00376060240767522,0.0478721249307834,0.0626136863688702,1.55399031422077e-48
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ACAN,Aggrecan core protein,40224,0.040262966546199,0.00274636988753328,0.0348800815666338,0.0456458515257643,2.40321203188453e-48
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GGT1,Glutathione hydrolase 1 proenzyme,40303,-0.0685404010402315,0.00467762985570208,-0.0777085555574075,-0.0593722465230554,2.67504636724536e-48
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LAMP2,Lysosome-associated membrane glycoprotein 2,39887,-0.0261439398995705,0.00178443698711537,-0.0296414363943166,-0.0226464434048243,2.79645409580003e-48
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DNAJC6,Putative tyrosine-protein phosphatase auxilin,37628,-0.119702113952728,0.00816816167218995,-0.135711710830221,-0.103692517075236,3.01114927230085e-48
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLEC4D,C-type lectin domain family 4 member D,40341,-0.0865323209334979,0.00591517069091217,-0.0981260554876857,-0.07493858637931,3.7790474273593e-48
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IGFBPL1,Insulin-like growth factor-binding protein-like 1,40359,-0.0478669703109824,0.00327359133871827,-0.0542832093348702,-0.0414507312870946,4.16249873076508e-48
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HBEGF,Proheparin-binding EGF-like growth factor,40434,-0.102049053787915,0.00698243947370321,-0.115734635156373,-0.0883634724194566,4.59541044930505e-48
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLEC1B,C-type lectin domain family 1 member B,40471,-0.135307919170378,0.0092951828527312,-0.153526477561731,-0.117089360779024,1.06638571076224e-47
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SORCS2,VPS10 domain-containing receptor SorCS2,39980,-0.0505851943921802,0.0034771313252476,-0.0574003717896655,-0.0437700169946949,1.23779778621274e-47
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,APLP1,Amyloid-like protein 1,40359,0.0731282305381228,0.00503009637993234,0.0632692416334554,0.0829872194427902,1.40220893532682e-47
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BCAN,Brevican core protein,40228,0.0471046738178782,0.00324140982483549,0.0407515105612007,0.0534578370745558,1.53728375587278e-47
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PAXX,Protein PAXX,37671,-0.0635935663980345,0.00439173447816849,-0.0722013659752447,-0.0549857668208242,3.70438986562217e-47
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,37942,-0.120760021094412,0.00834478464308763,-0.137115798994864,-0.10440424319396,4.14309425685648e-47
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LAT2,Linker for activation of T-cells family member 2,40305,-0.170772830848282,0.0118123507943638,-0.193925038405235,-0.147620623291329,4.50306041940048e-47
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NELL1,Protein kinase C-binding protein NELL1,40411,0.0593189187025676,0.00410614834962348,0.0512708679373056,0.0673669694678297,5.23138309368422e-47
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NRP2,Neuropilin-2,40332,0.040576160504873,0.00280953468702752,0.0350694725182991,0.046082848491447,5.56327171994409e-47
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VSIG4,V-set and immunoglobulin domain-containing protein 4,40309,-0.0544265248907852,0.00377168222498954,-0.0618190220517646,-0.0470340277298057,6.61269700867651e-47
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDHR2,Cadherin-related family member 2,40305,-0.107097706479358,0.00742613365578958,-0.121652928444706,-0.0925424845140107,7.47692163018444e-47
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GSN,Gelsolin,37928,0.0266524791508496,0.00184702606127997,0.0230323080707408,0.0302726502309583,7.49199897071402e-47
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PXN,Paxillin,39961,-0.0721402531746586,0.00500475259765691,-0.0819495682660661,-0.062330938083251,8.43474862628831e-47
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,A1BG,Alpha-1B-glycoprotein,38013,-0.0244470669924798,0.0016977409046289,-0.0277746391655524,-0.0211194948194071,1.14655885653931e-46
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DPP4,Dipeptidyl peptidase 4,40068,0.0416090427462723,0.00289243554281487,0.0359398690823552,0.0472782164101895,1.26798364488463e-46
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AGR2,Anterior gradient protein 2 homolog,39839,-0.141073457623594,0.00980798056930326,-0.160297099539429,-0.12184981570776,1.31666022798328e-46
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ERMAP,Erythroid membrane-associated protein,37598,-0.0624806921352094,0.00434242603185966,-0.0709918471576543,-0.0539695371127644,1.38110726838351e-46
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AP3S2,AP-3 complex subunit sigma-2,37942,-0.0648011737771642,0.00450821626487249,-0.0736372776563143,-0.0559650698980141,1.66106566084467e-46
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CALCA,Calcitonin,40192,-0.0762773091417998,0.00531500760974657,-0.0866947240569031,-0.0658598942266966,2.05214853430992e-46
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FGF23,Fibroblast growth factor 23,40469,-0.0854697109593912,0.00595930567965309,-0.0971499500915113,-0.0737894718272711,2.30844719393097e-46
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",40305,-0.134318704046242,0.00939232675864403,-0.152727664493184,-0.1159097435993,4.18082695398401e-46
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PLA2G15,Phospholipase A2 group XV,40411,-0.0355193327654394,0.00248586570381962,-0.0403916295449258,-0.0306470359859529,4.96174153571955e-46
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IPCEF1,Interactor protein for cytohesin exchange factors 1,40203,-0.122514465539673,0.00858431126100774,-0.139339715611248,-0.105689215468098,6.33222029458355e-46
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SIAE,Sialate O-acetylesterase,40374,-0.0644327493685711,0.00452148014445238,-0.0732948504516978,-0.0555706482854445,8.528215223356e-46
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GPKOW,G-patch domain and KOW motifs-containing protein,39961,-0.0366797128279047,0.00258709037106393,-0.04175040995519,-0.0316090157006194,2.40749794436991e-45
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NPC2,NPC intracellular cholesterol transporter 2,37815,-0.0425498161480823,0.00300154396346886,-0.0484328423164813,-0.0366667899796833,2.74669842841896e-45
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,YES1,Tyrosine-protein kinase Yes,40305,-0.155379089378838,0.0109676624073801,-0.176875707697303,-0.133882471060373,2.76955485669983e-45
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ASPN,Asporin,37990,0.0374466963337192,0.00264329171498157,0.0322658445723553,0.0426275480950831,3.09885767213054e-45
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DCTN1,Dynactin subunit 1,40489,-0.089575511936465,0.00634707967926991,-0.102015788107834,-0.077135235765096,5.8792793487283e-45
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ENO3,Beta-enolase,37628,-0.0775243257839298,0.00549764966707691,-0.0882997191314005,-0.066748932436459,7.8884441209831e-45
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LEP,Leptin,40359,-0.086839791119099,0.00617452859796428,-0.0989418671711089,-0.074737715067089,1.16709962840221e-44
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TOP2B,DNA topoisomerase 2-beta,37598,-0.107479236605435,0.00764279459024562,-0.122459114002316,-0.0924993592085533,1.35232114414796e-44
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SH2D1A,SH2 domain-containing protein 1A,40341,-0.0743228783959018,0.0052957701053569,-0.0847025878024013,-0.0639431689894023,1.7700227813396e-44
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,S100P,Protein S100-P,40042,-0.0728253864751873,0.00519123572961572,-0.0830002085052342,-0.0626505644451405,1.94297263990611e-44
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",37942,-0.0525468868700363,0.00374471476931109,-0.0598865278178861,-0.0452072459221866,2.02986244515522e-44
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,40414,-0.0787900858619692,0.00562369475584403,-0.0898125275834235,-0.0677676441405149,2.46562381776669e-44
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,INSL5,Insulin-like peptide INSL5,37901,-0.127416870642287,0.00909789306779396,-0.145248741055163,-0.10958500022941,2.96720722917594e-44
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NFKBIE,NF-kappa-B inhibitor epsilon,39980,-0.0670916090779891,0.00479339678783676,-0.0764866667821492,-0.057696551373829,3.03336463712525e-44
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SARG,Specifically androgen-regulated gene protein,37931,-0.147106764203037,0.0105114777985294,-0.167709260688155,-0.12650426771792,3.41397520285618e-44
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BACH1,Transcription regulator protein BACH1,40341,-0.098073499776557,0.00701358282394731,-0.111820122111494,-0.0843268774416203,3.5986154474464e-44
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL32,Interleukin-32,40341,0.0575815246048513,0.00412904987264559,0.049488586854466,0.0656744623552367,6.08633496946598e-44
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GZMA,Granzyme A,40516,-0.0474088880869985,0.00340302085335319,-0.0540788089595708,-0.0407389672144263,7.34578898966858e-44
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ARF6,ADP-ribosylation factor 6,37901,-0.141644814614172,0.0101666889112609,-0.161571524880243,-0.1217181043481,8.13175502620991e-44
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TACSTD2,Tumor-associated calcium signal transducer 2,38484,0.0422709998076246,0.00303694609963263,0.0363185854523446,0.0482234141629045,9.49675017701377e-44
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCL3,C-C motif chemokine 3,40341,-0.0825747649549182,0.00594763020694155,-0.0942321201605236,-0.0709174097493127,1.43005245275648e-43
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFSF14,Tumor necrosis factor ligand superfamily member 14,40228,-0.0770748101567481,0.00556192192036901,-0.0879761771206713,-0.0661734431928248,2.05600325655493e-43
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NCS1,Neuronal calcium sensor 1,40489,-0.038217197874416,0.00275936111735538,-0.0436255456644325,-0.0328088500843994,2.26021508777112e-43
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AMN,Protein amnionless,40044,-0.0637684546041889,0.00460849851773569,-0.0728011116989509,-0.054735797509427,2.7420290225087e-43
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTPRS,Receptor-type tyrosine-protein phosphatase S,40536,0.0324399902646227,0.00234471688371904,0.0278443451725334,0.037035635356712,2.76046560794851e-43
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NPL,N-acetylneuraminate lyase,37990,-0.0577210655270633,0.00417458489975729,-0.0659032519305876,-0.049538879123539,3.45330486714559e-43
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,REN,Renin,40359,-0.0952596800245019,0.00690247578467851,-0.108788532562472,-0.081730827486532,4.46371770970867e-43
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,YTHDF3,YTH domain-containing family protein 3,40044,-0.113068900940973,0.00819546758344455,-0.129132017404524,-0.0970057844774215,4.78804484207587e-43
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FABP5,Fatty acid-binding protein 5,40432,-0.0920793604896567,0.00667740086439287,-0.105167066183867,-0.0789916547954466,5.18347774261933e-43
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ATP6V1G1,V-type proton ATPase subunit G 1,37628,-0.0966688630517881,0.00700634024476455,-0.110401289931527,-0.0829364361720495,5.26250381715457e-43
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CEP85,Centrosomal protein of 85 kDa,39980,-0.0838409596152354,0.00608830832018193,-0.0957740439227919,-0.0719078753076788,6.82312523997834e-43
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NAA80,N-alpha-acetyltransferase 80,37572,-0.158598943067563,0.011518559923876,-0.18117532051836,-0.136022565616766,7.77333421868453e-43
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EEF1D,Elongation factor 1-delta,37990,-0.122050125664277,0.00886646898434636,-0.139428404873596,-0.104671846454958,7.99883962822399e-43
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ELOA,Elongin-A,40305,-0.0677812961815161,0.00493395627017457,-0.0774518504710583,-0.0581107418919739,1.05985327080736e-42
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DTYMK,Thymidylate kinase,37990,-0.0920643971883122,0.00670261447828725,-0.105201521565755,-0.0789272728108692,1.20015738953674e-42
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCARB2,Lysosome membrane protein 2,40011,-0.0408762775299679,0.00298407650753894,-0.0467250674847442,-0.0350274875751916,1.83680908182211e-42
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CRELD2,Protein disulfide isomerase CRELD2,40396,-0.0685840700465858,0.0050099815504777,-0.0784036338855221,-0.0587645062076495,2.03826812316211e-42
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",40305,0.0554731138522609,0.00405923955475208,0.0475170043249468,0.0634292233795749,2.81771394556744e-42
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CSF1,Macrophage colony-stimulating factor 1,40422,-0.035802096575998,0.00262054478615008,-0.0409383643568522,-0.0306658287951438,2.95530284807576e-42
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LAT,Linker for activation of T-cells family member 1,40516,-0.0996278234674859,0.00730215691674388,-0.113940051024304,-0.0853155959106679,3.78469827250805e-42
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",40341,-0.125516585360561,0.00920253200420186,-0.143553548088797,-0.107479622632326,4.03358899525712e-42
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD40,Tumor necrosis factor receptor superfamily member 5,40350,-0.0651455937910798,0.00477760701374183,-0.0745097035380138,-0.0557814840441458,4.24208578433265e-42
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",40277,-0.137222377895537,0.0100815296434705,-0.156982175996739,-0.117462579794335,5.91286092263863e-42
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL18,Interleukin-18,40292,-0.0623107469917968,0.00457986065424098,-0.0712872738741091,-0.0533342201094844,6.39938850224167e-42
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GAST,Gastrin,37942,-0.171445022915586,0.0126095290565533,-0.19615969986643,-0.146730345964741,7.92557692379674e-42
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CPE,Carboxypeptidase E,40360,0.0502011398930549,0.00369634636897726,0.0429563010098594,0.0574459787762503,8.84090834816824e-42
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",39980,-0.108036687269083,0.00796197910191382,-0.123642166308834,-0.0924312082293322,1.0560607221221e-41
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",37628,-0.0921425108032722,0.00678950678454515,-0.105449944100981,-0.0788350775055637,1.12892168699843e-41
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCAMP3,Secretory carrier-associated membrane protein 3,40305,-0.111814570856578,0.00824980483353337,-0.127984188330303,-0.0956449533828525,1.28652777572662e-41
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL7R,Interleukin-7 receptor subunit alpha,40332,0.0691248706472398,0.00510027017685094,0.059128341100612,0.0791214001938677,1.29272723590913e-41
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,37922,-0.109825559221928,0.00811542101080824,-0.125731784403112,-0.0939193340407439,1.86453793717262e-41
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NCAN,Neurocan core protein,40471,0.0487349231409222,0.00360571707578184,0.0416677176723898,0.0558021286094546,2.12158606744022e-41
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SNAP23,Synaptosomal-associated protein 23,40359,-0.113175111603576,0.0084064421055019,-0.12965173813036,-0.0966984850767921,4.34058461719042e-41
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD63,CD63 antigen,40203,-0.0677649900383364,0.0050399302485426,-0.0776432533254799,-0.0578867267511929,5.49716400073101e-41
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OSM,Oncostatin-M,40268,-0.0941983054435782,0.00701291195916025,-0.107943612883532,-0.0804529980036241,6.56937241957852e-41
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TIMP1,Metalloproteinase inhibitor 1,40167,-0.0365572518652515,0.00272234785970635,-0.0418930536702759,-0.031221450060227,6.9109056055101e-41
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL12A_IL12B,Interleukin-12,40305,-0.101715259609283,0.00758733525438305,-0.116586436707874,-0.0868440825106919,9.30666898070584e-41
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RNASE6,Ribonuclease K6,37917,-0.0384024034056523,0.00286350748404023,-0.0440148780743711,-0.0327899287369334,9.52130862390508e-41
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HEG1,Protein HEG homolog 1,37671,-0.0343349310184905,0.00256305491053977,-0.0393585186431485,-0.0293113433938326,1.17324152253404e-40
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ZBTB16,Zinc finger and BTB domain-containing protein 16,39980,-0.0905875494623421,0.00676663644604922,-0.103850156896599,-0.0773249420280857,1.2040715030725e-40
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,37901,-0.180817723202609,0.013507384310612,-0.207292196451408,-0.154343249953809,1.31763519321473e-40
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GPRC5C,G-protein coupled receptor family C group 5 member C,37900,-0.0744678675922059,0.00557725372705193,-0.0853992848972276,-0.0635364502871841,2.08298537283262e-40
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",37860,-0.139959547218391,0.0104916837433176,-0.160523247355293,-0.119395847081488,2.4467557762505e-40
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DKK1,Dickkopf-related protein 1,40471,-0.0767838229357052,0.00576354011841151,-0.0880803615677918,-0.0654872843036187,2.8117101839658e-40
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DAAM1,Disheveled-associated activator of morphogenesis 1,37671,-0.107021599878464,0.00805867976098415,-0.122816612209993,-0.0912265875469347,5.43243136785945e-40
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TPP1,Tripeptidyl-peptidase 1,40255,-0.0574932185469598,0.00433225113989774,-0.0659844307811594,-0.0490020063127603,5.58220476604269e-40
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SNCG,Gamma-synuclein,40228,-0.0858810376590721,0.00647229696351392,-0.0985667397075594,-0.0731953356105848,5.73328451159717e-40
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BOC,Brother of CDO,40042,0.0303661999210237,0.00228871703445104,0.0258803145334996,0.0348520853085477,5.86178992595926e-40
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,40330,-0.132187754130372,0.00997167421419953,-0.151732235590203,-0.112643272670541,6.75717115077984e-40
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AP1G2,AP-1 complex subunit gamma-like 2,37900,-0.102267283178027,0.00771080304659958,-0.117380457149362,-0.087154109206692,6.76708504122757e-40
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,40333,-0.0783894412366742,0.0059189079789663,-0.0899905008754481,-0.0667883815979002,7.95839266459208e-40
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPINK1,Serine protease inhibitor Kazal-type 1,40332,-0.0555496804715146,0.00419622525100186,-0.0637742819634783,-0.0473250789795509,8.60065413589182e-40
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FUS,RNA-binding protein FUS,39960,-0.0504909798087771,0.00381682869020002,-0.0579719640415691,-0.043009995575985,9.85872349755024e-40
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EREG,Proepiregulin,40192,-0.102252874456789,0.00775880884798973,-0.117460139798849,-0.0870456091147295,1.87688573449231e-39
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HYOU1,Hypoxia up-regulated protein 1,40536,-0.0276026796082188,0.00209586624998448,-0.0317105774581884,-0.0234947817582493,2.08719929725601e-39
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NFKB1,Nuclear factor NF-kappa-B p105 subunit,37562,-0.0945669434077529,0.00717821728892964,-0.108636249294055,-0.0804976375214508,2.19871357679778e-39
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FSTL3,Follistatin-related protein 3,40293,-0.0397862267293959,0.00302928864543896,-0.0457236324744563,-0.0338488209843355,3.37606076190902e-39
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CGREF1,Cell growth regulator with EF hand domain protein 1,40359,-0.0534461191036673,0.00407091500856014,-0.0614251125204452,-0.0454671256868894,3.60065202494574e-39
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,37594,-0.0492204982302625,0.00375003909160149,-0.0565705748498014,-0.0418704216107235,4.15289146982024e-39
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CEP20,Centrosomal protein 20,39980,-0.093277695952283,0.00711977927446845,-0.107232463330241,-0.0793229285743248,5.21798221801148e-39
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,APCS,Serum amyloid P-component,37882,-0.0455755885457293,0.00348138174055277,-0.0523990967572128,-0.0387520803342459,6.3953405901899e-39
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ESM1,Endothelial cell-specific molecule 1,40357,0.0427674142991512,0.00328091938147463,0.0363368123114609,0.0491980162868415,1.2174714393027e-38
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL12B,Interleukin-12 subunit beta,40516,-0.0684158756251417,0.00525156849249532,-0.0787089498704326,-0.0581228013798509,1.33566214415604e-38
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ARSA,Arylsulfatase A,40332,-0.0560907918504165,0.00431161911389046,-0.0645415653136418,-0.0476400183871912,1.70592709277013e-38
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MMP1,Interstitial collagenase,39757,-0.117376720091173,0.0090250050740485,-0.135065730036308,-0.0996877101460376,1.81524789262156e-38
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,40305,-0.0571790470841417,0.00439853160795912,-0.0658001690357416,-0.0485579251325418,1.93413083301063e-38
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,40403,-0.0529939462190584,0.00407762248602413,-0.0609860862916657,-0.0450018061464511,2.01268439110784e-38
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DNAJA2,DnaJ homolog subfamily A member 2,40471,-0.103034200075513,0.00793316187830733,-0.118583197356995,-0.0874852027940307,2.24230581111605e-38
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GH1,Somatotropin,40330,0.219751651288328,0.0169436840003555,0.186542030647632,0.252961271929025,2.84973630606018e-38
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FABP1,"Fatty acid-binding protein, liver",40357,-0.116783460106957,0.00900479668804869,-0.134432861615532,-0.0991340585983812,2.86617380984681e-38
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,STC1,Stanniocalcin-1,40471,-0.0518891865520874,0.00400243832501981,-0.0597339656691263,-0.0440444074350486,3.03325343299537e-38
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SUSD2,Sushi domain-containing protein 2,40332,0.0358430399158508,0.00277284275405033,0.0304082681179121,0.0412778117137894,4.96442697306594e-38
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AXIN1,Axin-1,40341,-0.117274949294694,0.00908544410799343,-0.135082419746362,-0.0994674788430273,6.2925368456065e-38
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TANK,TRAF family member-associated NF-kappa-B activator,40044,-0.0870163968571686,0.0067453355163241,-0.100237254469164,-0.0737955392451734,7.01099997100211e-38
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CSTB,Cystatin-B,40097,-0.0522095115976131,0.00404960386385348,-0.0601467351707659,-0.0442722880244603,7.73115522940418e-38
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDC27,Cell division cycle protein 27 homolog,39980,-0.0757021514307355,0.00588949625978032,-0.087245564099905,-0.0641587387615661,1.27430063676153e-37
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,39853,-0.110488083408499,0.00859961718744274,-0.127343333095887,-0.0936328337211117,1.37622506597411e-37
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OGFR,Opioid growth factor receptor,40305,-0.0410772299622913,0.00319764772271104,-0.047344619498805,-0.0348098404257777,1.39326532114199e-37
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTGDS,Prostaglandin-H2 D-isomerase,40234,-0.0367268355530314,0.00286425985400585,-0.0423407848668829,-0.03111288623918,1.88788276838356e-37
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD248,Endosialin,37998,0.0497618886070914,0.00388188227408374,0.0421533993498873,0.0573703778642956,2.11658130959924e-37
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TARBP2,RISC-loading complex subunit TARBP2,39961,-0.097863127724181,0.00763892723757278,-0.112835425109824,-0.0828908303385384,2.19835587596629e-37
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCPEP1,Retinoid-inducible serine carboxypeptidase,37563,-0.0614122072997162,0.00479227499343947,-0.0708050662868576,-0.0520193483125748,2.26925694325944e-37
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RNASE4,Ribonuclease 4,37575,-0.0339916850171408,0.00265584456177172,-0.0391971403582134,-0.0287862296760683,2.78074078426515e-37
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TJAP1,Tight junction-associated protein 1,40411,-0.102025133919318,0.00797688522064157,-0.117659828951776,-0.0863904388868607,2.83864078387844e-37
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDCD5,Programmed cell death protein 5,40471,-0.0719151832913073,0.00563911636810293,-0.082967851372789,-0.0608625152098255,4.54787159162003e-37
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CXCL17,C-X-C motif chemokine 17,40516,-0.051058690120128,0.00400514962416624,-0.0589087833834938,-0.0432085968567622,4.81936639789043e-37
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KRT19,"Keratin, type I cytoskeletal 19",40310,-0.0838687258534231,0.00658271401318886,-0.0967708453192733,-0.070966606387573,5.3295832040134e-37
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IGF2R,Cation-independent mannose-6-phosphate receptor,40332,-0.028204190919571,0.00221859768866527,-0.0325526423893549,-0.023855739449787,7.60846624374267e-37
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KRT5,"Keratin, type II cytoskeletal 5",39961,-0.060187626323158,0.00473447283485894,-0.0694671930794815,-0.0509080595668345,7.68215398803688e-37
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LRP1,Prolow-density lipoprotein receptor-related protein 1,40305,0.03247722307537,0.00255969798493379,0.0274602150248998,0.0374942311258402,1.04073117103633e-36
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FCN1,Ficolin-1,37967,-0.069473928863417,0.00547831427958097,-0.0802114248513957,-0.0587364328754383,1.20895304161553e-36
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HEXIM1,Protein HEXIM1,40341,-0.100134918376945,0.00789995289509645,-0.115618826051334,-0.084651010702556,1.2180836126444e-36
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PBLD,Phenazine biosynthesis-like domain-containing protein,39961,-0.0616587493305764,0.00486735284645825,-0.0711987609096346,-0.0521187377515182,1.35342679896833e-36
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PVR,Poliovirus receptor,40471,-0.0450159755462743,0.00355561243015118,-0.0519849759093706,-0.0380469751831779,1.46414795277611e-36
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IKBKG,NF-kappa-B essential modulator,40341,-0.112472417759215,0.00889162675875821,-0.129900006206381,-0.0950448293120489,1.69361944548143e-36
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,YOD1,Ubiquitin thioesterase OTU1,37562,-0.0779002806363015,0.00615810481945643,-0.0899701660824361,-0.0658303951901669,1.82597669170633e-36
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BANK1,B-cell scaffold protein with ankyrin repeats,40341,-0.12945235762213,0.0102498540785566,-0.149542071616101,-0.109362643628159,2.16692532458974e-36
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NFE2,Transcription factor NF-E2 45 kDa subunit,37628,-0.0915644110685311,0.00725736406891138,-0.105788844643597,-0.0773399774934648,2.76679633747895e-36
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IGSF3,Immunoglobulin superfamily member 3,40305,-0.0421418657012284,0.00334348600923435,-0.0486950982793277,-0.0355886331231291,2.98867496978445e-36
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PSME2,Proteasome activator complex subunit 2,40152,-0.0451815901360102,0.00358529052157798,-0.0522087595583031,-0.0381544207137174,3.08573893321736e-36
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCL7,C-C motif chemokine 7,40341,-0.0741284439356946,0.00588453461300905,-0.0856621317771923,-0.0625947560941969,3.26051795673546e-36
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ITGB1,Integrin beta-1,40333,0.0266949567364582,0.00212274617526011,0.0225343742329484,0.030855539239968,4.26994182417813e-36
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RRM2,Ribonucleoside-diphosphate reductase subunit M2,39980,-0.0641205397591785,0.00511367100816369,-0.0741433349351793,-0.0540977445831777,6.81223198668009e-36
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLEC4A,C-type lectin domain family 4 member A,40341,0.0417008029076874,0.00333001743270504,0.0351739687395856,0.0482276370757893,8.27938052222369e-36
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MTDH,Protein LYRIC,37598,-0.110831435007994,0.00886056594067252,-0.128198144251712,-0.0934647257642757,1.07232263685189e-35
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EZR,Ezrin,40471,-0.0285748621032327,0.00228857633618246,-0.0330604717221503,-0.0240892524843151,1.30604858296179e-35
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SSNA1,Sjoegren syndrome nuclear autoantigen 1,37901,-0.0616549402843054,0.00493694563136559,-0.0713313537217819,-0.0519785268468288,1.35928101941622e-35
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GFER,FAD-linked sulfhydryl oxidase ALR,39980,-0.0774713067780901,0.00620897494692129,-0.0896408976740558,-0.0653017158821244,1.47023041582606e-35
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BCHE,Cholinesterase,37748,-0.0342716969652005,0.00274586722515093,-0.0396535967264963,-0.0288897972039046,1.49575219127794e-35
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CNTN4,Contactin-4,40332,0.0293701677854594,0.00235476501812323,0.0247548283499378,0.0339855072209809,1.54445160205073e-35
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PLAU,Urokinase-type plasminogen activator,40332,0.0354345500248711,0.00284498176077402,0.029858385773754,0.0410107142759882,1.92058922337606e-35
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SELP,P-selectin,40403,-0.069392400714018,0.00558662322651061,-0.0803421822379788,-0.0584426191900572,2.92020564868914e-35
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNXB,Tenascin-X,40332,0.0306544952649011,0.00246814228153453,0.0258169363930934,0.0354920541367088,2.96528114024988e-35
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TGFBR2,TGF-beta receptor type-2,40411,-0.0379110248621553,0.00305535481509795,-0.0438995202997473,-0.0319225294245633,3.43394992254716e-35
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDHR5,Cadherin-related family member 5,40359,-0.0467192534440699,0.00376877269907515,-0.0541060479342572,-0.0393324589538826,3.97067351940169e-35
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PARP1,Poly [ADP-ribose] polymerase 1,40341,-0.0648142251514782,0.00523806725212587,-0.0750808369656449,-0.0545476133373115,5.25848363483494e-35
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,40471,0.054111219753979,0.00437837976233571,0.045529595419801,0.062692844088157,6.30456491536518e-35
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BMP10,Bone morphogenetic protein 10,37671,0.0344754102880615,0.00279132005548427,0.0290044229793123,0.0399463975968107,7.49448693581595e-35
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GASK1A,Golgi-associated kinase 1A,37562,-0.0518849086658723,0.00420205909815332,-0.0601209444982528,-0.0436488728334918,7.84642681542604e-35
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IFNGR2,Interferon gamma receptor 2,40228,-0.0616601540555029,0.00499728246248423,-0.071454827681972,-0.0518654804290338,8.10927960277724e-35
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RNF149,E3 ubiquitin-protein ligase RNF149,37628,-0.0362483665824386,0.00294207457212347,-0.0420148327438006,-0.0304819004210766,1.08798500658269e-34
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SULT2A1,Bile salt sulfotransferase,40341,-0.0633589752135469,0.00515409084026902,-0.0734609932604742,-0.0532569571666196,1.41911462266821e-34
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BTD,Biotinidase,38013,-0.0246566125668164,0.00200572033037692,-0.0285878244143552,-0.0207254007192776,1.505719317303e-34
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ALDH1A1,Retinal dehydrogenase 1,40332,-0.0626184940362389,0.00511171654183576,-0.072637458458237,-0.0525995296142409,2.40087745756016e-34
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",40305,-0.0382511737874444,0.00313031691023897,-0.0443865949315128,-0.0321157526433761,3.48137805641062e-34
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VNN1,Pantetheinase,37987,-0.0859059935498392,0.00703006044655435,-0.0996849120250857,-0.0721270750745927,3.68734916007642e-34
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ARSB,Arylsulfatase B,40305,-0.0648991125571366,0.0053185219538747,-0.075323415586731,-0.0544748095275422,4.28802187638274e-34
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL1RAP,Interleukin-1 receptor accessory protein,40332,0.0508648928457561,0.00417410948439131,0.0426836382563492,0.0590461474351631,5.24822500818483e-34
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LEPR,Leptin receptor,40359,0.0361862214928655,0.00297068043219357,0.0303636878457661,0.0420087551399649,5.55237484308286e-34
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,37990,-0.0908059211035125,0.00747012755722121,-0.105447371115666,-0.0761644710913589,8.01022522418137e-34
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,COL6A3,Collagen alpha-3(VI) chain,40536,-0.040411114530938,0.00332596120134565,-0.0469299984855754,-0.0338922305763005,8.04928295894373e-34
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCN2,CCN family member 2,40358,-0.0676421985389733,0.00557946529716371,-0.0785779505214142,-0.0567064465565324,1.11747684102609e-33
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,THOP1,Thimet oligopeptidase,40288,-0.0350534426351141,0.00289855362914049,-0.0407346077482294,-0.0293722775219987,1.60776558488055e-33
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IRAK1,Interleukin-1 receptor-associated kinase 1,40044,-0.080737105098605,0.00668311112826581,-0.093836002910006,-0.0676382072872041,1.88278280025273e-33
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,USP8,Ubiquitin carboxyl-terminal hydrolase 8,40042,-0.11271200714862,0.00934954124414229,-0.131037107987139,-0.0943869063101009,2.55671444496289e-33
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCL5,C-C motif chemokine 5,40403,-0.117012668021717,0.00971047796481491,-0.136045204832754,-0.0979801312106794,2.70109181085614e-33
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ISM1,Isthmin-1,40341,-0.045479625481901,0.00377494911443383,-0.0528785257461914,-0.0380807252176107,2.78373873073074e-33
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,37714,-0.13040424563604,0.0108312394158032,-0.151633474891014,-0.109175016381066,3.27616929435061e-33
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PIGR,Polymeric immunoglobulin receptor,40154,-0.0410082494194693,0.00340768414429822,-0.0476873103422938,-0.0343291884966447,3.29441006972764e-33
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTGR1,Prostaglandin reductase 1,37990,-0.0925775333902778,0.00770851457777252,-0.107686221962712,-0.0774688448178436,4.64766448962114e-33
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDH1,Cadherin-1,39806,-0.0466070144478894,0.00388515798198605,-0.054221924092582,-0.0389921048031967,5.22686324030229e-33
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,XCL1,Lymphotactin,40489,-0.0653980839161378,0.00545562782505704,-0.0760911144532496,-0.054705053379026,5.73120867517206e-33
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,40516,-0.115947502989001,0.00967649070407117,-0.134913424768981,-0.0969815812090219,6.07224750892066e-33
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,37942,-0.0466632051883054,0.00389630887596812,-0.0542999705852029,-0.0390264397914079,6.94613477812797e-33
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SERPINH1,Serpin H1,37714,-0.149593651882631,0.012496011021927,-0.174085833485608,-0.125101470279654,7.41673756958496e-33
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MAPK9,Mitogen-activated protein kinase 9,40341,-0.049698332198906,0.00415428116748548,-0.0578407232871776,-0.0415559411106345,7.66782635906724e-33
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TDRKH,Tudor and KH domain-containing protein,39961,-0.098541477967962,0.00824272232108793,-0.114697213717294,-0.0823857422186297,8.52239300547318e-33
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,37598,-0.0501086219340175,0.00419262933395949,-0.0583261754285781,-0.0418910684394569,9.41243505421077e-33
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,S100A4,Protein S100-A4,40411,-0.0667151550686252,0.00558508539002832,-0.0776619224330807,-0.0557683877041697,9.4827148373438e-33
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,37901,-0.0346701935916931,0.00290206817747284,-0.0403582472195399,-0.0289821399638464,9.88858498062573e-33
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CXCL10,C-X-C motif chemokine 10,40422,-0.0779569805521805,0.00653959243541244,-0.0907745817255889,-0.0651393793787721,1.2687338759941e-32
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ESAM,Endothelial cell-selective adhesion molecule,40536,-0.0361454607441434,0.00303462603513845,-0.0420933277730148,-0.0301975937152721,1.42171398077832e-32
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,USP25,Ubiquitin carboxyl-terminal hydrolase 25,37900,-0.0834562956765389,0.00700549598366101,-0.0971870678045145,-0.0697255235485633,1.47688737261036e-32
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MTSS2,Protein MTSS 2,37900,-0.113468016529644,0.00952554689951523,-0.132138088452694,-0.0947979446065938,1.49462704511827e-32
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NUDT5,ADP-sugar pyrophosphatase,40332,-0.0601384003112974,0.00505123209118098,-0.0700388152100122,-0.0502379854125827,1.52063119261727e-32
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",37608,-0.0930163016254821,0.00781059628723115,-0.108325070348455,-0.0777075329025091,1.56133887293622e-32
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BID,BH3-interacting domain death agonist,40341,-0.0770989939717949,0.00648079986155523,-0.0898013617004431,-0.0643966262431466,1.6952123740164e-32
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PPP1R9B,Neurabin-2,40516,-0.107958264063667,0.00908416395931738,-0.125763225423929,-0.0901533027034045,1.95487629358924e-32
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PLXNA4,Plexin-A4,40341,-0.0946507675254275,0.00798703523552279,-0.110305356587052,-0.0789961784638029,2.92314684823675e-32
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LGALS3BP,Galectin-3-binding protein,38013,-0.0340906648720501,0.00287814061594828,-0.0397318204793087,-0.0284495092647915,3.30451904689527e-32
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FUOM,Fucose mutarotase,37671,-0.0717322368257888,0.0060618762043454,-0.0836135141863058,-0.0598509594652718,3.81337320679886e-32
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,40228,-0.0621194610958557,0.00525307132676099,-0.0724154808963072,-0.0518234412954041,3.94539103497984e-32
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNIP1,TNFAIP3-interacting protein 1,37942,-0.10148888651591,0.00859221315500337,-0.118329624299716,-0.0846481487321033,4.88281639358361e-32
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ERBIN,Erbin,40305,-0.117014484818617,0.00991944216765624,-0.136456591467223,-0.0975723781700108,5.53768285474534e-32
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CNST,Consortin,40359,-0.123058412745137,0.0104410510287377,-0.143522872761463,-0.102593952728811,6.25686181677559e-32
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,STAB2,Stabilin-2,37998,-0.0319150485585846,0.00270785481541774,-0.0372224439968034,-0.0266076531203659,6.59066976977849e-32
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SRPK2,SRSF protein kinase 2,40341,-0.0942645462889615,0.00800153123721753,-0.109947547513908,-0.0785815450640151,6.65420424951718e-32
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TF,Serotransferrin,38013,-0.0249791278742008,0.0021202754151404,-0.029134867687876,-0.0208233880605256,6.98852939250226e-32
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,40305,-0.0315895649034588,0.00268301886040474,-0.0368482818698521,-0.0263308479370655,7.22366943970479e-32
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FMNL1,Formin-like protein 1,39961,-0.0684006524296803,0.00580996488596728,-0.0797881836061761,-0.0570131212531844,7.34980461743757e-32
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IMMT,MICOS complex subunit MIC60,37900,-0.0507398430830263,0.00430915031828005,-0.0591857777068552,-0.0422939084591974,7.53605282025323e-32
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",40280,-0.0862548763603662,0.00733152822604749,-0.100624671683419,-0.0718850810373131,8.02990405989809e-32
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TRIM5,Tripartite motif-containing protein 5,40341,-0.0969060877180589,0.00824017925595846,-0.113056839059737,-0.0807553363763803,8.47898417518229e-32
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SUOX,"Sulfite oxidase, mitochondrial",37959,-0.070406592665683,0.00598695219808999,-0.0821410189739394,-0.0586721663574266,8.96150992679231e-32
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,40357,-0.043736289001528,0.00372353626539257,-0.0510344200816974,-0.0364381579213585,1.00240435717878e-31
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VEGFD,Vascular endothelial growth factor D,40483,0.0378656574062632,0.00322671609690759,0.0315412938563243,0.0441900209562021,1.13578188170478e-31
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,40228,-0.107327593527023,0.00916251245613019,-0.125286117941038,-0.0893690691130077,1.46393573802837e-31
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,40379,-0.0375786496014531,0.00321031555906207,-0.0438708680972147,-0.0312864311056914,1.60630554518136e-31
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MAN2B2,Epididymis-specific alpha-mannosidase,37990,-0.0677567952520375,0.00578636142201334,-0.0790980636391836,-0.0564155268648914,1.61225033596114e-31
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,P4HB,Protein disulfide-isomerase,40266,-0.0437916295808952,0.00374120020600848,-0.0511243819846718,-0.0364588771771185,1.61645499760816e-31
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,37998,0.0293854054684015,0.00251229783027487,0.0244613017210627,0.0343095092157402,1.8785230143775e-31
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TAX1BP1,Tax1-binding protein 1,37942,-0.0725846561464885,0.00621899832476061,-0.0847738928630193,-0.0603954194299577,2.52276757523754e-31
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SEL1L,Protein sel-1 homolog 1,37628,-0.036821210203706,0.00315481706200775,-0.0430046516452412,-0.0306377687621708,2.5439517126511e-31
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLA2,Src-like-adapter 2,37959,-0.116601726792604,0.0100034693506178,-0.136208526719815,-0.0969949268653935,3.01316892784604e-31
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD27,CD27 antigen,40411,-0.0459126257506224,0.00394153923000424,-0.0536380426414308,-0.0381872088598141,3.12778069801048e-31
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PAK4,Serine/threonine-protein kinase PAK 4,39961,-0.0690572141694535,0.00592965871355916,-0.0806793452480295,-0.0574350830908776,3.24082996061704e-31
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CEP43,Centrosomal protein 43,39934,-0.0777640596651265,0.00668620518703739,-0.0908690218317198,-0.0646590974985332,3.88459418261886e-31
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VPS53,Vacuolar protein sorting-associated protein 53 homolog,40305,-0.0855921443673038,0.00737298046299057,-0.100043186074765,-0.0711411026598423,4.95849182031018e-31
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SDCCAG8,Serologically defined colon cancer antigen 8,37900,-0.12853512008577,0.0110690521595648,-0.150230462318517,-0.106839777853023,5.02853916274457e-31
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPARCL1,SPARC-like protein 1,40346,0.0310900616275694,0.0026800263093043,0.025837210061333,0.0363429131938058,5.45128483244737e-31
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PLEKHO1,Pleckstrin homology domain-containing family O member 1,37942,-0.0775627522320237,0.00668680586081,-0.0906688917192113,-0.0644566127448361,5.82165694312898e-31
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CSPG4,Chondroitin sulfate proteoglycan 4,37998,0.0370435107375059,0.00320041012111992,0.0307707069001109,0.0433163145749009,7.73957136012206e-31
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HEPH,Hephaestin,37990,-0.0281650816576157,0.00243359783987152,-0.0329349334237639,-0.0233952298914675,7.84732427732965e-31
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPINT2,Kunitz-type protease inhibitor 2,40422,-0.047039088602113,0.00406621904291568,-0.0550088779262278,-0.0390692992779983,7.91969324371683e-31
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,37990,0.037097509859401,0.00320578764413646,0.0308141660768936,0.0433808536419085,7.97433495879223e-31
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BCR,Breakpoint cluster region protein,40341,-0.101898976395553,0.00880998989185755,-0.119166556583594,-0.084631396207512,8.11305714407486e-31
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,APP,Amyloid-beta precursor protein,40309,-0.0750244128602739,0.00648741281711928,-0.0877397419818277,-0.0623090837387201,8.27743274434439e-31
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDH2,Cadherin-2,40359,-0.0394649762882536,0.00341469773916039,-0.0461577838570079,-0.0327721687194992,8.98998418516351e-31
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD99L2,CD99 antigen-like protein 2,40332,-0.0265831564554694,0.00230268031048142,-0.031096409864013,-0.0220699030469258,1.04432529838246e-30
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,JAM3,Junctional adhesion molecule C,37671,-0.056834726922149,0.00492230824311988,-0.0664824510786639,-0.047187002765634,1.08084892764686e-30
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FOXO1,Forkhead box protein O1,40341,-0.094331066386116,0.00818802381790299,-0.110379593069206,-0.0782825397030261,1.37400037799113e-30
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,40228,-0.0502186524733523,0.00436027994901787,-0.0587648011734273,-0.0416725037732773,1.43026785997406e-30
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FGR,Tyrosine-protein kinase Fgr,39961,-0.0617424299066252,0.00536201466243739,-0.0722519786450025,-0.0512328811682479,1.47941329947055e-30
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HSPB6,Heat shock protein beta-6,40489,-0.0406424631727031,0.00353141057337726,-0.0475640278965225,-0.0337208984488836,1.56917354766014e-30
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EHBP1,EH domain-binding protein 1,37990,-0.0833092655389723,0.00723888894149746,-0.0974974878643074,-0.0691210432136373,1.65591578659268e-30
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PENK,Proenkephalin-A,37671,-0.0345019439609062,0.00299907972522928,-0.0403801402223556,-0.0286237476994568,1.7552538045178e-30
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,37671,-0.0654293523890904,0.00569400279724466,-0.07658959787169,-0.0542691069064909,2.04338578246451e-30
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,37671,-0.0321180605946453,0.00279714112364732,-0.037600457196994,-0.0266356639922965,2.25148356183645e-30
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ARHGEF12,Rho guanine nucleotide exchange factor 12,40341,-0.11504717238906,0.0100324648885508,-0.13471080357062,-0.0953835412075005,2.52905314292096e-30
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BAG4,BAG family molecular chaperone regulator 4,37598,-0.0540891766701006,0.00471632086286026,-0.0633331655613068,-0.0448451877788945,2.6461042113795e-30
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LDLRAP1,Low density lipoprotein receptor adapter protein 1,37959,-0.106209273563816,0.00929389409581163,-0.124425305991607,-0.0879932411360253,4.17329507513323e-30
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DNMBP,Dynamin-binding protein,40228,-0.0680914820210188,0.00596522096622267,-0.0797833151148153,-0.0563996489272224,4.63098588010311e-30
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADH1B,All-trans-retinol dehydrogenase,37671,-0.0819777055588783,0.007181910080932,-0.096054249317505,-0.0679011618002516,4.89447201645171e-30
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDGFB,Platelet-derived growth factor subunit B,40422,-0.0947128335093099,0.00830297968545904,-0.11098667369281,-0.0784389933258102,5.03695836245839e-30
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,40042,-0.0540624624772996,0.00474112586419693,-0.0633550691711256,-0.0447698557834736,5.31923407819405e-30
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HDGFL2,Hepatoma-derived growth factor-related protein 2,37942,-0.0689488923578368,0.00604648138710653,-0.0807999958765656,-0.057097788839108,5.53236822321812e-30
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCL21,C-C motif chemokine 21,40422,-0.0468061507981891,0.00412271853137989,-0.0548866791196937,-0.0387256224766845,9.29507726257872e-30
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DAG1,Dystroglycan,40422,-0.0520517367282319,0.00458634672947816,-0.0610409763180091,-0.0430624971384547,9.72050181335406e-30
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,COMMD1,COMM domain-containing protein 1,37628,-0.0678668064176553,0.00597756056337088,-0.0795828251218622,-0.0561507877134483,9.78283888915489e-30
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SHISA5,Protein shisa-5,37998,-0.0273948028710152,0.00241321706951123,-0.0321247083272572,-0.0226648974147732,9.87744721560304e-30
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD274,Programmed cell death 1 ligand 1,40228,-0.0381742110835605,0.00336654846223651,-0.0447726460695441,-0.031575776097577,1.09235750295084e-29
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OTUD7B,OTU domain-containing protein 7B,37959,-0.0695259464603048,0.00613267334566224,-0.0815459862178028,-0.0575059067028068,1.17180891025576e-29
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GCC1,GRIP and coiled-coil domain-containing protein 1,37942,-0.117937846656253,0.0104069025258491,-0.138335375606917,-0.0975403177055884,1.23092575048187e-29
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,37900,-0.0424110826548208,0.00374274698477212,-0.0497468667449742,-0.0350752985646675,1.24777365825988e-29
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,REG4,Regenerating islet-derived protein 4,40379,-0.0533294651034885,0.00471964686453197,-0.0625799729579712,-0.0440789572490059,1.70971599425538e-29
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD36,Platelet glycoprotein 4,37598,-0.0486329997630642,0.00430223887695508,-0.0570653879618962,-0.0402006115642323,1.71287823692595e-29
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CTSF,Cathepsin F,40411,-0.0437566378971071,0.00387616038977897,-0.0513539122610738,-0.0361593635331403,1.93057787474242e-29
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HCLS1,Hematopoietic lineage cell-specific protein,40516,-0.0611282981537108,0.00541673916651985,-0.0717451069200897,-0.0505114893873319,2.00685488198315e-29
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VEGFC,Vascular endothelial growth factor C,40411,-0.0608586224463547,0.00540501223733654,-0.0714524464315344,-0.0502647984611751,2.67673584133615e-29
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,37900,-0.0520731695506649,0.00462473993328526,-0.061137659819904,-0.0430086792814258,2.80509587291615e-29
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,40192,-0.121658781749479,0.0108088497951476,-0.142844127347969,-0.10047343615099,2.81572674570017e-29
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,STK11,Serine/threonine-protein kinase STK11,40042,-0.0795093370069137,0.00707244015295086,-0.0933713197066974,-0.06564735430713,3.27960592456812e-29
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPINK4,Serine protease inhibitor Kazal-type 4,40341,-0.0710898565690365,0.00633229568669077,-0.0835011561149504,-0.0586785570231226,3.88808840762655e-29
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FEN1,Flap endonuclease 1,39980,-0.0673969352536888,0.00600810530495405,-0.0791728216513987,-0.0556210488559788,4.32077480684136e-29
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RASSF2,Ras association domain-containing protein 2,39980,-0.0597303429941108,0.00532905817882835,-0.0701752970246143,-0.0492853889636072,4.79258838429673e-29
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,40403,0.0482081668489625,0.00430205341817625,0.0397761421493371,0.056640191548588,4.89952465679575e-29
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ATG16L1,Autophagy-related protein 16-1,37901,-0.0918989205469814,0.00821014168640858,-0.107990798252342,-0.0758070428416206,5.90147742685428e-29
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,37562,-0.0610427355237775,0.00545542215594526,-0.0717353629494302,-0.0503501080981248,6.2161410642325e-29
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MFAP5,Microfibrillar-associated protein 5,40536,-0.0444376974889283,0.00397756447094717,-0.0522337238519847,-0.0366416711258718,7.13411064142787e-29
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GRPEL1,"GrpE protein homolog 1, mitochondrial",40305,-0.0648830656616185,0.00581497183505845,-0.076280410458333,-0.0534857208649039,8.38525269815671e-29
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,COCH,Cochlin,37990,-0.0504545926305167,0.0045259591027097,-0.0593254724718277,-0.0415837127892057,9.78718563709139e-29
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DCTN2,Dynactin subunit 2,40305,-0.101587042725694,0.00911819203504052,-0.119458699114373,-0.0837153863370142,1.01121324229553e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KLK14,Kallikrein-14,40489,0.049582177013896,0.0044520973787558,0.0408560661515346,0.0583082878762574,1.05816766828677e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PNLIPRP1,Inactive pancreatic lipase-related protein 1,37942,-0.0824848607765691,0.00740516891027187,-0.096998991840702,-0.0679707297124363,1.0829425940084e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KAZN,Kazrin,37901,-0.112105653280031,0.0100696574937707,-0.131842181967821,-0.0923691245922402,1.15619763084654e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MEGF10,Multiple epidermal growth factor-like domains protein 10,40357,0.0412327273732419,0.00370875617387227,0.0339635652724522,0.0485018894740315,1.31204411244983e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,WASHC3,WASH complex subunit 3,37942,-0.0808206366954232,0.00727440104328413,-0.0950784627402601,-0.0665628106505863,1.48707645498896e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TALDO1,Transaldolase,37966,-0.048018905182516,0.00432606460627493,-0.0564979918108149,-0.0395398185542171,1.66762808699502e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LGALS8,Galectin-8,40471,-0.064736690711852,0.00584839399050878,-0.0761995429332492,-0.0532738384904548,2.24431773673547e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RNF41,E3 ubiquitin-protein ligase NRDP1,39980,-0.0717638329485971,0.00648672661554246,-0.0844778171150603,-0.0590498487821339,2.41524429674163e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",37959,-0.0825157265804452,0.0074653703250565,-0.0971478524175559,-0.0678836007433345,2.79848587470337e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RAB27B,Ras-related protein Rab-27B,37990,-0.0879456700966834,0.00796024523244592,-0.103547750752277,-0.0723435894410894,2.95613834757235e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EPO,Erythropoietin,40341,-0.0838113247683469,0.00758969048439729,-0.0986871181177655,-0.0689355314189282,3.00959257867963e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EIF4B,Eukaryotic translation initiation factor 4B,40228,-0.0633284550507076,0.00573615717155282,-0.0745713231069512,-0.0520855869944641,3.10121480707792e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IQGAP2,Ras GTPase-activating-like protein IQGAP2,40305,-0.0581569421315772,0.00528346149971097,-0.0685125266710107,-0.0478013575921437,4.45095234592707e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IGFBP6,Insulin-like growth factor-binding protein 6,40291,-0.0309871476035988,0.00281531682634833,-0.0365051685832415,-0.0254691266239561,4.48766136228405e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PPBP,Platelet basic protein,37934,-0.0897822211945048,0.00815555813078067,-0.105767115130835,-0.0737973272581746,4.56808484361659e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,40411,-0.101482616916685,0.00922665623949302,-0.119566863146091,-0.0833983706872783,4.88028623088552e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DOK2,Docking protein 2,40359,-0.128581012466751,0.0116907203162567,-0.151494824286614,-0.105667200646888,4.89998375753578e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NCK2,Cytoplasmic protein NCK2,40422,-0.11133650806376,0.0101246090697803,-0.131180741840529,-0.0914922742869902,5.00062156103983e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,STAT5B,Signal transducer and activator of transcription 5B,40305,-0.146632445626241,0.0133430180778195,-0.172784761058767,-0.120480130193715,5.42025127765514e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,L1CAM,Neural cell adhesion molecule L1,40411,0.0301399062465545,0.00274335908228038,0.0247629224452849,0.0355168900478241,5.59058711983294e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,QDPR,Dihydropteridine reductase,40290,-0.0465563777054099,0.00424151969646726,-0.0548697563104857,-0.038242999100334,6.26136013092538e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,40332,-0.0386342175038042,0.00351983663878155,-0.0455330973158161,-0.0317353376917924,6.27159618979674e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RABEP1,Rab GTPase-binding effector protein 1,37671,-0.0842361622581761,0.00767499091627643,-0.0992791444540779,-0.0691931800622743,6.62127033288345e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLSTN2,Calsyntenin-2,40516,0.04142525322853,0.00378575273706673,0.0340051778638792,0.0488453285931808,9.05506356153798e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BGN,Biglycan,39956,0.128902036426356,0.0117842596890454,0.105804887435827,0.151999185416885,9.52862162149448e-28
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD302,CD302 antigen,40305,-0.0318947425589914,0.00291833780100344,-0.0376146846489582,-0.0261748004690247,1.05085354380102e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PLSCR3,Phospholipid scramblase 3,37919,-0.0634920333242168,0.00581043661508707,-0.0748804890897875,-0.0521035775586462,1.11602573977647e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NSFL1C,NSFL1 cofactor p47,40471,-0.0704706461864845,0.00645559246331674,-0.0831236074145853,-0.0578176849583837,1.20665341056075e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RBPMS2,RNA-binding protein with multiple splicing 2,37628,-0.10897101357819,0.00998547338903068,-0.12854254142069,-0.0893994857356895,1.31195934647722e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ANGPT1,Angiopoietin-1,40263,-0.0898046473781577,0.00823533102577559,-0.105945896188678,-0.0736633985676376,1.3708427462747e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DCXR,L-xylulose reductase,40411,-0.0551241122576196,0.00506023232067526,-0.0650421676061431,-0.0452060569090961,1.54588706425918e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RBKS,Ribokinase,39991,-0.0524952345107498,0.00482049692142858,-0.0619434084767498,-0.0430470605447498,1.61722241921385e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SHMT1,"Serine hydroxymethyltransferase, cytosolic",40396,-0.0921088494050483,0.00846176450603591,-0.108693907836879,-0.0755237909732179,1.69246560819605e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLITRK1,SLIT and NTRK-like protein 1,37598,0.0340790269023239,0.0031329284999829,0.0279384870423574,0.0402195667622904,1.92719127500927e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,S100A14,Protein S100-A14,37959,-0.0568782940022187,0.00522922919092664,-0.0671275832164349,-0.0466290047880024,1.92800766388617e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GOLGA3,Golgin subfamily A member 3,37959,-0.0825072249844604,0.00760790516890217,-0.0974187191155087,-0.0675957308534122,2.73070150761729e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFSF10,Tumor necrosis factor ligand superfamily member 10,40516,0.0271927361453218,0.00251019466276545,0.0222727546063015,0.0321127176843421,2.98592332498767e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PSMG3,Proteasome assembly chaperone 3,40341,-0.0537665606013331,0.00496616496536514,-0.0635002439334487,-0.0440328772692174,3.20609900165706e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDGFA,Platelet-derived growth factor subunit A,40536,-0.0753795132443287,0.00697053104661679,-0.0890417540956976,-0.0617172723929598,3.66322080527348e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDLIM7,PDZ and LIM domain protein 7,40422,-0.130964962014608,0.0121133851741916,-0.154707196956024,-0.107222727073193,3.76687948307973e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PLIN1,Perilipin-1,39961,-0.03712330074946,0.00343917664499987,-0.0438640869736597,-0.0303825145252602,4.57335513305341e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DTNB,Dystrobrevin beta,37878,-0.0436985590126076,0.00404878649386427,-0.0516341805405816,-0.0357629374846336,4.79600881005054e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TREH,Trehalase,37998,-0.0779254153503991,0.00722145279387371,-0.0920794628263916,-0.0637713678744067,4.89907301424498e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RFC4,Replication factor C subunit 4,37900,-0.0214674324924504,0.00199266287995861,-0.0253730517371693,-0.0175618132477315,5.93244176558983e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DGKA,Diacylglycerol kinase alpha,37598,-0.0567604795106502,0.00526922307732816,-0.0670881567422134,-0.0464328022790871,6.04192588910277e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AAMDC,Mth938 domain-containing protein,37628,-0.0561438103836812,0.00521329337694418,-0.0663618654024918,-0.0459257553648707,6.21797274440464e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ICAM4,Intercellular adhesion molecule 4,40341,0.0548915286227057,0.00511696653004566,0.0448622742238162,0.0649207830215952,9.35167091966311e-27
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NFX1,Transcriptional repressor NF-X1,37562,-0.0706318931438579,0.00658723533115027,-0.0835428743929124,-0.0577209118948033,1.02951157841579e-26
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ASAH2,Neutral ceramidase,40228,-0.054456084941407,0.00509032092926361,-0.0644331139627636,-0.0444790559200503,1.28367575052537e-26
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADGRD1,Adhesion G-protein coupled receptor D1,37671,-0.0379476017150344,0.00355257597899632,-0.0449106506338672,-0.0309845527962016,1.5902302472801e-26
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AP3B1,AP-3 complex subunit beta-1,37901,-0.0791092194978384,0.00741050106952271,-0.0936338015941029,-0.0645846374015739,1.69603937019816e-26
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SUGP1,SURP and G-patch domain-containing protein 1,37901,-0.0410283479205067,0.00384512231539752,-0.0485647876586858,-0.0334919081823276,1.79005094055344e-26
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,APOA1,Apolipoprotein A-I,38013,0.0286270340786099,0.00268375454619435,0.023366875168069,0.0338871929891509,1.85339966442666e-26
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ULBP2,UL16-binding protein 2,40228,-0.0384802462375085,0.00361475311142875,-0.0455651623359088,-0.0313953301391081,2.25290238994413e-26
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,40332,-0.0272795978820857,0.00256688568436372,-0.0323106938234386,-0.0222485019407329,2.72032894171062e-26
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD207,C-type lectin domain family 4 member K,40029,-0.0395745575105775,0.00372444441893199,-0.0468744685716842,-0.0322746464494708,2.78627581750243e-26
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,40305,-0.0455135908094102,0.00428712531917333,-0.0539163564349899,-0.0371108251838304,3.06449628289915e-26
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,COL4A1,Collagen alpha-1(IV) chain,40359,0.0407353689522695,0.00384122580391909,0.0332065663765881,0.0482641715279509,3.46268392971134e-26
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",37990,-0.0762538615759266,0.00719006800179777,-0.0903463948594502,-0.062161328292403,3.56114732733735e-26
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AHSG,Alpha-2-HS-glycoprotein,37987,-0.0278706067090798,0.00263164633692702,-0.0330286335294567,-0.0227125798887028,4.17014273941477e-26
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,METAP2,Methionine aminopeptidase 2,40453,-0.0602745837459233,0.00569606016541678,-0.0714388616701401,-0.0491103058217064,4.4137972573011e-26
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SERPINB8,Serpin B8,40516,-0.0559458937978639,0.0052872001228229,-0.0663088060385967,-0.045582981557131,4.42999756607269e-26
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RAB6A,Ras-related protein Rab-6A,40341,0.0489761397473443,0.00463076053915088,0.0398998490906086,0.05805243040408,4.68719927708024e-26
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SYTL4,Synaptotagmin-like protein 4,37990,-0.0751472455995838,0.00710923090949493,-0.0890813381821939,-0.0612131530169737,5.16318128639584e-26
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,37628,-0.0796168213578012,0.00753409791007998,-0.094383653261558,-0.0648499894540444,5.35482641225827e-26
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DFFA,DNA fragmentation factor subunit alpha,40516,-0.0694375194580442,0.00657977237937196,-0.0823338733216132,-0.0565411655944751,5.97144233288752e-26
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,WIF1,Wnt inhibitory factor 1,40489,0.0349625021315823,0.00331791977715912,0.0284593793683504,0.0414656248948142,7.05136850354773e-26
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PON1,Serum paraoxonase/arylesterase 1,37987,0.0265600812397779,0.00252080992308007,0.021619293790541,0.0315008686890148,7.3974477280533e-26
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TMSB10,Thymosin beta-10,40332,-0.0774291373033268,0.00735546634163656,-0.0918458513329345,-0.0630124232737192,7.91174555198992e-26
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,37959,-0.0483997864396475,0.00459987776820812,-0.0574155468653354,-0.0393840260139596,8.60950011316197e-26
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MYDGF,Myeloid-derived growth factor,37990,-0.102465194543007,0.0097475151777546,-0.121570324291406,-0.0833600647946075,9.56427742436271e-26
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,37628,0.0209492437708609,0.00199397691414567,0.0170410490191354,0.0248574385225864,1.02150966499846e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NIT1,Deaminated glutathione amidase,37628,-0.0506385470801016,0.00482065057588983,-0.0600870222088457,-0.0411900719513575,1.04055141632356e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LETM1,Mitochondrial proton/calcium exchanger protein,37959,-0.0530472282044719,0.00505447032135787,-0.0629539900343334,-0.0431404663746105,1.1419688828345e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,40422,-0.105237124699991,0.0100381352550382,-0.124911869799866,-0.0855623796001161,1.24289362515047e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",40332,-0.0464983737841801,0.00443561090562764,-0.0551921711592103,-0.0378045764091499,1.25425066597219e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLMAP,Sarcolemmal membrane-associated protein,37901,-0.0846559931624727,0.00808193575291115,-0.100496587238179,-0.0688153990867668,1.4158333724502e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ERBB3,Receptor tyrosine-protein kinase erbB-3,40311,-0.0192434280443829,0.00183770701386559,-0.0228453337915594,-0.0156415222972063,1.41608133027334e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HLA_E,,40341,-0.0292432224519563,0.00279420949956096,-0.0347198730710958,-0.0237665718328168,1.5040995221277e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OGA,Protein O-GlcNAcase,37901,-0.0713268490518619,0.00681548920578221,-0.084685207895195,-0.0579684902085288,1.56096950426006e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FCN2,Ficolin-2,40291,-0.0416681418591894,0.00398335847373431,-0.0494755244677086,-0.0338607592506701,1.58760195595184e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,COL1A1,Collagen alpha-1(I) chain,40536,0.0263321719977438,0.00252248323484034,0.0213881048574568,0.0312762391380309,1.98414680443889e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CFHR4,Complement factor H-related protein 4,37973,0.0746653062565668,0.00715049444488397,0.0606503371445942,0.0886802753685394,1.99216168455946e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TRIM40,E3 ubiquitin ligase TRIM40,37572,-0.0729065993731149,0.0069972891744726,-0.0866212861550812,-0.0591919125911486,2.5423489156643e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,B2M,Beta-2-microglobulin,38013,-0.0321649762386567,0.00308817021183582,-0.0382177898538549,-0.0261121626234585,2.62349282014166e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GLO1,Lactoylglutathione lyase,40042,-0.0598507740021234,0.00575003414413849,-0.0711208409246349,-0.048580707079612,2.73667103083904e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CTSS,Cathepsin S,37057,-0.0248998595730079,0.00239433815233142,-0.0295927623515775,-0.0202069567944383,3.1531754969957e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPOCK1,Testican-1,40228,0.0253551646990211,0.00244000515813201,0.0205727545890824,0.0301375748089598,3.27110982368492e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HPSE,Heparanase,37848,-0.0936602506030899,0.00901618952081774,-0.111331982063893,-0.0759885191422872,3.50404024274671e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NBN,Nibrin,40044,-0.0512329745223618,0.00494244968096488,-0.0609201758970529,-0.0415457731476706,4.27548559263209e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CXCL5,C-X-C motif chemokine 5,40309,-0.115222875559644,0.0111222525983007,-0.137022490652314,-0.0934232604669748,4.54738892717761e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,39939,-0.0580917301097972,0.00560765095424705,-0.0690827259801214,-0.0471007342394729,4.58164078329512e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",37901,-0.103691281185275,0.0100156851329872,-0.12332202404593,-0.0840605383246195,5.04128312940107e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BRAP,BRCA1-associated protein,37778,-0.109990660797634,0.0106267371447861,-0.130819065601415,-0.0891622559938537,5.18493564156606e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GIGYF2,GRB10-interacting GYF protein 2,37959,-0.0761055538904696,0.00736077937082368,-0.090532681457284,-0.0616784263236552,5.7959544540259e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RNASE1,Ribonuclease pancreatic,37987,-0.0243080877105031,0.00235208167317877,-0.0289181677899335,-0.0196980076310727,6.07723706964247e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADD1,Alpha-adducin,37671,-0.0705819608131307,0.00683005928990705,-0.0839688770213485,-0.0571950446049128,6.15216287419967e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,WFDC2,WAP four-disulfide core domain protein 2,39535,-0.0381071830469091,0.00369338529059164,-0.0453462182164687,-0.0308681478773495,7.09187227758684e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MDK,Midkine,40352,-0.0505724010289076,0.00490972879173298,-0.0601954694607043,-0.040949332597111,8.39265483940792e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PON2,Serum paraoxonase/arylesterase 2,40042,-0.0343253458452725,0.00333616231505668,-0.0408642239827836,-0.0277864677077614,9.49121407833856e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CRIM1,Cysteine-rich motor neuron 1 protein,40422,0.0205722533770444,0.00199981547296627,0.0166526150500305,0.0244918917040583,9.62700974069411e-25
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SERPINE2,Glia-derived nexin,37990,-0.0640966090344348,0.00623676966100152,-0.0763206775699978,-0.0518725404988719,1.10002113848075e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDC42BPB,Serine/threonine-protein kinase MRCK beta,37901,-0.102326679196014,0.00996110366942527,-0.121850442388087,-0.0828029160039401,1.15478560847197e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,40228,-0.0775928360177794,0.00755704727672349,-0.0924046486801575,-0.0627810233554014,1.17904922957787e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,STIP1,Stress-induced-phosphoprotein 1,40307,-0.0650189759354074,0.00634632584495143,-0.0774577745915122,-0.0525801772793026,1.48433063603571e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,37391,-0.0349424533250019,0.00340998291127538,-0.0416260198311017,-0.0282588868189022,1.51327567761625e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ANGPTL2,Angiopoietin-related protein 2,40377,-0.0395982300910029,0.00386760386533992,-0.0471787336670692,-0.0320177265149367,1.5887823672283e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,37628,0.0361335629869584,0.00353397986259714,0.029206962456268,0.0430601635176488,1.89838251093902e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PALM2,Paralemmin-2,37942,-0.0366841711260921,0.00358926274266273,-0.043719126101711,-0.0296492161504731,1.96972104514261e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPARC,SPARC,40411,-0.070025921035414,0.0068580737028643,-0.083467745493028,-0.0565840965778,2.11012167739962e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NOTCH2,Neurogenic locus notch homolog protein 2,37998,0.0210069608375884,0.00205741468796241,0.0169744280491821,0.0250394936259947,2.18375289385629e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RETN,Resistin,40283,-0.0410175539035273,0.0040213803635004,-0.0488994594159881,-0.0331356483910665,2.3614136917655e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AOC3,Membrane primary amine oxidase,40403,0.0300745978494932,0.00295449353254095,0.024283790525713,0.0358654051732735,2.91082483092137e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,B4GALT1,"Beta-1,4-galactosyltransferase 1",40422,-0.0270660699643176,0.00266020866166867,-0.0322800789411882,-0.021852060987447,3.0581619026385e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DAB2,Disabled homolog 2,40489,-0.108549066591306,0.0106716162582811,-0.129465434457537,-0.0876326987250749,3.14011323251217e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CTRB1,Chymotrypsinogen B,40332,-0.0524627511370264,0.00516111152446119,-0.0625785297249703,-0.0423469725490825,3.36932949478289e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AZI2,5-azacytidine-induced protein 2,37959,-0.0544039710352615,0.00535154698026711,-0.064893003116585,-0.043914938953938,3.43554844795077e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,STAMBP,STAM-binding protein,40192,-0.0636655997580094,0.00626516894688941,-0.0759453308939127,-0.0513858686221062,3.48549802443568e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NCF2,Neutrophil cytosol factor 2,40324,-0.0818658905044795,0.00806169863434899,-0.0976668198278035,-0.0660649611811555,3.73459363603392e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LYN,Tyrosine-protein kinase Lyn,40305,-0.0826168183089211,0.00813685616900945,-0.0985650564001796,-0.0666685802176626,3.79325995983501e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCGB3A2,Secretoglobin family 3A member 2,40396,0.0835089134814246,0.00822981800004485,0.0673784702013367,0.0996393567615125,4.04031074444138e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PGLYRP1,Peptidoglycan recognition protein 1,40451,-0.0420725053254037,0.00415147661139016,-0.0502093994837284,-0.033935611167079,4.59801391325672e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CHAD,Chondroadherin,37671,0.0530895016492135,0.00523834099413873,0.0428223533007015,0.0633566499977254,4.74031730563151e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CA6,Carbonic anhydrase 6,40295,0.0626597878646557,0.00618796725692911,0.0505313720410746,0.0747882036882367,5.00969151684196e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,40359,-0.0628588413527952,0.00620962717626052,-0.0750297106182658,-0.0506879720873246,5.17511662052823e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AGT,Angiotensinogen,37987,-0.0238816926904427,0.00235874600087049,-0.0285048348521488,-0.0192585505287365,5.22485283644877e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SIGLEC7,Sialic acid-binding Ig-like lectin 7,40359,-0.0273492290012198,0.00270288001787202,-0.032646873836249,-0.0220515841661907,5.40348832308406e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TXNDC5,Thioredoxin domain-containing protein 5,40471,-0.0656935882400423,0.00649319459455217,-0.0784202496453645,-0.05296692683472,5.46624366766449e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCL11,Eotaxin,40516,-0.0368913436328229,0.00364863256993945,-0.0440426634699042,-0.0297400237957416,5.82397102911797e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SNRPB2,U2 small nuclear ribonucleoprotein B'',37942,-0.0388013991758699,0.00383909281100945,-0.0463260210854484,-0.0312767772662914,6.26342191872767e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCN4,CCN family member 4,40489,-0.0400491067612871,0.00396592153562612,-0.0478223129711143,-0.03227590055146,6.62566687572639e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LCN2,Neutrophil gelatinase-associated lipocalin,39865,-0.0370569547959168,0.00367011346609424,-0.0442503771894616,-0.0298635324023721,6.76225116569874e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GORASP2,Golgi reassembly-stacking protein 2,37901,-0.0459044382769694,0.00455003546364434,-0.0548225077857123,-0.0369863687682265,7.52749997234497e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ABCA2,ATP-binding cassette sub-family A member 2,37562,-0.03627655812854,0.00359695277601044,-0.0433265855695205,-0.0292265306875596,7.83388610576233e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CALB2,Calretinin,39961,-0.0308167593362079,0.00305856971228462,-0.0368115559722858,-0.0248219627001301,8.38846643178462e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NIT2,Omega-amidase NIT2,37936,-0.073935287684858,0.00734141190298991,-0.0883244550147182,-0.0595461203549978,9.00740177222453e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,POF1B,Protein POF1B,37598,-0.0454626429195096,0.00451430381641671,-0.0543106783996863,-0.0366146074393328,9.06965360744859e-24
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,39980,-0.0433547972326599,0.00431459844620273,-0.0518114101872173,-0.0348981842781025,1.10307339186996e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CXCL11,C-X-C motif chemokine 11,40471,-0.0773632179382181,0.0077028400941859,-0.0924607845228225,-0.0622656513536137,1.15339433149558e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PACS2,Phosphofurin acidic cluster sorting protein 2,37562,-0.0604914462534906,0.00602143556415824,-0.0722934599592408,-0.0486894325477405,1.16490178966559e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TMPRSS5,Transmembrane protease serine 5,40159,0.0368016470483097,0.00366815674648653,0.0296120598251961,0.0439912342714233,1.28913723786845e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPINK6,Serine protease inhibitor Kazal-type 6,40489,-0.0524980064411843,0.00523385157121641,-0.0627563555207685,-0.0422396573616001,1.31441926576366e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DDT,D-dopachrome decarboxylase,37998,-0.0398157279036082,0.00397142974099616,-0.0475997301959607,-0.0320317256112557,1.4223370825223e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCARF1,Scavenger receptor class F member 1,40536,-0.0411519090071554,0.00410962018627791,-0.0492067645722601,-0.0330970534420507,1.55748208957167e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FARSA,Phenylalanine--tRNA ligase alpha subunit,37572,-0.0664268823242601,0.00663503992679671,-0.0794315605807816,-0.0534222040677385,1.64723527229139e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,40042,-0.0557094363913633,0.005571629601094,-0.0666298304095075,-0.044789042373219,1.81580789368875e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CPPED1,Serine/threonine-protein phosphatase CPPED1,40471,-0.0638716855111097,0.00639031418945718,-0.0763967013224457,-0.0513466696997736,1.87615085309748e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,WASF1,Wiskott-Aldrich syndrome protein family member 1,40042,-0.0892753437830213,0.00894146457182307,-0.106800614343795,-0.0717500732222481,2.09672933709828e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FGFBP3,Fibroblast growth factor-binding protein 3,37942,0.0356481624328874,0.00357405921566391,0.0286430063701861,0.0426533184955886,2.3828807315373e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CEBPB,CCAAT/enhancer-binding protein beta,40042,-0.0365930810375552,0.00367225892326489,-0.0437907085271544,-0.0293954535479561,2.55340922285381e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LRRN1,Leucine-rich repeat neuronal protein 1,40044,0.0372829050957907,0.0037436015575408,0.0299454460430107,0.0446203641485706,2.70125547790892e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCL22,C-C motif chemokine 22,40204,-0.0497028723357406,0.00499230822801998,-0.0594877964626598,-0.0399179482088215,2.78481029205677e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VCAN,Versican core protein,40471,0.0290263291327699,0.00291569743145211,0.0233115621671238,0.034741096098416,2.79692820211286e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SKAP2,Src kinase-associated phosphoprotein 2,40422,-0.100790389129856,0.0101261462865029,-0.120637635851401,-0.0809431424083098,2.84656226846564e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MOCS2,Molybdopterin synthase catalytic subunit,37671,-0.0648672891147064,0.00654612011952369,-0.0776976845489729,-0.05203689368044,4.56560816543021e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CTSE,Cathepsin E,37671,-0.0497293822448507,0.00502018428273664,-0.0595689434390146,-0.0398898210506869,4.72171827060993e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NT5C1A,Cytosolic 5'-nucleotidase 1A,37942,-0.0306365034111296,0.00309331937621889,-0.0366994093885187,-0.0245735974337406,4.78920345779217e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PQBP1,Polyglutamine-binding protein 1,39980,-0.0529116470677462,0.00535314248165038,-0.063403806331781,-0.0424194878037115,5.69718492515746e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RABGAP1L,Rab GTPase-activating protein 1-like,40044,-0.0576181611412803,0.00583802332742091,-0.0690606868630253,-0.0461756354195354,6.59058843916937e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PSAP,Prosaposin,37901,-0.0272516338590546,0.00276085989127882,-0.032662919245961,-0.0218403484721481,6.6717012431468e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TP53I3,Quinone oxidoreductase PIG3,37419,-0.051512656796079,0.00522262220504033,-0.0617489963179581,-0.0412763172742,7.22147965894062e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD69,Early activation antigen CD69,40288,-0.0839674387934182,0.0085205719627398,-0.100667759840388,-0.0672671177464482,7.61199024518654e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SAMD9L,Sterile alpha motif domain-containing protein 9-like,40341,-0.0688328512072826,0.00698566174133738,-0.0825247482203038,-0.0551409541942613,7.70086277753434e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FKBPL,FK506-binding protein-like,37901,-0.056422682174021,0.00572585619205556,-0.0676453603104499,-0.0452000040375921,7.86897481656685e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PF4,Platelet factor 4,37934,-0.0930888916520563,0.00945977230384169,-0.111630045367586,-0.0745477379365266,8.98879630123859e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NPDC1,Neural proliferation differentiation and control protein 1,40359,-0.0295709702931942,0.00300761078810668,-0.0354658874378833,-0.0236760531485051,9.51287842443022e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD34,Hematopoietic progenitor cell antigen CD34,40408,0.0231103412989366,0.00235121367814746,0.0185019624897676,0.0277187201081056,9.78806789778032e-23
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SH2B3,SH2B adapter protein 3,39980,-0.0930468191382009,0.00946922874996191,-0.111606507488126,-0.0744871307882755,1.0111504242473e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TADA3,Transcriptional adapter 3,37900,-0.0371267143164865,0.00377855761532145,-0.0445326872425165,-0.0297207413904564,1.04130270183488e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GFRA1,GDNF family receptor alpha-1,40453,-0.0264583472421641,0.00269638266506568,-0.0317432572656929,-0.0211734372186354,1.15215433381043e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KCTD5,BTB/POZ domain-containing protein KCTD5,37716,-0.0401743822314069,0.00410549429555839,-0.0482211510507014,-0.0321276134121125,1.54867780253481e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ANG,Angiogenin,40309,-0.0327321418997489,0.00334677391571882,-0.0392918187745578,-0.02617246502494,1.58560172581782e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HSPA1A,Heat shock 70 kDa protein 1A,40400,-0.0675205744578767,0.00691560774374033,-0.0810751656356078,-0.0539659832801457,1.86643269771186e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CMIP,C-Maf-inducing protein,37900,-0.0778117234250948,0.0079691310807299,-0.0934312203433254,-0.0621922265068642,1.905227679103e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ROBO2,Roundabout homolog 2,40471,0.0220414754145374,0.00225820157937037,0.0176154003189714,0.0264675505101033,1.91852831930695e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",37959,-0.0751153932469418,0.00769922642831752,-0.0902058770464441,-0.0600249094474394,2.05722811262396e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RAPGEF2,Rap guanine nucleotide exchange factor 2,37714,-0.0500177173289771,0.00512659095210992,-0.0600658355951125,-0.0399695990628416,2.05763640726148e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,40502,-0.0358616737328746,0.0036820912848571,-0.0430785726511945,-0.0286447748145546,2.35930157669488e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,37990,-0.0610279740231239,0.00627109185454902,-0.07331931405804,-0.0487366339882079,2.61529213039511e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,STAT2,Signal transducer and activator of transcription 2,37598,-0.0725131719937265,0.00745751301322622,-0.0871298974996499,-0.0578964464878031,2.84536277303006e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ATP6AP2,Renin receptor,39980,-0.039261000728186,0.00404564767829953,-0.0471904701776531,-0.0313315312787189,3.33569121635453e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AKT1S1,Proline-rich AKT1 substrate 1,39961,-0.0636018972640181,0.00655841813687518,-0.0764563968122935,-0.0507473977157428,3.56319109505644e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MITD1,MIT domain-containing protein 1,40228,-0.0907907568494855,0.00936604477950635,-0.109148204617318,-0.0724333090816531,3.70082763003199e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HAVCR2,Hepatitis A virus cellular receptor 2,40332,-0.0323675867502351,0.00334009136541902,-0.0389141658264564,-0.0258210076740138,3.80615232623367e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,37901,-0.0611967822996092,0.00631494323508939,-0.0735740710403844,-0.048819493558834,3.8980411608585e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,37959,-0.0618140582206292,0.00638000982782263,-0.0743188774831616,-0.0493092389580969,3.9748486115655e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,37959,0.0251337318966927,0.00259511882727808,0.0200472989952276,0.0302201647981577,4.12067303266802e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IDS,Iduronate 2-sulfatase,40516,0.00812553094925316,0.000839249271659187,0.00648060237680115,0.00977045952170517,4.13673700648145e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD58,Lymphocyte function-associated antigen 3,40335,0.0166033875614221,0.0017179995067957,0.0132361085281025,0.0199706665947416,4.91278776841748e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SEC31A,Protein transport protein Sec31A,37628,-0.0717125690631361,0.00743910274267787,-0.0862932104387848,-0.0571319276874875,6.40421861263638e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ESYT2,Extended synaptotagmin-2,37942,-0.0763264097201784,0.00792285069296323,-0.0918551970783863,-0.0607976223619705,6.77664091454398e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DEFA1_DEFA1B,Neutrophil defensin 1,40009,-0.0483492075182295,0.00502116822601717,-0.0581906972412232,-0.0385077177952358,6.93650712927983e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MYOC,Myocilin,40332,0.0427367227351721,0.00445020375339288,0.0340143233785221,0.0514591220918222,8.87120613772767e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SFRP4,Secreted frizzled-related protein 4,37671,-0.0391064724438582,0.00407455300757403,-0.0470925963387033,-0.0311203485490131,9.62081014764779e-22
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VASN,Vasorin,40116,0.0255658270199238,0.00266729556600708,0.0203379277105499,0.0307937263292977,1.06120269593783e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VSIG2,V-set and immunoglobulin domain-containing protein 2,37900,-0.0534829767244371,0.00557868552434522,-0.0644172003521537,-0.0425487530967205,1.06366154631231e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDGFC,Platelet-derived growth factor C,39980,-0.0275986741997875,0.002880530388647,-0.0332445137615357,-0.0219528346380394,1.10223698848523e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NADK,NAD kinase,40359,-0.0497724257653416,0.00519531427498605,-0.0599552417443142,-0.0395896097863689,1.10771539830095e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ALPI,Intestinal-type alkaline phosphatase,37598,-0.113173695523396,0.0118101975366063,-0.136321682695144,-0.0900257083516476,1.11276178169756e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,37901,-0.101311800364616,0.0105731350229083,-0.122035145009517,-0.0805884557197162,1.11627364930762e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NBL1,Neuroblastoma suppressor of tumorigenicity 1,40411,-0.0245902605061244,0.00257151457870163,-0.0296304290803796,-0.0195500919318692,1.31265349918197e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VPS28,Vacuolar protein sorting-associated protein 28 homolog,37714,-0.061849635353156,0.00646602966185597,-0.0745230534903937,-0.0491762172159183,1.31330878359131e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CRKL,Crk-like protein,40374,-0.0987043196710619,0.0103335586729567,-0.118958094670057,-0.0784505446720668,1.45568920413466e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CASP10,Caspase-10,39961,-0.0665348891969559,0.00696800111190424,-0.0801921713762882,-0.0528776070176236,1.50623362489448e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HS1BP3,HCLS1-binding protein 3,37628,-0.0830009954238866,0.00869563729066478,-0.10004444451359,-0.0659575463341836,1.59555326309886e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SBSN,Suprabasin,37977,0.031141747902034,0.00326468919971544,0.0247429570705917,0.0375405387334762,1.6857290344035e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AGXT,Serine--pyruvate aminotransferase,40359,-0.0710901463542542,0.00745529679872522,-0.0857025280797556,-0.0564777646287528,1.70224807158375e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SIRPB1,Signal-regulatory protein beta-1,40335,-0.0415830678485148,0.00436259405018991,-0.0501337521868871,-0.0330323835101426,1.76558687122583e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PILRA,Paired immunoglobulin-like type 2 receptor alpha,40332,-0.0389005277986811,0.00408557681297482,-0.0469082583521118,-0.0308927972452505,1.94865363472141e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,USO1,General vesicular transport factor p115,40305,-0.0836705914456217,0.00879021850388619,-0.100899419713239,-0.0664417631780048,2.00252169020751e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DNM3,Dynamin-3,37959,-0.0507440764350692,0.00533093083916744,-0.0611927008798374,-0.040295451990301,2.04476756239116e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GDF2,Growth/differentiation factor 2,40359,0.0329093732278312,0.00346735143177962,0.0261133644215431,0.0397053820341192,2.6002818239012e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,C3,Complement C3,37360,-0.0435942214961761,0.00459196773470301,-0.052594478256194,-0.0345939647361582,2.61977238001054e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD200,OX-2 membrane glycoprotein,40341,0.023898567363499,0.00252407987944801,0.0189513707997809,0.0288457639272171,3.23744644799151e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ARHGEF1,Rho guanine nucleotide exchange factor 1,37942,-0.0837118235860166,0.00884081031092994,-0.101039811795439,-0.066383835376594,3.2943337912396e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MBL2,Mannose-binding protein C,37810,0.0983964786910788,0.0103948074521206,0.0780226560849225,0.118770301297235,3.39048768770154e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HYAL1,Hyaluronidase-1,40214,-0.0211290974257598,0.00223302695329508,-0.0255058302542182,-0.0167523645973015,3.43580566610123e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DLK1,Protein delta homolog 1,40536,-0.0486850345182227,0.00514554221831386,-0.0587702972661179,-0.0385997717703276,3.44306365192225e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL15,Interleukin-15,40341,-0.0300976742327145,0.00318177931051189,-0.0363339616813178,-0.0238613867841112,3.5216542214601e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD6,T-cell differentiation antigen CD6,40502,-0.0486977530478508,0.00515142544887334,-0.0587945469276426,-0.0386009591680591,3.72808516250332e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PLXNB2,Plexin-B2,40472,-0.0213853183751028,0.0022626305419186,-0.0258200742372632,-0.0169505625129423,3.79073307949516e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PHACTR2,Phosphatase and actin regulator 2,37959,-0.104741860146608,0.0110793007267748,-0.126457289571087,-0.0830264307221298,3.79688826051401e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DDHD2,Phospholipase DDHD2,37959,-0.0607804032314979,0.00643198722336705,-0.0733870981892973,-0.0481737082736984,3.94850307455172e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GAS6,Growth arrest-specific protein 6,40429,0.0235546253233516,0.00249412813177109,0.0186661341850803,0.0284431164616229,4.07190618778263e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GOLM2,Protein GOLM2,40471,-0.0205320906146213,0.00217488839210065,-0.0247948718631386,-0.0162693093661041,4.20830427862452e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",40044,-0.0531128587771023,0.00563216119866904,-0.0641518947264936,-0.042073822827711,4.65380683816289e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DYNLT1,Dynein light chain Tctex-type 1,37572,-0.0744136365800919,0.00788985539956483,-0.089877753163239,-0.0589495199969449,4.71053503417638e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,40228,-0.0639633903883367,0.00678429959579789,-0.0772606175961006,-0.0506661631805729,4.7416466463787e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,37598,-0.0411049336345049,0.00435918116571592,-0.0496489287193081,-0.0325609385497017,4.80147286425146e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MMP9,Matrix metalloproteinase-9,40312,-0.0559185288185887,0.00593379145485452,-0.0675487600701035,-0.0442882975670738,4.9404913648086e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CPXM1,Probable carboxypeptidase X1,40411,-0.0627357841086983,0.00666438984476726,-0.0757979882044421,-0.0496735800129545,5.43524981191662e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD79B,B-cell antigen receptor complex-associated protein beta chain,40516,-0.040338316165047,0.00428539134376827,-0.0487376831988328,-0.0319389491312612,5.46171960689866e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LZTFL1,Leucine zipper transcription factor-like protein 1,37671,-0.065268270516723,0.00693414878089208,-0.0788592021272715,-0.0516773389061745,5.63044510740041e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MPHOSPH8,M-phase phosphoprotein 8,40042,-0.0682610400681221,0.00725635529287608,-0.0824834964421592,-0.054038583694085,5.79778434510685e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PPP1R2,Protein phosphatase inhibitor 2,40359,-0.0723193615646189,0.00768950393726204,-0.0873907892816525,-0.0572479338475853,5.90045994972738e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GMPR2,GMP reductase 2,37671,-0.0620865084720603,0.00660230344158169,-0.0750270232175605,-0.0491459937265602,6.11985160907585e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,C19orf12,Protein C19orf12,39961,-0.0567020940442792,0.00603483252784582,-0.068530365798857,-0.0448738222897014,6.45358535054812e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,39980,-0.0713985070766489,0.00759947979779603,-0.0862934874803292,-0.0565035266729687,6.49041344448781e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NME3,Nucleoside diphosphate kinase 3,40379,0.0218694217554024,0.00232803489992008,0.0173064733515591,0.0264323701592458,6.54614648270154e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TRIM24,Transcription intermediary factor 1-alpha,37687,-0.0587438648180024,0.00625586400832423,-0.0710053582743179,-0.0464823713616869,6.95392577516338e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CETN2,Centrin-2,39961,-0.061232624185136,0.00652372163829772,-0.0740191185961995,-0.0484461297740724,7.06941026823844e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EGFL7,Epidermal growth factor-like protein 7,39980,-0.0367305932917767,0.00391708176673039,-0.0444080735545683,-0.0290531130289851,7.70320857080966e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD8A,T-cell surface glycoprotein CD8 alpha chain,40471,-0.0439381591659645,0.00468848683971228,-0.0531275933718006,-0.0347487249601285,8.08398841285378e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FLT4,Vascular endothelial growth factor receptor 3,40411,-0.0301874090401761,0.00322389852504124,-0.0365062501492569,-0.0238685679310953,8.70976108323634e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,40489,-0.0283213384887523,0.0030247125713433,-0.0342497751285852,-0.0223929018489194,8.7307997123191e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,C1RL,Complement C1r subcomponent-like protein,37993,-0.0176732011183555,0.00188739231127706,-0.0213724900484585,-0.0139739121882524,8.88643742409601e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ELN,Elastin,37990,-0.0319726640721651,0.00341573259074313,-0.0386674999500217,-0.0252778281943086,9.1761684696601e-21
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IMPACT,Protein IMPACT,37942,-0.0515645998259665,0.00552754396937758,-0.0623985860059465,-0.0407306136459864,1.23689077575468e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,40305,0.0180010131802625,0.00193192041620117,0.0142144491645082,0.0217875771960168,1.34229126211143e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDH5,Cadherin-5,40536,0.0274396757290376,0.00295085680679999,0.0216559963877096,0.0332233550703656,1.59777656995229e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ATG4A,Cysteine protease ATG4A,39980,-0.0537113523743519,0.00577637406120197,-0.0650330455343078,-0.0423896592143961,1.61100173081065e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FAS,Tumor necrosis factor receptor superfamily member 6,40490,-0.0288735735333289,0.0031094181222379,-0.0349680330529152,-0.0227791140137427,1.80549760523906e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SORT1,Sortilin,40330,-0.0327034620743983,0.00352290021859831,-0.039608346502851,-0.0257985776459456,1.85444061772377e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,F12,Coagulation factor XII,38013,-0.0377543393374216,0.00406664295544468,-0.0457249595300932,-0.02978371914475,1.87835509144814e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AKR7L,Aflatoxin B1 aldehyde reductase member 4,37598,-0.0632333010225037,0.0068136698277101,-0.0765880938848155,-0.0498785081601919,1.95010537103968e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD226,CD226 antigen,37598,-0.0377699925833862,0.00407013112089333,-0.0457474495803371,-0.0297925355864352,1.96033934347625e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GPI,Glucose-6-phosphate isomerase,37987,-0.0421835101354573,0.00455837193259967,-0.0511179191233527,-0.033249101147562,2.48079838810634e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD72,B-cell differentiation antigen CD72,37671,-0.0381340948322308,0.00412646926834202,-0.0462219745981812,-0.0300462150662804,2.80170689129976e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PEBP1,Phosphatidylethanolamine-binding protein 1,40332,-0.0523583805526737,0.00567236350046716,-0.0634762130135893,-0.0412405480917581,3.0285003620432e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SNX15,Sorting nexin-15,37671,-0.0487138260529882,0.00527765905329014,-0.0590580377974369,-0.0383696143085395,3.10695439776722e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDA,Cytidine deaminase,37970,-0.0411213368865275,0.00445879830081076,-0.0498605815561166,-0.0323820922169384,3.32605434036959e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PCBP2,Poly(rC)-binding protein 2,37959,-0.0642472066234979,0.00697686164267378,-0.0779218554431386,-0.0505725578038573,3.78368662547203e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EPPK1,Epiplakin,37628,-0.0658506520502253,0.00715843390967456,-0.0798811825131874,-0.0518201215872632,4.14838536419768e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,40341,-0.0895953380787455,0.00974379791196019,-0.108693181986187,-0.0704974941713035,4.20131166169787e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCT5,T-complex protein 1 subunit epsilon,39980,-0.0405630485760878,0.00441130838496282,-0.0492092130106149,-0.0319168841415607,4.20752423333631e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MARS1,"Methionine--tRNA ligase, cytoplasmic",37642,-0.0764749936537941,0.00832370348099661,-0.0927894524765474,-0.0601605348310408,4.60915908318942e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLIP2,CAP-Gly domain-containing linker protein 2,40341,-0.0994867094036922,0.0108322195380562,-0.120717859698282,-0.0782555591091021,4.64176627884806e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NUB1,NEDD8 ultimate buster 1,40341,-0.0743251756858218,0.00809539485730542,-0.0901921496061405,-0.0584582017655032,4.77953637004513e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DNAJB14,DnaJ homolog subfamily B member 14,37901,-0.05733375563193,0.00624595438723334,-0.0695758262309074,-0.0450916850329527,4.96189475884755e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ANGPTL4,Angiopoietin-related protein 4,40396,0.0406506083096135,0.00443197700305074,0.031963933383634,0.0493372832355929,5.19415346844247e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCL2,C-C motif chemokine 2,40203,-0.0470502583318817,0.00513249480627635,-0.0571099481521834,-0.0369905685115801,5.44612125907912e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,39980,-0.0583377662242089,0.00636511060821586,-0.070813383016312,-0.0458621494321058,5.55107430177505e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BMPER,BMP-binding endothelial regulator protein,37671,-0.0200573709188063,0.0021892267908349,-0.0243482554288427,-0.0157664864087699,5.84368012448103e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HNMT,Histamine N-methyltransferase,40147,-0.0412051460024683,0.00450068903764313,-0.0500264965162488,-0.0323837954886877,6.07639560117086e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TCTN3,Tectonic-3,37990,-0.0259743181106724,0.00283679230334063,-0.03153443102522,-0.0204142051961248,6.13466541054016e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,WDR46,WD repeat-containing protein 46,37900,-0.0315674821044877,0.00345751515800465,-0.0383442118141768,-0.0247907523947986,7.80661844938448e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ATXN3,Ataxin-3,37942,-0.0552940462252159,0.0060572672547666,-0.0671662900445585,-0.0434218024058734,7.91598687200305e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ASPSCR1,Tether containing UBX domain for GLUT4,37959,-0.0605894236471638,0.00664083538408414,-0.0736054609999687,-0.0475733862943589,8.26967841325515e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,STX8,Syntaxin-8,40341,-0.0431995257262062,0.00473766136387918,-0.0524853419994094,-0.033913709453003,8.52513961209038e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DNAJB6,DnaJ homolog subfamily B member 6,37557,-0.0749839270003452,0.00822544578830683,-0.0911058007454265,-0.0588620532552638,8.90790784417479e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EVI5,Ecotropic viral integration site 5 protein homolog,37598,-0.0795214368232935,0.00872527894171289,-0.0966229835490508,-0.0624198900975363,9.08381733528461e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MAVS,Mitochondrial antiviral-signaling protein,39980,-0.0819826566537079,0.00899848335812176,-0.0996196840356266,-0.0643456292717893,9.16447238065577e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NAGK,N-acetyl-D-glucosamine kinase,37608,-0.0501813407986263,0.00550714146554586,-0.0609753380710962,-0.0393873435261565,9.23942073726981e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCL4,C-C motif chemokine 4,40376,-0.0597665981422,0.00656331781520534,-0.0726307010600024,-0.0469024952243975,9.52922091881366e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDCP1,CUB domain-containing protein 1,40228,-0.0428791253657691,0.00471004863348118,-0.0521108206873922,-0.033647430044146,9.7513493992142e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCL17,C-C motif chemokine 17,40333,-0.0799394835797504,0.00878359906249583,-0.0971553377422423,-0.0627236294172586,9.99377033060983e-20
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,37671,-0.0188300875584494,0.00206862768555006,-0.0228845978221276,-0.0147755772947713,1.00592761325385e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,REG1B,Lithostathine-1-beta,40536,-0.0493943948615587,0.00543094441671012,-0.0600390459183106,-0.0387497438048069,1.05438919452193e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TIMP3,Metalloproteinase inhibitor 3,40422,-0.116402677032222,0.0128027729837017,-0.141496112080277,-0.0913092419841666,1.08460482688966e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,REEP4,Receptor expression-enhancing protein 4,37959,-0.0549273346533242,0.00604261898895602,-0.066770867871678,-0.0430838014349704,1.12675332734497e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD83,CD83 antigen,40341,-0.029632082451369,0.003262435595709,-0.0360264562189586,-0.0232377086837793,1.1802648097818e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GIT1,ARF GTPase-activating protein GIT1,37598,-0.086220898724937,0.00949295151515349,-0.104827083694638,-0.0676147137552362,1.20943921066993e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,C4BPB,C4b-binding protein beta chain,40411,0.036324820113671,0.00400153921562852,0.0284818032510391,0.0441678369763029,1.23597541935258e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KLRD1,Natural killer cells antigen CD94,40516,-0.040162371415712,0.00442539578318034,-0.0488361471507454,-0.0314885956806785,1.26111971264716e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ANPEP,Aminopeptidase N,40370,0.0249572682413265,0.00275037036040812,0.0195665423349266,0.0303479941477264,1.27723568903867e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FAM13A,Protein FAM13A,37901,-0.0593580491105717,0.00654490825539506,-0.0721860692911461,-0.0465300289299974,1.36120006242417e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NXPH3,Neurexophilin-3,37598,0.0267390815175706,0.00295018223794242,0.0209567243312035,0.0325214387039377,1.43950980574904e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCL13,C-C motif chemokine 13,40483,-0.0611217456358267,0.0067598137277584,-0.0743709805422331,-0.0478725107294202,1.71217067266799e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SNCA,Alpha-synuclein,37671,-0.100243977892681,0.0110859404132539,-0.121972421102659,-0.078515534682703,1.74302774144739e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,COLEC12,Collectin-12,40357,-0.022421764824309,0.00248251426352675,-0.0272874927808215,-0.0175560368677966,1.8776845208168e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ANKRD54,Ankyrin repeat domain-containing protein 54,39980,-0.0506827802481115,0.00561358356049777,-0.0616854040266872,-0.0396801564695359,1.93954002882161e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TBCC,Tubulin-specific chaperone C,40228,-0.071092303564456,0.00787883331600034,-0.0865348168638167,-0.0556497902650954,2.03350479279047e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCL25,C-C motif chemokine 25,40516,-0.0427232285871453,0.00474228105855717,-0.0520180994619173,-0.0334283577123732,2.30882922826947e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNR,Tenascin-R,40228,0.0371103239646356,0.00412060042585653,0.0290339471299568,0.0451867007993144,2.37608896081522e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BIRC2,Baculoviral IAP repeat-containing protein 2,39980,-0.0553490095427722,0.00614958435160668,-0.0674021948719213,-0.0432958242136231,2.50406332333312e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CST7,Cystatin-F,40376,-0.0803718147611335,0.00893401078129405,-0.0978824758924699,-0.0628611536297972,2.59623462943547e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EGF,Pro-epidermal growth factor,40324,-0.0897587978342468,0.0099780729563824,-0.109315820828756,-0.0702017748397373,2.61029097324392e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,39980,-0.0537788298787933,0.00597886125696724,-0.0654973979424491,-0.0420602618151375,2.63482643040321e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OMG,Oligodendrocyte-myelin glycoprotein,40305,0.0549433681650182,0.00611477048943788,0.04295841800572,0.0669283183243164,2.86451289313265e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NPTX1,Neuronal pentraxin-1,40332,0.0344063438816558,0.00383057962274781,0.0268984078210701,0.0419142799422415,2.95165134291029e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ZBTB17,Zinc finger and BTB domain-containing protein 17,40042,-0.0355679446953682,0.00396137769004789,-0.0433322449678621,-0.0278036444228744,3.04805554215638e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RWDD1,RWD domain-containing protein 1,40471,-0.0560403814973418,0.00624441824294836,-0.0682794412535206,-0.0438013217411631,3.15715657454444e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DBI,Acyl-CoA-binding protein,40270,-0.0685094772370305,0.00765469226641917,-0.0835126740792121,-0.053506280394849,3.94286417575375e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,STX4,Syntaxin-4,40305,-0.0518336133929696,0.00579780451192473,-0.063197310236342,-0.0404699165495971,4.3051719920592e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,39980,-0.0742520092996736,0.00830831876738954,-0.0905363140837571,-0.0579677045155901,4.43835365249863e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DPEP1,Dipeptidase 1,40192,0.0439063589272922,0.00493229941615617,0.0342390520716261,0.0535736657829583,6.0840755929631e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DPP6,Dipeptidyl aminopeptidase-like protein 6,40305,0.0283681446413596,0.00318753176299258,0.0221205823858941,0.034615706896825,6.19421550978001e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FOXJ3,Forkhead box protein J3,37598,-0.0377467997159582,0.00424396949839765,-0.0460649799328176,-0.0294286194990988,6.64322472186952e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RRAS,Ras-related protein R-Ras,37572,-0.112916928264392,0.0127011974241396,-0.137811275215705,-0.0880225813130778,6.88460664435017e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IRAK4,Interleukin-1 receptor-associated kinase 4,40341,-0.0900884996795968,0.0101396967123402,-0.109962305235784,-0.07021469412341,7.08261674694932e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CASC3,Protein CASC3,37572,-0.0354484818297976,0.00399171402507078,-0.0432722413189363,-0.0276247223406588,7.51120768727086e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VAMP8,Vesicle-associated membrane protein 8,37598,-0.0764766141910698,0.00861427088983617,-0.0933605851351486,-0.0595926432469909,7.68721727934396e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL18BP,Interleukin-18-binding protein,40403,-0.0263176282925736,0.00296522452215525,-0.0321294683559979,-0.0205057882291493,7.69462961812723e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MIF,Macrophage migration inhibitory factor,40307,-0.0593219385729313,0.00668541155209654,-0.0724253452150405,-0.0462185319308221,7.84402214125627e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,YWHAQ,14-3-3 protein theta,37671,-0.0636409608427402,0.0071860272656472,-0.0777255742834087,-0.0495563474020716,9.3226089564776e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,40396,-0.0658167482794512,0.00743884165396879,-0.08039687792123,-0.0512366186376724,9.85479231091317e-19
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EFNA1,Ephrin-A1,40303,-0.0234384008541685,0.00265043725551256,-0.0286332578749731,-0.0182435438333639,1.02633969621322e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RAB33A,Ras-related protein Rab-33A,37562,-0.0573271473006424,0.00648254839297836,-0.07003294215088,-0.0446213524504048,1.04684840675233e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ANXA2,Annexin A2,37441,-0.0616050496145053,0.00697342918098815,-0.0752729708092421,-0.0479371284197686,1.13586045485282e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ICA1,Islet cell autoantigen 1,40044,-0.0679551887748312,0.00769670799926038,-0.0830407364533816,-0.0528696410962809,1.16546277724865e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,F2R,Proteinase-activated receptor 1,40396,-0.049259674646882,0.00557940593018569,-0.0601953102700459,-0.038324039023718,1.16586656813285e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ING1,Inhibitor of growth protein 1,39925,-0.0382656686087562,0.00433601820545553,-0.0467642642914491,-0.0297670729260634,1.20915714237343e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KDR,Vascular endothelial growth factor receptor 2,40411,-0.0216087555490215,0.00244903226763679,-0.0264088587935896,-0.0168086523044534,1.22368944393062e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL1R2,Interleukin-1 receptor type 2,40330,-0.0167224947447464,0.00189559266109553,-0.0204378563604936,-0.0130071331289991,1.24192999744005e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PAGR1,PAXIP1-associated glutamate-rich protein 1,37628,-0.0382867792960255,0.00434055637036987,-0.0467942697819504,-0.0297792888101006,1.27898723543479e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTPRB,Receptor-type tyrosine-protein phosphatase beta,37990,-0.0248684892058961,0.00282199071886712,-0.0303995910148757,-0.0193373873969166,1.37266387051078e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTP4A3,Protein tyrosine phosphatase type IVA 3,37598,-0.0454440627193184,0.00516130102664104,-0.0555602127315348,-0.0353279127071019,1.47363128813348e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RILP,Rab-interacting lysosomal protein,40434,-0.0513313693057299,0.00583684418338158,-0.0627715839051578,-0.039891154706302,1.58294095911913e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PCYT2,Ethanolamine-phosphate cytidylyltransferase,37901,-0.0658329648388056,0.00748578057539729,-0.0805050947665843,-0.0511608349110269,1.61115669777952e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GLOD4,Glyoxalase domain-containing protein 4,40328,-0.0309744767188931,0.00352724286187341,-0.0378878727281649,-0.0240610807096212,1.77520390414746e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,37959,-0.0919105025821984,0.0104744293010334,-0.112440384012224,-0.0713806211521728,1.91609243653834e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PPCDC,Phosphopantothenoylcysteine decarboxylase,40471,-0.0401252163253004,0.00457573023220236,-0.049093647580417,-0.0311567850701838,1.97854872314799e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",37901,-0.125527756278851,0.014328290405749,-0.153611205474119,-0.0974443070835826,2.16764722858146e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DBNL,Drebrin-like protein,40422,-0.0783552734465256,0.00895842251442904,-0.0959137815748065,-0.0607967653182447,2.41587538712545e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DKK3,Dickkopf-related protein 3,40536,0.0250275804303321,0.00286187973939382,0.0194182961411202,0.030636864719544,2.44411972847289e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IFNLR1,Interferon lambda receptor 1,40341,-0.0317421567514863,0.00362972474474493,-0.0388564172511863,-0.0246278962517862,2.44896343843207e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LRRC59,Leucine-rich repeat-containing protein 59,37990,-0.039965411863258,0.00456978711954013,-0.0489221946175567,-0.0310086291089594,2.47789813802748e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCL14,C-C motif chemokine 14,40309,-0.0331204075100723,0.00379029520168074,-0.0405493861053665,-0.025691428914778,2.60171323438015e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ZFYVE19,Abscission/NoCut checkpoint regulator,37901,-0.0772224423531151,0.00883632695231789,-0.0945416431796582,-0.059903241526572,2.62279845895344e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LAMP3,Lysosome-associated membrane glycoprotein 3,40502,-0.0431242924327135,0.00493747086820542,-0.0528017353343961,-0.0334468495310309,2.69498258991206e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PROC,Vitamin K-dependent protein C,40372,-0.0214122793614553,0.0024521934045482,-0.0262185784343697,-0.0166059802885408,2.74968153153391e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RAB11FIP3,Rab11 family-interacting protein 3,37990,-0.0908710040872761,0.0104050167502987,-0.111264836917862,-0.0704771712566906,2.75854418088273e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ATOX1,Copper transport protein ATOX1,40411,-0.0607113703997347,0.00695462321197848,-0.0743424318952126,-0.0470803089042569,2.80394768625456e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AHNAK,Neuroblast differentiation-associated protein AHNAK,37628,-0.0265491756379219,0.00304426890654449,-0.0325159426947491,-0.0205824085810947,3.08401217807144e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CHMP1A,Charged multivesicular body protein 1a,40228,-0.0671741455594097,0.00770627393329164,-0.0822784424686613,-0.0520698486501581,3.14215143111891e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,XIAP,E3 ubiquitin-protein ligase XIAP,37598,-0.0486014498663243,0.00559023094307173,-0.0595583025147449,-0.0376445972179038,3.91017552774008e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADA,Adenosine deaminase,40516,-0.0286875343191857,0.00330079479063995,-0.03515709210884,-0.0222179765295314,3.93087286209146e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SYAP1,Synapse-associated protein 1,37671,-0.0478295370372282,0.00550281075192021,-0.0586150461109918,-0.0370440279634646,3.98236342567921e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SIRT2,NAD-dependent protein deacetylase sirtuin-2,40305,-0.0754417979583607,0.00868436793422162,-0.0924631591094351,-0.0584204368072864,4.07663834996842e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PSG1,Pregnancy-specific beta-1-glycoprotein 1,40228,0.0984423987782601,0.0113414921482411,0.0762130741677076,0.120671723388813,4.34510296949421e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,37671,-0.0710330619162339,0.00818325377897188,-0.0870722393230188,-0.054993884509449,4.40547693529006e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PKD2,Polycystin-2,37562,-0.0502656280432736,0.00579183553716577,-0.0616176256961185,-0.0389136303904287,4.47125185933222e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PLG,Plasminogen,37705,-0.0189660016657894,0.00218546643116404,-0.0232495158708709,-0.0146824874607079,4.4841102211026e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",37671,-0.087749803378804,0.0101147710458256,-0.107574754628622,-0.0679248521289858,4.5976057936623e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AP2B1,AP-2 complex subunit beta,37572,-0.0413193666765214,0.00476587729368288,-0.0506604861721398,-0.031978247180903,4.83111511177483e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,37900,-0.02959354760105,0.00341352783482797,-0.0362840621573129,-0.0229030330447872,4.8326931059648e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,UROD,Uroporphyrinogen decarboxylase,37671,-0.059259403321465,0.00685449772434799,-0.0726942188611871,-0.045824587781743,5.97713248581901e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LARP1,La-related protein 1,37900,-0.0532792109827584,0.0061683446718259,-0.0653691665395372,-0.0411892554259797,6.38592628473622e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TRIM21,E3 ubiquitin-protein ligase TRIM21,40341,-0.0670694891142972,0.00777063928936175,-0.0822999421214462,-0.0518390361071482,6.6421292843132e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ZHX2,Zinc fingers and homeoboxes protein 2,37942,-0.0252519553643739,0.00293226911247086,-0.0309992028248168,-0.019504707903931,7.98652860952924e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GTPBP2,GTP-binding protein 2,37572,-0.0669958278804648,0.00777989937804551,-0.082244430661434,-0.0517472250994956,8.03398738556577e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CETN3,Centrin-3,37901,-0.064257296345201,0.00746223862443134,-0.0788832840490864,-0.0496313086413155,8.04128219774358e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LPP,Lipoma-preferred partner,37562,-0.0561724751912073,0.0065251491464623,-0.0689617675182734,-0.0433831828641411,8.23136054795392e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EPHA2,Ephrin type-A receptor 2,39759,-0.0257835797269831,0.00299752666744648,-0.0316587319951782,-0.019908427458788,8.61325124536763e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KYAT1,Kynurenine--oxoglutarate transaminase 1,40340,-0.0472680671794705,0.00549607795799805,-0.0580403799771467,-0.0364957543817943,8.68124898162714e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,40044,-0.0456163524196063,0.00530967894081929,-0.0560233231436121,-0.0352093816956005,9.4141037552771e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SUSD1,Sushi domain-containing protein 1,40042,-0.0411026817661164,0.00478447626498693,-0.0504802552454908,-0.0317251082867421,9.44093373083095e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SMOC2,SPARC-related modular calcium-binding protein 2,40422,-0.031942780660138,0.00372010169119564,-0.0392341799748815,-0.0246513813453946,9.77914158384272e-18
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,COMP,Cartilage oligomeric matrix protein,40198,0.0282392816030491,0.00329059113139927,0.0217897229855065,0.0346888402205916,1.01985422431355e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,40450,-0.0252709560648018,0.00294621605850178,-0.0310455395394653,-0.0194963725901383,1.05795272122918e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,40228,-0.0245137253874286,0.00285888635592527,-0.0301171426450422,-0.0189103081298151,1.08573530505492e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GMPR,GMP reductase 1,40516,-0.0424466545856396,0.00495210205131566,-0.0521527746062183,-0.0327405345650609,1.11377173203776e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,40411,0.0372205277994463,0.00435247955757599,0.0286896678665974,0.0457513877322952,1.32304223376235e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PZP,Pregnancy zone protein,38013,-0.0543323494806597,0.0063531747271337,-0.0667845719458418,-0.0418801270154777,1.33821129593017e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLC27A4,Long-chain fatty acid transport protein 4,39961,-0.055234156073332,0.006461521586361,-0.0678987383825996,-0.0425695737640644,1.36582849588079e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IGBP1,Immunoglobulin-binding protein 1,37959,-0.050873590843808,0.00595614912751475,-0.0625476431337369,-0.0391995385538791,1.46729712799969e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ARHGEF10,Rho guanine nucleotide exchange factor 10,37959,-0.076962775683468,0.00902831993287473,-0.0946582827519024,-0.0592672686150335,1.69481929847943e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TFF1,Trefoil factor 1,40261,-0.0642444317747588,0.00754999481704382,-0.0790424216161647,-0.0494464419333529,1.90657491177033e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,40403,-0.0342115183815953,0.00402083698754446,-0.0420923588771825,-0.0263306778860082,1.91572737878246e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MZB1,Marginal zone B- and B1-cell-specific protein,40405,-0.0421450441862169,0.00495759623770148,-0.0518619328121118,-0.032428155560322,2.04219831626343e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLEC6A,C-type lectin domain family 6 member A,39980,-0.0386319985161929,0.00454989867746746,-0.0475497999240291,-0.0297141971083566,2.23705907134959e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HARS1,"Histidine--tRNA ligase, cytoplasmic",40332,-0.0637186891905247,0.00751356583066509,-0.0784452782186283,-0.0489921001624212,2.43767137759883e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ATRN,"Attractin, Isoform 2",38013,-0.0135051739759481,0.00159279308305045,-0.016627048418727,-0.0103832995331693,2.50577928365254e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DKK4,Dickkopf-related protein 4,40203,-0.0374859558344389,0.00442373808232442,-0.0461564824757947,-0.028815429193083,2.58247063714266e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TWF2,Twinfilin-2,37998,-0.0681934862882816,0.00804835868510177,-0.083968269311081,-0.0524187032654821,2.6369345195396e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,37959,-0.0692006825343971,0.00817671454860686,-0.0852270430496666,-0.0531743220191277,2.86854261765698e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OPTC,Opticin,40305,0.0370090249376051,0.00438052667015833,0.0284231926640947,0.0455948572111154,3.20301147175188e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,39976,-0.0639000226954267,0.00756548133246396,-0.0787283661070561,-0.0490716792837974,3.27136115227309e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PHLDB1,Pleckstrin homology-like domain family B member 1,37901,-0.0435967281542415,0.00516525060978279,-0.0537206193494158,-0.0334728369590672,3.48370304472577e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ITPA,Inosine triphosphate pyrophosphatase,37562,-0.0557422497011087,0.00660605550738026,-0.068690118495574,-0.0427943809066433,3.56250225385941e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,37990,-0.0328661543472963,0.00389709216939538,-0.0405044549993112,-0.0252278536952813,3.69144389370288e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SRPX,Sushi repeat-containing protein SRPX,37990,0.0268267364787332,0.00318240657583211,0.0205892195901022,0.0330642533673641,3.81284977355374e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCARF2,Scavenger receptor class F member 2,40471,0.0243146196306786,0.00288517833905937,0.0186596700861222,0.029969569175235,3.83052091548917e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ECHS1,"Enoyl-CoA hydratase, mitochondrial",37628,-0.0800312234896952,0.00949858750866329,-0.0986484550066753,-0.0614139919727152,3.95867212618689e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MNDA,Myeloid cell nuclear differentiation antigen,40333,-0.0793301577167857,0.00941857897582876,-0.0977905725094101,-0.0608697429241613,3.98922736079035e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,APOBR,Apolipoprotein B receptor,37628,0.0347585414825783,0.00413026728064252,0.0266632176125189,0.0428538653526376,4.31037718158503e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BPIFA2,BPI fold-containing family A member 2,37150,0.0910132765911078,0.0108151506471569,0.0698155813226802,0.112210971859535,4.33414728676098e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FOXO3,Forkhead box protein O3,39980,-0.0791440786361845,0.00941348676284913,-0.0975945126913688,-0.0606936445810002,4.54765279704207e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ABRAXAS2,BRISC complex subunit Abraxas 2,37562,-0.0548403079156438,0.00652197397421228,-0.0676233769050999,-0.0420572389261877,4.57716947812323e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MDH1,"Malate dehydrogenase, cytoplasmic",37928,-0.0333458697776826,0.0039661562091586,-0.0411195359476334,-0.0255722036077317,4.60164585511877e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NTRK2,BDNF/NT-3 growth factors receptor,40359,0.0210436096001599,0.00250401059927253,0.0161357488255858,0.0259514703747341,4.67785367782012e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BTN2A1,Butyrophilin subfamily 2 member A1,40422,-0.0210701150559973,0.00251103128419558,-0.0259917363730207,-0.016148493738974,5.2185195577816e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CMC1,COX assembly mitochondrial protein homolog,37990,-0.0733774260294479,0.00875243059465919,-0.0905321899949799,-0.0562226620639159,5.63332973283559e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BIN2,Bridging integrator 2,40332,-0.0737356319236646,0.00880268216957553,-0.0909888889760326,-0.0564823748712965,5.90367878861485e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NID2,Nidogen-2,40332,-0.0599658772068803,0.00716193684806546,-0.0740032734290886,-0.045928480984672,6.08808273971229e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,37990,-0.0503125795347957,0.00600924956520036,-0.0620907086825885,-0.038534450387003,6.18939354825769e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CGA,Glycoprotein hormones alpha chain,40332,0.072833557283571,0.00870164224378733,0.0557783384857479,0.0898887760813942,6.23197132599406e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CX3CL1,Fractalkine,40228,0.0277629853972397,0.00331939794807805,0.0212569654190067,0.0342690053754726,6.57217057611754e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL12RB1,Interleukin-12 receptor subunit beta-1,40044,-0.0309048597918703,0.0036986893204026,-0.0381542908598594,-0.0236554287238812,7.05182505977975e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BOLA2_BOLA2B,BolA-like protein 2,37628,-0.0455947525506015,0.00545724090587949,-0.0562909447261253,-0.0348985603750777,7.19912253077728e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,37337,-0.0402018476814137,0.00481338764552708,-0.0496360874666468,-0.0307676078961806,7.38787663517557e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OPLAH,5-oxoprolinase,37628,-0.055361396366413,0.0066289640314255,-0.068354165868007,-0.042368626864819,7.4126390464081e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TBC1D23,TBC1 domain family member 23,40305,-0.072641925933715,0.00870068101476493,-0.0896952607226543,-0.0555885911447758,7.44755876976967e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TPR,Nucleoprotein TPR,37562,-0.0380942336353608,0.00456822042757431,-0.0470479456734064,-0.0291405215973151,8.23719004487488e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,STK24,Serine/threonine-protein kinase 24,39961,-0.0499902527532818,0.00600117832937244,-0.0617525622788518,-0.0382279432277118,8.74868497131874e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PARK7,Parkinson disease protein 7,40332,-0.043263443418068,0.00519378634951681,-0.053443264663121,-0.0330836221730151,8.74911139104288e-17
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD300C,CMRF35-like molecule 6,40471,-0.0274980182330491,0.00330947003073003,-0.03398457949328,-0.0210114569728183,1.04262402230765e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RGCC,Regulator of cell cycle RGCC,37959,-0.0605138866206169,0.00728334745927333,-0.0747892476407927,-0.0462385256004412,1.06068958315302e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SERPINB1,Leukocyte elastase inhibitor,40287,-0.0716897884077445,0.00863017561287625,-0.088604932608982,-0.0547746442065071,1.06132521023675e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLC16A1,Monocarboxylate transporter 1,39961,-0.0484821125539689,0.00584450862109234,-0.0599373494513099,-0.0370268756566279,1.17106536887231e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,37901,-0.0720837945462387,0.00869060729222359,-0.0891173848389969,-0.0550502042534805,1.19389754223975e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPART,Spartin,37671,-0.062303833870861,0.00751876033300441,-0.0770406041235496,-0.0475670636181723,1.27849888879419e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PLIN3,Perilipin-3,40359,-0.034141716857712,0.00412164802212717,-0.0422201469810812,-0.0260632867343427,1.29029453084277e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KLRF1,Killer cell lectin-like receptor subfamily F member 1,37598,-0.0347367927258834,0.00419267042514847,-0.0429544267591744,-0.0265191586925924,1.29341136070934e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,37900,-0.0663317913291461,0.00801120078748054,-0.0820337448726079,-0.0506298377856842,1.34856163141233e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPRY2,Protein sprouty homolog 2,40044,-0.0740269658785508,0.00894241341921707,-0.0915540961802163,-0.0564998355768854,1.35110298169938e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BPIFB2,BPI fold-containing family B member 2,37951,-0.0546077900362631,0.00660842260770525,-0.0675602983473653,-0.0416552817251608,1.54741144915042e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,40397,-0.0881290275987328,0.0106793928426238,-0.109060637570275,-0.0671974176271902,1.67481810728221e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,40042,0.0167707407666581,0.00203304014214453,0.0127859820880549,0.0207554994452614,1.72235951802927e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLAMF6,SLAM family member 6,39980,-0.030446299881008,0.00369141811725105,-0.03768147939082,-0.0232111203711959,1.74069377870945e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SERPINA7,Thyroxine-binding globulin,38013,-0.0150090096540159,0.00182311548815991,-0.0185823160108093,-0.0114357032972225,1.99793911859204e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TSC22D1,TSC22 domain family protein 1,37959,-0.0538533992907969,0.00654758474167655,-0.0666866653844829,-0.0410201331971109,2.13044439920919e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CACYBP,Calcyclin-binding protein,37642,-0.0820750093573946,0.00998548478926061,-0.101646559544345,-0.0625034591704438,2.23446789339177e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CXCL9,C-X-C motif chemokine 9,40422,-0.0540629595411028,0.00658113193781886,-0.0669619781392278,-0.0411639409429779,2.28574352243723e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TP53,Cellular tumor antigen p53,39980,-0.0342987226649504,0.00418243247708573,-0.0424962903200384,-0.0261011550098624,2.57618513476364e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BCL2L15,Bcl-2-like protein 15,37598,-0.0450343009783837,0.00549694210253126,-0.0558083074993449,-0.0342602944574224,2.79111267945343e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HEPACAM2,HEPACAM family member 2,37942,0.0324543109085328,0.00396269950176539,0.0246874198850726,0.040221201931993,2.84680680912999e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",40341,-0.0764212625507385,0.00934775653853828,-0.0947428653662735,-0.0580996597352035,3.1706471441079e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DOK1,Docking protein 1,37942,-0.10830171659864,0.013252475538479,-0.134276568654059,-0.0823268645432211,3.2966142140042e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,40228,-0.0751939805923836,0.00920871852773517,-0.0932430689067445,-0.0571448922780226,3.44064720207741e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OPHN1,Oligophrenin-1,37942,-0.0848098904511872,0.0103899323740706,-0.105174157904365,-0.0644456229980089,3.56490038519333e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ATXN2L,Ataxin-2-like protein,37959,-0.0383051878848569,0.00469582679063233,-0.0475090083944963,-0.0291013673752176,3.72717263617476e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TPD52L2,Tumor protein D54,37671,-0.0855961907093244,0.0105149247457464,-0.106205443210987,-0.0649869382076615,4.28868540292001e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TMED8,Protein TMED8,37901,-0.0812564224043757,0.00998326887354667,-0.100823629396527,-0.0616892154122242,4.3244454142734e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,37575,-0.0282087077209325,0.0034711109152808,-0.0350120851148828,-0.0214053303269821,4.80384825590996e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VWC2,Brorin,40167,-0.0306288306846231,0.0037739451913841,-0.0380257632597359,-0.0232318981095102,5.17776378467295e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CRYZL1,Quinone oxidoreductase-like protein 1,37628,-0.0736773401867309,0.00907776453521077,-0.091469758675744,-0.0558849216977178,5.23254701435685e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RPL14,60S ribosomal protein L14,37628,-0.0326803599093685,0.00402766206624897,-0.0405745775592165,-0.0247861422595205,5.33056858032092e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TIA1,Nucleolysin TIA-1 isoform p40,39836,-0.094923690197744,0.0117239307603483,-0.117902594488027,-0.0719447859074613,6.07327994716317e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DNAJB2,DnaJ homolog subfamily B member 2,37671,-0.042987951235065,0.00531217850303083,-0.0533998211010054,-0.0325760813691246,6.36132799392134e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PILRB,Paired immunoglobulin-like type 2 receptor beta,40359,-0.0451065565049006,0.00558340026630167,-0.0560500210268518,-0.0341630919829493,7.01288626344514e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KLF4,Krueppel-like factor 4,37541,-0.0308061195707636,0.00381693998857484,-0.0382873219483703,-0.0233249171931569,7.58426677393936e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RARRES1,Retinoic acid receptor responder protein 1,39980,-0.027491707351208,0.00340744681723735,-0.0341703031129932,-0.0208131115894228,7.65701674257288e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RBFOX3,RNA binding protein fox-1 homolog 3,37959,-0.0294357050898849,0.00365019423342176,-0.0365900857873915,-0.0222813243923782,7.9923537221444e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD86,T-lymphocyte activation antigen CD86,37901,0.0229513423907324,0.00284664069987332,0.0173719266189807,0.0285307581624841,8.09613259946629e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,UBAC1,Ubiquitin-associated domain-containing protein 1,40305,-0.0278488484207216,0.00345654406235932,-0.0346236747829458,-0.0210740220584973,8.38208398836103e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ZNRD2,Protein ZNRD2,37901,-0.0533343850453085,0.00661906528407244,-0.0663077530020905,-0.0403610170885265,8.42664134913965e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,39980,-0.0772679995695943,0.00959303862672983,-0.0960703552779848,-0.0584656438612039,8.54971301521743e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,40384,0.0239257403811336,0.00297461523786008,0.0180954945149278,0.0297559862473393,9.35541219939108e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MAX,Protein max,39961,-0.0816171442006738,0.0101496517494175,-0.101510461629532,-0.0617238267718154,9.52097726942872e-16
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ORM1,Alpha-1-acid glycoprotein 1,37950,-0.0155286585609422,0.00193274019826267,-0.019316829349537,-0.0117404877723474,1.0169169451728e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FABP3,"Fatty acid-binding protein, heart",37990,-0.0371711604018076,0.00462769345800943,-0.046241439579506,-0.0281008812241091,1.03499332209182e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PLPBP,Pyridoxal phosphate homeostasis protein,40359,-0.0529234920948947,0.00659291788819126,-0.0658456111557496,-0.0400013730340398,1.06534106801631e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ANGPTL3,Angiopoietin-related protein 3,40355,0.028292204664108,0.00352940285420882,0.0213745750698588,0.0352098342583573,1.16646641186508e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD300E,CMRF35-like molecule 2,40436,-0.0310113367734664,0.00387659844614223,-0.0386094697279052,-0.0234132038190277,1.33294565614646e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TACC3,Transforming acidic coiled-coil-containing protein 3,40305,-0.0899906200838996,0.0112554186900273,-0.112051240716353,-0.0679299994514461,1.38097573669763e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLEC3B,Tetranectin,37681,0.0164469020862102,0.00205691756723483,0.0124153436544299,0.0204784605179904,1.39262258436617e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NUDC,Nuclear migration protein nudC,40516,-0.0490319577529376,0.006137404578459,-0.0610612707267173,-0.037002644779158,1.45157942842882e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MCEMP1,Mast cell-expressed membrane protein 1,37598,-0.0717633405066443,0.00898121974005026,-0.0893665311971428,-0.0541601498161458,1.45682663354021e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LGALS1,Galectin-1,40359,-0.0260936587155492,0.00326682766592353,-0.0324966409407593,-0.019690676490339,1.47113002354178e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDNF,Cerebral dopamine neurotrophic factor,40305,-0.0251068349861465,0.00314621815787372,-0.031273422575579,-0.0189402473967141,1.56275478506429e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ITGA5,Integrin alpha-5,40332,-0.0192647818547724,0.00241627844937775,-0.0240006876155528,-0.0145288760939921,1.65454157680025e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,YJU2,Splicing factor YJU2,37900,-0.024793135880837,0.00311158741972249,-0.030891847223493,-0.0186944245381809,1.7417392597522e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TRAF2,TNF receptor-associated factor 2,40341,-0.055024285829812,0.00690752411074635,-0.0685630330868749,-0.0414855385727492,1.75144018426988e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NGRN,Neugrin,37942,-0.0170492388693104,0.0021432657553265,-0.0212500397497503,-0.0128484379888704,1.93655001157641e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ITGBL1,Integrin beta-like protein 1,37998,-0.0270131598898596,0.00339621447770279,-0.0336697402661571,-0.0203565795135621,1.94986967870425e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SERPINB6,Serpin B6,40433,-0.0460012144730496,0.00579231064756132,-0.0573541433422698,-0.0346482856038294,2.12489897872757e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TREML2,Trem-like transcript 2 protein,40332,-0.0258335478170078,0.00325471746144428,-0.0322127940414385,-0.019454301592577,2.20415497184143e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TMEM106A,Transmembrane protein 106A,37900,-0.0540148748613246,0.00681061984428269,-0.0673636897561187,-0.0406660599665306,2.34511062802951e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PLXNB3,Plexin-B3,40310,-0.0358971511995789,0.0045302317983992,-0.0447764055244414,-0.0270178968747165,2.45354485649752e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MINK1,Misshapen-like kinase 1,37942,-0.0713068902601986,0.00900448926469088,-0.0889556892189928,-0.0536580913014045,2.57987153401985e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BDNF,Brain-derived neurotrophic factor,37998,-0.0636317922806292,0.00803760112295068,-0.0793854904816126,-0.0478780940796459,2.62643444616083e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HTRA2,"Serine protease HTRA2, mitochondrial",40411,-0.0471292750695143,0.00595559620555773,-0.0588022436324075,-0.0354563065066211,2.66703283784942e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDLIM5,PDZ and LIM domain protein 5,37959,-0.0910348882714051,0.0115145579159892,-0.113603421786744,-0.0684663547560662,2.86157310654232e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TXNDC9,Thioredoxin domain-containing protein 9,37942,-0.0408156850465707,0.00516805005685584,-0.0509450631580082,-0.0306863069351333,3.05980144966681e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NRGN,Neurogranin,37987,-0.0696262924987846,0.00882573250049925,-0.0869247281997632,-0.0523278567978061,3.2785748611705e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PLAUR,Urokinase plasminogen activator surface receptor,40264,-0.0204480507761371,0.00259450758351371,-0.025533285639824,-0.0153628159124503,3.45032179727997e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CASP2,Caspase-2,40341,-0.0516427264161675,0.00655884174873858,-0.0644980562436951,-0.0387873965886399,3.66251212457724e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,37598,-0.0277516189898756,0.00352397023374155,-0.034658600648009,-0.0208446373317422,3.67078546813791e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CRTAC1,Cartilage acidic protein 1,40536,0.0224156467661195,0.00284750840367593,0.0168345302949147,0.0279967632373243,3.71070719725075e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL6,Interleukin-6,40305,-0.0557590709794887,0.00709297162888124,-0.0696612953720959,-0.0418568465868814,4.04896751957474e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PI3,Elafin,40074,-0.0409006004255223,0.00520342566288434,-0.0510993147247756,-0.030701886126269,4.0801690669026e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TREM2,Triggering receptor expressed on myeloid cells 2,40357,-0.038389596240266,0.00488914937388464,-0.0479723290130799,-0.0288068634674521,4.35436276114127e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TBCB,Tubulin-folding cofactor B,40228,-0.077006047352509,0.00981275483259558,-0.0962390468243963,-0.0577730478806217,4.51337615904599e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ANGPT2,Angiopoietin-2,40489,-0.0295004144085108,0.00375937882454676,-0.0368687969046225,-0.0221320319123992,4.52300702586083e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RHOC,Rho-related GTP-binding protein RhoC,40152,-0.0882902207274851,0.0112859350414853,-0.110410653408796,-0.0661697880461739,5.48326928448601e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SOST,Sclerostin,40330,-0.0293415553279291,0.00375239201507415,-0.0366962436774745,-0.0219868669783838,5.63806147162118e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GRAP2,GRB2-related adapter protein 2,40359,-0.0961651985792362,0.0123137995544216,-0.120300245705903,-0.0720301514525699,6.09556461002649e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TSNAX,Translin-associated protein X,37562,-0.0299856214212538,0.00384021691524178,-0.0375124465751277,-0.0224587962673799,6.23451882384095e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CAPG,Macrophage-capping protein,40185,-0.0439936987476737,0.0056375817048709,-0.0550433588892207,-0.0329440386061268,6.39065273981751e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EIF4E,Eukaryotic translation initiation factor 4E,37598,-0.0691698397422941,0.0088649908512146,-0.0865452218106748,-0.0517944576739135,6.52166615895079e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OTUD6B,Deubiquitinase OTUD6B,37901,-0.0446736714950251,0.0057259103777469,-0.055896455835409,-0.0334508871546412,6.5400717317166e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PECAM1,Platelet endothelial cell adhesion molecule,40332,-0.0226699191583263,0.00290634343126235,-0.0283663522836005,-0.0169734860330521,6.56582078423447e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,UBXN1,UBX domain-containing protein 1,37671,-0.0525106080556914,0.00673506731223993,-0.0657113399876817,-0.0393098761237011,6.83429963074189e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ANXA3,Annexin A3,40442,-0.0528155131969118,0.00678839977231627,-0.0661207767506517,-0.039510249643172,7.67759973739423e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CTSL,Cathepsin L1,40359,-0.0182792077543213,0.00235430234979266,-0.0228936403599149,-0.0136647751487277,8.71616133292712e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BAX,Apoptosis regulator BAX,39934,-0.0674370268018015,0.00868695778042629,-0.084463464051437,-0.050410589552166,8.80958626495263e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NEXN,Nexilin,37987,-0.0516478074097946,0.00665568312865456,-0.0646929463419576,-0.0386026684776317,9.10263709861084e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PNLIP,Pancreatic triacylglycerol lipase,37987,-0.0456144116903824,0.00588200352251199,-0.0571431385945059,-0.0340856847862589,9.47026143241357e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,COMT,Catechol O-methyltransferase,39877,-0.0641352122164721,0.00827427108334236,-0.0803527835398231,-0.0479176408931211,9.6713515372826e-15
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CEMIP2,Cell surface hyaluronidase,37598,-0.0254451064414765,0.00328591806897569,-0.0318855058566689,-0.0190047070262842,1.03625473841993e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,39961,-0.0481053175878629,0.0062209167190537,-0.0602983143572082,-0.0359123208185177,1.11615159856714e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",40192,-0.07149545332298,0.00924725595907111,-0.0896200750027594,-0.0533708316432006,1.12660894712847e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TRIAP1,TP53-regulated inhibitor of apoptosis 1,40489,-0.0472649120457212,0.00611799535968957,-0.0592561829507127,-0.0352736411407296,1.17926979758416e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SOD1,Superoxide dismutase [Cu-Zn],39978,-0.036838143155293,0.00476946794970079,-0.0461863003367066,-0.0274899859738795,1.1983551986301e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SEZ6L,Seizure 6-like protein,40411,0.0205916662693779,0.00266611397476177,0.0153660828788448,0.025817249659911,1.19894238536345e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FGF2,Fibroblast growth factor 2,40341,-0.04962320913975,0.00642730613079957,-0.0622207291561172,-0.0370256891233829,1.2256926816254e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DRG2,Developmentally-regulated GTP-binding protein 2,40305,-0.0419394579944667,0.00545150028593757,-0.0526243985549044,-0.0312545174340291,1.5191504757455e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RBM17,Splicing factor 45,37959,-0.0571327914022128,0.00742576294739308,-0.0716872867791032,-0.0425782960253223,1.5262758054629e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,WARS,"Tryptophan--tRNA ligase, cytoplasmic",40332,-0.0282967520949401,0.00367957166769881,-0.0355087125636298,-0.0210847916262505,1.55449900772961e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DLG4,Disks large homolog 4,37942,-0.05239294548317,0.00681785450169903,-0.0657559403065001,-0.0390299506598399,1.63960180958701e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MSRA,Mitochondrial peptide methionine sulfoxide reductase,40411,-0.0542103199675085,0.00705857629235693,-0.0680451295005281,-0.0403755104344889,1.68200311080689e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SELL,L-selectin,38013,0.0173395850573951,0.0022599125154888,0.012910156527037,0.0217690135877532,1.7990578524937e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD300A,CMRF35-like molecule 8,37671,-0.0221108371335849,0.00288579487350323,-0.0277669950856512,-0.0164546791815185,1.9584606707626e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DDX58,Antiviral innate immune response receptor RIG-I,39980,-0.04252528840604,0.00555870077123662,-0.0534203419176638,-0.0316302348944162,2.12376393537922e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LAG3,Lymphocyte activation gene 3 protein,40305,0.0305895252809576,0.00399896006169604,0.0227515635600333,0.0384274870018818,2.1353242523431e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SOD3,Extracellular superoxide dismutase,37987,0.0441275135312255,0.00576955202241032,0.0328191915673013,0.0554358354951498,2.17293504370431e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KRT8,"Keratin, type II cytoskeletal 8",37541,-0.0460235419422119,0.00602011671966212,-0.0578229707127497,-0.0342241131716742,2.23554708448417e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,THBS2,Thrombospondin-2,40332,-0.02655587046146,0.00347852194127305,-0.0333737734663552,-0.0197379674565649,2.40039478233001e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNC,Tenascin,40403,0.0350539976643314,0.00459966116208767,0.0260386617866395,0.0440693335420232,2.65838029334123e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDAP1,28 kDa heat- and acid-stable phosphoprotein,37990,-0.0724999723578905,0.00952763266878837,-0.0911741323887158,-0.0538258123270653,2.93432871052236e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CIAPIN1,Anamorsin,40411,-0.0470652643779389,0.00619108112305179,-0.0591997833791204,-0.0349307453767574,3.07508043076177e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FIS1,Mitochondrial fission 1 protein,40354,-0.056934936868665,0.00749385620803884,-0.0716228950364211,-0.0422469787009089,3.18554743396383e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,JPT2,Jupiter microtubule associated homolog 2,37901,-0.0648076540320943,0.00852912062207564,-0.0815247304513626,-0.0480905776128261,3.19606582197977e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ST13,Hsc70-interacting protein,37671,-0.0421957086392686,0.00555446808936569,-0.0530824660944254,-0.0313089511841118,3.24131211098962e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MMP8,Neutrophil collagenase,40442,-0.0539599546434526,0.00710898115662962,-0.0678935577104467,-0.0400263515764586,3.36486235443747e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TOR1AIP1,Torsin-1A-interacting protein 1,37628,-0.0371781231930295,0.00490705075281097,-0.046795942668539,-0.02756030371752,3.78739942633327e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ASAH1,Acid ceramidase,37882,-0.0339622462046982,0.00449138057733029,-0.0427653521362656,-0.0251591402731309,4.23782590739029e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD46,Membrane cofactor protein,40250,-0.0210610252240211,0.00278693745551102,-0.0265234226368227,-0.0155986278112195,4.34876970468015e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FCRLB,Fc receptor-like B,39980,-0.0447585114813797,0.00593361350597028,-0.0563883939530814,-0.0331286290096779,4.83881739666885e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,40341,-0.0274144774650805,0.00363556747651361,-0.0345401897190471,-0.0202887652111138,4.9291958289427e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTGES2,Prostaglandin E synthase 2,37484,-0.040107527870579,0.00532052430419358,-0.0505357555067984,-0.0296793002343596,5.07700741340897e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GLRX,Glutaredoxin-1,40260,-0.041440301700082,0.005499378486526,-0.0522190835336729,-0.030661519866491,5.12954712679123e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RNASEH2A,Ribonuclease H2 subunit A,37959,-0.0362777484553305,0.00481751330194268,-0.0457200745271382,-0.0268354223835229,5.37946305636964e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MICALL2,MICAL-like protein 2,37572,-0.0502069480851947,0.00667278604443489,-0.0632856087322871,-0.0371282874381023,5.65229595722657e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDH3,Cadherin-3,40471,-0.0258776092230427,0.003441945624411,-0.0326238226468882,-0.0191313957991971,5.84216633943773e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,37714,-0.0777553972568942,0.0103461377216683,-0.0980338271913641,-0.0574769673224244,6.03692530580014e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,37959,-0.0427352878623229,0.00569069808894193,-0.0538890561166491,-0.0315815196079967,6.29885752373752e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ARHGAP25,Rho GTPase-activating protein 25,39980,-0.043281271961753,0.00576576170427632,-0.0545821649021346,-0.0319803790213714,6.39721466090189e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ARHGAP45,Rho GTPase-activating protein 45,37671,-0.0601699413741593,0.00801845621529972,-0.0758861155561468,-0.0444537671921719,6.58869392342192e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",37942,-0.0704749864052393,0.00940125400005294,-0.0889014442453431,-0.0520485285651356,6.97124743326736e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MAP2,Microtubule-associated protein 2,37942,-0.0334159675754538,0.00445980441274929,-0.0421571842244424,-0.0246747509264652,7.16663346503033e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CTSC,Dipeptidyl peptidase 1,40349,-0.0309104613905298,0.0041391150708929,-0.0390231269294799,-0.0227977958515797,8.57140802282841e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GP1BB,Platelet glycoprotein Ib beta chain,37562,-0.0491421568259935,0.00658055265175077,-0.062040040023425,-0.036244273628562,8.67065210460086e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,40359,-0.0608300875429684,0.00815145176506648,-0.0768069330024987,-0.0448532420834381,8.92909641602615e-14
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,37714,-0.0319960834307394,0.00429918699297134,-0.0404224899369632,-0.0235696769245156,1.04993243301846e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SERPINA9,Serpin A9,40228,-0.052150446078634,0.00700898756967063,-0.0658880617151885,-0.0384128304420796,1.05459555068235e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LGALS3,Galectin-3,40374,-0.0213721586920245,0.00287303997407977,-0.0270033170412209,-0.0157410003428282,1.0672716794479e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AZU1,Azurocidin,39809,-0.0562276125071655,0.00756023609459641,-0.0710456752525745,-0.0414095497617565,1.08206108194636e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GIPC2,PDZ domain-containing protein GIPC2,37942,-0.0210931935599829,0.00283824090147885,-0.0266561457268815,-0.0155302413930844,1.13586688981065e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KLB,Beta-klotho,39961,0.0530563349815828,0.007156166108773,0.0390302494083878,0.0670824205547779,1.28803046813584e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SMTN,Smoothelin,37905,-0.069418770588097,0.00936906468031376,-0.087782137361512,-0.0510554038146821,1.3447231969631e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,STX7,Syntaxin-7,37598,-0.0362867684474922,0.00489734833714039,-0.0458855711882874,-0.026687965706697,1.34539599221833e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LACTB2,Endoribonuclease LACTB2,40359,-0.0474794621148921,0.00641128167955304,-0.0600455742068161,-0.0349133500229682,1.37085676972489e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCL8,C-C motif chemokine 8,40470,-0.0433246232478917,0.0058557657485629,-0.054801924115075,-0.0318473223807084,1.44417145745495e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IFT20,Intraflagellar transport protein 20 homolog,37572,-0.0311199152177147,0.00420625685959655,-0.039364178662524,-0.0228756517729055,1.46121817378553e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CASP7,Caspase-7,37942,-0.0602107682217814,0.00814474365232275,-0.076174465780334,-0.0442470706632288,1.52471072054781e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CXCL8,Interleukin-8,40209,-0.0486077266584854,0.00658073926346103,-0.061505975614869,-0.0357094777021018,1.58451588576707e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RNF5,E3 ubiquitin-protein ligase RNF5,37628,-0.0527717864943909,0.00715045796300081,-0.0667866841018725,-0.0387568888869094,1.67524439559723e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD40LG,CD40 ligand,40516,-0.0548228116946676,0.00743213666195296,-0.0693897995520954,-0.0402558238372398,1.70494930545892e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,37900,-0.0774092231080598,0.0104962618660832,-0.097981896365583,-0.0568365498505366,1.74046518971593e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ACYP1,Acylphosphatase-1,37622,-0.0475444397655764,0.00644834697736107,-0.0601831998412041,-0.0349056796899487,1.76630897973952e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ELAC1,Zinc phosphodiesterase ELAC protein 1,37959,-0.0613204102537752,0.00831700504404607,-0.0776217401401055,-0.0450190803674449,1.76672965036905e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,THTPA,Thiamine-triphosphatase,37884,-0.0634642447887489,0.00861082705212882,-0.0803414658109214,-0.0465870237665764,1.80210763603816e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FSHB,Follitropin subunit beta,37628,0.0500639631130748,0.00681056845951815,0.0367152489324193,0.0634126772937304,2.08447539076254e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NAMPT,Nicotinamide phosphoribosyltransferase,39980,-0.0368404981969289,0.0050134323726111,-0.0466668256472466,-0.0270141707466111,2.10639621066578e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CFB,Complement factor B,37770,-0.0235233930829148,0.00320215479612244,-0.0297996164833148,-0.0172471696825148,2.15919432142045e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AIF1,Allograft inflammatory factor 1,39980,-0.0375893011309591,0.00512492773765247,-0.047634159496758,-0.0275444427651603,2.3336450280089e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PLA2G1B,Phospholipase A2,40514,0.0299134706712392,0.00407862753818216,0.0219193606964021,0.0379075806460762,2.33688014522234e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,COL3A1,Collagen alpha-1(III) chain,37998,-0.0164841927957901,0.0022496575007336,-0.020893521497228,-0.0120748640943523,2.47891461742103e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RALY,RNA-binding protein Raly,37900,-0.0344090966299125,0.0046980951846283,-0.0436173631917839,-0.025200830068041,2.54277863527879e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LAP3,Cytosol aminopeptidase,40044,-0.0349531352819513,0.00477507518626831,-0.0443122826470372,-0.0255939879168654,2.60235699735154e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPTLC1,Serine palmitoyltransferase 1,37942,-0.0255967817361357,0.0034964553770745,-0.0324498342752017,-0.0187437291970697,2.60486837514466e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL4R,Interleukin-4 receptor subunit alpha,40341,-0.0258077354631911,0.00352635070053318,-0.0327193828362361,-0.0188960880901461,2.62671128380551e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,S100A12,Protein S100-A12,40139,-0.0544151316932281,0.00744567315830399,-0.0690086510835039,-0.0398216123029523,2.83598518916545e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,37598,-0.0252753444507453,0.00346054734329096,-0.0320580172435956,-0.018492671657895,2.95733565988217e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AARSD1,Alanyl-tRNA editing protein Aarsd1,40305,-0.0395274052000651,0.00541396410008316,-0.0501387748362281,-0.0289160355639021,2.99172609344226e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CBLIF,Cobalamin binding intrinsic factor,40330,-0.0518040436894431,0.00709568048525957,-0.0657115774405518,-0.0378965099383343,2.99647641917155e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CKAP4,Cytoskeleton-associated protein 4,40457,-0.0185100220918272,0.00253883399841886,-0.0234861367287282,-0.0135339074549263,3.22624164188818e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCL19,C-C motif chemokine 19,40471,-0.0926835630897967,0.0127175255611628,-0.117609913189676,-0.0677572129899175,3.29596414635563e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TRIM58,E3 ubiquitin-protein ligase TRIM58,37900,-0.0614266446674577,0.00842766077635201,-0.0779448597891076,-0.0449084295458077,3.30431783478729e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,40228,-0.0289423398834295,0.00397315449801069,-0.0367297226995304,-0.0211549570673285,3.38192766135664e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PPP3R1,Calcineurin subunit B type 1,40228,-0.0291993227892251,0.00401169365325365,-0.0370622423496023,-0.021336403228848,3.53318607405964e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,37901,-0.0213676125038286,0.00293597248067405,-0.0271221185659497,-0.0156131064417075,3.57947854052339e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MYO9B,Unconventional myosin-IXb,40044,-0.0468683554702517,0.00644506511969571,-0.0595006831048553,-0.0342360278356482,3.71099247028767e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CEP170,Centrosomal protein of 170 kDa,37628,-0.05472237714453,0.00752847105724305,-0.0694781804167264,-0.0399665738723336,3.83344461966702e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KIFBP,KIF-binding protein,40305,-0.0581056889081649,0.00800095781124636,-0.0737875662182078,-0.042423811598122,3.98122830136709e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNF,Tumor necrosis factor,40014,-0.0280875145473895,0.00387013985852732,-0.035672988670103,-0.0205020404246759,4.12951029584449e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ERP29,Endoplasmic reticulum resident protein 29,37671,-0.0837991391863405,0.0115492404019764,-0.106435650374214,-0.0611626279984669,4.21511836671037e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TFF2,Trefoil factor 2,40396,-0.0401969725014278,0.0055439224324581,-0.0510630604690457,-0.02933088453381,4.33852161813688e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GYS1,"Glycogen [starch] synthase, muscle",40042,-0.0655122199731785,0.00904643100329508,-0.0832432247396369,-0.0477812152067202,4.6354331057852e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTPRF,Receptor-type tyrosine-protein phosphatase F,40536,0.0203912113496629,0.00281723048735043,0.014869439594456,0.0259129831048697,4.7579730848057e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GP6,Platelet glycoprotein VI,40311,-0.0617481486582282,0.00853701138118648,-0.0784806909653537,-0.0450156063511027,4.94051932132602e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CRISP2,Cysteine-rich secretory protein 2,40489,0.0428805012294895,0.00595052363791388,0.0312174748991783,0.0545435275598007,6.01078965446173e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DXO,Decapping and exoribonuclease protein,37942,-0.032107456969979,0.00445781337033093,-0.0408447711758277,-0.0233701427641304,6.22462862383154e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FAM3D,Protein FAM3D,37901,-0.0577307548986091,0.0080155024293166,-0.0734411396600697,-0.0420203701371486,6.23129845512825e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,40341,-0.0427172618084289,0.00593837123989732,-0.0543564694386277,-0.0310780541782302,6.60022999158389e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,WFDC1,WAP four-disulfide core domain protein 1,37653,-0.0381978293381658,0.0053092870502221,-0.0486040319566011,-0.0277916267197305,6.60574151584941e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SH3GLB2,Endophilin-B2,37942,-0.0468678361215419,0.00651466018414282,-0.0596365700824618,-0.034099102160622,6.6137807339075e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NCR1,Natural cytotoxicity triggering receptor 1,40306,-0.0251680124393682,0.00349940821311957,-0.0320268525370826,-0.0183091723416539,6.66645593535764e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,37598,-0.0341212443841228,0.00475262387349695,-0.0434363871761768,-0.0248061015920688,7.37508057450632e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TBCA,Tubulin-specific chaperone A,37671,-0.0609161924000294,0.00849608684741282,-0.0775685226209585,-0.0442638621791003,7.9034034217308e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ITGAM,Integrin alpha-M,40332,0.022052977654469,0.00307859171218874,0.0160189378985791,0.028087017410359,8.21953173294801e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BCAM,Basal cell adhesion molecule,40332,0.0164432188427787,0.00230224572122228,0.011930817229183,0.0209556204563743,9.57973962186874e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD164,Sialomucin core protein 24,40332,-0.0183961253059135,0.00257744733718242,-0.023447922086791,-0.0133443285250359,9.92690286272e-13
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD160,CD160 antigen,40516,-0.0316714917951572,0.00443998785797635,-0.0403738679967909,-0.0229691155935236,1.02216823789902e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ENTR1,Endosome-associated-trafficking regulator 1,37628,-0.0396025736872855,0.00555304485249873,-0.050486541598183,-0.028718605776388,1.04320364217915e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,COMMD9,COMM domain-containing protein 9,37900,-0.0272678143801299,0.00382373515752819,-0.0347623352888851,-0.0197732934713746,1.04581996960112e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PPME1,Protein phosphatase methylesterase 1,40305,-0.0424381424937144,0.00595819565670342,-0.0541162059808531,-0.0307600790065757,1.10422119251183e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PGA4,Pepsin A-4,37987,-0.0472426458996449,0.00663637254309279,-0.0602499360841067,-0.034235355715183,1.14403005649249e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LONP1,"Lon protease homolog, mitochondrial",37628,-0.0600326440653478,0.00844564193710405,-0.0765861022620717,-0.0434791858686239,1.23690735989733e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ITGB1BP2,Integrin beta-1-binding protein 2,40042,-0.0763657452007026,0.0107476548519852,-0.0974311487105937,-0.0553003416908115,1.25223393433695e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDIA4,Protein disulfide-isomerase A4,37998,-0.0417619789210799,0.00587771240477902,-0.0532822952344468,-0.030241662607713,1.26205687657658e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDC37,Hsp90 co-chaperone Cdc37,40411,-0.0576298255363175,0.00812177724432401,-0.0735485089351926,-0.0417111421374425,1.34094538721176e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GMFG,Glia maturation factor gamma,37990,-0.0494774232713646,0.00698040894119445,-0.0631590247961057,-0.0357958217466234,1.42759715270187e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,37598,-0.0549242808771646,0.00775142312948874,-0.0701170702109626,-0.0397314915433667,1.45390440021539e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LPA,Apolipoprotein(a),37735,0.121463054342517,0.0171792756498259,0.0877916740688585,0.155134434616176,1.62298229814496e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DENR,Density-regulated protein,37598,-0.0396031521138563,0.00560400772155039,-0.0505870072480951,-0.0286192969796175,1.66380857864489e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VPS4B,Vacuolar protein sorting-associated protein 4B,37900,-0.0648417781766536,0.00917682026952537,-0.0828283459049233,-0.0468552104483839,1.67529056721948e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KLKB1,Plasma kallikrein,37721,-0.0173614472551436,0.00245709654561762,-0.0221773564845542,-0.0125455380257331,1.67617599283974e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CASP3,Caspase-3,40536,-0.0604350691150648,0.00855563075571717,-0.0772041053962704,-0.0436660328338591,1.68675332001289e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RAB10,Ras-related protein Rab-10,37990,-0.0368439518207576,0.00522423305836628,-0.0470834486151556,-0.0266044550263597,1.84247539896061e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DYNLT3,Dynein light chain Tctex-type 3,37900,-0.029855091386778,0.00423430896033003,-0.0381543369490249,-0.0215558458245312,1.86630785029265e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,APOA4,Apolipoprotein A-IV,38013,-0.0253097891912527,0.00359118522529247,-0.032348512232826,-0.0182710661496795,1.90614195766854e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CIT,Citron Rho-interacting kinase,37572,-0.0309294434414961,0.00439804023223297,-0.0395496022966728,-0.0223092845863195,2.1283780553289e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADGRF5,Adhesion G protein-coupled receptor F5,37990,-0.0204566944535382,0.0029092454826771,-0.0261588155995853,-0.0147545733074911,2.1394693580877e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SMAD3,Mothers against decapentaplegic homolog 3,37900,-0.0346215117183699,0.00493127194743799,-0.0442868047353484,-0.0249562187013915,2.31174835225986e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MGLL,Monoglyceride lipase,40396,-0.0587577767334486,0.00838402509258627,-0.0751904659149177,-0.0423250875519795,2.50890630756955e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LRG1,Leucine-rich alpha-2-glycoprotein,38013,0.0174609792346821,0.00249423903468904,0.0125722707266916,0.0223496877426727,2.6700069347163e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SH3BP1,SH3 domain-binding protein 1,37901,-0.0318457601034246,0.00454967083373769,-0.0407631149375505,-0.0229284052692987,2.68911553412078e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLEC4G,C-type lectin domain family 4 member G,40341,-0.0223640711229055,0.00319724043143956,-0.0286306623685271,-0.016097479877284,2.76224674892366e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD7,T-cell antigen CD7,37567,-0.0292303101578486,0.00417910952578238,-0.037421364828382,-0.0210392554873151,2.79340333184118e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GGCT,Gamma-glutamylcyclotransferase,37978,-0.0329014232534604,0.00470639185332835,-0.042125951285984,-0.0236768952209368,2.86148947611399e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NECAP2,Adaptin ear-binding coat-associated protein 2,37562,-0.0458199458987139,0.00657752742714391,-0.058711899655916,-0.0329279921415119,3.41314917572649e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CWC15,Spliceosome-associated protein CWC15 homolog,37835,-0.0397130461901496,0.00571575451465413,-0.0509159250388717,-0.0285101673414275,3.87644924868287e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",37714,-0.0333237438831624,0.00480607835092335,-0.0427436574509722,-0.0239038303153526,4.2905631029089e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CRADD,Death domain-containing protein CRADD,40192,-0.0514870694516743,0.00743257498339864,-0.0660549164191356,-0.0369192224842129,4.4582293902444e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ALPP,"Alkaline phosphatase, placental type",40305,-0.069288167677584,0.0100206989364669,-0.0889287375930591,-0.0496475977621089,4.87426159111771e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CA2,Carbonic anhydrase 2,40291,-0.0474271216858954,0.00686273607200901,-0.0608780843870331,-0.0339761589847578,5.00240130058374e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CXCL16,C-X-C motif chemokine 16,40517,-0.0159473138487559,0.00230889789299097,-0.0204727537190182,-0.0114218739784936,5.13955509650535e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DPP10,Inactive dipeptidyl peptidase 10,40341,0.0228537780565491,0.0033089115323345,0.0163683114531735,0.0293392446599247,5.14737435346513e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,37671,-0.0278782395315901,0.00403680783387414,-0.0357903828859834,-0.0199660961771968,5.21257976856064e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MED18,Mediator of RNA polymerase II transcription subunit 18,39980,-0.0512789734541676,0.00743452980132998,-0.0658506518647744,-0.0367072950435609,5.50051726631628e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FHIT,Bis(5'-adenosyl)-triphosphatase,39961,-0.050509346327676,0.00732687500238434,-0.0648700213323493,-0.0361486713230027,5.64527076474959e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,37628,-0.035449857256927,0.00514207866736192,-0.0455283314449563,-0.0253713830688976,5.66873690350736e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GFAP,Glial fibrillary acidic protein,39959,0.0313334631067605,0.00455791296844425,0.0223999536886098,0.0402669725249112,6.45719604605754e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CA4,Carbonic anhydrase 4,40536,0.0156146027262891,0.00227205487417678,0.0111613751729026,0.0200678302796755,6.54217371982304e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPP1,Osteopontin,40497,0.0318082902177807,0.00463249708108061,0.0227285959388627,0.0408879844966987,6.82868669920576e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,37901,-0.0776347838005448,0.011332120657734,-0.0998457402897035,-0.0554238273113861,7.65998700920362e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CXCL3,C-X-C motif chemokine 3,40350,-0.0619149989190551,0.00904032629225579,-0.0796340384518765,-0.0441959593862338,7.72241746246232e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,37990,-0.0597030785923233,0.00874074991676396,-0.0768349484291807,-0.0425712087554659,8.82751122702497e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,37598,-0.0376280302180509,0.00551377796955387,-0.0484350350383765,-0.0268210253977253,9.21868017719521e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DPP7,Dipeptidyl peptidase 2,40251,-0.0384452655694565,0.00563855740917985,-0.049496838091449,-0.027393693047464,9.54746127154835e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLGN,Calmegin,37572,-0.0295816591493694,0.00433829874622918,-0.0380847246919786,-0.0210785936067602,9.58743161505798e-12
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BOLA1,BolA-like protein 1,37541,-0.0364562241151107,0.00535498226383796,-0.0469519893522331,-0.0259604588779883,1.03346831934969e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DMD,Dystrophin,37628,-0.0344991499938922,0.00506904968884423,-0.0444344873840269,-0.0245638126037575,1.04806133341277e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MAPKAPK2,MAP kinase-activated protein kinase 2,37714,-0.0484445377903455,0.00713773657284862,-0.0624345014731288,-0.0344545741075622,1.19272169477413e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL13RA1,Interleukin-13 receptor subunit alpha-1,40109,-0.0136673245182071,0.0020147358540175,-0.0176162067920814,-0.00971844224433278,1.21349553988981e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FUT8,"Alpha-(1,6)-fucosyltransferase",40228,-0.0386137141695286,0.00569368234388146,-0.0497733315635362,-0.0274540967755209,1.22858274616363e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GIMAP7,GTPase IMAP family member 7,37671,0.0214283321656264,0.00316670462201253,0.0152215911064818,0.0276350732247709,1.37247049566542e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD84,SLAM family member 5,40341,-0.0202206912955258,0.00299136028920073,-0.0260837574623592,-0.0143576251286924,1.43092478187274e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VASH1,Tubulinyl-Tyr carboxypeptidase 1,40341,-0.0531508568013114,0.00786394149775236,-0.068564182136906,-0.0377375314657168,1.43973010350526e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,QPCT,Glutaminyl-peptide cyclotransferase,40373,-0.0176205974006792,0.0026149591561534,-0.0227459173467398,-0.0124952774546185,1.65651601077566e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SGSH,N-sulphoglucosamine sulphohydrolase,37790,-0.036809052732051,0.00546302276594892,-0.0475165773533109,-0.0261015281107911,1.67340301388575e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BAG6,Large proline-rich protein BAG6,40042,-0.0234836753420101,0.00349253767868811,-0.0303290491922388,-0.0166383014917814,1.82997745476768e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL19,Interleukin-19,39924,-0.0444487955831719,0.0066108709222875,-0.0574061025908554,-0.0314914885754884,1.8350472152485e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TBC1D5,TBC1 domain family member 5,40341,-0.0511514555075849,0.00760849708707815,-0.0660641097982581,-0.0362388012169117,1.84161352848178e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BCL2L1,Bcl-2-like protein 1,37942,-0.0651730380516385,0.00970888467274265,-0.0842024520102141,-0.0461436240930629,1.98664020325021e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BLNK,B-cell linker protein,37598,-0.0250305086642998,0.0037309225329125,-0.0323431168288084,-0.0177179004997913,2.04080828482777e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LMNB2,Lamin-B2,37942,-0.0178425497569336,0.00266373830715964,-0.0230634768389665,-0.0126216226749007,2.19197533594376e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,UNC79,Protein unc-79 homolog,37482,-0.0368689340751592,0.00551009964310714,-0.0476687293756492,-0.0260691387746692,2.30467359690676e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",40305,-0.0452571149280408,0.00676728652146402,-0.0585209965101103,-0.0319932333459713,2.34393769211558e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,THPO,Thrombopoietin,40042,-0.0248031625933257,0.00371246640372696,-0.0320795967446305,-0.0175267284420208,2.45275496293112e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,COL5A1,Collagen alpha-1(V) chain,37671,-0.0259330840334712,0.00388177859939815,-0.0335413700882916,-0.0183247979786509,2.4728771688697e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",37990,-0.0481700375048032,0.00723401684034673,-0.0623487105118828,-0.0339913644977236,2.86675955685571e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,37959,-0.064202505476236,0.00964172707324454,-0.0831002905397953,-0.0453047204126767,2.86710528998717e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,37671,-0.0394798018800016,0.00595923365880441,-0.0511598998512583,-0.027799703908745,3.60744511925369e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CRYBB1,Beta-crystallin B1,37990,-0.0417922285853313,0.00630997376501259,-0.054159777164756,-0.0294246800059067,3.64772186381985e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,40471,-0.0367964521968218,0.00556139609279494,-0.0476967885386999,-0.0258961158549437,3.7970355899716e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OLFM4,Olfactomedin-4,37177,-0.0795899921958171,0.0120384418094209,-0.103185338142282,-0.0559946462493521,3.96114992115101e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MESD,LRP chaperone MESD,40332,-0.0775804375106303,0.011749104081875,-0.100608681511105,-0.0545521935101553,4.15438391079604e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DNAJC9,DnaJ homolog subfamily C member 9,37901,-0.0494587356109234,0.00749162081627551,-0.0641423124108234,-0.0347751588110234,4.21227628462425e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HIP1R,Huntingtin-interacting protein 1-related protein,37910,-0.0263954802415363,0.00399825814758922,-0.0342320662108111,-0.0185588942722614,4.21582803848219e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EFCAB2,Dynein regulatory complex protein 8,37714,-0.0223166517745918,0.00339009487241699,-0.0289612377245291,-0.0156720658246545,4.78723396495648e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PPIB,Peptidyl-prolyl cis-trans isomerase B,40338,-0.0600594983466552,0.00913261650771492,-0.0779594267017765,-0.042159569991534,4.97103159709608e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LGMN,Legumain,40422,-0.0226907621897833,0.00345092052503792,-0.0294545664188577,-0.015926957960709,5.00686376792285e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,STX16,Syntaxin-16,39980,-0.037765080137367,0.00574364926868191,-0.0490226327039836,-0.0265075275707505,5.01712762141063e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDCD6,Programmed cell death protein 6,40359,0.0446199469669131,0.00678685339227342,0.0313177143180572,0.0579221796157691,5.03474869064185e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SERPINB9,Serpin B9,40228,-0.0214228799320131,0.00325967660799712,-0.0278118460836875,-0.0150339137803388,5.11698385715194e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GFRAL,GDNF family receptor alpha-like,37477,0.0397523607356213,0.00604888691877206,0.0278965423748281,0.0516081790964146,5.1586680928383e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,COX6B1,Cytochrome c oxidase subunit 6B1,37990,-0.0206943123124184,0.00315261362876569,-0.0268734350247992,-0.0145151896000377,5.42274644377413e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TBL1X,F-box-like/WD repeat-containing protein TBL1X,39980,-0.0539101510575594,0.00821526209190231,-0.070012064757688,-0.0378082373574309,5.47002240330195e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VAV3,Guanine nucleotide exchange factor VAV3,37541,-0.063823931684944,0.00972994739488311,-0.0828946285789149,-0.0447532347909731,5.60051742157002e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,40359,0.020099069248485,0.00306501870353287,0.0140916325895606,0.0261065059074095,5.63774330087433e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LAYN,Layilin,40192,-0.0218873222814504,0.00333915622023641,-0.0284320684731137,-0.015342576089787,5.74693258400479e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CNTN2,Contactin-2,40489,0.0285381446923281,0.00435557622705285,0.0200012152873045,0.0370750740973517,5.84638315410515e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,COL2A1,Collagen alpha-1(II) chain,37628,-0.0525531089236514,0.00802116330302056,-0.0682745889975717,-0.0368316288497311,5.89582155941702e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DARS1,"Aspartate--tRNA ligase, cytoplasmic",40192,-0.0471412648416513,0.00719768741045475,-0.0612487321661427,-0.03303379751716,5.9518528128635e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BSG,Basigin,40502,-0.0128272043450065,0.001962151137721,-0.0166730205749397,-0.00898138811507338,6.45211617423316e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD59,CD59 glycoprotein,39665,-0.014333344990915,0.00219656153754646,-0.0186386056045061,-0.010028084377324,6.99850221982793e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CTRL,Chymotrypsin-like protease CTRL-1,37942,0.0416747783751064,0.00639544475730949,0.0291397066507798,0.054209850099433,7.46112028871315e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,40442,-0.0176112266123876,0.00270681994534323,-0.0229165937052603,-0.0123058595195148,7.93430354451005e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,40400,-0.0329444349381867,0.00506707466535751,-0.0428759012822874,-0.023012968594086,8.1794087698345e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",40310,-0.0397619475430611,0.00612709536331657,-0.0517710544551616,-0.0277528406309606,8.86600747779984e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,37564,-0.0180240522464941,0.00277908697887144,-0.0234710627250821,-0.0125770417679061,9.15488329572167e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PROS1,Vitamin K-dependent protein S,38013,-0.0158488095637629,0.00244671209138529,-0.0206443652628781,-0.0110532538646477,9.6411556966432e-11
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GNAS,Neuroendocrine secretory protein 55,37959,-0.0568906563396882,0.00879212605432024,-0.0741232234061559,-0.0396580892732206,1.00956828261071e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CBS,Cystathionine beta-synthase,37628,-0.032027203919527,0.00495030294851597,-0.0417297976986183,-0.0223246101404357,1.01638222826821e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CFC1,Cryptic protein,39980,-0.0290151180606841,0.00448885590577448,-0.0378132756360021,-0.0202169604853662,1.05142705938996e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GFRA3,GDNF family receptor alpha-3,40194,0.0179246983070328,0.00277499338021526,0.0124857112818109,0.0233636853322547,1.08226239080075e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CTF1,Cardiotrophin-1,40042,-0.0530654196268382,0.00822287106331528,-0.0691822469109361,-0.0369485923427402,1.12600851331794e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,37959,-0.0503227521144592,0.00779812770496816,-0.0656070824161968,-0.0350384218127216,1.13261853788477e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD93,Complement component C1q receptor,39725,0.0198231427789829,0.00307499689804886,0.0137961488588072,0.0258501366991587,1.17852778683735e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MZT1,Mitotic-spindle organizing protein 1,39980,-0.0329937393376236,0.00512467413298007,-0.0430381006382645,-0.0229493780369827,1.24437646634832e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CNPY4,Protein canopy homolog 4,40305,-0.0465820217265038,0.00726505043202322,-0.0608215205732693,-0.0323425228797383,1.47882435913964e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MAGED1,Melanoma-associated antigen D1,39980,-0.0302835136847691,0.00472584190928017,-0.0395461638269582,-0.02102086354258,1.51622242079765e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FXYD5,FXYD domain-containing ion transport regulator 5,40044,-0.041259701888773,0.00643977993224712,-0.0538816705559773,-0.0286377332215687,1.52661649117014e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CTRC,Chymotrypsin-C,40360,0.0390951060399757,0.0061071254414055,0.027125140174821,0.0510650719051305,1.58108440360251e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VSNL1,Visinin-like protein 1,37942,-0.0233070104084797,0.00364684751684236,-0.0304548315414907,-0.0161591892754687,1.70220783434591e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IGFBP3,Insulin-like growth factor-binding protein 3,40403,-0.0169082057262599,0.00264622288193161,-0.0220948025748459,-0.011721608877674,1.70973155296253e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",40305,-0.0215334261729758,0.00337033779903793,-0.0281392882590902,-0.0149275640868615,1.71517979398572e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IST1,IST1 homolog,37812,-0.0622347627432264,0.00974627489807076,-0.0813374615434451,-0.0431320639430078,1.76500575246412e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDC26,Anaphase-promoting complex subunit CDC26,37879,-0.0437767760089939,0.00685729403887856,-0.0572170723251958,-0.0303364796927919,1.78227916726326e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ITGA6,Integrin alpha-6,40341,-0.0329382639322519,0.00516278269298627,-0.043057318010505,-0.0228192098539988,1.82053917982859e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ATP5IF1,"ATPase inhibitor, mitochondrial",40422,-0.0685044747146448,0.0107401305583039,-0.0895551306089204,-0.0474538188203693,1.83909906241253e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IGLC2,Immunoglobulin lambda constant 2,37978,-0.0151249817100798,0.0023713895133352,-0.0197729051562168,-0.0104770582639428,1.85119652142924e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL6ST,Interleukin-6 receptor subunit beta,40359,0.0108314366164862,0.00169931486576506,0.00750077947958666,0.0141620937533857,1.89228281718951e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DCN,Decorin,40042,0.0141144866568093,0.00222017443869416,0.00976294475696871,0.0184660285566498,2.10934789892618e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ITGB7,Integrin beta-7,40489,0.0281079432952623,0.00442215425759458,0.0194405209503769,0.0367753656401477,2.1243859166977e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,37901,-0.0281883012085096,0.00443433035855895,-0.0368795887112852,-0.0194970137057341,2.12604450181367e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CIRBP,Cold-inducible RNA-binding protein,37901,-0.058941836285545,0.00927358826553528,-0.0771180692859941,-0.0407656032850958,2.139207430217e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRSS22,Brain-specific serine protease 4,37598,-0.0218824963744999,0.00344371868215281,-0.0286321849915194,-0.0151328077574804,2.16254930594869e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TTF2,Transcription termination factor 2,37572,-0.030038349534291,0.00474769678586089,-0.0393438352345784,-0.0207328638340037,2.58211995361031e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,40305,-0.0580201488491944,0.00918190743240098,-0.0760166874167003,-0.0400236102816885,2.70350884825011e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BST2,Bone marrow stromal antigen 2,40471,-0.0327941458455158,0.00520056386151824,-0.0429872510140916,-0.0226010406769401,2.94063707838899e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DCTD,Deoxycytidylate deaminase,37671,-0.0580655041578381,0.00921390296024403,-0.0761247539599164,-0.0400062543557598,3.03266213872836e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FOLR1,Folate receptor alpha,40299,-0.0173687332158452,0.00275660907445712,-0.0227716870017812,-0.0119657794299093,3.04009177083601e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DPEP2,Dipeptidase 2,40305,0.0175653879497295,0.00279074851890394,0.0120955208526777,0.0230352550467812,3.17214030832543e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",40341,-0.0275806606084124,0.00438828627047222,-0.036181701698538,-0.0189796195182868,3.36263222861381e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IDO1,"Indoleamine 2,3-dioxygenase 1",37628,-0.0397071201067971,0.00632042673640508,-0.052095156510151,-0.0273190837034431,3.43989668791643e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CARHSP1,Calcium-regulated heat-stable protein 1,39961,-0.0321699399605673,0.00512782886330827,-0.0422204845326515,-0.0221193953884831,3.62156259509936e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SRC,Proto-oncogene tyrosine-protein kinase Src,40385,-0.072824272620839,0.0116178510478381,-0.0955952606746017,-0.0500532845670763,3.74382010825424e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GGACT,Gamma-glutamylaminecyclotransferase,37990,-0.043240317859053,0.00689911928387635,-0.0567625916554507,-0.0297180440626554,3.7798531522885e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IFNG,Interferon gamma,40044,-0.0691345722185448,0.0110625347029874,-0.0908171402364002,-0.0474520042006894,4.22649352264645e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GRSF1,G-rich sequence factor 1,37402,-0.0479878133930762,0.00769353712660977,-0.0630671461612314,-0.0329084806249211,4.58693761176686e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDZD2,PDZ domain-containing protein 2,37562,-0.0372482810074292,0.00598207950182349,-0.0489731568310032,-0.0255234051838551,4.91078076372905e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,39708,0.0225967127078008,0.00364100004456593,0.0154603526204516,0.0297330727951501,5.56900168460353e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OSCAR,Osteoclast-associated immunoglobulin-like receptor,40379,-0.0201437647751117,0.00325055040299486,-0.0265148435649817,-0.0137726859852418,5.89533180098885e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DTD1,D-aminoacyl-tRNA deacylase 1,37671,-0.0527025792130489,0.00851750296191161,-0.0693968850183957,-0.0360082734077022,6.29058505811345e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCL20,C-C motif chemokine 20,40516,-0.0533150015154518,0.00861903325994346,-0.070208306704941,-0.0364216963259627,6.33130637757965e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HMOX2,Heme oxygenase 2,39961,-0.0274348553942412,0.00443651018098774,-0.0361304153489772,-0.0187392954395052,6.41115156506235e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TCOF1,Treacle protein,37990,-0.0181926549135289,0.00294547657449281,-0.0239657889995348,-0.012419520827523,6.74255503120493e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CPXM2,Inactive carboxypeptidase-like protein X2,37990,-0.0151215866630111,0.00244970360868777,-0.0199230057360391,-0.0103201675899831,6.89965786677235e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ASRGL1,Isoaspartyl peptidase/L-asparaginase,37628,-0.0616120192683613,0.00998165710085344,-0.0811760671860341,-0.0420479713506886,6.9180161656271e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MPO,Myeloperoxidase,40332,-0.0280500800921571,0.00454497757990096,-0.0369582361487629,-0.0191419240355512,6.9215075808819e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SEMA4C,Semaphorin-4C,40305,0.0170020648284177,0.00275608065752227,0.011600146739674,0.0224039829171614,7.04234634575532e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SEZ6,Seizure protein 6 homolog,37572,0.0188574690213316,0.0030565791157139,0.0128665739545323,0.0248483640881308,7.05349754732265e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ITGAL,Integrin alpha-L,37598,-0.0261898671672543,0.00424554341845469,-0.0345111322674255,-0.0178686020670831,7.08332516515471e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CXCL1,Growth-regulated alpha protein,40329,-0.0582020674665703,0.00944435872255876,-0.0767130105627854,-0.0396911243703551,7.32749403996645e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SEPTIN8,Septin-8,37921,-0.0191145927013944,0.00310514472941322,-0.0252006763710443,-0.0130285090317445,7.68289072780595e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GP1BA,Platelet glycoprotein Ib alpha chain,40283,-0.019255543627033,0.00313513471568492,-0.0254004076697755,-0.0131106795842906,8.35120146964368e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,37635,0.0291519255865605,0.00474603543228873,0.0198496961392746,0.0384541550338464,8.36353241378405e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,39980,-0.0345493283693147,0.00562857624884058,-0.0455813378170422,-0.0235173189215872,8.54903524740326e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DCTN6,Dynactin subunit 6,39961,-0.0422242333075042,0.00688528448565646,-0.0557193908993908,-0.0287290757156175,8.85881799767053e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NARS1,"Asparagine--tRNA ligase, cytoplasmic",37959,-0.0284244648306364,0.00463892900411219,-0.0375167656786963,-0.0193321639825765,9.18229727439845e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,37562,-0.0166916953030511,0.00272681483261212,-0.0220362523749708,-0.0113471382311313,9.54537677229483e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,40341,-0.0597679154739506,0.00976922226713617,-0.0789155911175375,-0.0406202398303637,9.69900436095855e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NFAT5,Nuclear factor of activated T-cells 5,37598,-0.0521279194938423,0.00852583212958467,-0.0688385504678282,-0.0354172885198563,9.9844173744022e-10
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,APOA2,Apolipoprotein A-II,37987,0.0283592523667343,0.00464125274749664,0.0192623969816408,0.0374561077518277,1.0219867953171e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL2RA,Interleukin-2 receptor subunit alpha,40208,-0.0239480468502028,0.00392125812796066,-0.0316337127810057,-0.0162623809193999,1.03751751974906e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ERI1,3'-5' exoribonuclease 1,37714,-0.0200044729542554,0.00327943172655433,-0.0264321591383019,-0.0135767867702089,1.09031553081177e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SNX5,Sorting nexin-5,37628,-0.0178221202423736,0.00292349799580029,-0.0235521763141422,-0.012092064170605,1.11679247073284e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SNX9,Sorting nexin-9,40359,-0.040637764647465,0.00667443610242547,-0.0537196594082189,-0.027555869886711,1.16541820191148e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HAVCR1,Hepatitis A virus cellular receptor 1,40470,-0.0360691748991812,0.00593485268533218,-0.0477014861624323,-0.0244368636359301,1.24821689647941e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AKR1C4,Aldo-keto reductase family 1 member C4,40042,-0.0326876473565894,0.00539950594405151,-0.0432706790069303,-0.0221046157062484,1.44691614986893e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ATP6V1F,V-type proton ATPase subunit F,39925,-0.0388598318892158,0.00642987078522819,-0.051462378628263,-0.0262572851501685,1.54131889937254e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KLK13,Kallikrein-13,40032,-0.025508875131415,0.004222157434489,-0.0337843037030135,-0.0172334465598166,1.55999997227265e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HPCAL1,Hippocalcin-like protein 1,40516,-0.0429453216217572,0.0071250049961226,-0.0569103314141575,-0.0289803118293569,1.70251023025215e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HSPB1,Heat shock protein beta-1,40116,-0.0396571843990444,0.00657949231513061,-0.0525529893367004,-0.0267613794613884,1.70362342375763e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDH6,Cadherin-6,40359,0.022221621517474,0.00368791866703527,0.0149933009300849,0.0294499421048631,1.7228584580331e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,37901,0.0405883793359113,0.00673818329213474,0.0273815400833272,0.0537952185884954,1.74989514519402e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PPM1F,Protein phosphatase 1F,37990,-0.0306781993136908,0.00509590525504021,-0.0406661736135696,-0.020690225013812,1.78743843875209e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CHRDL2,Chordin-like protein 2,40359,-0.0333130236189334,0.0055372673747326,-0.0441660676734093,-0.0224599795644575,1.82530402199581e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ZBP1,Z-DNA-binding protein 1,37598,-0.0235806814355022,0.00392245804779841,-0.0312686992091871,-0.0158926636618173,1.88440187572443e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SIGLEC1,Sialoadhesin,40422,-0.0252435929396926,0.00421335349564411,-0.033501765791155,-0.0169854200882301,2.12601548825417e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SEMA4D,Semaphorin-4D,40471,-0.017335878784788,0.00289704411961404,-0.0230140852592316,-0.0116576723103445,2.22378386018209e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ACRBP,Acrosin-binding protein,37900,-0.0220333410181173,0.00368507416465483,-0.0292560863808408,-0.0148105956553939,2.30093374911611e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PNMA1,Paraneoplastic antigen Ma1,37628,-0.0325902071552772,0.00545139518173437,-0.0432749417114765,-0.0219054725990778,2.31275034926383e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ARL13B,ADP-ribosylation factor-like protein 13B,37562,-0.0404842339653102,0.00677307403262307,-0.0537594590692514,-0.027209008861369,2.32856047660509e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",37990,-0.0314588591568005,0.00527467839075569,-0.0417972288026816,-0.0211204895109193,2.52073963188951e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,40422,0.0240444190421326,0.00403695204804811,0.0161319930279583,0.0319568450563069,2.63777772166332e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OGN,Mimecan,40332,-0.0235756249041384,0.0039597196609715,-0.0313366754396425,-0.0158145743686342,2.67406560553868e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,39961,-0.0649923064831371,0.0109230896708562,-0.0864015622380153,-0.0435830507282589,2.73926858863406e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EPHB4,Ephrin type-B receptor 4,40536,-0.0142584278932171,0.00239678311618144,-0.0189561228009328,-0.00956073298550153,2.75404853122519e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLC51B,Organic solute transporter subunit beta,37562,-0.0462123923019246,0.00776902896035381,-0.0614396890642181,-0.0309850955396312,2.77872418037601e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RANBP1,Ran-specific GTPase-activating protein,37628,-0.0308042033895461,0.00518011376619779,-0.0409572263712938,-0.0206511804077985,2.8065642510163e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ELOB,Elongin-B,37562,-0.0232500642763376,0.00391135412319709,-0.0309163183578039,-0.0155838101948713,2.84784476587173e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL22RA1,Interleukin-22 receptor subunit alpha-1,40044,-0.025255053798877,0.00425079655868139,-0.0335866150538926,-0.0169234925438615,2.88874931739836e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TSPAN8,Tetraspanin-8,37901,-0.0601750095286942,0.0101290415181818,-0.0800279309043305,-0.040322088153058,2.90573139567482e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ANXA11,Annexin A11,40312,-0.0388137556543698,0.00654020326754848,-0.0516325540587648,-0.0259949572499748,3.00625477555069e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL7,Interleukin-7,40341,-0.0371063476240056,0.00625783342072468,-0.049371701128626,-0.0248409941193852,3.09998230256012e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CENPF,Centromere protein F,37714,-0.0315461076377696,0.00532972223041164,-0.0419923632093765,-0.0210998520661628,3.32101548540233e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MCFD2,Multiple coagulation factor deficiency protein 2,40291,-0.024831118897931,0.00419759112019889,-0.0330583974935209,-0.0166038403023412,3.37553516814364e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,40341,-0.0864568531104013,0.0146255825081533,-0.115122994826382,-0.0577907113944208,3.46275434133657e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CYB5R2,NADH-cytochrome b5 reductase 2,37746,-0.0320299226657717,0.00542641606569977,-0.0426656981545432,-0.0213941471770002,3.6655496783606e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",40042,-0.0504198006204086,0.00854674606357533,-0.0671714229050162,-0.0336681783358009,3.72610705846084e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TDP1,Tyrosyl-DNA phosphodiesterase 1,37900,-0.0377446250259107,0.00639818741319591,-0.0502850723557747,-0.0252041776960467,3.73893458658992e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SMS,Spermine synthase,37541,-0.0368293875306596,0.00624757387684089,-0.0490746323292677,-0.0245841427320514,3.8393366088322e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SORBS1,Sorbin and SH3 domain-containing protein 1,37959,-0.0227843859912154,0.0038690370294306,-0.0303676985688994,-0.0152010734135315,3.98005901268542e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EHD3,EH domain-containing protein 3,37628,-0.0671898032499963,0.0114148033259515,-0.0895628177688612,-0.0448167887311315,4.04791701895475e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,C8B,Complement component C8 beta chain,38013,0.0175397198069813,0.00298156747561157,0.0116958475547826,0.0233835920591799,4.13097808362682e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FBP1,"Fructose-1,6-bisphosphatase 1",40359,-0.0413403288853294,0.00704003245144357,-0.0551387924901588,-0.0275418652805,4.38675053527248e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,37901,-0.0453416772938339,0.00773028490899131,-0.0604930357154568,-0.0301903188722109,4.58413850241156e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,STX6,Syntaxin-6,39980,-0.039206924834485,0.00669651087442766,-0.0523320861483633,-0.0260817635206068,4.87138022693803e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",40044,-0.040974144304666,0.00700507618458637,-0.0547040936264553,-0.0272441949828768,5.03809690556817e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CERT,Ceramide transfer protein,39961,-0.0350031232568926,0.00598438360405532,-0.0467325151208411,-0.0232737313929442,5.04256288065838e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RAB44,Ras-related protein Rab-44,37900,-0.0227109545487593,0.00388282406160623,-0.0303212897095075,-0.0151006193880111,5.05783748450086e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PCDH9,Protocadherin-9,37901,-0.0192224182454195,0.00329368070633598,-0.025678032429838,-0.012766804061001,5.46512681093513e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CTSV,Cathepsin L2,40444,0.0240246796898527,0.00412298002503207,0.0159436388407898,0.0321057205389155,5.7511408577995e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CORO1A,Coronin-1A,39990,-0.0507886361213091,0.00873993082736395,-0.0679189005429424,-0.0336583716996757,6.32780144486212e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GBP1,Guanylate-binding protein 1,37931,-0.0364192621662252,0.00626852796315964,-0.0487055769740181,-0.0241329473584323,6.39376304128615e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GET3,ATPase GET3,37990,-0.0317775329965865,0.00547267816341569,-0.0425039821968813,-0.0210510837962918,6.51930354620038e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KITLG,Kit ligand,40359,0.0205394717263756,0.00353882529507819,0.0136033741480224,0.0274755693047289,6.59693067094876e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,37959,-0.0386358404219535,0.00665863280450628,-0.0516867607187858,-0.0255849201251212,6.6850808712648e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",37990,-0.0172627559260929,0.00297595943137329,-0.0230956364115845,-0.0114298754406012,6.74997379452023e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CHCHD6,MICOS complex subunit MIC25,37900,-0.0163754106304216,0.00282388860610862,-0.0219102322983944,-0.0108405889624487,6.82564759737652e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CHM,Rab proteins geranylgeranyltransferase component A 1,37572,-0.0345775079915563,0.00596928787908012,-0.0462773122345533,-0.0228777037485592,7.09080867160497e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LPCAT2,Lysophosphatidylcholine acyltransferase 2,40305,-0.0209453211951604,0.00361881163527326,-0.028038192000296,-0.0138524503900248,7.2618099107179e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HGFAC,Hepatocyte growth factor activator,37849,0.0163657612663866,0.00282929104043966,0.0108203508271248,0.0219111717056483,7.43953290250723e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DSC2,Desmocollin-2,40177,-0.0189665663116627,0.00328123866145387,-0.0253977940881123,-0.0125353385352131,7.59774069080032e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FN1,Fibronectin,38013,-0.014774025897921,0.00255601015450583,-0.0197838058007524,-0.00976424599508954,7.62928972655604e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCN5,CCN family member 5,40332,-0.0220441252291191,0.00381492429818048,-0.0295213768535529,-0.0145668736046854,7.68314477410645e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EDF1,Endothelial differentiation-related factor 1,37959,-0.0391604068797731,0.00678363292394988,-0.0524563274107149,-0.0258644863488313,7.96887770709382e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCGN,Secretagogin,40044,-0.0246079681995648,0.00427423216793148,-0.0329854632487105,-0.0162304731504191,8.70863265419202e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MMP12,Macrophage metalloelastase,40346,-0.0289455819701492,0.00502793360721909,-0.0388003318402987,-0.0190908320999998,8.72254806524347e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LGALS7_LGALS7B,Galectin-7,40270,-0.0224848465669848,0.00390576859006098,-0.0301401530035043,-0.0148295401304653,8.72969172539527e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD109,CD109 antigen,40332,0.018704345829787,0.00324973364025224,0.0123348678948926,0.0250738237646814,8.7898860425738e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCDC134,Coiled-coil domain-containing protein 134,37900,-0.0275018267597344,0.00478253744885223,-0.0368756001594848,-0.0181280533599841,9.09318050292621e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ARAF,Serine/threonine-protein kinase A-Raf,37714,-0.0376856529898898,0.00655495955375425,-0.0505333737152481,-0.0248379322645315,9.16519409805827e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GAL,Galanin peptides,40422,0.034840174938515,0.00607475361503252,0.0229336578530513,0.0467466920239788,9.91355662768459e-09
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MASP1,Mannan-binding lectin serine protease 1,40192,-0.0132432867099895,0.00230974053102294,-0.0177703781507945,-0.00871619526918458,1.00083627258409e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FAM172A,Cotranscriptional regulator FAM172A,37628,-0.0345237119100688,0.00602203822427625,-0.0463269068296503,-0.0227205169904874,1.00895873915332e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AHSP,Alpha-hemoglobin-stabilizing protein,40311,-0.0488213415412903,0.00852116648446982,-0.0655228278508511,-0.0321198552317294,1.02603380354668e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NELL2,Protein kinase C-binding protein NELL2,40422,0.0157266019787229,0.0027488732290393,0.0103388104498059,0.02111439350764,1.07727550217604e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MSR1,Macrophage scavenger receptor types I and II,40471,-0.0248096094523765,0.00434276874105547,-0.0333214361848452,-0.0162977827199078,1.13069404083676e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,INPP1,Inositol polyphosphate 1-phosphatase,40305,-0.0298888639062859,0.00523246731534648,-0.040144499844365,-0.0196332279682068,1.13530358434234e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MPI,Mannose-6-phosphate isomerase,40305,-0.0475914698725834,0.00834463475063583,-0.0639469539838297,-0.0312359857613372,1.19646081470897e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SMARCA2,Probable global transcription activator SNF2L2,39961,-0.0405970997606415,0.00712660154856099,-0.054565238795821,-0.0266289607254619,1.24468609851433e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FRMD4B,FERM domain-containing protein 4B,37562,-0.0390784843078791,0.00686072471600555,-0.05252550475125,-0.0256314638645083,1.2530819799112e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GP5,Platelet glycoprotein V,37671,-0.0199486490559092,0.00350368254880802,-0.026815866851573,-0.0130814312602455,1.27017195787746e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRKG1,cGMP-dependent protein kinase 1,37671,-0.069416573126684,0.0122147980440458,-0.0933575772930138,-0.0454755689603542,1.35155488394191e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CHRDL1,Chordin-like protein 1,40396,0.0168657869038618,0.00296941294615558,0.0110457375293969,0.0226858362783267,1.37173741633274e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AMFR,E3 ubiquitin-protein ligase AMFR,39961,-0.0356147009768683,0.00627728941401775,-0.0479181882283431,-0.0233112137253935,1.42341853775412e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,REG1A,Lithostathine-1-alpha,40274,-0.0269463933867301,0.00475059278913097,-0.0362575552534268,-0.0176352315200334,1.43426440228461e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NPTX2,Neuronal pentraxin-2,37998,0.0179959736690271,0.00318129842222874,0.0117606287614588,0.0242313185765954,1.57340623106515e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HSPA2,Heat shock-related 70 kDa protein 2,37900,-0.0182705154447311,0.00323653380771025,-0.0246141217078432,-0.011926909181619,1.68435676782116e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",37628,-0.0201149909009779,0.00356678967908926,-0.0271058986719929,-0.013124083129963,1.74028280025934e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OSMR,Oncostatin-M-specific receptor subunit beta,40424,0.0115281824364089,0.00204554556870186,0.00751891312175326,0.0155374517510645,1.77242689287186e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DBN1,Drebrin,37598,-0.0283675072408118,0.00503727520467582,-0.0382405666419764,-0.0184944478396472,1.82290760535791e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ATRAID,All-trans retinoic acid-induced differentiation factor,37901,-0.0149659154188084,0.00266155799052671,-0.0201825690802407,-0.00974926175737606,1.91416185034209e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SART1,U4/U6.U5 tri-snRNP-associated protein 1,37562,-0.0195706075714809,0.00348414068208601,-0.0263995233083694,-0.0127416918345923,1.98191922087082e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PLA2G4A,Cytosolic phospholipase A2,40422,-0.0473057469557196,0.0084638092238183,-0.0638948130344035,-0.0307166808770357,2.31876359251609e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SIGLEC10,Sialic acid-binding Ig-like lectin 10,40341,-0.0182504022368563,0.00326556138483168,-0.0246509025511264,-0.0118499019225862,2.32469868175147e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,37714,-0.0201443170244621,0.00360639238198282,-0.0272128460931484,-0.0130757879557757,2.37305297406412e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SV2A,Synaptic vesicle glycoprotein 2A,37572,-0.0336538900057318,0.00602893006511956,-0.0454705929333662,-0.0218371870780975,2.42391812725952e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,37628,-0.0257546740749337,0.00461549267948291,-0.0348010397267201,-0.0167083084231472,2.45193757910109e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCRIB,Protein scribble homolog,37628,-0.0506104281165417,0.00907408386616514,-0.0683956324942254,-0.032825223738858,2.48846900205372e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCG3,Secretogranin-3,40379,0.0181036249915926,0.0032476121904652,0.0117383050982808,0.0244689448849044,2.52355102792708e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDGFRA,Platelet-derived growth factor receptor alpha,40359,0.0154240625211432,0.00276973344081634,0.00999538497714316,0.0208527400651432,2.6066706597259e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BTC,Probetacellulin,39980,-0.0407813336682505,0.00732672288866518,-0.0551417105300343,-0.0264209568064668,2.64803036673679e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FABP2,"Fatty acid-binding protein, intestinal",40359,0.0418224139911079,0.00751772360001724,0.0270876757350741,0.0565571522471417,2.69180503414201e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PKN3,Serine/threonine-protein kinase N3,37714,-0.0418143457255231,0.007529212862687,-0.0565716029363896,-0.0270570885146565,2.85204222840325e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PLB1,"Phospholipase B1, membrane-associated",37942,0.0328049186050325,0.00591651399890075,0.0212085511671871,0.044401286042878,3.00099612205681e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PADI4,Protein-arginine deiminase type-4,39934,-0.0374605678955826,0.00676748247258997,-0.050724833541859,-0.0241963022493063,3.15604830874793e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GPA33,Cell surface A33 antigen,40305,-0.0732886140716698,0.0132583239865254,-0.0992749290852595,-0.0473022990580801,3.29493999949808e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CSF2,Granulocyte-macrophage colony-stimulating factor,37562,-0.0192026262463063,0.00348075571277106,-0.0260249074433376,-0.012380345049275,3.51776846486004e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",37959,-0.0254620271683053,0.00462541336744818,-0.0345278373685038,-0.0163962169681069,3.76305404363723e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SIGLEC6,Sialic acid-binding Ig-like lectin 6,40489,-0.0180797687427913,0.00328465766881605,-0.0245176977736707,-0.0116418397119118,3.76305441825758e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NPTXR,Neuronal pentraxin receptor,40359,0.0181638125491336,0.0033028889440982,0.0116901502187011,0.0246374748795661,3.87021938040978e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GIMAP8,GTPase IMAP family member 8,37482,-0.0277504254626779,0.00504828656067941,-0.0376450671216096,-0.0178557838037463,3.93575390492852e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AKT2,RAC-beta serine/threonine-protein kinase,37959,-0.0672115832217376,0.0122336895765973,-0.0911896147918683,-0.0432335516516069,4.00099867427017e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LY96,Lymphocyte antigen 96,40228,-0.0185189417273875,0.00337493730707833,-0.0251338188492611,-0.011904064605514,4.14655899156081e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MANF,Mesencephalic astrocyte-derived neurotrophic factor,40422,-0.0633261864710717,0.011546965422497,-0.0859582386991659,-0.0406941342429776,4.21586250308304e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,37942,-0.033292232469044,0.00607266967481091,-0.0451946650316733,-0.0213897999064146,4.27363401282373e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCN4B,Sodium channel subunit beta-4,37628,-0.0224104371879099,0.00409112135828675,-0.0304290350501519,-0.0143918393256679,4.38491371124096e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ABHD14B,Protein ABHD14B,40171,-0.0311423356952605,0.00568670378549043,-0.0422882751148218,-0.0199963962756993,4.40870000156697e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SERPINF2,Alpha-2-antiplasmin,37755,-0.00724480718241279,0.00132432414280284,-0.00984048250230636,-0.00464913186251922,4.56700838096876e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DNAJC21,DnaJ homolog subfamily C member 21,37942,-0.0200429218116007,0.00366438944953315,-0.0272251251326856,-0.0128607184905157,4.58961350236195e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AKAP12,A-kinase anchor protein 12,37671,0.0116545687541431,0.00213078224869554,0.0074782355466998,0.0158309019615863,4.59201150415293e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PAMR1,Inactive serine protease PAMR1,40332,-0.0148254895123935,0.0027130470132613,-0.0201430616583857,-0.00950791736640134,4.71160950026265e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ENG,Endoglin,40536,0.00905865044896009,0.00165932845917568,0.00580636666897576,0.0123109342289444,4.85295317409325e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AKR1B1,Aldo-keto reductase family 1 member B1,39980,-0.0407543235457359,0.00746580618292103,-0.0553873036642611,-0.0261213434272107,4.86723890519657e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PLXDC2,Plexin domain-containing protein 2,37942,0.0142136926291104,0.00260551418432999,0.00910688482782366,0.0193205004303972,4.97702973921782e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SUSD5,Sushi domain-containing protein 5,37604,0.0182290579007492,0.0033450948732004,0.0116726719492764,0.0247854438522219,5.14245843948648e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,40042,0.0169939959281213,0.00312490144416683,0.0108691890975543,0.0231188027586882,5.46164555920858e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ATXN10,Ataxin-10,39961,-0.0383392550635079,0.00705399561139663,-0.0521650864618453,-0.0245134236651705,5.55890069917509e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,C7,Complement component C7,37678,0.0167293959908801,0.00307939874104713,0.0106937744584278,0.0227650175233325,5.64954134331345e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TSPYL1,Testis-specific Y-encoded-like protein 1,37598,-0.0214572509083924,0.00395569259187134,-0.0292104083884602,-0.0137040934283246,5.91793251493266e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RILPL2,RILP-like protein 2,37990,-0.05126984964685,0.0094744064296288,-0.0698396862489225,-0.0327000130447776,6.35965895511648e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLAMF8,SLAM family member 8,39980,-0.0281302052412789,0.00520816400934136,-0.038338206699588,-0.0179222037829698,6.71802020264416e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,40228,-0.013429702312875,0.00248726582704677,-0.0183047433338867,-0.00855466129186333,6.78376203972877e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FADD,FAS-associated death domain protein,40359,-0.0400241994002407,0.00742099656073559,-0.0545693526592824,-0.0254790461411989,7.01350846830733e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SMPD1,Sphingomyelin phosphodiesterase,40380,-0.0249007030629748,0.00461782877363064,-0.0339516474592909,-0.0158497586666587,7.0554330116787e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL17C,Interleukin-17C,40044,-0.0368459741917331,0.0068364275968605,-0.0502453722815796,-0.0234465761018865,7.16198723953534e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MRI1,Methylthioribose-1-phosphate isomerase,37572,-0.0361809684863674,0.00672564643548097,-0.0493632354999101,-0.0229987014728247,7.59531109325017e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ACVRL1,Serine/threonine-protein kinase receptor R3,40203,-0.0126248253417298,0.00235340071693066,-0.0172374907469139,-0.00801215993654571,8.23191772161603e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,APRT,Adenine phosphoribosyltransferase,40216,-0.0252665289203946,0.0047105556363795,-0.0344992179676984,-0.0160338398730908,8.26339472502876e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FGA,Fibrinogen alpha chain,37698,0.0161170203560895,0.00300931789278649,0.0102187572862279,0.022015283425951,8.66473749901387e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPAG1,Sperm-associated antigen 1,37959,-0.0300486719827433,0.00561312786568376,-0.0410504025994835,-0.0190469413660031,8.77845181891345e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,JAM2,Junctional adhesion molecule B,40471,-0.0135218680290199,0.00253720217332178,-0.0184947842887305,-0.00854895176930917,9.98496651821389e-08
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SFTPD,Pulmonary surfactant-associated protein D,40359,-0.034373856429224,0.00646023171985861,-0.0470359106001468,-0.0217118022583011,1.04689054285629e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCL18,C-C motif chemokine 18,40172,-0.036383953900155,0.00683920469076442,-0.0497887950940533,-0.0229791127062568,1.05241169598982e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ECI2,Enoyl-CoA delta isomerase 2,37562,-0.0325409170330031,0.00611637906506257,-0.0445290200005257,-0.0205528140654804,1.05306003690665e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,B4GAT1,"Beta-1,4-glucuronyltransferase 1",40332,0.012478715935839,0.00234575612638074,0.00788103392813273,0.0170763979435452,1.05348828241247e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,39980,-0.0350079241393516,0.00659786934620133,-0.0479397480579062,-0.022076100220797,1.13630708492821e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DIPK2B,Divergent protein kinase domain 2B,37671,0.0138418675004117,0.00261014930361473,0.0087259748653268,0.0189577601354965,1.15690688059956e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FCAR,Immunoglobulin alpha Fc receptor,40341,-0.0242467109755657,0.00457448882188964,-0.0332127090664694,-0.015280712884662,1.17080755212982e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRSS27,Serine protease 27,40314,-0.0208170829337984,0.00393213652560346,-0.0285240705239812,-0.0131100953436156,1.21204578751933e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,37671,-0.0326166272627996,0.00616814741442543,-0.0447061961950734,-0.0205270583305257,1.25691054823379e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RPE,Ribulose-phosphate 3-epimerase,37714,-0.0360065036999944,0.00682107583563421,-0.0493758123378374,-0.0226371950621513,1.32146303157083e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CPQ,Carboxypeptidase Q,37986,-0.0187658561255026,0.00355639650169653,-0.0257363932688278,-0.0117953189821774,1.33597829504479e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AHCY,Adenosylhomocysteinase,40359,-0.0347459644366347,0.00659143391706296,-0.0476651749140781,-0.0218267539591913,1.37169697174283e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AK2,"Adenylate kinase 2, mitochondrial",37942,-0.0540766468745061,0.0102753118124814,-0.0742162580269697,-0.0339370357220426,1.44072219322087e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BLVRB,Flavin reductase,40332,-0.0339339493662864,0.00645167525058551,-0.046579232857434,-0.0212886658751388,1.46153963056045e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,STK4,Serine/threonine-protein kinase 4,40359,-0.0439228414600093,0.00835689858430637,-0.0603023626852498,-0.0275433202347688,1.49222721422541e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TGFBR3,Transforming growth factor beta receptor type 3,40536,0.0168915524254939,0.0032164684855226,0.0105872741938696,0.0231958306571182,1.52717488644408e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TPMT,Thiopurine S-methyltransferase,39980,-0.0377887918814024,0.00719710647376793,-0.0518951205699875,-0.0236824631928172,1.53641933331189e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ANXA1,Annexin A1,37608,-0.0212742696734916,0.0040523552755817,-0.0292168860136317,-0.0133316533333514,1.54590075474064e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GNPDA2,Glucosamine-6-phosphate isomerase 2,37671,-0.0186654116537816,0.00355599680588894,-0.0256351653933239,-0.0116956579142393,1.55298318808562e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TXN,Thioredoxin,37819,-0.0227781986027633,0.00434622177659937,-0.031296793284898,-0.0142596039206285,1.62209819472724e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SELENOP,Selenoprotein P,38013,0.0115630540460411,0.00220683855556293,0.0072376504771377,0.0158884576149444,1.63295178161004e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KIF22,Kinesin-like protein KIF22,37562,-0.0624269222824105,0.0119152313748212,-0.0857807757770602,-0.0390730687877609,1.6372589299736e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,C1S,Complement C1s subcomponent,38013,-0.0105764612571596,0.00202387002439209,-0.0145432465049681,-0.00660967600935112,1.75918549767485e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LAMP1,Lysosome-associated membrane glycoprotein 1,37621,-0.0146041416425623,0.00279539397201696,-0.0200831138277155,-0.00912516945740903,1.77426022029264e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GIPC3,PDZ domain-containing protein GIPC3,37901,-0.0496976047966939,0.00952801141720543,-0.0683725071744165,-0.0310227024189713,1.85595196968002e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,37959,-0.0339297161742122,0.00650662837156545,-0.0466827077824805,-0.0211767245659439,1.86895571323698e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCRG1,Scrapie-responsive protein 1,37990,-0.0139471787939025,0.00267537632267302,-0.0191909163863416,-0.00870344120146339,1.88377518765816e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,COL9A1,Collagen alpha-1(IX) chain,40341,0.0238973808092644,0.00458590670628848,0.0149090036649389,0.0328857579535898,1.90125448133183e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RSPO3,R-spondin-3,40489,-0.0144678734778159,0.00277699752336716,-0.0199107886236155,-0.00902495833201626,1.9128406718887e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PSMD9,26S proteasome non-ATPase regulatory subunit 9,40305,-0.0277401258862538,0.00534449468167248,-0.0382153354623319,-0.0172649163101757,2.12420351472437e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPRR3,Small proline-rich protein 3,37942,-0.0359558702838895,0.00693798792120581,-0.0495543266094529,-0.0223574139583261,2.22134692467388e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,C2,Complement C2,40372,-0.0120929158023666,0.00233416258370074,-0.01666787446642,-0.00751795713831313,2.2358846734414e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,WASF3,Wiskott-Aldrich syndrome protein family member 3,39961,-0.0421973132767626,0.0081551746182793,-0.05818145552859,-0.0262131710249352,2.31620448511748e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NID1,Nidogen-1,40355,-0.0198484679438371,0.00385232696314465,-0.0273990287916006,-0.0122979070960736,2.60343527542419e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PARD3,Partitioning defective 3 homolog,37714,-0.0371793985478745,0.00724414117574668,-0.051377915252338,-0.022980881843411,2.90207357894691e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL15RA,Interleukin-15 receptor subunit alpha,40044,-0.0177979895503115,0.00346998179351679,-0.0245991538656044,-0.0109968252350186,2.94572589200458e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,37942,-0.0238908226929551,0.00466301841700472,-0.0330303387902843,-0.0147513065956258,3.04108790719424e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,WAS,Wiskott-Aldrich syndrome protein,40044,-0.0339979752216839,0.00663977059454914,-0.0470119255870002,-0.0209840248563676,3.08594076721625e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CASP1,Caspase-1,39961,-0.0335201116549236,0.00655169925242883,-0.0463614421896841,-0.0206787811201631,3.15394397835808e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AXL,Tyrosine-protein kinase receptor UFO,40403,0.0136798520010092,0.00268067026582095,0.00842573828000018,0.0189339657220183,3.37890149005733e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HMBS,Porphobilinogen deaminase,40489,-0.022536100628244,0.00441743731922145,-0.031194277773918,-0.0138779234825699,3.4059568305523e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD70,CD70 antigen,40341,0.0205856979899457,0.00404343763953109,0.0126605602164647,0.0285108357634266,3.59988446511684e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AK1,Adenylate kinase isoenzyme 1,40359,-0.0316476638907214,0.00621689321495769,-0.0438327745920384,-0.0194625531894043,3.61020746318931e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SUGT1,Protein SGT1 homolog,39980,-0.0402464048830997,0.00791310908927745,-0.0557560986980835,-0.0247367110681159,3.69872059349536e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RAD23B,UV excision repair protein RAD23 homolog B,39980,-0.023552936186753,0.00463327987058132,-0.0326341647330924,-0.0144717076404136,3.74996042708233e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MTIF3,"Translation initiation factor IF-3, mitochondrial",37901,-0.0431931331335772,0.00850380366926224,-0.0598605883253311,-0.0265256779418232,3.83956729047043e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,S100G,Protein S100-G,37959,0.0220424534149579,0.00434135662777665,0.0135333944245157,0.0305515124054002,3.8789320985073e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,37900,-0.0270493538077416,0.0053306119310315,-0.0374973531925633,-0.0166013544229198,3.94024105220604e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FAP,Prolyl endopeptidase FAP,40536,0.0133510917110856,0.00263224153802938,0.00819189829654806,0.0185102851256232,3.9774780529987e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HDGF,Hepatoma-derived growth factor,40471,-0.0470185561333899,0.00927319222695022,-0.0651940128982123,-0.0288430993685675,4.01463085626311e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SWAP70,Switch-associated protein 70,37901,-0.0173529458108639,0.00342706700953961,-0.0240699971495616,-0.0106358944721663,4.17078867117059e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,APPL2,DCC-interacting protein 13-beta,37671,-0.0549049553144933,0.0108922404722298,-0.0762537466400637,-0.0335561639889229,4.69868283075214e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDH15,Cadherin-15,40435,-0.021685772610451,0.00430481798842046,-0.0301232158677551,-0.0132483293531469,4.76648150819787e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CRYM,Ketimine reductase mu-crystallin,37541,-0.0379233467971312,0.00753569939137576,-0.0526933176042277,-0.0231533759900347,4.90571610130852e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TST,Thiosulfate sulfurtransferase,39923,-0.0370433703747397,0.0073798013876967,-0.0515077810946252,-0.0225789596548542,5.23648222129421e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AMOTL2,Angiomotin-like protein 2,37855,-0.0234836501811336,0.00468593585121475,-0.0326680844495145,-0.0142992159127527,5.46911546875259e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PI16,Peptidase inhibitor 16,37987,0.0120551182392557,0.00240647229522411,0.00733843254061646,0.016771803937895,5.52721842103922e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",37628,-0.0244884499999155,0.0048982712013806,-0.0340890615546215,-0.0148878384452096,5.82461333684125e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FCER2,Low affinity immunoglobulin epsilon Fc receptor,40332,-0.0236226434317439,0.00472579422950924,-0.032885200121582,-0.0143600867419058,5.83445575428382e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NAA10,N-alpha-acetyltransferase 10,37562,-0.0250045348463404,0.00500300287985763,-0.0348104204908614,-0.0151986492018195,5.87042451902157e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,XRCC4,DNA repair protein XRCC4,39961,-0.0180841026583373,0.00362695319835791,-0.0251929309271188,-0.0109752743895558,6.22976642534033e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,37901,-0.0247749289612099,0.00497423562684546,-0.034524430789827,-0.0150254271325928,6.41572728071513e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DHPS,Deoxyhypusine synthase,37900,-0.0199751240835048,0.00401161543376067,-0.0278378903336757,-0.0121123578333339,6.4598501245741e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,37628,-0.0201478794700153,0.00404970352670032,-0.0280852983823479,-0.0122104605576826,6.60197305352012e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TREML1,Trem-like transcript 1 protein,37987,-0.0255604430066966,0.00514834384245554,-0.0356511969379095,-0.0154696890754837,6.96132180046938e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FCRL6,Fc receptor-like protein 6,40341,-0.0325464780413057,0.00656739583111397,-0.0454185738702891,-0.0196743822123223,7.27874421049016e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",37990,-0.0427535793325973,0.00862786834210166,-0.0596642012831165,-0.025842957382078,7.30957828586715e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPON1,Spondin-1,40379,0.0158255001680152,0.00320309972170102,0.0095474247134812,0.0221035756225492,7.86394745596981e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NFYA,Nuclear transcription factor Y subunit alpha,37562,-0.0185052557451428,0.00374868613162882,-0.0258526805631353,-0.0111578309271504,8.0529965551385e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LIF,Leukemia inhibitory factor,39961,-0.0252706606746849,0.00512950531404997,-0.0353244910902228,-0.015216830259147,8.45656889265849e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CRH,Corticoliberin,39947,-0.0414956463442098,0.00845647200843364,-0.0580703314807398,-0.0249209612076799,9.34343706542122e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RTBDN,Retbindin,40305,-0.0139653402415596,0.00284608607630093,-0.0195436689511094,-0.00838701153200977,9.3465862639883e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,APOE,Apolipoprotein E,38013,0.03591825379839,0.00732033890019122,0.0215703895540152,0.0502661180427648,9.37266750184567e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BAP18,Chromatin complexes subunit BAP18,37942,-0.0309646390700242,0.00631200373417914,-0.0433361663890154,-0.0185931117510331,9.41926750233619e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SF3B4,Splicing factor 3B subunit 4,40305,-0.0350025655577658,0.00713604964936535,-0.0489892228705219,-0.0210159082450097,9.43373235736053e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,40517,-0.0129709463768738,0.00264685355475873,-0.0181587793442009,-0.00778311340954665,9.65174096415097e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DLL1,Delta-like protein 1,40411,-0.013942372982431,0.00284660551011953,-0.0195217197822653,-0.00836302618259669,9.7817748910229e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL13RA2,Interleukin-13 receptor subunit alpha-2,37541,0.013689320014501,0.00279561132704887,0.00820992181348522,0.0191687182155168,9.86140896810853e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,40228,-0.0165449334094743,0.00337924598694725,-0.0231682555438909,-0.00992161127505769,9.87530748984428e-07
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NAP1L4,Nucleosome assembly protein 1-like 4,37879,-0.0198220921401594,0.00405940904630133,-0.02777853387091,-0.0118656504094088,1.05686972673408e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NT5E,5'-nucleotidase,40411,-0.0274287106587008,0.00562016430586645,-0.038444232698199,-0.0164131886192025,1.06887591384329e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL22,Interleukin-22,37900,-0.030976492456896,0.00636227675938259,-0.0434465549052858,-0.0185064300085061,1.13568499190803e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD80,T-lymphocyte activation antigen CD80,37990,-0.016146982388962,0.00331843976943553,-0.0226511243370557,-0.00964284044086837,1.15257875292949e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RGS10,Regulator of G-protein signaling 10,37959,-0.0283868194606011,0.00584071743391391,-0.0398346256310723,-0.0169390132901298,1.18609188036082e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,40228,-0.0493913706351649,0.0101635226280935,-0.0693118749862282,-0.0294708662841016,1.18711450056677e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",39980,-0.0241234064191264,0.0049778340836593,-0.0338799612230987,-0.0143668516151542,1.27086767896741e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GPNMB,Transmembrane glycoprotein NMB,39957,0.0132989602003183,0.00274512368142485,0.00791851778472558,0.018679402615911,1.28108476908905e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PADI2,Protein-arginine deiminase type-2,40044,-0.0264331637456896,0.005464401266954,-0.0371433902289194,-0.0157229372624598,1.32845788126787e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD244,Natural killer cell receptor 2B4,40516,-0.0124877420707916,0.00258836074731185,-0.0175609291355229,-0.00741455500606041,1.41589394396471e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ITGB2,Integrin beta-2,40221,0.0134293638973167,0.00279359619325173,0.00795391535854331,0.0189048124360901,1.54473442385798e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CFP,Properdin,38013,-0.0102339856881784,0.00213242343917122,-0.014413535628954,-0.00605443574740277,1.6097653979403e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VASP,Vasodilator-stimulated phosphoprotein,37987,-0.0337047334864069,0.00703952568903967,-0.0475022038369246,-0.0199072631358891,1.7029663635633e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CAT,Catalase,37786,-0.0254462941074428,0.00531682496083764,-0.0358672710306846,-0.0150253171842011,1.71968045898341e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GFRA2,GDNF family receptor alpha-2,40305,0.0098903699640873,0.0020670020487416,0.00583904594855376,0.0139416939796208,1.72625327813417e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CSNK1D,Casein kinase I isoform delta,37598,-0.0296891557335939,0.00620810376944556,-0.0418570391217072,-0.0175212723454806,1.75161151378143e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GZMH,Granzyme H,40042,-0.0347441932908957,0.00726807294239143,-0.0489896162579829,-0.0204987703238085,1.76556080572939e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CASP8,Caspase-8,40434,-0.0286243994749669,0.00600761031325974,-0.040399315688956,-0.0168494832609778,1.9080720970299e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PMVK,Phosphomevalonate kinase,39951,-0.051299534481256,0.0107803749945868,-0.0724290694706462,-0.0301699994918658,1.9669515596427e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,C2CD2L,Phospholipid transfer protein C2CD2L,39925,-0.0202735315793746,0.00426427060737674,-0.0286315019698331,-0.0119155611889162,2.0094940544601e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RLN2,Prorelaxin H2,37643,-0.0654937370819856,0.0137844101917188,-0.0925111810577544,-0.0384762931062169,2.04253631567832e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CRLF1,Cytokine receptor-like factor 1,40422,-0.012150963156167,0.00255814959546139,-0.0171649363632714,-0.0071369899490627,2.05283088119414e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SIL1,Nucleotide exchange factor SIL1,37628,-0.0147965504112027,0.00312486600732902,-0.0209212877855676,-0.00867181303683787,2.21228940856989e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DEFB103A_DEFB103B,Beta-defensin 103,37539,-0.019000105172322,0.00401472957759847,-0.026868975144415,-0.011131235200229,2.23983371973917e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ASGR2,Asialoglycoprotein receptor 2,37987,-0.0119264756028802,0.00252393952864688,-0.0168733970790281,-0.00697955412673234,2.32040266419862e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FDX1,"Adrenodoxin, mitochondrial",37562,-0.0289893322915744,0.00613830183849584,-0.0410204038950263,-0.0169582606881226,2.35151150908615e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLEC7A,C-type lectin domain family 7 member A,40516,-0.0268962487919879,0.00569860498674179,-0.0380655145660018,-0.015726983017974,2.38072928697449e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",37628,-0.0419684727897242,0.00890882122389678,-0.0594297623885619,-0.0245071831908866,2.49156961005962e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PCDH7,Protocadherin-7,37901,-0.0160050407096539,0.00339911415166121,-0.0226673044469099,-0.00934277697239795,2.51925166000382e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCN3,CCN family member 3,40522,-0.0154698857352609,0.00328597168509151,-0.0219103902380403,-0.00902938123248153,2.52423942638617e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PREB,Prolactin regulatory element-binding protein,40044,-0.0135908809499363,0.00288789262269532,-0.0192511504904191,-0.00793061140945346,2.54597013466405e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ERBB2,Receptor tyrosine-protein kinase erbB-2,40411,-0.0110747168371865,0.00235504544176565,-0.0156906059030472,-0.0064588277713258,2.59083767164644e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CFHR2,Complement factor H-related protein 2,37911,-0.0261512455650331,0.00558146639525855,-0.0370909196997398,-0.0152115714303263,2.82188182689246e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FLT3LG,Fms-related tyrosine kinase 3 ligand,40516,-0.0150055965385075,0.00320339775513798,-0.0212842561385779,-0.00872693693843704,2.83253573700252e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TLR3,Toll-like receptor 3,40516,-0.0276557386126324,0.00592119769073827,-0.0392612860864794,-0.0160501911387854,3.02705649601461e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,40228,0.0128594233206316,0.00275516382090477,0.00745930223165822,0.0182595444096049,3.07559572568944e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,S100A16,Protein S100-A16,39934,-0.0282941797071881,0.0060621937899963,-0.0401760795355808,-0.0164122798787953,3.07716196397498e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LYPD3,Ly6/PLAUR domain-containing protein 3,40284,0.0158022914656161,0.00338836071292829,0.0091611044682767,0.0224434784629556,3.13114752837989e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CRYGD,Gamma-crystallin D,37942,-0.0435827398319303,0.00935084113223618,-0.0619103884511133,-0.0252550912127474,3.17941819907568e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDH17,Cadherin-17,40359,-0.0307020309469804,0.00658933680703278,-0.0436171310887647,-0.0177869308051962,3.1977893458294e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KLK11,Kallikrein-11,40260,-0.0134475572650473,0.00288758694822717,-0.0191072276835726,-0.00778788684652204,3.23426532177259e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PAEP,Glycodelin,40228,-0.0594972757359156,0.0127915573529389,-0.0845687281476758,-0.0344258233241554,3.32538386492115e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MATN3,Matrilin-3,40203,0.0141446484123298,0.00304153815075128,0.00818323363685733,0.0201060631878023,3.33834663709477e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GM2A,Ganglioside GM2 activator,37714,-0.0174536986376761,0.00375372698429412,-0.0248110035268925,-0.0100963937484596,3.3562802784963e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GBP4,Guanylate-binding protein 4,39961,-0.0223063119610699,0.00480355272364506,-0.0317212752994142,-0.0128913486227255,3.45013619386935e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ICAM1,Intercellular adhesion molecule 1,40291,-0.0128124322641332,0.00277684688282542,-0.018255052154471,-0.0073698123737954,3.98046472536532e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CSDE1,Cold shock domain-containing protein E1,37562,-0.052645471946943,0.0114104739873911,-0.0750100009622295,-0.0302809429316566,3.99147671844916e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SDC4,Syndecan-4,40359,-0.020245479448385,0.00439826603363038,-0.0288660808743006,-0.0116248780224695,4.19549220542996e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GRK5,G protein-coupled receptor kinase 5,40042,-0.0235497576343713,0.0051247919051797,-0.0335943497685235,-0.0135051655002191,4.35595850211574e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MTUS1,Microtubule-associated tumor suppressor 1,37714,-0.0247927717318279,0.00540752102777492,-0.0353915129462668,-0.0141940305173891,4.58425164473445e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CNTNAP2,Contactin-associated protein-like 2,40341,0.0178934513320657,0.00390454821332232,0.010240536833954,0.0255463658301775,4.62459750452177e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LTBR,Tumor necrosis factor receptor superfamily member 3,40289,-0.0122425872732953,0.00267189506273665,-0.0174795015962591,-0.00700567295033143,4.64094564304727e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LTA,Lymphotoxin-alpha,40341,-0.0179301853691023,0.00391445898815098,-0.0256025249858782,-0.0102578457523264,4.67386338305499e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",37959,-0.0194869048904772,0.00426555896409615,-0.0278474004601056,-0.0111264093208487,4.95742115516015e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VSTM1,V-set and transmembrane domain-containing protein 1,39961,-0.0216310650643426,0.00473914593796591,-0.0309197911027558,-0.0123423390259294,5.04920083680573e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KIAA0319,Dyslexia-associated protein KIAA0319,37942,0.0138044301959,0.00302609259761528,0.00787328870457408,0.019735571687226,5.11638503441323e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",40341,-0.0365137502242409,0.00800507744046373,-0.0522037020075498,-0.020823798440932,5.12121338405451e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IDI2,Isopentenyl-diphosphate delta-isomerase 2,39961,-0.0206232310029853,0.00452378724900623,-0.0294898540110375,-0.0117566079949331,5.18296210151808e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NPR1,Atrial natriuretic peptide receptor 1,37562,0.0179384104153704,0.00393463925547165,0.0102265174746459,0.0256503033560948,5.18383984323196e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DAPK2,Death-associated protein kinase 2,37598,-0.0232600278047682,0.00510265383866264,-0.033261229328547,-0.0132588262809895,5.2005284517687e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FUCA1,Tissue alpha-L-fucosidase,40437,-0.03595651824573,0.00790244476700208,-0.0514453099890541,-0.0204677265024059,5.40279536220846e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RCOR1,REST corepressor 1,40042,-0.0198535523244032,0.0043637794509906,-0.0284065600483447,-0.0113005446004616,5.4147528612723e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AKT3,RAC-gamma serine/threonine-protein kinase,39897,-0.0253555788350297,0.00557388173795916,-0.0362803870414296,-0.0144307706286297,5.43121559374533e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,37562,0.00895453230407881,0.00197262254748745,0.00508819211100341,0.0128208724971542,5.69152976158631e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",39925,-0.020806789619121,0.00458422626099408,-0.0297918730906694,-0.0118217061475726,5.70071162541443e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,40355,0.0220472972248936,0.00485909314932914,0.0125234746522084,0.0315711197975787,5.73885806623734e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLTA,Clathrin light chain A,40042,-0.020912824593712,0.00461583830010574,-0.0299598676619192,-0.0118657815255047,5.92344157528626e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BRSK2,Serine/threonine-protein kinase BRSK2,37959,-0.0173366848944182,0.00383059969518971,-0.0248446602969901,-0.0098287094918464,6.06694571125495e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SERPINA3,Alpha-1-antichymotrypsin,37958,0.00651380898416275,0.00143942763491626,0.00369253081972689,0.00933508714859861,6.08312136311695e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TBC1D17,TBC1 domain family member 17,39961,-0.0202693978846039,0.00448148549384108,-0.0290531094525324,-0.0114856863166754,6.14447024867304e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AMPD3,AMP deaminase 3,37942,-0.0318772024949555,0.0070714009640538,-0.045737148384501,-0.0180172566054101,6.60221914965389e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,C7orf50,Uncharacterized protein C7orf50,37942,-0.00964269247233699,0.00213939619281155,-0.0138359090102476,-0.00544947593442636,6.62406047502919e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCRN1,Secernin-1,40341,-0.0246264369650429,0.00546620256213767,-0.0353401939868327,-0.013912679943253,6.67773541417203e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CA13,Carbonic anhydrase 13,40173,-0.0452089224951186,0.0100848855505322,-0.0649752981741616,-0.0254425468160755,7.41770229236469e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ENO2,Gamma-enolase,40471,-0.0286407061077523,0.00638976897066942,-0.0411646532902644,-0.0161167589252402,7.4363312746924e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TRAF3,"TNF receptor-associated factor 3, Isoform 2",37598,-0.0153189194863404,0.0034296660867052,-0.0220410650162826,-0.0085967739563982,8.0138350377392e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",37998,-0.0269881119828023,0.00604426104039323,-0.038834863621973,-0.0151413603436315,8.06856412930531e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KLRK1,NKG2-D type II integral membrane protein,37942,-0.0200652203607705,0.00449566729731139,-0.0288767282635009,-0.0112537124580402,8.13856254658165e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTK7,Inactive tyrosine-protein kinase 7,39961,-0.0167624420987401,0.00375918847898617,-0.024130451517553,-0.00939443267992723,8.28983524636353e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CPB2,Carboxypeptidase B2,37981,-0.00970236244193273,0.00218073741448035,-0.0139766077743142,-0.00542811710955124,8.69111647040513e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,THY1,Thy-1 membrane glycoprotein,40471,-0.012108486405646,0.00272332110560749,-0.0174461957726367,-0.00677077703865532,8.79816899334491e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GCLM,Glutamate--cysteine ligase regulatory subunit,37562,-0.0197634726166357,0.00445351782214023,-0.0284923675480306,-0.0110345776852408,9.16577995927322e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPINK2,Serine protease inhibitor Kazal-type 2,37671,-0.0164450711801672,0.00371507211495694,-0.0237266125254828,-0.00916352983485163,9.65052021376961e-06
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD276,CD276 antigen,40357,0.0154389347967517,0.00350352322897569,0.00857202926795935,0.0223058403255441,1.0564982106659e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MSLN,Mesothelin,40271,-0.0232257906198277,0.00527438715862031,-0.0335635894507235,-0.0128879917889319,1.07214566397731e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRSS53,Serine protease 53,37942,0.0157740303138453,0.00358196063621656,0.00875338746686083,0.0227946731608297,1.07218536106991e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RANBP2,E3 SUMO-protein ligase RanBP2,37541,0.0143341703829473,0.00325679940553944,0.00795084354809003,0.0207174972178046,1.08453242119581e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TPK1,Thiamin pyrophosphokinase 1,37990,-0.0116223795066728,0.00264168841889568,-0.0168000888077083,-0.00644467020563725,1.09278101659037e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LEFTY2,Left-right determination factor 2,40453,-0.0220339511551507,0.00504110526731709,-0.0319145174790922,-0.0121533848312092,1.24539828429363e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BMP6,Bone morphogenetic protein 6,40024,-0.0180076310399053,0.00412041844370821,-0.0260836511895733,-0.00993161089023716,1.24856200924455e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PSAPL1,Proactivator polypeptide-like 1,37901,0.0215089028682588,0.00493616177828697,0.0118340257828164,0.0311837799537013,1.32583744241032e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,F3,Tissue factor,40393,0.0118864635877021,0.00272960262262823,0.00653644244735076,0.0172364847280534,1.34111177969182e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TYRO3,Tyrosine-protein kinase receptor TYRO3,40359,0.0119620528057909,0.00274788074722922,0.00657620654122165,0.0173478990703602,1.3500712466332e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD1C,T-cell surface glycoprotein CD1c,40411,0.0101248056582449,0.00232681481353375,0.00556424862371874,0.014685362692771,1.36137132201511e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDIA5,Protein disulfide-isomerase A5,37482,-0.0260651601303387,0.00599314594788809,-0.0378117261881994,-0.0143185940724781,1.37697418934135e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LYZL2,Lysozyme-like protein 2,37482,-0.0151883227547302,0.00350100305734589,-0.0220502887471281,-0.0083263567623322,1.44684556311006e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,REG3G,Regenerating islet-derived protein 3-gamma,37900,-0.0170145966707087,0.00393375129418838,-0.0247247492073179,-0.00930444413409949,1.53432661007076e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",37959,-0.0382548297976131,0.00885370133735876,-0.0556080844188363,-0.0209015751763899,1.56595307918629e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EDA2R,Tumor necrosis factor receptor superfamily member 27,40489,-0.0148968044102704,0.00344791677143199,-0.0216547212822771,-0.00813888753826366,1.56596242225738e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CXCL12,Stromal cell-derived factor 1,40044,0.0170900069282681,0.00395743493694103,0.00933343445186365,0.0248465794046725,1.58095483089471e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NEK7,Serine/threonine-protein kinase Nek7,37714,-0.0319618970512106,0.00740476970271397,-0.04647524566853,-0.0174485484338912,1.59749653794773e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,40330,-0.0132242493112036,0.00306715597029117,-0.0192358750129743,-0.00721262360943291,1.63078757204526e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,UNC5D,Netrin receptor UNC5D,37598,0.0112227955132207,0.00261042798933757,0.00610635665411901,0.0163392343723223,1.72637969800173e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NOTCH1,Neurogenic locus notch homolog protein 1,40536,0.00648688374562591,0.00151114574341951,0.00352503808852367,0.00944872940272815,1.77552652913748e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FLT3,Receptor-type tyrosine-protein kinase FLT3,39980,0.012924583570103,0.00301357655354751,0.00701797352514988,0.0188311936150561,1.80738141415161e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RGMA,Repulsive guidance molecule A,40471,0.0128904121674105,0.00300805281924937,0.00699462864168173,0.0187861956931393,1.83557211906173e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD99,CD99 antigen,40332,0.00807325689993623,0.00188947342396732,0.00436988898896028,0.0117766248109122,1.94196999516754e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OLR1,Oxidized low-density lipoprotein receptor 1,40225,-0.02422434163426,0.0056710254967881,-0.0353395516079647,-0.0131091316605553,1.95213876545235e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,S100A11,Protein S100-A11,40207,-0.0186698538878167,0.0043716460083472,-0.0272382800641772,-0.0101014277114562,1.96029161662076e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IMPA1,Inositol monophosphatase 1,40228,-0.0252798082766976,0.0059234382354527,-0.0368897472181849,-0.0136698693352103,1.98598548130288e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,UXS1,UDP-glucuronic acid decarboxylase 1,39980,-0.0223326413453441,0.00523683767660784,-0.0325968431914954,-0.0120684394991927,2.01509526740884e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GRN,Progranulin,40262,-0.0100629436505369,0.00236083239018324,-0.014690175135296,-0.00543571216577772,2.03364400094602e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ACP5,Tartrate-resistant acid phosphatase type 5,40419,-0.0131880611860545,0.00309650724728004,-0.0192572153907234,-0.00711890698138562,2.06507267025159e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRDX5,"Peroxiredoxin-5, mitochondrial",40516,-0.0287093933441412,0.00674089591297546,-0.0419215493335731,-0.0154972373547093,2.06522402364915e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PER3,Period circadian protein homolog 3,37598,-0.0489255590655756,0.0115041660457207,-0.0714737245151882,-0.0263773936159631,2.12520706869721e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AKR1B10,Aldo-keto reductase family 1 member B10,37572,-0.0250958695256027,0.00591525214549884,-0.0366897637307805,-0.013501975320425,2.22491557963736e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MGMT,Methylated-DNA--protein-cysteine methyltransferase,40341,-0.0504299053478555,0.0119091562461002,-0.0737718515902119,-0.0270879591054992,2.30298881099968e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MMP7,Matrilysin,40015,-0.0198960542160245,0.00469919179358641,-0.0291064701314538,-0.0106856383005951,2.3095927070665e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRTN3,Myeloblastin,39897,-0.0193613686108863,0.00457843781490873,-0.0283351067281074,-0.0103876304936652,2.36277264885691e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",40434,-0.0300222896089638,0.00714483218182676,-0.0440261606853443,-0.0160184185325834,2.66052064007649e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ACOT13,Acyl-coenzyme A thioesterase 13,37901,-0.0463518274250651,0.0110415622905323,-0.0679932895145085,-0.0247103653356217,2.71084822892216e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL17A,Interleukin-17A,40028,-0.0174073154690908,0.00415968336540329,-0.0255602948652813,-0.00925433607290038,2.87021386240713e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CSNK2A1,Casein kinase II subunit alpha,37959,0.018470618003457,0.00441558048757051,0.00981608024781878,0.0271251557590952,2.89434015148303e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",37671,-0.0362817590679569,0.00868446173357691,-0.0533033040657677,-0.0192602140701462,2.96260830098182e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TGFBI,Transforming growth factor-beta-induced protein ig-h3,40273,-0.0109801007661616,0.00263029675324672,-0.0161354824025252,-0.00582471912979804,3.00275271891603e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LYAR,Cell growth-regulating nucleolar protein,39980,-0.0213346396227749,0.00511756413979739,-0.0313650653367778,-0.011304213908772,3.07725932294158e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PMM2,Phosphomannomutase 2,37562,-0.0245745245629274,0.00589471539269186,-0.0361281667326034,-0.0130208823932513,3.08029305633721e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTN,Pleiotrophin,40042,-0.0202982333089149,0.00489010074382444,-0.0298828307668108,-0.010713635851019,3.32955347840644e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL1B,Interleukin-1 beta,39946,-0.0227612674098735,0.0054946125229853,-0.0335307079549247,-0.0119918268648223,3.45407870295359e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LYPD8,Ly6/PLAUR domain-containing protein 8,39980,-0.0207170632848563,0.00500907610783093,-0.0305348524562049,-0.0108992741135077,3.55418372219497e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,37628,0.0148482618322298,0.00360149503260332,0.00778933156832732,0.0219071920961323,3.76579994967423e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GZMB,Granzyme B,40341,-0.0252015154510759,0.00612116379644552,-0.0371989964921091,-0.0132040344100427,3.85588580854688e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PEPD,Xaa-Pro dipeptidase,37987,0.0103791553297013,0.00252211685100242,0.00543580630173657,0.0153225043576661,3.89041566923448e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CASP9,Caspase-9,37598,-0.02503023926949,0.00608652487496776,-0.0369598280244268,-0.0131006505145532,3.93944941472311e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,37865,-0.0125251888180757,0.00305463184552453,-0.0185122672353038,-0.0065381104008476,4.14882053524216e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFSF13,Tumor necrosis factor ligand superfamily member 13,40422,-0.0105297233841506,0.00257072755017771,-0.0155683493824989,-0.00549109738580225,4.22405650592227e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RABEPK,Rab9 effector protein with kelch motifs,39980,-0.0239694898060895,0.00585285466612772,-0.0354410849516999,-0.0124978946604792,4.2366668203887e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ATP6V1G2,V-type proton ATPase subunit G 2,37562,-0.0404695909340579,0.00988211872369917,-0.0598385436325083,-0.0211006382356075,4.24273640727549e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,37562,-0.0267964339786335,0.0065452414765722,-0.0396251072727151,-0.013967760684552,4.26476302504307e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PKD1,Polycystin-1,37990,0.0103063031548657,0.00252382337740652,0.00535960933514894,0.0152529969745825,4.45969676891522e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FBLN2,Fibulin-2,37998,0.0122757441569084,0.0030063450564086,0.00638330784634752,0.0181681804674692,4.46598796426786e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ANXA10,Annexin A10,39961,-0.0328589026541094,0.00804794301405307,-0.0486328709616534,-0.0170849343465654,4.47012755867387e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CSF3R,Granulocyte colony-stimulating factor receptor,37598,-0.0124534357260129,0.00306058213072326,-0.0184521767022305,-0.00645469474979529,4.74960505510401e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,C2orf69,UPF0565 protein C2orf69,37572,-0.0239446028897328,0.0058927116620671,-0.0354943177473843,-0.0123948880320813,4.86390915654657e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LMOD1,Leiomodin-1,37959,0.0143508528947633,0.00353758455673149,0.00741718716356956,0.021284518625957,5.00547157535317e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HMOX1,Heme oxygenase 1,40184,0.0184908965941923,0.00455989016057415,0.00955351187946693,0.0274282813089176,5.03502105551385e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SNX18,Sorting nexin-18,37901,-0.0179680949805706,0.00443622440830527,-0.0266630948208489,-0.00927309514029226,5.14363130946606e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,STAM,Signal transducing adapter molecule 1,37900,-0.0148071114375818,0.00365823186647099,-0.0219772458958649,-0.00763697697929866,5.20319665245449e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,37671,-0.0265760694706113,0.00658286116696495,-0.0394784773578626,-0.0136736615833601,5.44070665763067e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RP2,Protein XRP2,40305,-0.0162225396440113,0.00401881460887779,-0.0240994162774118,-0.00834566301061087,5.44750944106417e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KLK1,Kallikrein-1,40209,0.0499987846798303,0.0123989946496813,0.025696755166455,0.0743008141932057,5.54495379889877e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RAB37,Ras-related protein Rab-37,40044,-0.0326938223517864,0.0081191221371981,-0.0486073017406947,-0.0167803429628782,5.68163891258772e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADGRB3,Adhesion G protein-coupled receptor B3,40203,0.0131583271091593,0.00326814427230406,0.00675276433544333,0.0195638898828752,5.69416945221084e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NACC1,Nucleus accumbens-associated protein 1,37900,-0.0215453684997884,0.00535153899086765,-0.032034384921889,-0.0110563520776878,5.70415947384661e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MAPK13,Mitogen-activated protein kinase 13,37482,-0.0161664835000022,0.00403391852441872,-0.0240729638078629,-0.00826000319214149,6.1670369689852e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TUBB3,Tubulin beta-3 chain,37541,0.0109030999820946,0.00272561009416665,0.00556090419752796,0.0162452957666612,6.36257801312534e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GC,Vitamin D-binding protein,38013,-0.0101377605579333,0.00253837894812708,-0.0151129832962624,-0.00516253781960426,6.53676551614288e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NAGA,Alpha-N-acetylgalactosaminidase,37567,-0.0231493526609942,0.00579897778520037,-0.0345153491199869,-0.0117833562020014,6.5883194150972e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,37562,0.0203004505626936,0.00508697024574691,0.0103299888810296,0.0302709122443575,6.62437378887058e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NPTN,Neuroplastin,39980,0.0328382116333673,0.00823077305815151,0.0167058964393903,0.0489705268273443,6.64640154409667e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRL,Prolactin,40471,0.0297184689060177,0.00745825465822481,0.0151002897758971,0.0443366480361383,6.78813101710366e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PODXL,Podocalyxin,40305,0.0058939905083757,0.0014798167162559,0.00299354974451413,0.00879443127223727,6.8377876724727e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL10,Interleukin-10,40044,-0.0333383356042599,0.00838445089044201,-0.0497718593495263,-0.0169048118589936,7.03382714982944e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ANXA4,Annexin A4,40279,-0.027750672074893,0.00698037409415182,-0.0414322052994305,-0.0140691388503554,7.05352072405644e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ICAM3,Intercellular adhesion molecule 3,40536,0.00976470014804951,0.00245801674979814,0.00494698731844515,0.0145824129776539,7.14043126652977e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,F13B,Coagulation factor XIII B chain,37934,-0.0100093418355137,0.00252049265363359,-0.0149495074366355,-0.00506917623439186,7.18875616041268e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCGB3A1,Secretoglobin family 3A member 1,37671,0.00970348277114104,0.00244484154921861,0.00491159333467257,0.0144953722076095,7.25680420923661e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,THBD,Thrombomodulin,40359,-0.0107095403412132,0.00269993155018431,-0.0160014061795744,-0.00541767450285192,7.32255698804258e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,40536,0.0105892725046213,0.00267268805362125,0.00535080391952363,0.0158277410897189,7.4635571685932e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FXN,"Frataxin, mitochondrial",40489,-0.0284630180751109,0.00718427285627045,-0.042544192873401,-0.0143818432768208,7.46927346541195e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,37628,-0.023897623547074,0.00605103950266607,-0.0357576609722995,-0.0120375861218485,7.87742559045305e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CSF3,Granulocyte colony-stimulating factor,40044,-0.0187732768690125,0.00475743987250282,-0.028097859019118,-0.00944869471890694,7.97866083702945e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,JUN,Transcription factor AP-1,40044,-0.0199210219992531,0.0050523468561149,-0.0298236218372383,-0.0100184221612679,8.0845785954027e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCL28,C-C motif chemokine 28,40278,-0.0228176083880805,0.00580207221510801,-0.0341896699296922,-0.0114455468464688,8.43672993143516e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TSHB,Thyrotropin subunit beta,40359,0.0319840806351858,0.00815998948596617,0.0159905012426921,0.0479776600276795,8.90591374253652e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MB,Myoglobin,40536,-0.0186959402257156,0.00478443210701204,-0.0280734271554592,-0.00931845329597203,9.35754197730747e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,37562,-0.0155163970131752,0.00397685443119113,-0.0233110316983098,-0.00772176232804059,9.60062889153748e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HSBP1,Heat shock factor-binding protein 1,37628,-0.0363323035726518,0.00932502572497672,-0.0546093539936062,-0.0180552531516974,9.81908706234688e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SERPINI2,Serpin I2,37901,-0.0212410022075861,0.00545606172999122,-0.0319348831983689,-0.0105471212168033,9.94487016836089e-05
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LACRT,Extracellular glycoprotein lacritin,37863,-0.0201906960006982,0.00518850231072322,-0.0303601605297157,-0.0100212314716807,0.000100136825545202
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LTA4H,Leukotriene A-4 hydrolase,40489,0.021914686561025,0.00563244941253637,0.0108750857124537,0.0329542874095963,0.000100321417284861
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,C1QL2,Complement C1q-like protein 2,37598,0.0162966278654364,0.00419140736077822,0.0080814694383111,0.0245117862925617,0.000101527109227673
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,40341,-0.044878047825044,0.0115949081884786,-0.0676040678744621,-0.0221520277756259,0.000109048292007404
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DIABLO,"Diablo homolog, mitochondrial",40314,-0.0411113364406207,0.0106363391191505,-0.0619585611141557,-0.0202641117670857,0.000111450791763338
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GSTT2B,Glutathione S-transferase theta-2B,37942,-0.0899412315512643,0.0232783564301128,-0.135566810154285,-0.0443156529482433,0.000112192185756958
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KIAA1549L,UPF0606 protein KIAA1549L,37714,0.0109533518863687,0.00284111542240813,0.00538476565844877,0.0165219381142886,0.000116133492629767
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CALB1,Calbindin,40305,-0.0159162091379192,0.00412914611018419,-0.0240093355138803,-0.00782308276195822,0.000116376028915274
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,40359,-0.0218385003925717,0.0056732226610908,-0.0329580168083097,-0.0107189839768338,0.000118870948335524
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ASS1,Argininosuccinate synthase,37562,-0.0301257577971004,0.00782890302295139,-0.0454704077220851,-0.0147811078721157,0.00011964201148675
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GGH,Gamma-glutamyl hydrolase,40077,-0.0128061563576222,0.00333117415953415,-0.0193352577103091,-0.00627705500493524,0.000121357770959107
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DDX1,ATP-dependent RNA helicase DDX1,37901,-0.0194106737215602,0.00505147764151485,-0.0293115698989293,-0.00950977754419104,0.000122310661190654
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDH22,Cadherin-22,37714,0.0109848633319354,0.00288417843571206,0.00533187359793973,0.016637853065931,0.000140350228047614
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,37714,-0.0323845694602148,0.00851720477337987,-0.0490782908160393,-0.0156908481043902,0.000144028412685317
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLIT2,Slit homolog 2 protein,39961,-0.0193805857136431,0.00510911322912525,-0.0293944476427286,-0.00936672378455759,0.000149200775269994
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD3D,T-cell surface glycoprotein CD3 delta chain,37541,0.0127278039475497,0.00335611730302636,0.00614981403361803,0.0193057938614814,0.000149857367996917
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EPHB6,Ephrin type-B receptor 6,40192,-0.0115047258703171,0.00303610818814592,-0.0174554979190831,-0.00555395382155111,0.000151634980223251
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DNPEP,Aspartyl aminopeptidase,37942,-0.0219221438053572,0.00579718161847336,-0.033284619777565,-0.0105596678331494,0.000156547737147547
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RBP2,Retinol-binding protein 2,40305,0.0279851752284595,0.00740956503675022,0.0134624277564291,0.0425079227004899,0.000159373543059239
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TGOLN2,Trans-Golgi network integral membrane protein 2,37987,-0.00945032560402871,0.00250496047487269,-0.0143600481347792,-0.00454060307327824,0.000162214716803831
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VWC2L,von Willebrand factor C domain-containing protein 2-like,37959,0.0174054731034526,0.00461478172985507,0.00836050091293665,0.0264504452939685,0.000162844945481317
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PROCR,Endothelial protein C receptor,37562,0.0136019047854155,0.00360844307181773,0.00652935636465276,0.0206744532061782,0.000164314552339774
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,37598,-0.0111962795655612,0.00297114493822611,-0.0170197236444844,-0.00537283548663802,0.000165055881539745
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,37572,-0.0198007717273632,0.00525641609620995,-0.0301033472759347,-0.00949819617879168,0.000165962038289864
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ABO,Histo-blood group ABO system transferase,37987,0.0531031382077952,0.0140997264965292,0.0254676742745981,0.0807386021409924,0.000166417599987462
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MNAT1,CDK-activating kinase assembly factor MAT1,37714,-0.015817154372519,0.00420412948338455,-0.0240572481599527,-0.00757706058508524,0.000169089465101981
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TAFA5,Chemokine-like protein TAFA-5,40305,-0.0131270413635329,0.00349293635344735,-0.0199731966162897,-0.00628088611077614,0.000171775741273073
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SEPTIN9,Septin-9,40305,-0.0102828404327299,0.00273941025621809,-0.0156520845349174,-0.00491359633054247,0.000174886726107361
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,39925,-0.017389482999207,0.00464445611689798,-0.026492616988327,-0.00828634901008693,0.000181670130489992
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NOS1,"Nitric oxide synthase, brain",39961,-0.0181830013051848,0.00486271250229103,-0.0277139178096752,-0.00865208480069434,0.000185218204719279
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MAEA,E3 ubiquitin-protein transferase MAEA,39980,-0.0147782192963154,0.00395474284280351,-0.0225295152682103,-0.00702692332442055,0.000187019270267683
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CEBPA,CCAAT/enhancer-binding protein alpha,37598,-0.0139917567120365,0.0037585443071609,-0.0213585035540718,-0.00662500987000112,0.000197962998444052
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PODXL2,Podocalyxin-like protein 2,40411,0.0098782053802389,0.00265429853963363,0.00467578024255699,0.0150806305179208,0.000198653583929138
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,40471,0.00987964279924276,0.00265814491455623,0.00466967876671256,0.015089606831773,0.000202494010550453
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,COPB2,Coatomer subunit beta',37562,-0.0156364316014968,0.00421421209629441,-0.0238962873102339,-0.00737657589275977,0.000207783609499522
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PLA2G2A,"Phospholipase A2, membrane associated",40293,0.0208756765521949,0.00563210693033356,0.00983674696874108,0.0319146061356486,0.000210818866105181
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ART3,Ecto-ADP-ribosyltransferase 3,40403,0.0119778913810875,0.00323915662724364,0.00562914439168994,0.018326638370485,0.000218168753335361
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD101,Immunoglobulin superfamily member 2,37901,-0.0153363327787918,0.00414751380235518,-0.0234654598314079,-0.00720720572617562,0.000218412381568612
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LAMB1,Laminin subunit beta-1,37628,-0.0105927186169991,0.00288009201121513,-0.0162376989589807,-0.00494773827501741,0.000236088693654627
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTX3,Pentraxin-related protein PTX3,40341,0.0175371541577542,0.00477883309864456,0.00817064128441086,0.0269036670310975,0.000243575750610092
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SNX2,Sorting nexin-2,37900,-0.0277668107611806,0.00760086505136636,-0.0426645062618587,-0.0128691152605025,0.000260065829115003
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",40306,-0.0246287868358023,0.00674347202854414,-0.0378459920117488,-0.0114115816598558,0.000260798570523784
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LEO1,RNA polymerase-associated protein LEO1,37959,-0.0110320579144674,0.00302452953298837,-0.0169601357991246,-0.00510398002981022,0.000265770966221993
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCS,Copper chaperone for superoxide dismutase,40228,-0.017100258594933,0.00469542185510762,-0.0263032854309439,-0.00789723175892208,0.0002714993292504
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HBQ1,Hemoglobin subunit theta-1,40489,0.0208872245007485,0.00574501322605202,0.00962699857768651,0.0321474504238104,0.000278079416773716
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GLYR1,Putative oxidoreductase GLYR1,37900,-0.021481603841104,0.0059103738838007,-0.0330659366533533,-0.00989727102885458,0.000279494504742198
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PECR,Peroxisomal trans-2-enoyl-CoA reductase,37628,-0.0101329290022708,0.00278945454613832,-0.0156002599127019,-0.00466559809183968,0.000281662411571678
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADAMTSL4,ADAMTS-like protein 4,37628,-0.0083269596221893,0.0022937792143674,-0.0128227668823494,-0.00383115236202919,0.000284235088932704
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CREB3,Cyclic AMP-responsive element-binding protein 3,37482,0.0203959304376666,0.00562870725286903,0.00936366422204326,0.0314281966532899,0.000291686914620202
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SIGLEC8,Sialic acid-binding Ig-like lectin 8,37628,-0.0159930573414271,0.00441491614428105,-0.024646292984218,-0.00733982169863627,0.000292859979559696
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KIF1C,Kinesin-like protein KIF1C,37562,-0.0132831733812439,0.00366859513313819,-0.0204736198421947,-0.00609272692029302,0.000294824444591764
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLU,Clusterin,38013,0.0116662575614491,0.00323307238355038,0.00532943568969032,0.0180030794332078,0.000309185470429453
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TYMP,Thymidine phosphorylase,40257,-0.0233870306998385,0.00648591023382778,-0.0360994147581409,-0.010674646641536,0.000312125724498715
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,UROS,Uroporphyrinogen-III synthase,37572,-0.0247307017243062,0.00686380770716603,-0.0381837648303516,-0.0112776386182608,0.000315657854062595
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SERPING1,Plasma protease C1 inhibitor,37981,0.00653282959327583,0.00181761698364062,0.00297030030534021,0.0100953588812114,0.000326580332629376
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PSMG4,Proteasome assembly chaperone 4,37598,-0.019782697167538,0.00550507735490591,-0.0305726487831536,-0.00899274555192242,0.000327412175632146
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FCRL5,Fc receptor-like protein 5,40332,-0.0195644849963563,0.00544594071746101,-0.0302385288025799,-0.00889044119013272,0.00032852364003486
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RAB2B,Ras-related protein Rab-2B,37900,-0.0214650070187344,0.00598012322021763,-0.033186048530361,-0.00974396550710787,0.000332629182628922
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PALM,Paralemmin-1,37824,-0.0102222106220611,0.00285543703177678,-0.0158188672043436,-0.00462555403977862,0.000344928818479895
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TCL1A,T-cell leukemia/lymphoma protein 1A,40215,-0.0327819040703555,0.00916496366609533,-0.0507452328559024,-0.0148185752848087,0.000348771555533813
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IFNL1,Interferon lambda-1,39961,-0.0157925779168158,0.00441996707199469,-0.0244557133779254,-0.00712944245570617,0.000353973929910638
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",37959,-0.0252792196779743,0.00708925313097829,-0.0391741558146917,-0.0113842835412569,0.000363930912565851
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDH23,Cadherin-23,37942,0.00918842453614426,0.00257973586358298,0.00413214224352162,0.0142447068287669,0.000369632902592905
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFSF8,Tumor necrosis factor ligand superfamily member 8,37998,0.0123897990215326,0.00348320413764762,0.00556271891174329,0.019216879131322,0.000376377603973617
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GAS2,Growth arrest-specific protein 2,37714,-0.0185829705225867,0.00522713989480343,-0.0288281647164014,-0.00833777632877194,0.000379159847423575
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MIA,Melanoma-derived growth regulatory protein,40411,-0.0127809936924441,0.00359544008924412,-0.0198280562673625,-0.00573393111752561,0.000379390919145115
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KLK8,Kallikrein-8,39801,-0.0122059634799666,0.00344369669464658,-0.0189556090014739,-0.00545631795845929,0.000394623352551114
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PCDH17,Protocadherin-17,40359,-0.0119910828139465,0.00339204892012203,-0.0186394986973857,-0.00534266693050729,0.000408846764622171
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PSPN,Persephin,40341,-0.0341488252102384,0.0096697919997984,-0.0531016175298432,-0.0151960328906335,0.000414387770153869
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OBP2B,Odorant-binding protein 2b,40184,0.0227436511173268,0.00644574599221126,0.0101099889725927,0.0353773132620608,0.000419154079801842
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MST1,Hepatocyte growth factor-like protein,37787,-0.0212231076364617,0.00601670854727212,-0.0330158563891151,-0.0094303588838084,0.000421133690084758
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SDHB,Succinate dehydrogenase,37901,-0.0244608096246517,0.00693577419463312,-0.0380549270461327,-0.0108666922031708,0.000422079350291166
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CNDP1,Beta-Ala-His dipeptidase,40403,-0.015640873174861,0.00445217800690579,-0.0243671420683964,-0.00691460428132569,0.000444163964526557
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",40536,-0.00977171673252139,0.00278330106405921,-0.0152269868180774,-0.00431644664696533,0.000447920973257703
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TSPAN1,Tetraspanin-1,40042,-0.0104442751121055,0.00297487826367919,-0.0162750365089167,-0.0046135137152943,0.000447981249858987
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LIFR,Leukemia inhibitory factor receptor,40341,0.00835109140827172,0.00238230187753491,0.00368177972830329,0.0130204030882402,0.000457055287747154
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EDN1,Endothelin-1,37628,-0.00995008225023821,0.00284149593254895,-0.0155194142780342,-0.00438075022244227,0.000463820472230167
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,37562,0.00874219216314518,0.00250704942252252,0.00382837529500104,0.0136560090312893,0.000489990280024265
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD28,T-cell-specific surface glycoprotein CD28,39980,-0.0122114726941129,0.00350238831148514,-0.0190761537846238,-0.00534679160360204,0.000490530531890234
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD48,CD48 antigen,40396,-0.00995512619656043,0.0028568124628282,-0.0155544786237037,-0.00435577376941715,0.000494017721752826
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,APOH,Beta-2-glycoprotein 1,40332,-0.0120260065006225,0.00345236379278808,-0.0187926395344872,-0.00525937346675789,0.000496398528340147
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ARID4B,AT-rich interactive domain-containing protein 4B,39961,-0.0138880955747278,0.00399280426033428,-0.021713991924983,-0.00606219922447263,0.000506024358391191
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TG,Thyroglobulin,37900,0.0397610358673021,0.0114584597357235,0.0173024547852841,0.0622196169493201,0.000522059458886219
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFSF12,Tumor necrosis factor ligand superfamily member 12,40516,0.00981450731729516,0.00282891072755716,0.00426984229128312,0.0153591723433072,0.000523069616359349
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLURP1,Secreted Ly-6/uPAR-related protein 1,37919,-0.0128990627762217,0.00372321742599348,-0.0201965689311689,-0.00560155662127446,0.000532884168997179
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LRRC38,Leucine-rich repeat-containing protein 38,37572,-0.0167229207119151,0.00483907801885607,-0.026207513628873,-0.00723832779495722,0.000550383963582793
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CTNNA1,Catenin alpha-1,37541,0.0122911362003516,0.00355686546153561,0.00531967989574178,0.0192625925049614,0.000550792610168252
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ACP6,Lysophosphatidic acid phosphatase type 6,40453,-0.0221487039131454,0.0064287121453765,-0.0347489797180833,-0.00954842810820747,0.000571934617660804
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CHGA,Chromogranin-A,37998,-0.0303215388043051,0.00880072720941084,-0.0475709641347504,-0.0130721134738599,0.000572060143692413
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NEDD9,Enhancer of filamentation 1,37598,-0.0110937511082799,0.00322444461375958,-0.0174136625512487,-0.00477383966531117,0.000582411389262968
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DGCR6,Protein DGCR6,37541,-0.0152815134195734,0.0044482632048475,-0.0240001093010745,-0.00656291753807227,0.00059354042313138
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,THBS4,Thrombospondin-4,40355,0.0150971322283277,0.00439719877244752,0.00647862263433056,0.0237156418223248,0.000597686042375417
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PEAR1,Platelet endothelial aggregation receptor 1,40536,0.00754415094106886,0.00219890653030948,0.00323429414166228,0.0118540077404754,0.000603172088271432
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LAMTOR5,Ragulator complex protein LAMTOR5,37900,-0.0136754613931179,0.00399593057151553,-0.0215074853132884,-0.00584343747294748,0.00062267867695874
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CA1,Carbonic anhydrase 1,40003,-0.0208470722541435,0.00609567429333867,-0.0327945938690873,-0.00889955063919975,0.000627870166882895
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EDAR,Tumor necrosis factor receptor superfamily member EDAR,40341,-0.0304458172748414,0.00893079729579935,-0.0479501799746081,-0.0129414545750746,0.000653438577603805
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SERPINA12,Serpin A12,39903,-0.0379439143668817,0.0111357560331001,-0.0597699961917579,-0.0161178325420055,0.000657534567599667
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLEC10A,C-type lectin domain family 10 member A,40228,0.0119337970032611,0.00350951425394592,0.00505514906552706,0.0188124449409951,0.00067450931225181
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LIPF,Gastric triacylglycerol lipase,37628,-0.0198243694594908,0.00583215268587351,-0.0312553887238029,-0.00839335019517874,0.000677956108091272
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DTX2,Probable E3 ubiquitin-protein ligase DTX2,37572,0.0219216947553109,0.00645172512845598,0.0092763135035372,0.0345670760070846,0.000681310256934893
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RNF43,E3 ubiquitin-protein ligase RNF43,37714,-0.0196343361173668,0.00578423611419661,-0.0309714389011921,-0.00829723333354144,0.000689664472301518
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IGSF21,Immunoglobulin superfamily member 21,37628,0.0129612725645082,0.00381945355719918,0.00547514359239777,0.0204474015366185,0.000692116256820647
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BCL2,Apoptosis regulator Bcl-2,37901,-0.0178622211491094,0.00527374799276585,-0.0281987672149305,-0.00752567508328832,0.000708620117827632
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FMR1,Synaptic functional regulator FMR1,39980,-0.0115677537308467,0.00342119263385897,-0.0182732912932103,-0.00486221616848317,0.000723465730524605
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EPHX2,Bifunctional epoxide hydrolase 2,40042,-0.0206301880327534,0.00610863414076425,-0.0326031109486513,-0.00865726511685547,0.000734020373420431
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VAMP5,Vesicle-associated membrane protein 5,40042,-0.0184228467079819,0.00545822653561012,-0.0291209707177777,-0.00772472269818603,0.000739301473352869
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FGF19,Fibroblast growth factor 19,40422,-0.0251435297799655,0.00745442244900235,-0.0397541977800101,-0.0105328617799209,0.000745391677957856
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BAG3,BAG family molecular chaperone regulator 3,40203,-0.0130010215469217,0.00385792746617068,-0.0205625593806163,-0.00543948371322721,0.000753623569284485
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VNN2,Vascular non-inflammatory molecule 2,40305,-0.0147060634298201,0.00437299880075251,-0.0232771410792951,-0.00613498578034523,0.000773040382420473
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CHRM1,Muscarinic acetylcholine receptor M1,37572,0.0123776031190513,0.00368351581347788,0.00515791212463468,0.019597294113468,0.000780887087107499
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TPSAB1,Tryptase alpha/beta-1,40498,-0.0172145038130033,0.00512934155218177,-0.0272680132552795,-0.007160994370727,0.00079237831056484
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,37225,-0.0354251467061429,0.0105693254180095,-0.0561410245254416,-0.0147092688868442,0.000805517065444944
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DBH,Dopamine beta-hydroxylase,37967,0.0345191081754176,0.010317537772401,0.0142967341415116,0.0547414822093236,0.000823066769779745
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,37714,-0.0241598678404725,0.00724253247102341,-0.0383552314836784,-0.0099645041972666,0.000852781791282242
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,STXBP3,Syntaxin-binding protein 3,39980,-0.0142695433791585,0.00430019347322478,-0.022697922586679,-0.00584116417163789,0.000907594155536474
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDCD1LG2,Programmed cell death 1 ligand 2,40305,-0.00999806960536698,0.00301619534634391,-0.015909812484201,-0.00408632672653292,0.00091916035439668
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDGFRB,Platelet-derived growth factor receptor beta,40536,0.0112367678285269,0.00339151935565376,0.00458938989144549,0.0178841457656082,0.000924399307118579
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FCRL2,Fc receptor-like protein 2,40442,-0.0156574198555103,0.00473729862908584,-0.0249425251685185,-0.00637231454250204,0.000951389111856074
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MPRIP,Myosin phosphatase Rho-interacting protein,37863,-0.0139574442313706,0.00422503197361031,-0.0222385068996468,-0.00567638156309444,0.000957318811598948
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NTproBNP,N-terminal prohormone of brain natriuretic peptide,40359,0.0315293674982477,0.00954466957829834,0.012821815124783,0.0502369198717125,0.000957485201554913
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RNASE3,Eosinophil cationic protein,40288,-0.0348897152251352,0.0105637657946334,-0.0555946961826167,-0.0141847342676537,0.00095946120455862
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MYL4,Myosin light chain 4,37628,-0.0169660320484651,0.00513998133701252,-0.0270403954690097,-0.00689166862792059,0.000966669959041786
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,40359,-0.0156409423012208,0.00474995295795124,-0.0249508500988052,-0.00633103450363635,0.000993892554967538
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",37900,-0.0118537166830142,0.00360160835664575,-0.0189128690620399,-0.0047945643039885,0.00100007713181782
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDK1,Cyclin-dependent kinase 1,37482,-0.0117733179750124,0.00357782278404911,-0.0187858506317486,-0.00476078531827615,0.00100226171269647
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DGKZ,Diacylglycerol kinase zeta,40044,-0.0112171043674281,0.00341408890379765,-0.0179087186188715,-0.00452549011598469,0.00102013994533462
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,39823,0.0277255073974262,0.00844517093863908,0.0111729723576936,0.0442780424371588,0.00102937468683562
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NFIC,Nuclear factor 1 C-type,37959,-0.0139665127328449,0.00425877166023636,-0.0223137051869082,-0.00561932027878169,0.00104265557977473
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,37541,0.0197314305482858,0.00602103860111203,0.00793019489010619,0.0315326662064654,0.00105159487793512
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MYOM3,Myomesin-3,37671,0.0288338624678871,0.00880956834084663,0.0115671085198277,0.0461006164159465,0.0010667941501622
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLC12A2,Solute carrier family 12 member 2,37562,0.00913784869777656,0.00279394222530348,0.00366172193618174,0.0146139754593714,0.00107599166205613
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CST5,Cystatin-D,40070,-0.0175007233974048,0.00536428232176232,-0.028014716748059,-0.00698673004675068,0.001106892641805
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL10RA,Interleukin-10 receptor subunit alpha,40044,-0.019099224678331,0.00586988477577924,-0.0306041988388583,-0.0075942505178037,0.00114128992149174
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GDNF,Glial cell line-derived neurotrophic factor,39961,-0.0121210916924308,0.00373105702898034,-0.0194339634692322,-0.00480821991562932,0.00116179675365844
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,40044,-0.0133040921642111,0.00409615257172596,-0.021332551204794,-0.00527563312362823,0.001164862098816
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EIF5,Eukaryotic translation initiation factor 5,37562,-0.0143648967671419,0.00443646328236833,-0.0230603648005838,-0.00566942873369996,0.00120705606097173
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NECTIN4,Nectin-4,40411,-0.00959986579574454,0.00297302431116686,-0.0154269934456316,-0.00377273814585749,0.00124479450858312
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CSF2RB,Cytokine receptor common subunit beta,37598,0.0139562001650286,0.00432524321448826,0.00547872346463165,0.0224336768654256,0.00125539632938066
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CELA2A,Chymotrypsin-like elastase family member 2A,37998,-0.0185050919201132,0.00574245086175868,-0.0297602956091602,-0.0072498882310662,0.00127374304363693
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PLA2G10,Group 10 secretory phospholipase A2,40228,0.0186734947602024,0.0058183856062,0.00726945897205037,0.0300775305483544,0.00133280912363526
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPINK5,Serine protease inhibitor Kazal-type 5,40332,0.0101309083737853,0.00316223015882714,0.00393293726248416,0.0163288794850865,0.00135930925824145
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,USP28,Ubiquitin carboxyl-terminal hydrolase 28,37942,-0.0117208948589491,0.00366233862827342,-0.018899078570365,-0.00454271114753323,0.00137561723469524
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LEG1,Protein LEG1 homolog,37231,0.0218099207006493,0.00681916692128609,0.00844435353492857,0.0351754878663701,0.00138564848110373
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ENAH,Protein enabled homolog,40044,-0.0147277913188543,0.00460685720507787,-0.023757231440807,-0.00569835119690169,0.00139176643789689
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,40228,0.021640353052977,0.00677919978088242,0.00835312148244749,0.0349275846235066,0.00141485466282528
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,APOB,Apolipoprotein B-100,37987,0.0069568950647253,0.00218247760835055,0.00267923895235822,0.0112345511770924,0.00143778334473572
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PCSK7,Proprotein convertase subtilisin/kexin type 7,37900,-0.0140640507619604,0.00441706926928158,-0.0227215065297523,-0.00540659499416851,0.00145574418637543
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ARFIP1,Arfaptin-1,37959,-0.0211902287888757,0.00669967482861559,-0.0343215914529623,-0.00805886612478916,0.00156565693168095
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,STXBP1,Syntaxin-binding protein 1,37959,-0.0238344438841764,0.00754140630896497,-0.0386156002497478,-0.00905328751860511,0.00157858614466841
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TK1,"Thymidine kinase, cytosolic",37714,-0.0137839207148299,0.00437250249281836,-0.0223540256007539,-0.00521381582890596,0.00162289435417614
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SETMAR,Histone-lysine N-methyltransferase SETMAR,40182,-0.00913382500437568,0.00289995758986272,-0.0148177418805066,-0.00344990812824474,0.00163777266148228
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MYBPC1,"Myosin-binding protein C, slow-type",37990,-0.0194415340705146,0.00618000441085021,-0.031554342715781,-0.0073287254252482,0.00165948202366587
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GGT5,Glutathione hydrolase 5 proenzyme,40228,-0.00692126080059679,0.00220482191201548,-0.0112427117481471,-0.00259980985304644,0.00169752629535031
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,37901,-0.0120556246735201,0.00384493253268459,-0.0195916924375818,-0.00451955690945826,0.00171955479433169
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,40167,-0.00980058689996688,0.00313606048157148,-0.015947265443847,-0.00365390835608678,0.00178051959384109
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RBP7,Retinoid-binding protein 7,37901,-0.017807058971858,0.00570068626119381,-0.0289804040437979,-0.00663371389991817,0.00178990399031642
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VEGFB,Vascular endothelial growth factor B,37598,-0.00866925878914543,0.00278251944910558,-0.0141229969093924,-0.00321552066889849,0.00183956974666243
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EPCAM,Epithelial cell adhesion molecule,40358,-0.0302518640235308,0.00972006541997588,-0.0493031922466835,-0.011200535800378,0.00185957890420172
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TJP3,Tight junction protein ZO-3,37541,0.0133520003933675,0.00430911401311651,0.00490613692765914,0.0217978638590759,0.00194882893309792
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCND2,G1/S-specific cyclin-D2,37714,0.0111182025184971,0.00358947944050727,0.00408282281510282,0.0181535822218913,0.0019560654519921
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PSMC3,26S proteasome regulatory subunit 6A,37482,0.00913040826102925,0.00295270125567876,0.00334311379989888,0.0149177027221596,0.0019908374382254
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TINAGL1,Tubulointerstitial nephritis antigen-like,40325,0.00671253101164371,0.00217603400300388,0.0024475043657561,0.0109775576575313,0.00204070216930603
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CFD,Complement factor D,38013,-0.00572754417968703,0.00186065466699573,-0.00937442732699865,-0.00208066103237541,0.00208641818701276
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,STEAP4,Metalloreductase STEAP4,37541,0.0226919103476293,0.00738663381248504,0.00821410807515857,0.0371697126200999,0.00213049666985461
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLIC5,Chloride intracellular channel protein 5,37572,0.00970241815843938,0.00315851770943672,0.00351172344794342,0.0158931128689353,0.00213189013294822
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",39980,-0.0239386662857976,0.00780789334154055,-0.0392421372352171,-0.00863519533637812,0.00217347126953469
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RPS10,40S ribosomal protein S10,37562,0.0126390806627995,0.00413015610135162,0.00454397470415031,0.0207341866214486,0.0022164033143927
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,37562,0.017911370529981,0.00585500286010316,0.00643556492417878,0.0293871761357832,0.00222409080455072
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MANSC1,MANSC domain-containing protein 1,40411,0.0081212841760083,0.00266641492099395,0.00289511093086016,0.0133474574211564,0.00232464612233677
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PPL,Periplakin,37598,-0.00974393504970695,0.00321758005781711,-0.0160503919630285,-0.00343747813638541,0.0024637598768078
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,37714,-0.0106336089445511,0.00351881136903087,-0.0175304792278516,-0.00373673866125059,0.00251646051572445
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ENSA,Alpha-endosulfine,37900,-0.0155429413568923,0.00514638619532361,-0.0256298582997266,-0.00545602441405803,0.00253110327500302
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LAMA4,Laminin subunit alpha-4,40422,-0.00962727566307054,0.00319244917907602,-0.0158844760540595,-0.00337007527208155,0.00256841129964539
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ALDH2,"Aldehyde dehydrogenase, mitochondrial",37900,-0.0152055225825188,0.00504587351715065,-0.0250954346761341,-0.00531561048890354,0.0025877064747246
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRG3,Proteoglycan 3,37998,0.0146372106495438,0.00488427915014388,0.00506402351526184,0.0242103977838258,0.00273323358233953
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CA7,Carbonic anhydrase 7,37714,0.0103023484229985,0.00343827424783139,0.00356333089724893,0.017041365948748,0.00273718261361765
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RLN1,Prorelaxin H1,37959,-0.0240816162217269,0.00806188706860015,-0.0398829148761832,-0.00828031756727057,0.00282148574314388
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PFDN2,Prefoldin subunit 2,39961,-0.0163455801861375,0.00547424450960883,-0.0270750994249708,-0.00561606094730419,0.00283180862768591
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCT,Secretin,37572,-0.0133992332353177,0.00449323493384673,-0.0222059737056573,-0.00459249276497811,0.00286813294458799
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,REST,RE1-silencing transcription factor,37482,0.010439569671595,0.00350694145333262,0.00356596442306305,0.0173131749201269,0.0029178043504413
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDIA3,Protein disulfide-isomerase A3,37671,-0.0074283136684392,0.00249685492745198,-0.0123221493262451,-0.00253447801063332,0.00293452954879087
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RCC1,Regulator of chromosome condensation,37900,-0.014823935732274,0.00498485303492305,-0.0245942476807232,-0.00505362378382482,0.00294662466349688
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRG2,Bone marrow proteoglycan,37998,0.0150268218026428,0.00508729991715003,0.00505571396502873,0.0249979296402568,0.00314435731641122
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,M6PR,Cation-dependent mannose-6-phosphate receptor,37628,-0.0121843733375835,0.00413209855588801,-0.020283286507124,-0.00408546016804303,0.00319660275748183
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,40276,0.0171914736270583,0.00586707555847471,0.00569200553244791,0.0286909417216688,0.00339270870392363
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LSM1,U6 snRNA-associated Sm-like protein LSm1,39980,-0.0162034397691981,0.00554523977211464,-0.0270721097225428,-0.00533476981585338,0.00348242565553316
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,40341,-0.0241829499552795,0.00829054033395093,-0.0404324090098233,-0.00793349090073569,0.00353986539962208
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,THAP12,52 kDa repressor of the inhibitor of the protein kinase,37457,-0.0254148196950939,0.00871633639974999,-0.0424988390386039,-0.00833080035158388,0.0035541947281635
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLAMF1,Signaling lymphocytic activation molecule,40044,-0.0168980035163627,0.00580059337010311,-0.0282671665217647,-0.00552884051096056,0.00358309626017775
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCDC80,Coiled-coil domain-containing protein 80,40359,-0.00994756400669639,0.00341926341986446,-0.0166493203096307,-0.00324580770376204,0.00362774289497026
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,REPS1,RalBP1-associated Eps domain-containing protein 1,37598,-0.011098354760614,0.00381858003200394,-0.0185827716233417,-0.00361393789788628,0.0036621384966308
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IGHMBP2,DNA-binding protein SMUBP-2,37562,-0.0157327101736101,0.00542421191166162,-0.0263641655204668,-0.0051012548267533,0.0037323451413385
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FGF5,Fibroblast growth factor 5,40044,0.00911676874113051,0.00314410710669507,0.00295431881200817,0.0152792186702529,0.00374116707541232
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,37900,-0.0135351460089756,0.00466919141951227,-0.0226867611912196,-0.0043835308267315,0.00375175307120824
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SAT2,Thialysine N-epsilon-acetyltransferase,37714,-0.0194164507273735,0.00670599428391655,-0.0325601995238499,-0.00627270193089705,0.0037930914427302
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MAMDC2,MAM domain-containing protein 2,37990,0.00958551710714872,0.00331559669315181,0.00308694758857116,0.0160840866257263,0.00384581957113289
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EVPL,Envoplakin,37714,0.00974800539858085,0.00337679397651045,0.00312948920462037,0.0163665215925413,0.00389855276377056
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CTLA4,Cytotoxic T-lymphocyte protein 4,37998,0.00829876914068546,0.00288051550067249,0.00265295875936738,0.0139445795220035,0.0039703608011228
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MATN2,Matrilin-2,40379,0.00830855084522041,0.00288962885716118,0.00264487828518449,0.0139722234052563,0.00404178266069853
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SATB1,DNA-binding protein SATB1,37959,-0.00845178750516514,0.00294157768879131,-0.0142172797751961,-0.00268629523513417,0.00406949779431212
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ITGB6,Integrin beta-6,40044,0.00844527568657407,0.00293983018176952,0.00268320853030582,0.0142073428428423,0.00407518329656621
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,40434,-0.00942933850414419,0.00328257881578576,-0.0158631929830843,-0.0029954840252041,0.00407722601049363
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DDI2,Protein DDI1 homolog 2,37671,-0.0218529992435587,0.00764579305071457,-0.0368387536229592,-0.00686724486415813,0.00426753844040559
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PSMD1,26S proteasome non-ATPase regulatory subunit 1,37959,-0.0135349751614223,0.00474100365563439,-0.0228273423264657,-0.00424260799637891,0.00431192709768191
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDCD1,Programmed cell death protein 1,40455,-0.0121375878949201,0.00425611689413713,-0.0204795770074289,-0.00379559878241136,0.00435283028830013
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,40332,0.00998910512149685,0.00350439294351689,0.00312049495220375,0.01685771529079,0.00437133219026464
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TMPRSS11D,Transmembrane protease serine 11D,37921,-0.0107366139455537,0.00376815050762533,-0.0181221889404994,-0.00335103895060811,0.0043881157407556
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,USP47,Ubiquitin carboxyl-terminal hydrolase 47,37562,-0.0235007292222309,0.00824981003857909,-0.0396703568978459,-0.00733110154661589,0.00439750412777098
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,37562,0.00885280198445028,0.00310840736972602,0.00276032353978729,0.0149452804291133,0.00440607825507357
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCGB2A2,Mammaglobin-A,37562,0.00889904347702294,0.00313176847127557,0.00276077727332281,0.0150373096807231,0.0044965566068583
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLMP,CXADR-like membrane protein,40489,-0.00563195905283457,0.00198287840960073,-0.009518400735652,-0.00174551737001713,0.00451286203168351
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",39961,-0.0152910106879942,0.00538984391540994,-0.0258551047621977,-0.00472691661379074,0.00455980299497387
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,YAP1,Transcriptional coactivator YAP1,37942,-0.00736081921978095,0.0025978293402769,-0.0124525647267237,-0.00226907371283823,0.00461168574146559
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,POLR2A,DNA-directed RNA polymerase II subunit RPB1,37598,0.00813725672823391,0.00287221407514524,0.00250771714094924,0.0137667963155186,0.00461697762929473
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NUDT16,U8 snoRNA-decapping enzyme,37880,-0.0241500828403286,0.00853137673024396,-0.0408715812316068,-0.00742858444905043,0.00465098958057454
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SIGLEC5,Sialic acid-binding Ig-like lectin 5,40332,-0.0328067908005875,0.0115947223336839,-0.055532446574608,-0.0100811350265671,0.0046685253600249
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,40365,-0.0136126031597626,0.00481457294305154,-0.0230491661281436,-0.00417604019138156,0.00469899093389973
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EGFLAM,Pikachurin,37901,-0.00846927924505046,0.00300266333257776,-0.0143544993769029,-0.00258405911319806,0.00480057517869766
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FNDC1,Fibronectin type III domain-containing protein 1,37942,-0.0126051495150054,0.00447213018717422,-0.0213705246818669,-0.00383977434814394,0.00483036943130835
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GRIK2,"Glutamate receptor ionotropic, kainate 2",37959,0.0115723314436788,0.00413104958298193,0.0034754742610342,0.0196691886263234,0.00509687096097184
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TLR4,Toll-like receptor 4,37598,0.00774769462351199,0.00277625067832641,0.00230624329399224,0.0131891459530318,0.00526693054798439
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TGFB2,Transforming growth factor beta-2 proprotein,37900,-0.0144097349044007,0.00516547047390997,-0.0245340570332642,-0.00428541277553715,0.00528430721121894
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,37572,0.0142517690333273,0.00511136774265001,0.00423348825773327,0.0242700498089213,0.00530699873249388
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,37482,-0.018038562723935,0.00650306293517372,-0.0307845660768755,-0.00529255937099449,0.005547493985297
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,STC2,Stanniocalcin-2,40309,-0.00732137040993284,0.0026426096865455,-0.012500885395562,-0.00214185542430366,0.00560341269288269
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SERPINA11,Serpin A11,40536,0.0108160280325502,0.00391266771514197,0.00314719931087198,0.0184848567542285,0.00570992386318229
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLITRK6,SLIT and NTRK-like protein 6,40042,0.00919734008187471,0.00332786533833143,0.00267472401874512,0.0157199561450043,0.00572108714875093
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD2,T-cell surface antigen CD2,37562,-0.0103009060314718,0.00373181427020269,-0.0176152620010691,-0.00298655006187454,0.00578295268640668
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FGF20,Fibroblast growth factor 20,37598,0.0120204032356669,0.00436795477781503,0.00345921187114944,0.0205815946001844,0.00593223374415376
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ARHGAP1,Rho GTPase-activating protein 1,39980,-0.0122273009044226,0.00446389119909733,-0.0209765276546533,-0.0034780741541918,0.0061667140795566
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CRNN,Cornulin,39857,0.0175508258741283,0.00646432982650433,0.0048807394141798,0.0302209123340768,0.00663443243957369
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IGFBP7,Insulin-like growth factor-binding protein 7,40536,0.00779229891791393,0.00287334798516368,0.00216053686699311,0.0134240609688347,0.0066965184146059
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",37598,-0.0118213937582206,0.00435980654568849,-0.02036661458777,-0.00327617292867112,0.00670768604554661
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,40044,-0.0110543022445805,0.00407872689996261,-0.0190486069685072,-0.00305999752065377,0.00673093959413282
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TSPAN15,Tetraspanin-15,37562,0.0135200281004593,0.00498963679145593,0.00374033998920571,0.0232997162117129,0.00674475440058651
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MRPL24,"39S ribosomal protein L24, mitochondrial",37562,-0.0105962139943045,0.00391405268472154,-0.0182677572563587,-0.00292467073225025,0.00679365469667114
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNPO1,Transportin-1,37714,0.00939452258580051,0.00347218120349514,0.00258904742695003,0.016199997744651,0.00682570685360524
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MUC16,Mucin-16,40305,-0.0493617565777286,0.0182486044893819,-0.0851290213769172,-0.01359449177854,0.00683854600629721
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DNAJA4,DnaJ homolog subfamily A member 4,37942,-0.01878759568449,0.0069539558528273,-0.0324173491560315,-0.00515784221294846,0.00690694265400663
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GBA,Lysosomal acid glucosylceramidase,37572,-0.0139304126849986,0.00516751603302537,-0.0240587441097283,-0.00380208126026887,0.00703165861993672
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KLK4,Kallikrein-4,40489,0.015942046697016,0.0059155232169747,0.00434762119174561,0.0275364722022864,0.00704722874386728
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DNLZ,DNL-type zinc finger protein,37541,0.0250467592908477,0.00932919096012798,0.00676154500899685,0.0433319735726985,0.00726705187793274
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ARHGAP5,Rho GTPase-activating protein 5,37482,-0.0202709414504041,0.00755839552765319,-0.0350853966846044,-0.00545648621620387,0.00732952792923592
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IFNW1,Interferon omega-1,37562,0.00963966550962181,0.00359700177521881,0.00258954203019294,0.0166897889890507,0.00737324695670994
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,37998,0.0100940242919875,0.00377723966008905,0.00269063455821297,0.0174974140257621,0.00754170880996447
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",37901,-0.0265525238118079,0.00994078562841452,-0.0460364636435004,-0.00706858398011548,0.00757011194560852
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,REG3A,Regenerating islet-derived protein 3-alpha,40536,-0.0158249545010082,0.00593690014176178,-0.0274612787788613,-0.00418863022315512,0.00769450502208622
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GAD1,Glutamate decarboxylase 1,37482,0.006712146764443,0.00252897053892394,0.00175536450815207,0.0116689290207339,0.00796162558225206
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CBX2,Chromobox protein homolog 2,37562,0.0106517907291971,0.00401940880265318,0.00277374947599691,0.0185298319823974,0.00805671865862007
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ELAVL4,ELAV-like protein 4,37541,-0.0226106914446041,0.00853735001346574,-0.0393438974709969,-0.00587748541821121,0.00809603098543795
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRTG,Protogenin,40489,0.00647705527655245,0.00244786237723753,0.00167924501716688,0.011274865535938,0.00815281765658724
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HTR1B,5-hydroxytryptamine receptor 1B,37541,0.0110236918839214,0.00417200952033244,0.00284655322406985,0.019200830543773,0.00824435705991898
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SNU13,NHP2-like protein 1,37562,-0.0160825028444964,0.00609072698865672,-0.0280203277422635,-0.00414467794672919,0.00828843680239116
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DCLRE1C,Protein artemis,37482,0.00818989567892945,0.0031064545224759,0.00210124481487668,0.0142785465429822,0.00838871394267169
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,UBE2B,Ubiquitin-conjugating enzyme E2 B,37900,-0.00731056356754912,0.00277386617892016,-0.0127473412782326,-0.00187378585686561,0.00841063164779441
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PMS1,PMS1 protein homolog 1,37572,-0.013394172683338,0.0050891225953942,-0.0233688529703106,-0.00341949239636536,0.00850027736700528
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RNASE10,Inactive ribonuclease-like protein 10,37628,-0.0125413685084476,0.00477457745274353,-0.021899540315825,-0.00318319670107032,0.0086317826501169
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BRK1,Protein BRICK1,39961,-0.0112707276692506,0.00430520992204464,-0.0197089391164581,-0.00283251622204313,0.0088551522385357
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,XPNPEP2,Xaa-Pro aminopeptidase 2,40411,-0.0223704281305149,0.00854754089108853,-0.0391236082770484,-0.00561724798398135,0.00887439442381062
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MMP10,Stromelysin-2,40341,0.0152694460233522,0.00583585520533989,0.00383116982088598,0.0267077222258183,0.00889235173356957
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KIRREL1,Kin of IRRE-like protein 1,37541,0.0157992425341758,0.00605409933833303,0.00393320783104305,0.0276652772373085,0.00907309552759026
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CEP164,Centrosomal protein of 164 kDa,40044,-0.0162426326519782,0.00623711664396256,-0.0284673812741448,-0.00401788402981155,0.00921791977645679
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CFHR5,Complement factor H-related protein 5,37785,0.0106351785347057,0.00408388633957806,0.00263076130913267,0.0186395957602787,0.00921962835129762
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ANXA5,Annexin A5,39896,-0.00772514792166014,0.00298486312537011,-0.0135754796473856,-0.00187481619593472,0.00965951161312294
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCL26,C-C motif chemokine 26,40341,-0.0223156174138875,0.00864023054995959,-0.0392504692918083,-0.00538076553596675,0.009810284890119
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",37628,0.00860349620204001,0.00333770321513186,0.00206159790038156,0.0151453945036985,0.00995766825343896
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VIPR1,Vasoactive intestinal polypeptide receptor 1,37628,0.00655490663556383,0.00254669761999087,0.00156337930038173,0.0115464339707459,0.0100671964516072
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CRISP3,Cysteine-rich secretory protein 3,37875,0.00680161568745633,0.00264390173928321,0.00161956827846124,0.0119836630964514,0.0101053740761544
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CPVL,Probable serine carboxypeptidase CPVL,40465,0.0101131669477712,0.00394209698987684,0.00238665684761258,0.0178396770479298,0.010313874451154
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRKD2,Serine/threonine-protein kinase D2,37562,-0.0118568393572,0.0046313620755324,-0.0209343090252435,-0.00277936968915645,0.0104747310015902
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HCG22,Protein PBMUCL2,37562,0.0133457994528633,0.00522065094825898,0.00311332359427574,0.0235782753114509,0.0105889034265232
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GLI2,Zinc finger protein GLI2,37598,0.00840287671914301,0.00328865012788249,0.00195712246849334,0.0148486309697927,0.0106264549100134
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CTSH,Pro-cathepsin H,40013,-0.0180190326690646,0.00705614584809564,-0.0318490785313321,-0.00418898680679715,0.0106690233885973
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,C1GALT1C1,C1GALT1-specific chaperone 1,37562,0.00818008224073162,0.00320589640358436,0.00189652528970626,0.014463639191757,0.0107350004118104
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPON2,Spondin-2,40267,-0.00854877101815905,0.00336019734627019,-0.0151347578168486,-0.00196278421946948,0.0109645311544162
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MRPL46,"39S ribosomal protein L46, mitochondrial",39961,-0.0068437609259382,0.00269106924456628,-0.0121182566452881,-0.00156926520658828,0.0109958048768495
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DNAJB8,DnaJ homolog subfamily B member 8,40042,-0.0144778155825746,0.00572470852158907,-0.0256982442848892,-0.00325738688026005,0.0114484217351399
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CEND1,Cell cycle exit and neuronal differentiation protein 1,37541,0.0143158011242848,0.00566159448233151,0.00321907593891507,0.0254125263096546,0.0114641131261071
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TIMP2,Metalloproteinase inhibitor 2,37990,0.00614739813512866,0.0024369828292369,0.00137091178982433,0.010923884480433,0.0116622786294302
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MRC1,Macrophage mannose receptor 1,37987,-0.00693751078571913,0.00276190967744327,-0.0123508537535079,-0.00152416781793032,0.0120214571652709
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,INSL4,Early placenta insulin-like peptide,37900,-0.0132683702756355,0.00528358059214951,-0.0236241882362486,-0.0029125523150225,0.0120422125478593
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IGF1R,Insulin-like growth factor 1 receptor,40305,-0.0053593524338915,0.00213848573760642,-0.00955078447960008,-0.00116792038818292,0.012215537399041
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL3RA,Interleukin-3 receptor subunit alpha,40044,-0.00776098233149624,0.00310600165274842,-0.0138487455708831,-0.00167321909210934,0.0124750052973919
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,C5,Complement C5,38013,-0.00371697303795109,0.00149409530893453,-0.00664539984346277,-0.000788546232439419,0.0128664193309394
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,37541,0.00770850060318817,0.00310312638950854,0.00162637287975142,0.0137906283266249,0.0130000582610755
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDSN,Corneodesmosin,40456,0.0104378210889756,0.00420311676149864,0.00219971223643832,0.018675929941513,0.0130253783614671
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CBLN1,Cerebellin-1,37541,0.0238699431504505,0.009625208356671,0.00500453477137533,0.0427353515295257,0.0131529173621959
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TPSG1,Tryptase gamma,37598,0.00657713911592611,0.00266678210318855,0.00135024619367656,0.0118040320381757,0.0136635802612639
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ITM2A,Integral membrane protein 2A,40341,0.0141313351715422,0.00575428322183142,0.00285294005675262,0.0254097302863318,0.0140679927709325
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CADPS,Calcium-dependent secretion activator 1,37572,0.0108241534001026,0.00441100422609725,0.00217858511695202,0.0194697216832532,0.014144619627131
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD82,CD82 antigen,37714,0.0100550342094548,0.00409821566095398,0.00202253151398502,0.0180875369049246,0.0141595307469498
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AFAP1,Actin filament-associated protein 1,37671,-0.0203036720748555,0.00827992207035408,-0.0365323193327495,-0.00407502481696154,0.0142130913068632
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PXDNL,Peroxidasin-like protein,37900,0.0140096632417357,0.00571884185107197,0.00280073321363468,0.0252185932698368,0.0143086863440971
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TFRC,Transferrin receptor protein 1,40391,0.00942571344348727,0.00385638535839674,0.00186719814102965,0.0169842287459449,0.0145288013456502
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,37572,0.00767898721515734,0.00314510970411265,0.00151457219509655,0.0138434022352181,0.0146369076018577
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PLXDC1,Plexin domain-containing protein 1,39980,-0.0080609881289413,0.00330734061982741,-0.014543375743803,-0.00157860051407958,0.014808459980114
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SAT1,Diamine acetyltransferase 1,37562,0.0123691476232956,0.00510545848043318,0.00236244900164655,0.0223758462449446,0.015417828261621
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SAFB2,Scaffold attachment factor B2,37959,-0.0065347551902766,0.00270426241177735,-0.0118351095173602,-0.001234400863193,0.0156852073765757
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,C1R,Complement C1r subcomponent,38013,-0.00469270733381585,0.00194486673392177,-0.00850464613230252,-0.000880768535329171,0.0158407153347578
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MYH7B,Myosin-7B,37482,0.0107637839525299,0.0044697424933636,0.0020030886655372,0.0195244792395225,0.0160476511746214
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PBK,Lymphokine-activated killer T-cell-originated protein kinase,37482,0.00709884570766593,0.00295111216522803,0.00131466586381898,0.0128830255515129,0.0161650166601418
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD200R1,Cell surface glycoprotein CD200 receptor 1,40291,-0.00807710060189792,0.00335867436851013,-0.0146601023641778,-0.00149409883961807,0.0161906034236015
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GUK1,Guanylate kinase,37562,0.00943194620392517,0.00392490881078319,0.00173912493479011,0.0171247674730602,0.0162705699581924
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ENPEP,Glutamyl aminopeptidase,37562,0.0108924206319004,0.0045331571754086,0.00200743256809958,0.0197774086957013,0.0162824143987918
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLEC12A,C-type lectin domain family 12 member A,37598,-0.00478425869656412,0.00199805379303642,-0.0087004441309155,-0.00086807326221274,0.0166588043943914
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FABP6,Gastrotropin,40017,-0.0130349991817509,0.00544490944014569,-0.0237070216844365,-0.00236297667906539,0.0166784625814968
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTPRM,Receptor-type tyrosine-protein phosphatase mu,40324,-0.00567334829558112,0.00236994226503909,-0.0103184351350577,-0.0010282614561045,0.016682912772017
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CXCL14,C-X-C motif chemokine 14,40044,-0.014339476718318,0.00599098346116856,-0.0260818043022084,-0.00259714913442761,0.0166997912857149
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GBP2,Guanylate-binding protein 2,40044,-0.0138617784431677,0.00579935989382434,-0.0252285238350634,-0.00249503305127197,0.016849824227479
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PNLIPRP2,Pancreatic lipase-related protein 2,40357,-0.0677179979707351,0.0285076757245502,-0.123593042390854,-0.0118429535506166,0.0175402816389496
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MKI67,Proliferation marker protein Ki-67,37598,-0.00875500073665236,0.00368639014969101,-0.0159803254300467,-0.00152967604325798,0.0175654810805052
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD300LF,CMRF35-like molecule 1,40489,-0.0140210807401147,0.00590444532088459,-0.0255937935690485,-0.00244836791118092,0.0175765702102879
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTPRH,Receptor-type tyrosine-protein phosphatase H,37901,-0.0110853418078909,0.00468170305761145,-0.0202614798008093,-0.00190920381497245,0.0179082159685874
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HRG,Histidine-rich glycoprotein,37934,-0.00728282970299456,0.00307953356682305,-0.0133187154939677,-0.00124694391202139,0.0180483752550537
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MDM1,Nuclear protein MDM1,37572,-0.00722047203107731,0.00305894560050052,-0.0132160054080583,-0.00122493865409628,0.0182675856176056
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DSCAM,Down syndrome cell adhesion molecule,37959,-0.00810805969685602,0.00343662842028976,-0.014843851400624,-0.00137226799308808,0.0183232781102249
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LXN,Latexin,40183,0.0152206927319118,0.00645916844170665,0.00256072258616675,0.0278806628776568,0.0184628566690548
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",37628,-0.0106045167664318,0.00450589601889253,-0.0194360729634611,-0.00177296056940242,0.0186134325921021
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LY75,Lymphocyte antigen 75,40341,0.00890383471259976,0.00378565541275252,0.00148395010360482,0.0163237193215947,0.0186852664778454
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,37714,0.0169455061926206,0.00721824642643156,0.00279774319681472,0.0310932691884264,0.018909762889782
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BRD1,Bromodomain-containing protein 1,37714,0.00710852769501301,0.00303261660430519,0.00116459915057484,0.0130524562394512,0.0190915968924793
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ITGB1BP1,Integrin beta-1-binding protein 1,39980,-0.00947787996945769,0.0040446784992044,-0.0174054498278983,-0.00155031011101706,0.0191267473849804
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RBM25,RNA-binding protein 25,37482,0.0105587282677002,0.00453276636063005,0.00167450620086528,0.0194429503345351,0.0198518926616822
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NTF3,Neurotrophin-3,40341,0.00790694838400175,0.00340074353847732,0.00124149104858621,0.0145724057194173,0.0200810369705603
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GPR15L,Protein GPR15L,37901,-0.0136584964436529,0.00588217369123921,-0.0251875568784817,-0.00212943600882401,0.020246976355333
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CREBZF,CREB/ATF bZIP transcription factor,37482,0.00599158186807463,0.00258054101803117,0.00093372147273353,0.0110494422634157,0.0202573388088701
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,40377,0.0050896094454764,0.00219659313639884,0.000784286898134672,0.00939493199281814,0.0205137930058935
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KRT6C,"Keratin, type II cytoskeletal 6C",37562,-0.00931619303287246,0.00402449574928548,-0.017204204701472,-0.00142818136427293,0.0206352987967611
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FGFR4,Fibroblast growth factor receptor 4,37671,-0.0121113438573385,0.00523248114182547,-0.0223670068953165,-0.00185568081936063,0.0206475338846598
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BRME1,Break repair meiotic recombinase recruitment factor 1,37541,0.00936900495622755,0.00404773557626257,0.00143544322675292,0.0173025666857022,0.0206486571108584
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NPHS1,Nephrin,37598,0.00782378467469863,0.003384231743594,0.00119069045725439,0.0144568788921429,0.0208021687791701
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MOG,Myelin-oligodendrocyte glycoprotein,40489,0.0072890335189079,0.00315517864022663,0.00110488338406371,0.0134731836537521,0.020890770013818
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TSPAN7,Tetraspanin-7,37541,0.0207061904360647,0.00898442759301512,0.00309671235375508,0.0383156685183743,0.0212003256498098
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,40042,-0.00785924714792758,0.00341236265263654,-0.0145474779470952,-0.00117101634875996,0.0212824455921481
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GALNT7,N-acetylgalactosaminyltransferase 7,40305,-0.00472806576462825,0.00205909972897602,-0.00876390123342126,-0.000692230295835252,0.0216785143107463
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HPGDS,Hematopoietic prostaglandin D synthase,39980,0.00837267290538771,0.00365865152444537,0.00120171591747478,0.0155436298933006,0.022124192217693
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",37562,0.00980667126363192,0.00431375158639806,0.00135171815429173,0.0182616243729721,0.0230211421707964
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HSD17B3,Testosterone 17-beta-dehydrogenase 3,37562,-0.0108372424303973,0.00477096764877332,-0.020188339021993,-0.00148614583880164,0.0231329964623463
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NT5C3A,Cytosolic 5'-nucleotidase 3A,40312,-0.0196076634977123,0.00863652261431059,-0.0365352478217611,-0.00268007917366354,0.0232015747988383
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TDGF1,Teratocarcinoma-derived growth factor 1,39961,-0.0314164259665677,0.0138799649876532,-0.058621157342368,-0.00421169459076746,0.0236225249819436
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MYH4,Myosin-4,37562,0.0105125386649711,0.00465068445043045,0.00139719714212745,0.0196278801878148,0.0238110132476918
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GABARAP,Gamma-aminobutyric acid receptor-associated protein,37900,-0.0110918601765192,0.00491331885583124,-0.0207219651339484,-0.00146175521908996,0.0239922750485321
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CEP112,Centrosomal protein of 112 kDa,37562,-0.0104068748258372,0.00461312182264306,-0.0194485935982176,-0.00136515605345685,0.0240914940120091
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCARA5,Scavenger receptor class A member 5,40471,-0.00642546819502323,0.00284927546403739,-0.0120100481045365,-0.000840888285509941,0.0241390159182248
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,37572,0.0108194667638133,0.00480022719134758,0.00141102146877207,0.0202279120588546,0.0242158151430675
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL20RB,Interleukin-20 receptor subunit beta,37598,0.00929982712475694,0.00416952249046028,0.00112756304345479,0.0174720912060591,0.0257357345915979
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL1R1,Interleukin-1 receptor type 1,40303,-0.00484604678177814,0.00217286336421665,-0.00910485897564276,-0.000587234587913509,0.0257442365418734
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LAMA1,Laminin subunit alpha-1,37562,0.0121842389588667,0.00548683544848458,0.00143004147983696,0.0229384364378965,0.0263929657448189
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DLL4,Delta-like protein 4,37628,-0.0182941519689907,0.00824056738052471,-0.0344456640348191,-0.00214263990316222,0.0264349589999825
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LRRC25,Leucine-rich repeat-containing protein 25,40305,-0.00838081144102578,0.00378181973851361,-0.0157931781285125,-0.000968444753539098,0.0267002357394004
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,37562,0.0104824641858015,0.00473846288501216,0.00119507693117767,0.0197698514404253,0.0269694887207681
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",37598,-0.0133521711076554,0.00603784250247328,-0.025186342412503,-0.00151799980280775,0.0270243020054344
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADGRV1,Adhesion G-protein coupled receptor V1,37541,0.0152518938750213,0.00696438242692171,0.00160170431825478,0.0289020834317879,0.0285429007611369
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",37628,-0.0166426837343733,0.00760744955105489,-0.0315532848544409,-0.00173208261430573,0.0287102504742779
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL1RL2,Interleukin-1 receptor-like 2,40044,-0.00861204103552598,0.00394287656040306,-0.016340079093916,-0.000884002977135981,0.0289622125893443
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SYT1,Synaptotagmin-1,37942,0.00834035531733116,0.00381921993601703,0.000854684242737779,0.0158260263919245,0.0289952133694003
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ERVV_1,,37562,0.0103031786914784,0.00472510933535241,0.00104196439418767,0.0195643929887691,0.0292369185035663
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ECM1,Extracellular matrix protein 1,37655,0.00789400024372095,0.00362276091289121,0.000793388854454184,0.0149946116329877,0.0293492012541198
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GOT1,"Aspartate aminotransferase, cytoplasmic",37998,-0.00853197515003284,0.00392185902586193,-0.0162188188407222,-0.000845131459343446,0.029610455877812
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ACP1,Low molecular weight phosphotyrosine protein phosphatase,37598,-0.00927447249218441,0.00426838388691937,-0.0176405049105464,-0.000908440073822448,0.0298109164136854
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDHR1,Cadherin-related family member 1,39961,-0.00931042604330139,0.00428743513873944,-0.0177137989152307,-0.000907053171372092,0.0299039137257323
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,37562,0.0149742172583259,0.0068982601415545,0.00145362738087906,0.0284948071357727,0.0299699446854215
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AMY2A,Pancreatic alpha-amylase,39695,0.00995775485551754,0.00459730953569057,0.000947028165564022,0.0189684815454711,0.0303269309106634
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TRIM26,Tripartite motif-containing protein 26,37482,-0.0116362764722937,0.0053786242214681,-0.0221783799463712,-0.00109417299821624,0.0305262493858141
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SERPINC1,Antithrombin-III,37981,-0.00311057363903341,0.00143833458119592,-0.00592970941817742,-0.000291437859889396,0.0305877490101802
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,37562,0.00797441072617481,0.00369836559832866,0.000725614153450629,0.015223207298899,0.0310862918816222
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,WFDC12,WAP four-disulfide core domain protein 12,40465,-0.0133324395303717,0.00621134102555363,-0.0255066679404568,-0.00115821112028661,0.0318507037798599
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,STX5,Syntaxin-5,37598,-0.00877066370725365,0.00408938691857427,-0.0167858620676592,-0.000755465346848084,0.0319920703609506
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLITRK2,SLIT and NTRK-like protein 2,40489,-0.00785671700157517,0.00368429314088605,-0.0150779315577118,-0.000635502445438517,0.0329817597496649
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ANGPTL1,Angiopoietin-related protein 1,40136,-0.00612439355670296,0.00288175872316561,-0.0117726406541076,-0.000476146459298365,0.0335832018349156
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LBP,Lipopolysaccharide-binding protein,40403,0.0120577196247896,0.00567520477976777,0.000934318256444801,0.0231811209931345,0.0336326957586867
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ATP6V1D,V-type proton ATPase subunit D,40305,-0.00543952257295,0.00256232517928873,-0.0104616799243559,-0.000417365221544094,0.0337789132874258
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,37901,-0.00444885937240672,0.00209610316955332,-0.00855722158473123,-0.000340497160082202,0.0338187814878732
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CEP350,Centrosome-associated protein 350,37482,0.0077819845274925,0.00366682940220804,0.00059499889916475,0.0149689701558202,0.0338342827879601
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,37562,0.0112029893716896,0.00528566386381402,0.000843088198614155,0.0215628905447651,0.0340665788540705
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CR1,Complement receptor type 1,37959,0.00748753939999386,0.00354062982408563,0.000547904944786026,0.0144271738552017,0.0344697076725186
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NXPE4,NXPE family member 4,37562,0.0075125632592039,0.00355500162959758,0.000544760065192637,0.0144803664532152,0.0345992770161307
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MFAP4,Microfibril-associated glycoprotein 4,37671,-0.00647650331116276,0.0030666351913848,-0.012487108286277,-0.000465898336048554,0.0347115985701248
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",39961,-0.00622827664328615,0.00295394314317433,-0.0120180052039078,-0.000438548082664467,0.0350070477100666
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NRTN,Neurturin,40044,-0.0101453960251828,0.00482740467176794,-0.0196071091818479,-0.000683682868517615,0.0356021104274157
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDRG1,p53 and DNA damage-regulated protein 1,37572,-0.01106966686631,0.00526968030956998,-0.0213982402730671,-0.000741093459552811,0.0356921872750385
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KCNH2,Potassium voltage-gated channel subfamily H member 2,37572,0.0163026577172398,0.00777126526453578,0.00107097779874971,0.03153433763573,0.0359407880933751
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLPS,Colipase,40311,0.0139880092426629,0.00667058208445,0.000913668357140868,0.0270623501281849,0.0360120434935627
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TERF1,Telomeric repeat-binding factor 1,37598,0.00608582823480633,0.00290244704783732,0.000397032021045178,0.0117746244485675,0.0360310356500862
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DNAJA1,DnaJ homolog subfamily A member 1,37482,0.00961523480145355,0.00459636323112136,0.000606362868455683,0.0186241067344514,0.0364647724803631
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,37541,0.0133680878243154,0.00639460899859406,0.000834654187071088,0.0259015214615598,0.0365899374041335
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ATF4,Cyclic AMP-dependent transcription factor ATF-4,37482,0.00703402846505606,0.00337760508306124,0.000413922502256021,0.0136541344278561,0.0373117991498239
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRAME,Melanoma antigen preferentially expressed in tumors,37482,0.0051822193392829,0.00249867528509651,0.000284815780493742,0.0100796228980721,0.0381001385585195
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MCTS1,Malignant T-cell-amplified sequence 1,37901,-0.00526369227160646,0.00253974663681811,-0.0102415956797699,-0.000285788863442977,0.0382353707589936
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BSND,Barttin,37482,0.00693567652360258,0.00335509701142147,0.000359686381216491,0.0135116666659887,0.0387344520113187
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CNTF,Ciliary neurotrophic factor,37541,0.0068595945759947,0.00332169386482385,0.000349074600939963,0.0133701145510494,0.0389341933773613
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RGMB,RGM domain family member B,40471,-0.00520526779207583,0.00252451455652721,-0.0101533163228692,-0.000257219261282499,0.0392344353823422
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL31RA,Interleukin-31 receptor subunit alpha,37544,0.00812930393286691,0.00395030173184625,0.000386712538448263,0.0158718953272856,0.0396200211494013
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NLGN2,Neuroligin-2,37541,0.00974553122937494,0.00473699999262681,0.000461011243826385,0.0190300512149235,0.0396750908674988
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ATP2B4,Plasma membrane calcium-transporting ATPase 4,37562,0.012574558142706,0.00612047023407566,0.000578436483917703,0.0245706798014943,0.0399462790853441
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FES,Tyrosine-protein kinase Fes/Fps,39980,-0.00948661314706522,0.00462772926250799,-0.0185569625015809,-0.000416263792549569,0.0403860771048072
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,COL9A2,Collagen alpha-2(IX) chain,37714,-0.00929316744328284,0.00453706961816164,-0.0181858238948797,-0.000400510991686021,0.0405526818970649
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRUNE2,Protein prune homolog 2,37714,-0.00591208753078363,0.00288986004651822,-0.0115762132219593,-0.000247961839607922,0.0407953319204717
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,39980,-0.0152811057674704,0.00747961626802256,-0.0299411536527946,-0.000621057882146179,0.0410659796458743
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CALY,Neuron-specific vesicular protein calcyon,37562,0.00763719029800289,0.0037398618567301,0.000307061058811886,0.0149673195371939,0.0411610930035975
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ITGA2,Integrin alpha-2,37671,-0.00674602785149102,0.0033081178612896,-0.0132299388596186,-0.000262116843363408,0.041446482541336
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EFHD1,EF-hand domain-containing protein D1,37959,0.00689439765513998,0.00338952170916275,0.000250935105180994,0.013537860205099,0.0419678084614151
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SERPINI1,Neuroserpin,37642,0.0063203482679445,0.00311920382356331,0.000206708773760423,0.0124339877621286,0.042757236345755
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CRTAM,Cytotoxic and regulatory T-cell molecule,40228,0.00993370897736626,0.00491223539233,0.000305727608399458,0.0195616903463331,0.0431686141573483
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",37942,-0.0106476450550397,0.00528987917092373,-0.0210158082300502,-0.000279481880029211,0.0441519981201382
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLASP1,CLIP-associating protein 1,37482,-0.0140218801637416,0.00697938110201713,-0.0277014671236952,-0.000342293203788055,0.0445531085542068
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,37572,-0.0203384036895975,0.010157972090865,-0.0402480289876929,-0.000428778391502037,0.045282585362
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL5,Interleukin-5,40044,0.0284569089830237,0.014226261982739,0.000573435496855214,0.0563403824691922,0.045484300918798
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GHRL,Appetite-regulating hormone,40359,-0.0153138248619504,0.00767149937558093,-0.030349963638089,-0.000277686085811744,0.0459294885815633
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TXNL1,Thioredoxin-like protein 1,37525,-0.0186570211750024,0.00934959082483671,-0.0369822191916824,-0.000331823158322492,0.046010107219859
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RPA2,Replication protein A 32 kDa subunit,37598,-0.00634671559349935,0.00318557887629228,-0.0125904501910322,-0.000102980995966485,0.0463558095396126
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BAMBI,BMP and activin membrane-bound inhibitor homolog,39980,-0.00585868432403163,0.00294231913915586,-0.0116256298367771,-9.17388112861538e-05,0.0464786948580923
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ACSL1,Long-chain-fatty-acid--CoA ligase 1,37562,0.00740614208106824,0.00373298373952202,8.9493951605079e-05,0.0147227902105314,0.0472795769241538
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AHNAK2,Protein AHNAK2,37628,-0.00554586844227923,0.00279682771066618,-0.0110276507551849,-6.40861293735159e-05,0.047397782858171
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ICAM2,Intercellular adhesion molecule 2,40536,-0.00601412280554658,0.00303598336444212,-0.0119646501998531,-6.35954112400165e-05,0.0476141981203358
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CSPG5,Chondroitin sulfate proteoglycan 5,37541,0.00972726245869765,0.00491856381976516,8.68773719579254e-05,0.0193676475454374,0.0479876615136457
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PKLR,Pyruvate kinase PKLR,40374,-0.0128128054408903,0.00648016153708581,-0.0255139220535785,-0.000111688828202143,0.0480322374973318
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRR4,Proline-rich protein 4,37577,0.0132858308349527,0.00673943829415188,7.6531778415035e-05,0.0264951298914904,0.0487041642378164
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,UPK3A,Uroplakin-3a,37541,0.00965829027712888,0.00491031231835846,3.40781331463046e-05,0.0192825024211115,0.0492112059236557
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TFPI2,Tissue factor pathway inhibitor 2,40357,0.00757437417595489,0.00386979028236753,-1.04147774854764e-05,0.0151591631293952,0.0503286500299702
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL36G,Interleukin-36 gamma,37551,-0.0131787124555612,0.00673573075780842,-0.0263807447408657,2.33198297433321e-05,0.0504230393867587
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TGM2,Protein-glutamine gamma-glutamyltransferase 2,40333,-0.0141429306069617,0.00723103889489751,-0.0283157668409608,2.99056270374638e-05,0.0504986522662869
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,37959,-0.0062737738320453,0.00320893914111286,-0.0125632945486265,1.57468845359129e-05,0.0505927111936217
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BEX3,Protein BEX3,37482,0.00913174914306843,0.00467325413333576,-2.78289582696534e-05,0.0182913272444065,0.0507172508879733
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD177,CD177 antigen,40316,-0.0242932920465847,0.0124421279535976,-0.0486798628356361,9.32787424666667e-05,0.0508960790367959
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TEX33,Testis-expressed protein 33,37714,0.00754110673132174,0.00386462954630354,-3.35671794331966e-05,0.0151157806420767,0.0510406986142117
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SMAD5,Mothers against decapentaplegic homolog 5,40305,-0.00391163453403679,0.00200992753832501,-0.00785109250915381,2.78234410802424e-05,0.0516535290065251
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CA3,Carbonic anhydrase 3,40500,-0.0115199377832432,0.00594552288241189,-0.0231731626327705,0.000133287066284125,0.0526917693314971
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BRD2,Bromodomain-containing protein 2,37541,0.00654524875600873,0.00338778051032337,-9.48010442250709e-05,0.0131852985562425,0.0533789917469814
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SAG,S-arrestin,37541,0.0100940348456495,0.00523598421848483,-0.000168494222580747,0.0203565639138798,0.0538991345569305
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ODAM,Odontogenic ameloblast-associated protein,39934,0.0100704748318615,0.00522645490559147,-0.00017337678309778,0.0203143264468208,0.0540194637821512
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ERC2,ERC protein 2,37572,-0.0145048897023687,0.00753033329809457,-0.0292643429666341,0.000254563561896614,0.0541016196938901
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AMY2B,Alpha-amylase 2B,39311,0.00900423959235789,0.00470090305504234,-0.000209530395525093,0.0182180095802409,0.0554571635370033
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPINT1,Kunitz-type protease inhibitor 1,40278,0.00475980175594686,0.0024916265599721,-0.000123786301598464,0.00964338981349218,0.0561101966329722
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",37628,-0.0127909336262205,0.00669653579423684,-0.0259161437829247,0.000334276530483714,0.056144322232804
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GLP1R,Glucagon-like peptide 1 receptor,37541,0.00718557024726628,0.00376501579490101,-0.000193860710739696,0.0145650012052723,0.0563471850687384
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,WASL,Neural Wiskott-Aldrich syndrome protein,37598,0.011638947303345,0.00610648579701078,-0.000329764858796077,0.0236076594654862,0.0566723038077968
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LY6D,Lymphocyte antigen 6D,40268,-0.00692894433464261,0.00363833198702949,-0.0140600750292204,0.000202186359935195,0.0568724823564447
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,37562,0.00756916210889506,0.00399095183801965,-0.000253103493623459,0.0153914277114136,0.0579052647801691
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ENO1,Alpha-enolase,40299,-0.0145883204810613,0.00771034601085054,-0.0297005986623284,0.000523957700205756,0.0585032175403301
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",37572,0.0144750910162438,0.00768129741869021,-0.000580251924389003,0.0295304339568766,0.0595249856164125
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MN1,Transcriptional activator MN1,37572,0.0109450928962665,0.0058439686259646,-0.000509085610624141,0.0223992714031571,0.0611062094172193
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",37541,0.0106287362752645,0.00568000148979007,-0.000504066644724063,0.021761539195253,0.0613319109510944
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CEP290,Centrosomal protein of 290 kDa,37714,-0.00973206394025845,0.00521535171203986,-0.0199541532958566,0.000490025415339662,0.0620575843291989
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DEFB116,Beta-defensin 116,37541,0.0144465175518936,0.0077584389246958,-0.000760022740510201,0.0296530578442974,0.0626199553971003
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCN2B,Sodium channel subunit beta-2,37572,0.00540388142299894,0.00290456164211934,-0.000289059395554954,0.0110968222415528,0.0628398771426245
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CPTP,Ceramide-1-phosphate transfer protein,37562,-0.00731988017309716,0.0039400363997503,-0.0150423515166078,0.000402591170413437,0.0632169201409114
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADRA2A,Alpha-2A adrenergic receptor,37562,0.0129830460076779,0.00703295884243534,-0.000801553323495378,0.0267676453388511,0.0649105233952256
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RYR1,Ryanodine receptor 1,37562,0.00623503808885993,0.00337786908959527,-0.000385585326746794,0.0128556615044667,0.0649365869300113
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SSH3,Protein phosphatase Slingshot homolog 3,37482,-0.00524861482029561,0.00285408698861787,-0.0108426253179866,0.000345395677395423,0.0659405635189771
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",37714,-0.0128555511509431,0.00701610376062952,-0.026607114521777,0.000896012219890727,0.0669303316698833
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ART5,Ecto-ADP-ribosyltransferase 5,37541,0.0114360048976041,0.00624300393771044,-0.000800282820308362,0.0236722926155166,0.0670022573717628
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RGS8,Regulator of G-protein signaling 8,40044,-0.0118689606573829,0.00648340350019799,-0.024576431517771,0.000838510203005153,0.0671691569870882
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LUZP2,Leucine zipper protein 2,37900,-0.00797503215688205,0.00435813391368232,-0.0165169746276994,0.000566910313935307,0.0672841725594301
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDKL5,Cyclin-dependent kinase-like 5,37541,0.00969785300965642,0.0053213252923889,-0.000731944563425827,0.0201276505827387,0.0684094327264901
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRDX2,Peroxiredoxin-2,37763,-0.011174888892098,0.0061347746057392,-0.0231990471193468,0.000849269335150825,0.068543493883751
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IMPG1,Interphotoreceptor matrix proteoglycan 1,37541,0.0053545463476678,0.00294085926782621,-0.000409537817271564,0.0111186305126072,0.0686688877024152
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,37541,-0.0110399267940626,0.0060641279552696,-0.022925617586391,0.000845763998265782,0.0687011577330716
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VGF,Neurosecretory protein VGF,37959,-0.00541701970751024,0.00297597813107442,-0.0112499368444161,0.000415897429395616,0.0687432916449411
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PALLD,Palladin,37598,0.00738095343064207,0.00405681730121151,-0.000570408479732486,0.0153323153410166,0.0688739130918862
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KLHL41,Kelch-like protein 41,37959,-0.00843866348038627,0.00464001024458463,-0.0175330835597721,0.000655756598999609,0.0689833983985227
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",37598,0.00814134151241483,0.00448380410656567,-0.000646914536453881,0.0169295975612835,0.0694358073456454
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MORC3,MORC family CW-type zinc finger protein 3,37942,-0.00500141242236968,0.00275930941132238,-0.0104096588685615,0.000406834023822182,0.0699220126685681
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TP53INP1,Tumor protein p53-inducible nuclear protein 1,40042,0.00581183041327121,0.00320992673602666,-0.000479625989341036,0.0121032868158835,0.070225072027243
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRELP,Prolargin,40357,0.00409106976124033,0.00226057941097202,-0.000339665884264836,0.0085218054067455,0.0703543818832703
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,37562,0.0086914341201863,0.00480940200200095,-0.000734993803735554,0.0181178620441082,0.0707578131429934
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GUCA2A,Guanylin,40276,-0.00588525859984278,0.00325876968750173,-0.0122724471873462,0.000501929987660616,0.070941141879659
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL6R,Interleukin-6 receptor subunit alpha,40273,-0.0058959791633808,0.00327920086726108,-0.0123232128632125,0.000531254536450911,0.0721972252184669
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL12RB2,Interleukin-12 receptor subunit beta-2,37598,0.0073675248634577,0.00411086611341904,-0.00068977271884361,0.015424822445759,0.0731227294502449
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCN3B,Sodium channel subunit beta-3,37541,0.00804924436636457,0.00450242837022554,-0.000775515239277498,0.0168740039720066,0.0738384719333921
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL36A,Interleukin-36 alpha,37598,0.0103269019262824,0.00577714212284305,-0.000996296634489998,0.0216501004870547,0.0738724623163919
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FOLR2,Folate receptor beta,40471,0.00510684409344635,0.0028648819291747,-0.000508324487736069,0.0107220126746288,0.0746757425093638
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLINT1,Clathrin interactor 1,37482,0.00800555974262021,0.00449349471773003,-0.000801689904130645,0.0168128093893711,0.0748396009628852
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,37598,-0.00546106210639898,0.00306594533281132,-0.0114703149587092,0.000548190745911213,0.0749028510427769
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SIRT1,NAD-dependent protein deacetylase sirtuin-1,37598,-0.0152370103853912,0.00857125171063439,-0.0320366637382347,0.00156264296745216,0.0754782411009896
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GSTM4,Glutathione S-transferase Mu 4,37562,0.0124431389118692,0.00700257360635788,-0.00128190535659221,0.0261681831803307,0.0756016280982917
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,37562,-0.0114546417971444,0.00644876437618603,-0.024094219974469,0.00118493638018027,0.0757142924923137
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FLT1,Vascular endothelial growth factor receptor 1,40272,0.00400105016433629,0.00225505353326078,-0.000418854760854845,0.00842095508952742,0.0760394644070623
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KLK10,Kallikrein-10,40354,-0.00676803581990651,0.00381798454855024,-0.014251285535065,0.000715213895251964,0.0763021480081477
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLC13A1,Solute carrier family 13 member 1,37900,-0.0107159242679159,0.00606067694188324,-0.0225948510740071,0.00116300253817522,0.0770657158346555
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DSG4,Desmoglein-4,40250,0.00875568929576396,0.00495765579744878,-0.000961316067235657,0.0184726946587636,0.0773992842156823
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,37184,0.00842715858657101,0.00478139579571848,-0.000944377173037218,0.0177986943461792,0.0780106647104236
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DDC,Aromatic-L-amino-acid decarboxylase,40330,0.00828935467109423,0.00473326593080512,-0.000987846553283806,0.0175665558954723,0.079914062663322
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MMP13,Collagenase 3,39961,0.00562378942467472,0.00321563555029972,-0.00067885625391274,0.0119264351032622,0.0803300019299075
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL21R,Interleukin-21 receptor,37598,0.00955530029729506,0.00547304533208173,-0.00117186855358513,0.0202824691481752,0.0808545331470665
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EPN1,Epsin-1,37714,-0.00754714540936144,0.00432833854315245,-0.0160306889539402,0.000936398135217355,0.0812417820687507
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,37541,0.00984729227495777,0.00565036302543258,-0.00122741925489009,0.0209220038048056,0.0813970008808543
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ENOPH1,Enolase-phosphatase E1,37900,0.00973882942770437,0.00559626454246496,-0.00122984907552695,0.0207075079309357,0.0818401976266026
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,APOL1,Apolipoprotein L1,37987,-0.0110439227752446,0.00635679625671378,-0.0235032434384037,0.00141539788791437,0.0823497456033143
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DLGAP5,Disks large-associated protein 5,37959,0.00911553586686316,0.00525206764625672,-0.00117851671980001,0.0194095884535263,0.0826557998436382
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FGF9,Fibroblast growth factor 9,37457,0.00688093359251218,0.00397187857239214,-0.000903948409376421,0.0146658155944008,0.0832237849891329
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TMED10,Transmembrane emp24 domain-containing protein 10,37562,0.00882241014715658,0.00510267725968289,-0.00117883728182188,0.018823657576135,0.0838368049765678
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SIGLEC15,Sialic acid-binding Ig-like lectin 15,39961,-0.0136563742964385,0.00790609700369164,-0.0291523244236741,0.00183957583079709,0.0841297822670856
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CPA4,Carboxypeptidase A4,37410,-0.00741468226024625,0.00429504489968679,-0.0158329702636324,0.00100360574313986,0.0843111684335745
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CBLN4,Cerebellin-4,40489,0.00528404347143331,0.00306206790853911,-0.000717609629303342,0.01128569657217,0.0844304852650401
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,40471,-0.00771915869030465,0.00448779254450195,-0.0165152320775285,0.00107691469691918,0.085445457170056
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,F11,Coagulation factor XI,37810,0.00508670204132324,0.00296040120413612,-0.000715684318783559,0.01088908840143,0.0857746493458237
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLC1A4,Neutral amino acid transporter A,37572,-0.00883569087248245,0.00514573848638705,-0.0189213383058011,0.00124995656083617,0.0859865151572596
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FDX2,"Ferredoxin-2, mitochondrial",37562,-0.00957197140724346,0.00562412200142708,-0.0205952505300405,0.00145130771555363,0.0887885519225194
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BRDT,Bromodomain testis-specific protein,37562,-0.00613484598078131,0.00363214126644489,-0.0132538428630133,0.000984150901450682,0.0912348008546639
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CYB5A,Cytochrome b5,37482,-0.0121101893769549,0.0071782421688678,-0.0261795440279358,0.00195916527402601,0.0916140335247821
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BMP4,Bone morphogenetic protein 4,40203,0.00745064017286979,0.00442109238938781,-0.00121470091033032,0.0161159812560699,0.0919604089000696
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CTHRC1,Collagen triple helix repeat-containing protein 1,37998,-0.00455432780580102,0.00270814105063974,-0.0098622842650549,0.000753628653452871,0.092646711553383
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TOP1,DNA topoisomerase 1,37901,-0.0175255264052172,0.0104254809137926,-0.0379594689962506,0.00290841618581628,0.0927806761419333
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PCNA,Proliferating cell nuclear antigen,37482,0.010250813160348,0.00611767454753629,-0.00173982895282309,0.0222414552735192,0.0938393545231829
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EP300,Histone acetyltransferase p300,37598,-0.00486986377066435,0.00291245166105676,-0.0105782690263356,0.00083854148500691,0.0945315606690199
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CABP2,Calcium-binding protein 2,37572,-0.0106781922153775,0.00639639564166066,-0.0232151276730323,0.00185874324227744,0.0950604634869721
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FASLG,Tumor necrosis factor ligand superfamily member 6,40516,0.00592498870769367,0.00355195205430659,-0.00103683731874724,0.0128868147341346,0.0953166250844636
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLC39A14,Zinc transporter ZIP14,39961,-0.00541900467489833,0.00325828350787117,-0.0118052403503258,0.000967231000529168,0.0963032048994738
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RASA1,Ras GTPase-activating protein 1,39961,-0.00526688772768667,0.00317810927069469,-0.0114959818982483,0.000962206442874912,0.0974913210074963
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,40044,-0.00581507196359387,0.00352165051379757,-0.0127175069706371,0.00108736304344937,0.098710773491699
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,INSR,Insulin receptor,37598,-0.00272032427383706,0.00164759265104091,-0.00594960586987725,0.000508957322203124,0.0987440200697904
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HTR1A,5-hydroxytryptamine receptor 1A,37541,0.0130828743831955,0.00793550825484326,-0.00247072179629724,0.0286364705626883,0.0992433918864774
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTPRC,Receptor-type tyrosine-protein phosphatase C,37998,-0.00359385220057544,0.00218144862331563,-0.00786949150227408,0.000681787101123186,0.0994864568265209
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DDX25,ATP-dependent RNA helicase DDX25,37572,0.00632587007986319,0.00384030663079686,-0.00120113091649866,0.013852871076225,0.0995346317899982
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PHLDB2,Pleckstrin homology-like domain family B member 2,37482,0.0153734813253631,0.00933535773008149,-0.00292381982559659,0.0336707824763229,0.0996229630422865
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CST6,Cystatin-M,39992,-0.00766578046612935,0.00466239864008514,-0.0168040818006962,0.00147252086843753,0.100161120645273
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CORO6,Coronin-6,37541,0.00587234495905232,0.00357350344640633,-0.0011317217959041,0.0128764117140087,0.100344506566484
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL5RA,Interleukin-5 receptor subunit alpha,40341,-0.0087750864590664,0.00536525092401111,-0.0192909782701282,0.00174080535199538,0.101955549424245
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CST1,Cystatin-SN,36179,-0.0166558124741578,0.0101982611530648,-0.0366444043341649,0.0033327793858493,0.102453530850121
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ECE1,Endothelin-converting enzyme 1,39961,0.00561336176534142,0.00343734091930348,-0.00112382643649341,0.0123505499671763,0.102478035755958
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLSTN1,Calsyntenin-1,39961,0.00834321258555708,0.00512767646314671,-0.00170703328221046,0.0183934584533246,0.1037374093218
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TXNDC15,Thioredoxin domain-containing protein 15,40411,-0.0042975407323049,0.00264405824897414,-0.00947989490029421,0.000884813435684418,0.104106085443688
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCAR2,Cell cycle and apoptosis regulator protein 2,37942,-0.00893793355163569,0.00551229369874623,-0.0197420292011783,0.00186616209790691,0.104943565898235
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HBZ,Hemoglobin subunit zeta,37990,0.0165426063988508,0.0102520424162628,-0.00355139673702419,0.0366366095347258,0.106639412907265
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,UHRF2,E3 ubiquitin-protein ligase UHRF2,37562,0.00570482682454243,0.00353742047736165,-0.0012285173110864,0.0126381709601713,0.106831999242676
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL33,Interleukin-33,40044,-0.0060706365820839,0.00377209927183043,-0.0134639511548715,0.00132267799070375,0.107559576938597
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RRP15,RRP15-like protein,37541,0.0143233384225371,0.00894110398406598,-0.00320122538623225,0.0318479022313064,0.109187411653366
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DENND2B,DENN domain-containing protein 2B,37562,0.00820322918561276,0.00513039346042064,-0.0018523419968117,0.0182588003680372,0.10985639289275
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VWA5A,von Willebrand factor A domain-containing protein 5A,37482,-0.0128133502051266,0.00803280630267511,-0.0285576505583698,0.00293095014811664,0.110707980404175
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RICTOR,Rapamycin-insensitive companion of mTOR,37598,0.00786507443205199,0.00493302492690954,-0.0018036544246907,0.0175338032887947,0.11087688798966
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LSM8,U6 snRNA-associated Sm-like protein LSm8,37714,-0.0142855353407907,0.00896795311245048,-0.0318627234411937,0.0032916527596122,0.111194378575864
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GJA8,Gap junction alpha-8 protein,37482,-0.00968961607392541,0.0060939915164405,-0.0216338394461488,0.00225460729829796,0.111852793702187
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KIRREL2,Kin of IRRE-like protein 2,39961,0.00619290296290407,0.00391482174817351,-0.001480147663516,0.0138659535893241,0.11369008389355
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,40228,-0.00929251474991521,0.00590464363775264,-0.0208656162799104,0.00228058678007997,0.115562105313271
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CUZD1,CUB and zona pellucida-like domain-containing protein 1,37572,-0.005621875552959,0.00357689587827098,-0.0126325914743701,0.00138884036845212,0.11603982545063
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,37598,-0.00929466138652117,0.00591510805813455,-0.0208882731804649,0.00229895040742254,0.116127153013709
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADAMTSL5,ADAMTS-like protein 5,37990,-0.0059343545846044,0.00378548469152859,-0.0133539045800004,0.00148519541079165,0.116983771137183
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL4,Interleukin-4,40044,-0.0136625911035266,0.00876234670279224,-0.0308367906409994,0.00351160843394619,0.118960162344914
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,40042,0.00457806429118924,0.00295662735535601,-0.00121692532530854,0.010373053907687,0.121544488844195
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CA9,Carbonic anhydrase 9,40489,0.00675197543807385,0.00437755468442379,-0.00182803174339678,0.0153319826195445,0.122994205520482
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ACTN4,Alpha-actinin-4,40044,-0.00486191917787476,0.00316841420789823,-0.0110720110253553,0.00134817266960577,0.124927947013283
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,37987,0.00710419740549224,0.0046306108004876,-0.00197179976346346,0.0161801945744479,0.125008381647294
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NEO1,Neogenin,37959,0.00318699799041288,0.00208355961303907,-0.000896778851143698,0.00727077483196946,0.126140945670891
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,37714,-0.00994514541418703,0.00650846401716056,-0.0227017348878217,0.00281144405944767,0.126528284422985
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LELP1,Late cornified envelope-like proline-rich protein 1,37541,0.0113242308087215,0.00741177144954345,-0.00320284123238366,0.0258513028498267,0.126568728349851
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLNS1A,Methylosome subunit pICln,37572,-0.00501690067385977,0.00329096928473974,-0.0114672004719497,0.00143339912423012,0.127421764692158
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FOSB,Protein fosB,39961,-0.00581128433077102,0.00381311785188874,-0.0132849953204729,0.00166242665893091,0.127523026450644
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ATP1B4,Protein ATP1B4,37482,0.00629163970723868,0.00413672574188097,-0.00181634274684803,0.0143996221613254,0.128303524495122
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DTX3,Probable E3 ubiquitin-protein ligase DTX3,40305,-0.00354288339709304,0.00233033402071392,-0.00811033807769233,0.00102457128350626,0.128447281565517
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRKCQ,Protein kinase C theta type,40044,-0.00657715927708783,0.00432680197527373,-0.0150576911486243,0.00190337259444868,0.128506842049562
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CNPY2,Protein canopy homolog 2,40042,-0.00904788223534633,0.00595947307392057,-0.0207284494602307,0.00263268498953799,0.128975375462239
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLEC11A,C-type lectin domain family 11 member A,40296,0.00708092828972608,0.00466498169275149,-0.00206243582806685,0.016224292407519,0.129062124924631
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TIE1,Tyrosine-protein kinase receptor Tie-1,40536,0.00613693482697412,0.00404591569172875,-0.00179305992881423,0.0140669295827625,0.129331227972296
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SEMA7A,Semaphorin-7A,40490,-0.00397087486464282,0.00261891971269573,-0.00910395750152646,0.00116220777224081,0.129481856398229
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ZNF75D,Zinc finger protein 75D,37714,-0.00882780385733987,0.00582294577776554,-0.0202407775817603,0.00258516986708059,0.129533717139
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HMCN2,Hemicentin-2,37648,-0.00847035801764276,0.00559434237287283,-0.0194352690684735,0.00249455303318799,0.130026049872598
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLK,STE20-like serine/threonine-protein kinase,37714,-0.0115134969788842,0.00760538046576654,-0.0264200426917866,0.00339304873401825,0.130084657399804
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EPHA10,Ephrin type-A receptor 10,39961,0.00963537362003552,0.00637607748182569,-0.00286173824434284,0.0221324854844139,0.130764055023518
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,39757,-0.00958720111614935,0.00634923918497277,-0.022031709918696,0.00285730768639728,0.131070098364378
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",37541,0.00814773441739288,0.00540057170493812,-0.00243738612428583,0.0187328549590716,0.131404720148811
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MSLNL,Mesothelin-like protein,37572,0.00554845243375693,0.00368282003508017,-0.0016698748350002,0.0127667797025141,0.131943158921754
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LTBP3,Latent-transforming growth factor beta-binding protein 3,39980,-0.00793824321781405,0.0052752632404685,-0.0182777591691323,0.00240127273350421,0.132394522019411
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL20RA,Interleukin-20 receptor subunit alpha,40044,-0.00678391808168954,0.00451064161246061,-0.0156247756421123,0.00205693947873326,0.132606581786765
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MORF4L2,Mortality factor 4-like protein 2,37482,0.00533061439293372,0.00356226992746999,-0.00165143466490746,0.0123126634507749,0.134571207923689
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IFNL2,Interferon lambda-2,37541,-0.009478309271722,0.00635139769538153,-0.0219270487546698,0.00297043021122581,0.13563972953001
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ROBO4,Roundabout homolog 4,37628,0.00260277187857907,0.00174686235485764,-0.000821078336941895,0.00602662209410004,0.136256154397361
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDIA2,Protein disulfide-isomerase A2,37482,0.006055291141886,0.00406896409552702,-0.00191987848534696,0.014030460769119,0.136731507662731
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TCL1B,T-cell leukemia/lymphoma protein 1B,40042,-0.0116172491926974,0.00781498215476327,-0.0269346142160334,0.00370011583063862,0.137157729758048
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,37541,0.00493811118142808,0.00332294560461638,-0.00157486220362003,0.0114510845664762,0.137286171339758
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCARB1,Scavenger receptor class B member 1,39961,-0.00857461432875921,0.00578393389025846,-0.0199111247536658,0.00276189609614738,0.138230732460372
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PROK1,Prokineticin-1,40341,-0.00992542249602937,0.00670305290351474,-0.0230634061869183,0.00321256119485952,0.138697928302957
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VCPKMT,Protein-lysine methyltransferase METTL21D,37482,-0.0128503818270224,0.00870092716836617,-0.0299041990770201,0.00420343542297528,0.139727151612311
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCDC28A,Coiled-coil domain-containing protein 28A,37572,-0.00423909156866517,0.00288815322021063,-0.00989987188027801,0.00142168874294767,0.142195674808043
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AGBL2,Cytosolic carboxypeptidase 2,37541,0.0130993315933637,0.00893088499093935,-0.0044052029888774,0.0306038661756048,0.142469440261692
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ITGB5,Integrin beta-5,40411,0.00528234748583521,0.00360426720059048,-0.00178201622732213,0.0123467111989925,0.142782023428678
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL18RAP,Interleukin-18 receptor accessory protein,40128,0.0249309952333996,0.0170285285603678,-0.00844492074492125,0.0583069112117205,0.143194274829492
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL31,Interleukin-31,37598,0.00831442287760233,0.00568772619572113,-0.00283352046601108,0.0194623662212157,0.143814880032148
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLSTN3,Calsyntenin-3,37942,0.00433247371723636,0.00298189722591371,-0.00151204484555451,0.0101769922800272,0.146267774429598
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,37714,0.00718836903640568,0.00494903745820301,-0.00251174438167222,0.0168884824544836,0.146392343391782
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BABAM1,BRISC and BRCA1-A complex member 1,37598,-0.00417066270955596,0.00287498636005793,-0.0098056359752695,0.00146431055615759,0.146895026988519
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LCP1,Plastin-2,37998,-0.00664293794849239,0.00459041085238922,-0.0156401432191753,0.00235426732219048,0.147882639275833
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL25,Interleukin-25,37429,-0.00492255788571612,0.00341492809651745,-0.0116158169548903,0.00177070118345807,0.149472647167745
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NRCAM,Neuronal cell adhesion molecule,40359,0.00391277211309837,0.00272393278238265,-0.00142613614037162,0.00925168036656836,0.150896206476507
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KCNC4,Potassium voltage-gated channel subfamily C member 4,37541,0.00804685608605149,0.00560487198896043,-0.00293869301231094,0.0190324051844139,0.151114599527919
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,37900,-0.00958237424248289,0.00667525562235233,-0.0226658752622935,0.00350112677732768,0.15116601511264
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLSPN,Claspin,39925,-0.00476910736116896,0.00332849781291101,-0.0112929630744745,0.00175474835213662,0.151932138778637
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TPM3,Tropomyosin alpha-3 chain,37562,0.00594059192145456,0.00414715196899988,-0.00218782593778521,0.0140690097806943,0.15203863884457
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RNF31,E3 ubiquitin-protein ligase RNF31,37598,-0.00516180957240218,0.00360704882440091,-0.012231625268228,0.00190800612342359,0.152444236260729
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,H2AP,Huntingtin-interacting protein M,37482,0.00727232403210035,0.00509869933846036,-0.00272112667128196,0.0172657747354827,0.153802940559491
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NRN1,Neuritin,37959,-0.00509341475259453,0.00357946658445225,-0.0121091692581209,0.00192233975293187,0.154772710648128
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RAB39B,Ras-related protein Rab-39B,37562,-0.0123711406612157,0.00870306954758902,-0.0294291569744902,0.00468687565205881,0.155204343237585
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EPHA4,Ephrin type-A receptor 4,37671,-0.00389155771231447,0.0027569139137814,-0.00929510898332602,0.00151199355869708,0.158102205789648
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TGFBR1,TGF-beta receptor type-1,37598,-0.00296905268626946,0.00210422613130367,-0.00709333590362466,0.00115523053108574,0.158269733193028
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,C9orf40,Uncharacterized protein C9orf40,37901,-0.0113493565359723,0.00804378233903631,-0.0271151699204835,0.00441645684853885,0.158283153693807
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TMOD4,Tropomodulin-4,37482,0.00576825828392859,0.00409623696837001,-0.00226036617407664,0.0137968827419338,0.159100239640647
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KIAA1549,UPF0606 protein KIAA1549,37714,-0.00975019976810419,0.00693442755087536,-0.0233416777678199,0.00384127823161152,0.159730655147332
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PVALB,Parvalbumin alpha,40417,-0.0154279977755718,0.0109780745012384,-0.0369450237979991,0.00608902824685547,0.159937747493577
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,37900,-0.00891036302719817,0.0063431290824241,-0.0213428960287494,0.00352216997435306,0.160125648372773
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ACTN2,Alpha-actinin-2,37562,0.00749908741881322,0.00534014409754315,-0.00296759501237136,0.0179657698499978,0.160257512374122
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MUC2,Mucin-2,37998,0.0124132556355407,0.00884405606505092,-0.00492109425195913,0.0297476055230405,0.160469726542567
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NEFL,Neurofilament light polypeptide,39903,-0.00582552693948789,0.00416279938826971,-0.0139846137404965,0.00233355986152075,0.161705548510106
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL17D,Interleukin-17D,40044,0.00467191850581057,0.00333884154131847,-0.00187221091517363,0.0112160479267948,0.161753927140054
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EDDM3B,Epididymal secretory protein E3-beta,37900,0.00582373323664681,0.00416746502915574,-0.00234449822049843,0.013991964693792,0.162307891253923
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CYTL1,Cytokine-like protein 1,37998,0.00312110592583764,0.00224166209091488,-0.00127255177235552,0.00751476362403081,0.163849052889707
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,UBQLN3,Ubiquilin-3,37562,0.00611619727330775,0.00441141682432555,-0.00253017970237033,0.0147625742489858,0.165633915602471
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FOLR3,Folate receptor gamma,40355,0.0247939263976755,0.0179453088337078,-0.0103788789163917,0.0599667317117428,0.167102189919813
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NME1,Nucleoside diphosphate kinase A,37598,0.00296195152586379,0.00214496545059773,-0.00124218075730777,0.00716608380903535,0.167337666565043
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ATP5F1D,"ATP synthase subunit delta, mitochondrial",37562,0.00712443897713053,0.00515995581951909,-0.0029890744291269,0.017237952383388,0.167389514360585
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RBPMS,RNA-binding protein with multiple splicing,37598,-0.00870913391152128,0.00631192783385956,-0.021080512465886,0.00366224464284345,0.167674827679856
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,40042,-0.00363532084718652,0.00264222410592516,-0.00881408009479984,0.0015434384004268,0.168885872308778
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NGFR,Tumor necrosis factor receptor superfamily member 16,37990,-0.00396519686714793,0.00288246368039094,-0.00961482568071417,0.00168443194641831,0.1689596868444
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,37959,-0.0050809178644434,0.00369484246977922,-0.0123228091052107,0.00216097337632388,0.169111508308418
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KRT17,"Keratin, type I cytoskeletal 17",37562,-0.00513033988862736,0.00374673790833171,-0.0124739461889575,0.00221326641170279,0.170934672349337
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PITHD1,PITH domain-containing protein 1,37457,0.010991977134038,0.00803207363618388,-0.00475088719288237,0.0267348414609584,0.171175976195377
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,40536,0.00935452621014996,0.00683573857143469,-0.00404352138986203,0.0227525738101619,0.171183065611901
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NMRK2,Nicotinamide riboside kinase 2,37482,0.00583725166683257,0.0042657307566908,-0.0025235806162814,0.0141980839499465,0.171208612973447
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLC,Galectin-10,40333,0.00875271516850623,0.00640442820961884,-0.0037999641223467,0.0213053944593592,0.171749323551527
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BLMH,Bleomycin hydrolase,40536,-0.00428073638458274,0.00314501320248199,-0.0104449622614474,0.00188348949228195,0.173495239573447
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,37572,-0.00725862703047419,0.00533298389618006,-0.0177112754669871,0.00319402140603872,0.173511234222735
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,STX3,Syntaxin-3,37942,-0.00513017537327258,0.00377763314530664,-0.0125343363380736,0.00227398559152844,0.17447383420347
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SH3GL3,Endophilin-A3,37643,-0.011000147673287,0.00811427056522148,-0.0269041179811211,0.00490382263454709,0.175232320908254
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FOS,Proto-oncogene c-Fos,37457,-0.00465664289934248,0.00343560917612295,-0.0113904368845435,0.0020771510858585,0.1753119994266
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,40396,-0.0117056071773407,0.00863725077642238,-0.0286346186991286,0.00522340434444717,0.175358111421438
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BHLHE40,Class E basic helix-loop-helix protein 40,37541,0.00943146431902317,0.00696020296576176,-0.00421053349386988,0.0230734621319162,0.175423122267374
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GBP6,Guanylate-binding protein 6,37562,0.00628505156130332,0.00464060810010852,-0.00281054031490937,0.015380643437516,0.17564506106728
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AMBN,Ameloblastin,40044,0.00390819200563368,0.00289482105490892,-0.00176565726198782,0.00958204127325517,0.177015238977426
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GSTP1,Glutathione S-transferase P,39871,0.00919287717628395,0.00681404747219657,-0.00416265586922132,0.0225484102217892,0.177322503527987
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DDA1,DET1- and DDB1-associated protein 1,37562,-0.00533744007224971,0.00398315583577809,-0.0131444255103748,0.00246954536587535,0.180267650640597
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,POMC,Pro-opiomelanocortin,37628,-0.00891283800129685,0.00665900314686135,-0.0219644841691451,0.00413880816655141,0.180768224415521
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GPR101,Probable G-protein coupled receptor 101,37541,0.00846234019401886,0.00633332771271305,-0.00395098212289871,0.0208756625109364,0.181520157102855
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PPIE,Peptidyl-prolyl cis-trans isomerase E,37714,0.00839249716886368,0.00631148835452273,-0.00397802000600088,0.0207630143437282,0.183634202458285
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TP73,Tumor protein p73,37572,0.00455410820190155,0.00342523197283713,-0.00215934646485923,0.0112675628686623,0.183680935845864
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,40471,-0.00933160815521246,0.00702329773635187,-0.0230972717184621,0.00443405540803721,0.183977524464937
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRDX6,Peroxiredoxin-6,40489,0.00771803895573079,0.00581362857228184,-0.00367667304594161,0.0191127509574032,0.18433681932128
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GKN1,Gastrokine-1,39602,-0.00361350366752302,0.00272731398386323,-0.00895903907589495,0.00173203174084891,0.185213920422739
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VIM,Vimentin,40042,-0.0152718680396164,0.0115473445701915,-0.0379046633971918,0.00736092731795896,0.186006561607983
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DNM1,Dynamin-1,37901,-0.0146274852507286,0.0110631203213208,-0.0363112010805174,0.00705623057906028,0.186129235780794
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,C1QA,Complement C1q subcomponent subunit A,40442,-0.00291580614311054,0.00221055532511844,-0.00724849458034268,0.00141688229412161,0.187175347799271
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GPC5,Glypican-5,40228,-0.0071798718212265,0.00544642373023085,-0.017854862332479,0.00349511869002597,0.187431509021903
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NINJ1,Ninjurin-1,39980,0.00720790921326725,0.00548863978082009,-0.00354982475714013,0.0179656431836746,0.189121008911114
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MYL3,Myosin light chain 3,37628,-0.00876018269630323,0.00667983135828798,-0.0218526521585477,0.00433228676594121,0.189732779408946
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TMPRSS11B,Transmembrane protease serine 11B,37541,0.0101050539137728,0.00770689087136084,-0.00500045219409443,0.0252105600216401,0.189822906533019
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RAC3,Ras-related C3 botulinum toxin substrate 3,37572,0.00898155708052572,0.00686644864286933,-0.00447668225949817,0.0224397964205496,0.190884259512969
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IFNGR1,Interferon gamma receptor 1,40422,0.00260796978669623,0.00199489517202991,-0.00130202475048239,0.00651796432387485,0.191122292034947
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RALB,Ras-related protein Ral-B,37598,-0.00377184264380826,0.00289257537200719,-0.00944129037294234,0.00189760508532582,0.1922653304187
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FST,Follistatin,40396,-0.00657074632771786,0.00505973270296876,-0.0164878224255366,0.0033463297701009,0.194087978567134
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SDC1,Syndecan-1,40359,-0.00505731601024228,0.00389578397756746,-0.0126930526062745,0.00257842058578994,0.194254260737293
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MMP3,Stromelysin-1,40332,0.00608905842503654,0.00470319067866183,-0.00312919530514065,0.0153073121552137,0.195454491560296
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,REXO2,"Oligoribonuclease, mitochondrial",37562,0.00620186320241912,0.00479083660356733,-0.00318817654057285,0.0155919029454111,0.195506547263592
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",37677,-0.00831954318350527,0.00644317852654833,-0.02094817309554,0.00430908672852946,0.196650927589983
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FGF6,Fibroblast growth factor 6,37598,0.00540913867895661,0.00420374711234684,-0.00283020566124319,0.0136484830191564,0.198206827477498
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",37942,0.00327063080774551,0.00254571376473528,-0.00171896817113564,0.00826022978662666,0.198898280139686
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CENPJ,Centromere protein J,37714,-0.0091653247057836,0.00717296785756842,-0.0232243417066177,0.00489369229505051,0.201356757312613
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LRRC37A2,Leucine-rich repeat-containing protein 37A2,37901,-0.00523380763510706,0.00410781743771411,-0.0132851298130267,0.0028175145428126,0.202646764937194
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LRP2,Low-density lipoprotein receptor-related protein 2,37572,0.00447095257094662,0.00353155526448633,-0.00245089574744658,0.0113928008893398,0.205535195355084
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TPRKB,EKC/KEOPS complex subunit TPRKB,37482,0.00793672876342798,0.00627854402345281,-0.00436921752253952,0.0202426750493955,0.206215533762533
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MSMB,Beta-microseminoprotein,40236,-0.0085057310456036,0.00674350992392162,-0.02172301049649,0.00471154840528278,0.207211839725877
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,40489,0.00310038693948276,0.00246154648347161,-0.0017242441681216,0.00792501804708711,0.207857981291293
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DRAXIN,Draxin,40228,-0.0052756113584103,0.00421650038861374,-0.0135399521200932,0.00298872940327263,0.210886466997452
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GPC1,Glypican-1,40489,-0.00356848343447004,0.0028550170955394,-0.00916431694172727,0.00202735007278719,0.211354630098219
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADGRE5,Adhesion G protein-coupled receptor E5,40451,-0.00362171000712883,0.00290546875816869,-0.00931642877313945,0.0020730087588818,0.212593683949135
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DCUN1D1,DCN1-like protein 1,37541,0.00912097843765615,0.00733441843928241,-0.00525448170333737,0.0234964385786497,0.213674326632353
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CRTAP,Cartilage-associated protein,37572,-0.00589291689965891,0.00474028401324366,-0.0151838735656165,0.00339803976629867,0.213832226736695
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,38013,0.00237774445309053,0.00191309771893326,-0.00137192707601866,0.00612741598219972,0.213934786272144
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OTOA,Otoancorin,37541,0.0066721286917826,0.00537556012343451,-0.00386396915014903,0.0172082265337142,0.21455525441147
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD22,B-cell receptor CD22,40516,-0.00494488723541956,0.00398582350132209,-0.0127571012980109,0.00286732682717175,0.214764753112701
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ESPL1,Separin,37482,0.00693137380412921,0.00560879455532017,-0.00406186352429832,0.0179246111325568,0.216553503734644
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLEC4C,C-type lectin domain family 4 member C,40341,0.00548419433384698,0.00444312691611142,-0.00322433442173139,0.0141927230894254,0.217105804241817
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ARTN,Artemin,40044,-0.00534792925478501,0.00434229434332709,-0.0138588261677061,0.00316296765813609,0.21812059762311
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ATP5PO,"ATP synthase subunit O, mitochondrial",39961,-0.00516940598094749,0.00420488137816594,-0.0134109734821527,0.00307216152025776,0.218947221748123
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL3,Interleukin-3,37482,0.00723141427354982,0.00589086524546058,-0.00431468160755292,0.0187775101546526,0.219632848340631
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCP2,Non-specific lipid-transfer protein,39980,-0.00932343357764271,0.00760245442719191,-0.0242242442549389,0.00557737709965344,0.220077495313838
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SSB,Lupus La protein,39961,-0.00722670118133451,0.00589344947692352,-0.0187778621561046,0.0043244597934356,0.22013224417032
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KRT14,"Keratin, type I cytoskeletal 14",39530,-0.00340127460527191,0.00279296880933724,-0.00887549347157289,0.00207294426102908,0.223319423662114
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADA2,Adenosine deaminase 2,40258,0.00497241055494587,0.00408416553679815,-0.0030325538971785,0.0129773750070702,0.223437890158605
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LCN15,Lipocalin-15,37959,-0.0075724346976674,0.0062339728059725,-0.0197910213973735,0.0046461520020387,0.22450005777467
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NDRG1,Protein NDRG1,39961,-0.00811622801280456,0.00670842136788653,-0.0212647338938622,0.00503227786825304,0.22635235522328
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RELB,Transcription factor RelB,37598,-0.0060883428962008,0.0050380623174037,-0.0159629450383121,0.00378625924591046,0.226888591399617
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MUCL3,Mucin-like protein 3,37482,0.00532467517405707,0.00441020359814061,-0.00331932387829853,0.0139686742264127,0.227317913842172
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD55,Complement decay-accelerating factor,39802,0.00308869153981309,0.00256062096791351,-0.00193012555729739,0.00810750863692356,0.227748357229423
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HMMR,Hyaluronan mediated motility receptor,37460,0.00574452738104768,0.004764771881778,-0.0035944255072372,0.0150834802693326,0.227984103199083
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RAD51,DNA repair protein RAD51 homolog 1,37714,-0.00638776907024502,0.00531639461777284,-0.0168079025210798,0.00403236438058974,0.22956994381978
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD33,Myeloid cell surface antigen CD33,40411,-0.0092541455822434,0.00772302985307592,-0.0243912840942722,0.00588299292978541,0.230836236666605
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AFP,Alpha-fetoprotein,40182,0.00808759115222232,0.00676310244196958,-0.00516808963403805,0.0213432719384827,0.231776871720564
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADGRE2,Adhesion G protein-coupled receptor E2,40422,0.00321668604482281,0.00271062069945475,-0.00209613052610851,0.00852950261575412,0.235364725253886
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MORF4L1,Mortality factor 4-like protein 1,37714,0.00473756269857148,0.00400068913434312,-0.00310378800474104,0.012578913401884,0.236360404957842
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,S100A3,Protein S100-A3,37900,0.00529975851749215,0.00448379600962449,-0.00348848166137184,0.0140879986963561,0.237234420209282
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CRYBB2,Beta-crystallin B2,37942,-0.00793367563464949,0.00671273413157601,-0.0210906345325385,0.00522328326323949,0.237272412645552
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLEC5A,C-type lectin domain family 5 member A,40314,0.00324560520662106,0.0027484180858643,-0.00214129424167297,0.00863250465491508,0.237660405066358
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GAMT,Guanidinoacetate N-methyltransferase,37562,0.00448284501040529,0.00380649825391095,-0.00297789156726016,0.0119435815880707,0.23894472763036
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FZD10,Frizzled-10,37572,-0.00702619325017179,0.00596692046502868,-0.018721357361628,0.00466897086128443,0.239007703608856
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NTF4,Neurotrophin-4,39980,-0.00468293737935509,0.00397761306655771,-0.0124790589898082,0.00311318423109802,0.239084451346605
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TSLP,Thymic stromal lymphopoietin,40042,-0.00694596206414112,0.00594269818959754,-0.0185936505157523,0.00470172638747006,0.242492840992685
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CELA3A,Chymotrypsin-like elastase family member 3A,40522,0.00627405393080686,0.00538105479491243,-0.00427281346722149,0.0168209213288352,0.243650981913543
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SUSD4,Sushi domain-containing protein 4,37900,-0.00505578725834642,0.00435426800560834,-0.0135901525493388,0.00347857803264592,0.245617485235947
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NPHS2,Podocin,37598,0.0118732188863421,0.0102514867694257,-0.00821969518173231,0.0319661329544166,0.246805581598443
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,39980,-0.00492966311503857,0.00426261510809111,-0.0132843887268971,0.00342506249682,0.247499406998767
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TCN1,Transcobalamin-1,37766,0.00372227766049975,0.00323268221878458,-0.00261377948831802,0.0100583348093175,0.249567103352515
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",37628,0.00290753968695396,0.0025328194196703,-0.00205678637559982,0.00787186574950774,0.251011736547564
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,COPE,Coatomer subunit epsilon,39961,-0.0053963449382546,0.00471551317341633,-0.0146387507581506,0.0038460608816414,0.252483214984915
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DDR1,Epithelial discoidin domain-containing receptor 1,40471,0.00255857045687884,0.00224072538182701,-0.00183325129150209,0.00695039220525977,0.253533780311897
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TMEM132A,Transmembrane protein 132A,37628,0.0070052366489942,0.00614427196829352,-0.00503753640886109,0.0190480097068495,0.25425504905369
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDH4,Cadherin-4,37541,0.00553809759705302,0.00485780591691807,-0.0039832020001064,0.0150593971942124,0.254290108348767
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPINK8,Serine protease inhibitor Kazal-type 8,37562,0.00434682095055457,0.00381729118393937,-0.00313506976996659,0.0118287116710757,0.254841297340829
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL2RG,Cytokine receptor common subunit gamma,37900,-0.00429124351989999,0.00377040458813636,-0.0116812365126472,0.00309874947284727,0.255082830356514
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",37562,0.00549478963919546,0.0048426442414002,-0.00399679307394893,0.0149863723523398,0.256535525648015
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IFNAR1,Interferon alpha/beta receptor 1,37901,-0.00291405323883067,0.00257732326988288,-0.00796560684780112,0.00213750037013977,0.25822215768258
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ARG1,Arginase-1,40227,-0.00580614806891396,0.0051379073799096,-0.0158764465335368,0.00426415039570886,0.258467759578937
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCIN,Adseverin,37541,-0.00813055853495869,0.00720206117867341,-0.0222465984451586,0.0059854813752412,0.258951826113469
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HDDC2,5'-deoxynucleotidase HDDC2,37901,-0.00478461984217106,0.00424555405640308,-0.0131059057927211,0.00353666610837898,0.259774496415455
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ARHGEF5,Rho guanine nucleotide exchange factor 5,37541,-0.00815540154300903,0.00724126919583873,-0.0223482891668529,0.00603748608083487,0.260084915010717
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCDC50,Coiled-coil domain-containing protein 50,37959,-0.00860302078978328,0.00766407081725787,-0.0236245995916087,0.00641855801204214,0.261664243916479
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SAA4,Serum amyloid A-4 protein,38013,-0.00357878332974979,0.00319193371544096,-0.00983497341201408,0.0026774067525145,0.262224293399387
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SEPTIN3,Neuronal-specific septin-3,37959,-0.00807293107289384,0.0072032377442367,-0.0221912770515978,0.00604541490581009,0.262419989300895
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FRZB,Secreted frizzled-related protein 3,40176,0.00289346615307549,0.00259272856236382,-0.00218828182915759,0.00797521413530857,0.264442312740048
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FCRL3,Fc receptor-like protein 3,40044,-0.00594338979254226,0.00533451627551821,-0.016399041692558,0.00451226210747342,0.265236961527421
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MRPL28,"39S ribosomal protein L28, mitochondrial",37959,-0.00399032107423748,0.00360666501911061,-0.0110593845116943,0.00307874236321932,0.268584298120109
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FCRL1,Fc receptor-like protein 1,40359,-0.00484500549538362,0.00438268662994687,-0.0134350712900795,0.00374506029931225,0.268965106725476
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EDNRB,Endothelin receptor type B,37598,-0.00505396545541058,0.00463100799812844,-0.0141307411317423,0.00402281022092116,0.275146990720184
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,37671,0.00409712613656597,0.00375878637298419,-0.00327009515448304,0.011464347427615,0.275727271958517
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KLK7,Kallikrein-7,37352,0.00409594438135501,0.00379161062017674,-0.0033356124341914,0.0115275011969014,0.280044370658476
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HDAC9,Histone deacetylase 9,37541,0.0067110545982564,0.00622049960073572,-0.00548112461918561,0.0189032338156984,0.280669564622884
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,F2,Prothrombin,38013,-0.00154820115827212,0.00143725096149766,-0.00436521304280753,0.00126881072626329,0.281411820210502
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SERPINA6,Corticosteroid-binding globulin,38013,0.00187465440973482,0.00174659104960291,-0.00154866404748689,0.00529797286695653,0.283145814591955
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PSMA1,Proteasome subunit alpha type-1,39980,-0.004863729121945,0.00453796811916737,-0.013758146635513,0.00403068839162305,0.283832976055555
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ICOSLG,ICOS ligand,40305,-0.00199158531743873,0.001862104979539,-0.00564131107733517,0.00165814044245772,0.284845224440708
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TLR2,Toll-like receptor 2,37714,-0.00240007784864381,0.0022496887999299,-0.00680946789650641,0.0020093121992188,0.286059527988975
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,UGDH,UDP-glucose 6-dehydrogenase,37562,0.0101325991742559,0.00950101110272623,-0.00848938258708749,0.0287545809355993,0.286228215660036
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],40305,-0.00592414445113157,0.00556098452300936,-0.0168236741162299,0.00497538521396677,0.286754168959517
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NMI,N-myc-interactor,37857,-0.00743532879709774,0.00698362902554326,-0.0211232416871625,0.00625258409296704,0.287040028352725
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,37482,-0.00274937136736072,0.00259170788459816,-0.00782911882117311,0.00233037608645166,0.288785093402402
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,37628,0.00276214907899671,0.0026067791350026,-0.00234713802560839,0.00787143618360181,0.289345005684161
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MARCO,Macrophage receptor MARCO,40359,0.0027301828752222,0.00258573747000749,-0.00233786256599249,0.00779822831643688,0.291047137049428
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VIT,Vitrin,37990,0.00379737872164355,0.00359806753616491,-0.00325483364923968,0.0108495910925268,0.291264020886764
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,METAP1,Methionine aminopeptidase 1,39961,-0.00315289399932887,0.00299699417418265,-0.00902700258072687,0.00272121458206914,0.292807347986149
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,39980,-0.00489657796183516,0.0046601857829658,-0.0140305420964481,0.00423738617277781,0.293400842699901
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,37671,0.00414169398029499,0.00394967782645471,-0.00359967455955624,0.0118830625201462,0.294374221418265
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,40374,-0.00581998959922253,0.00555162405973037,-0.0167011727562941,0.005061193557849,0.294497896681838
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",39961,-0.00505193216111947,0.00482846755625143,-0.0145157285713723,0.00441186424913334,0.295447783703245
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TOP1MT,"DNA topoisomerase I, mitochondrial",37482,0.00506287773176812,0.00484531324509996,-0.00443393622862779,0.014559691692164,0.296087627182695
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,37572,0.00420683755472901,0.00404747719917249,-0.00372621775564906,0.0121398928651071,0.298650560455409
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KDM3A,Lysine-specific demethylase 3A,37598,0.00937623840855623,0.00905129623245844,-0.00836430220706231,0.0271167790241748,0.300267818983557
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IGLON5,IgLON family member 5,37482,0.00951795610980993,0.0092174653780655,-0.00854827603119845,0.0275841882508183,0.301810224087639
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IGFL4,Insulin growth factor-like family member 4,37598,-0.00792351735374384,0.00769219027592588,-0.0230002102945586,0.00715317558707088,0.302994699367638
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FH,"Fumarate hydratase, mitochondrial",37541,0.00863194823802345,0.00839323264281694,-0.00781878774189775,0.0250826842179446,0.303761229573794
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PCDH1,Protocadherin-1,40475,-0.00217432900685597,0.00211775159739023,-0.00632512213774081,0.00197646412402888,0.304569810424885
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,COL28A1,Collagen alpha-1(XXVIII) chain,37572,-0.00728608805013396,0.00709834509635667,-0.021198844438993,0.00662666833872511,0.304698993044935
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,37572,0.00511226693406266,0.0049826454787893,-0.00465371820436437,0.0148782520724897,0.304903625068311
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD3G,T-cell surface glycoprotein CD3 gamma chain,37598,-0.00940316293603567,0.00916535558251116,-0.0273672598777576,0.00856093400568622,0.304935759299146
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EXOSC10,Exosome component 10,37562,0.00627901158513391,0.00614154912772397,-0.00575842470520507,0.0183164478754729,0.30661882385111
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LPO,Lactoperoxidase,39831,-0.00586276851892056,0.00576784350343029,-0.0171677417856439,0.00544220474780281,0.309427506134296
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SFTPA2,Pulmonary surfactant-associated protein A2,39980,-0.00491611063117238,0.00484070652790117,-0.0144038954258587,0.00457167416351392,0.309846644335949
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DUSP3,Dual specificity protein phosphatase 3,39961,-0.00837881234001282,0.00827001804765893,-0.0245880477134243,0.00783042303339868,0.311001809146287
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MFAP3,Microfibril-associated glycoprotein 3,40042,-0.00491613380705524,0.00485758423915219,-0.0144369989157935,0.00460473130168305,0.311528310783419
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VCAM1,Vascular cell adhesion protein 1,40372,0.00265485916964984,0.00263538544502849,-0.002510496302606,0.00782021464190569,0.31376302910378
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VTCN1,V-set domain-containing T-cell activation inhibitor 1,39980,0.00317943480782475,0.00316080640384639,-0.00301574574371417,0.00937461535936367,0.314482448376015
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SOD2,"Superoxide dismutase [Mn], mitochondrial",40332,-0.00362475555979328,0.00360848421312181,-0.010697384617512,0.00344787349792547,0.315148548840234
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,37714,-0.00520787517371864,0.00519137496237221,-0.0153829700999682,0.00496721975253088,0.315793100865698
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RAB6B,Ras-related protein Rab-6B,39961,-0.00476899594572452,0.00475917450361414,-0.0140969779728082,0.0045589860813592,0.316328469008988
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SHPK,Sedoheptulokinase,37714,0.0041918597390368,0.00419527148417926,-0.00403087236995456,0.0124145918480282,0.317722456653155
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,WNT9A,Protein Wnt-9a,40044,0.00278348454196663,0.00279587270045688,-0.00269642595092886,0.00826339503486213,0.319474991495549
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NRXN3,Neurexin-3,37572,-0.0033785809820528,0.00341284700666986,-0.0100677611151257,0.00331059915102011,0.32221207614102
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NOS2,"Nitric oxide synthase, inducible",37562,-0.00379688658664578,0.00384049310108446,-0.0113242530647713,0.00373047989147976,0.322854815794297
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRDX1,Peroxiredoxin-1,39953,0.00856513269881636,0.00867078058326685,-0.00842959724438667,0.0255598626420194,0.323258363308428
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,37562,0.0032154582114263,0.00327689972956619,-0.00320726525852343,0.00963818168137602,0.326487527323496
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ACE,Angiotensin-converting enzyme,37987,0.00243698688133142,0.00249789380264155,-0.00245888497184602,0.00733285873450886,0.329271887103349
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SERPINB5,Serpin B5,40042,-0.00464422125195337,0.0047609907449974,-0.0139757631121483,0.00468732060824152,0.329340477349936
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HRAS,GTPase Hras,37697,0.00939216434181037,0.00963764704792343,-0.00949762387211955,0.0282819525557403,0.329811857883477
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ANKRA2,Ankyrin repeat family A protein 2,37482,0.00534473749226996,0.00552367904328948,-0.00548167343257741,0.0161711484171173,0.333259816272668
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HLA_A,,37959,0.00309083038767815,0.00319480649222323,-0.00317099033707938,0.00935265111243568,0.333334124978841
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL11,Interleukin-11,40044,-0.00598945811333686,0.00622798551926921,-0.0181963097311045,0.00621739350443079,0.336214877706016
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SEPTIN7,Septin-7,37714,-0.00492013418127173,0.00513709286617868,-0.0149888361989819,0.00514856783643847,0.33819809944393
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ALMS1,Alstrom syndrome protein 1,37714,0.00421899226897466,0.0044113601550569,-0.00442727363493686,0.0128652581728862,0.338891348128028
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,40305,-0.00415886965396808,0.00438075213004842,-0.012745143828863,0.00442740452092682,0.342456799214932
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RTKN2,Rhotekin-2,37562,0.00488163585260045,0.00515027698066614,-0.00521290702950518,0.0149761787347061,0.343228649309981
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MLLT1,Protein ENL,37482,0.00660235981985288,0.00701025688643875,-0.00713774367756706,0.0203424633172728,0.346305209492163
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FSTL1,Follistatin-related protein 1,37628,0.00205662542193841,0.00219743746156048,-0.00225035200272013,0.00636360284659695,0.34933158974657
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,37998,0.00227954438367967,0.0024367165233414,-0.00249642000206948,0.00705550876942882,0.349548189301433
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PGR,Progesterone receptor,37598,0.009454048973125,0.0101190676689927,-0.0103793236581008,0.0292874216043507,0.350176310669
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GPHA2,Glycoprotein hormone alpha-2,37901,0.00445898563587099,0.00478446623101336,-0.0049185681769152,0.0138365394486572,0.351368041713128
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLEC1A,C-type lectin domain family 1 member A,40042,-0.0030022891067866,0.00322276325237173,-0.00931890508143519,0.00331432686786199,0.351563666842545
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CINP,Cyclin-dependent kinase 2-interacting protein,37714,-0.00409624569149877,0.00440105260159479,-0.0127223087906246,0.00452981740762702,0.352003840087591
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ANK2,Ankyrin-2,37562,0.00675348851480509,0.00725843871260672,-0.00747305136190407,0.0209800283915143,0.352164241782141
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GNPDA1,Glucosamine-6-phosphate isomerase 1,37628,-0.00296696220959544,0.00320129880008248,-0.00924150785775709,0.00330758343856622,0.354047606813912
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,JCHAIN,Immunoglobulin J chain,40044,0.00557464937692502,0.00602254289147948,-0.00622953469037477,0.0173788334442248,0.354652364166179
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AMIGO2,Amphoterin-induced protein 2,40305,0.00202634696704769,0.00219586241517459,-0.00227754336669451,0.00633023730078989,0.356124267196542
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,S100A13,Protein S100-A13,37598,0.00313139621379047,0.00339940412600726,-0.00353143587318376,0.00979422830076471,0.35698363198792
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VWF,von Willebrand factor,40536,-0.00640188126064201,0.00696523138594288,-0.0200537347770901,0.00724997225580603,0.358046758611224
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,37541,0.00542277041520671,0.00591804004938528,-0.00617658808158844,0.0170221289120019,0.35952021943734
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ICAM5,Intercellular adhesion molecule 5,40359,0.00393248594688332,0.00429562955381451,-0.00448694797859313,0.0123519198723598,0.359962980381164
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DKKL1,Dickkopf-like protein 1,40305,0.00780010804389977,0.00856766263207921,-0.00899251071497549,0.024592726802775,0.362618795260552
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MILR1,Allergin-1,40044,0.00442441004894633,0.00486711758216829,-0.00511514041210352,0.0139639605099962,0.363342468187867
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL24,Interleukin-24,40044,-0.00437202079432426,0.00481129560356641,-0.0138021601773144,0.00505811858866591,0.363522935605913
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SMPD3,Sphingomyelin phosphodiesterase 3,37598,0.00520020133272004,0.00572370797946669,-0.00601826630703467,0.0164186689724747,0.363611150639096
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FAM171A2,Protein FAM171A2,37959,-0.0142673202705085,0.0157177829797569,-0.0450741749108321,0.016539534369815,0.364043232615019
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,38013,-0.00239261065053526,0.00263591818596768,-0.00755901029503192,0.00277378899396139,0.364055336647287
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CGN,Cingulin,37572,-0.00371934606193007,0.00411159419287286,-0.0117780706799609,0.00433937855610072,0.365694208896846
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FBN2,Fibrillin-2,37572,-0.0053755167582356,0.00596831075004575,-0.0170734058283253,0.00632237231185406,0.367776921599525
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL9,Interleukin-9,37714,0.00506212092102252,0.00562770677671298,-0.00596818436133491,0.01609242620338,0.36840285289778
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",37562,0.00529405358140656,0.00594382548713655,-0.00635584437338109,0.0169439515361942,0.373116571508697
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FAM171B,Protein FAM171B,37900,0.0023935340840905,0.0027028930655272,-0.0029041363243428,0.00769120449252381,0.375878465579018
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VSTM2B,V-set and transmembrane domain-containing protein 2B,37714,0.00356757077809653,0.0040314736932369,-0.0043341176606478,0.0114692592168409,0.376210595598256
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DOC2B,Double C2-like domain-containing protein beta,37572,0.00312099857799374,0.00352837796498748,-0.00379462223338172,0.0100366193893692,0.376419898196098
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MYBPC2,"Myosin-binding protein C, fast-type",37628,-0.00709366064716814,0.00807439151930724,-0.0229194680250103,0.00873214673067406,0.379667787049542
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ATXN2,Ataxin-2,37541,-0.00988816682798911,0.0112798603628211,-0.0319966931391184,0.0122203594831402,0.380708407222772
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TLR1,Toll-like receptor 1,37598,-0.00223801290551436,0.00255732513316911,-0.00725037016652581,0.00277434435549708,0.381514704523546
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,39980,0.00303708494339145,0.00347442259807403,-0.00377278334883365,0.00984695323561655,0.382062873799358
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ARG2,"Arginase-2, mitochondrial",37900,-0.00376038116819955,0.00434029016395395,-0.0122673498895493,0.00474658755315019,0.386292140040903
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,37990,-0.00617710883067949,0.00716052729121752,-0.0202117423214658,0.00785752466010685,0.388339070156282
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,37714,0.00586337516910849,0.0067982566076061,-0.00746120778179946,0.0191879581200164,0.388437831363434
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,37900,-0.00717058184987519,0.00832291786682052,-0.0234835008688434,0.00914233716909302,0.388952411305308
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",40182,0.00343016768115799,0.00398507290189338,-0.00438057520655302,0.011240910568869,0.389386631088576
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,COL4A4,Collagen alpha-4(IV) chain,37688,0.00439936332881245,0.00513904978088277,-0.00567317424171779,0.0144719008993427,0.391977035650079
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLC4A1,Band 3 anion transport protein,37998,-0.00383736972188169,0.00450583146768797,-0.0126687993985501,0.00499405995478673,0.394426102119649
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MERTK,Tyrosine-protein kinase Mer,40516,0.00215761182099673,0.00254632399776262,-0.002833183214618,0.00714840685661146,0.396816150451488
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ID4,DNA-binding protein inhibitor ID-4,37714,0.00377344919123236,0.00445729360851311,-0.00496284628145334,0.012509744663918,0.397245345651718
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ACRV1,Acrosomal protein SP-10,37598,0.00290581820257731,0.00344255751319093,-0.00384159452327693,0.00965323092843154,0.398636125349273
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PSMD5,26S proteasome non-ATPase regulatory subunit 5,37572,-0.00471328055239371,0.00558793403864315,-0.0156656312681343,0.00623907016334686,0.398978430541389
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD164L2,CD164 sialomucin-like 2 protein,37572,0.00303582568739839,0.00360895724293199,-0.0040377305087483,0.0101093818835451,0.400255754875316
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FHIP2A,FHF complex subunit HOOK interacting protein 2A,37562,-0.00389597989596353,0.0046392034015347,-0.0129888185629716,0.00519685877104448,0.401038642267184
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SFRP1,Secreted frizzled-related protein 1,40178,-0.00353843911946806,0.00423898079209363,-0.0118468414719716,0.00476996323303546,0.403877818930716
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,40400,0.00519680801380049,0.00623120300126842,-0.00701634986868562,0.0174099658962866,0.404294857782112
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SULT1A1,Sulfotransferase 1A1,40471,-0.0103044133894181,0.0125091224343094,-0.0348222933606645,0.0142134665818284,0.4100928061706
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MELTF,Melanotransferrin,37990,0.00231752509924396,0.00285101779015737,-0.00327046976946448,0.0079055199679524,0.41630321671094
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",37959,-0.00547848243045022,0.00674899585930573,-0.0187065143146895,0.00774954945378901,0.416950674370299
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCL24,C-C motif chemokine 24,40396,0.00654538959681298,0.00807116521119634,-0.00927409421713185,0.0223648734107578,0.417400927877862
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TAP1,Antigen peptide transporter 1,37714,0.00488934624167575,0.00603561564917886,-0.00694046043071482,0.0167191529140663,0.417907331941581
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,37482,0.00350833975589556,0.00436790691175675,-0.00505275779114767,0.0120694373029388,0.421868911306928
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ENDOU,Poly(U)-specific endoribonuclease,36973,-0.00394039340905477,0.00490740378078185,-0.0135589048193872,0.00567811800127767,0.422019636269153
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AGER,Advanced glycosylation end product-specific receptor,40311,-0.0031642237303264,0.00394921887632442,-0.0109046927279223,0.00457624526726947,0.423011816274399
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GID8,Glucose-induced degradation protein 8 homolog,37959,-0.00264735301883513,0.00330580679062839,-0.00912673432846678,0.00383202829079652,0.423250500779827
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NUP50,Nuclear pore complex protein Nup50,37562,0.00277625709352109,0.00347283919165891,-0.00403050772213038,0.00958302190917255,0.424061402912686
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNNI3,"Troponin I, cardiac muscle",40042,-0.00656828177760429,0.00826111758825958,-0.0227600722505931,0.00962350869538448,0.426576790222293
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,YY1,Transcriptional repressor protein YY1,37598,0.00218145531569925,0.00274406717443985,-0.00319691634620285,0.00755982697760136,0.426644407758085
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CSF1R,Macrophage colony-stimulating factor 1 receptor,37987,-0.00305928782376252,0.00385094243270077,-0.010607134991856,0.00448855934433099,0.426961548080395
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MTPN,Myotrophin,40042,-0.00255752291209526,0.00323060214368262,-0.00888950311371321,0.00377445728952268,0.428573808988518
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KIF20B,Kinesin-like protein KIF20B,37541,-0.00605265863679454,0.00766310229661448,-0.0210723391381589,0.00896702186456984,0.429632938422115
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DCDC2C,Doublecortin domain-containing protein 2C,37482,0.0049047799526769,0.00621301345833669,-0.007272726425663,0.0170822863310168,0.429871261130352
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ARMCX2,Armadillo repeat-containing X-linked protein 2,37541,-0.00510916335887529,0.00653529935664548,-0.0179183500979004,0.00770002338014985,0.434358285097103
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL1RL1,Interleukin-1 receptor-like 1,40490,0.00343488075921242,0.00441205104291749,-0.00521273928490586,0.0120825008033307,0.436272566406064
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FZD8,Frizzled-8,37541,0.00340682688337731,0.00440342851089928,-0.00522389299798527,0.0120375467647399,0.439136398628483
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TFAP2A,Transcription factor AP-2-alpha,37541,0.00460083665706115,0.00594904888119426,-0.0070592991500796,0.0162609724642019,0.439315344605817
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,37990,0.00199223021269021,0.00258535538191174,-0.00307506633585681,0.00705952676123723,0.440967747035468
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GSR,"Glutathione reductase, mitochondrial",37944,-0.00165942751303037,0.00216393827520085,-0.00590074653242404,0.0025818915063633,0.443180976867933
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ZP4,Zona pellucida sperm-binding protein 4,37482,0.00243050765970075,0.00318414875415169,-0.00381042389843656,0.00867143921783805,0.445289536635176
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CSH1,Chorionic somatomammotropin hormone 1,37987,-0.00258258076998125,0.00341861302976508,-0.0092830623083208,0.0041179007683583,0.449994000331542
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SHH,Sonic hedgehog protein,37598,0.00320589320334244,0.00424638528045137,-0.00511702194634225,0.0115288083530271,0.450280548950626
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EIF5A,Eukaryotic translation initiation factor 5A-1,40044,0.00214446357496907,0.00285032738924395,-0.00344217810794907,0.0077311052578872,0.451847795543851
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,37562,0.00379682940950397,0.00508788753298301,-0.00617543015514273,0.0137690889741507,0.455530580941812
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KLK6,Kallikrein-6,40387,-0.00220974843372004,0.0029612952320775,-0.00801388708859193,0.00359439022115185,0.455551511345067
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BCL7A,B-cell CLL/lymphoma 7 protein family member A,37482,0.00464069312618032,0.00623204988482186,-0.00757412464807052,0.0168555109004312,0.456497036289584
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MEP1B,Meprin A subunit beta,40359,-0.00853333995664176,0.011522444098807,-0.0311173303903035,0.01405065047702,0.458956526687963
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TET2,Methylcytosine dioxygenase TET2,37697,-0.00730023235494052,0.00986089174485544,-0.0266275801748572,0.0120271154649761,0.459117926321691
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MTR,Methionine synthase,37562,0.00473438681176827,0.00639755114594935,-0.00780481343429247,0.017273587057829,0.459294375471414
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NAPRT,Nicotinate phosphoribosyltransferase,37942,-0.00238648602879519,0.00323102877187263,-0.00871930242166555,0.00394633036407518,0.460153717094157
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,37562,-0.0032877525437484,0.00446531414480777,-0.0120397682675716,0.00546426318007484,0.461569258791649
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CPLX2,Complexin-2,37482,0.00222430564917407,0.00303229092622697,-0.00371898456623079,0.00816759586457893,0.463242546433489
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ECSCR,Endothelial cell-specific chemotaxis regulator,37541,0.00363020033654179,0.00495285578031898,-0.00607739699288342,0.013337797665967,0.463601473526807
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MAPT,Microtubule-associated protein tau,39961,-0.0037779045264162,0.0051838480056946,-0.0139382466175776,0.00638243756474521,0.466144917845917
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MRPS16,"28S ribosomal protein S16, mitochondrial",37598,-0.00205774135588652,0.00283563668431548,-0.00761558925714487,0.00350010654537183,0.468052959186682
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MRPL52,"39S ribosomal protein L52, mitochondrial",37460,-0.00178943814037603,0.0024713441139455,-0.00663327260370922,0.00305439632295715,0.469032800115738
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CRX,Cone-rod homeobox protein,40042,0.00754349197767478,0.0104844410092824,-0.0130060124005187,0.0280929963558683,0.471847407621493
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPESP1,Sperm equatorial segment protein 1,37990,0.00191796507679614,0.00269479650529482,-0.0033638360735817,0.00719976622717398,0.476644811226154
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL20,Interleukin-20,40044,0.00353935297256957,0.00497586782598463,-0.0062133479663603,0.0132920539114994,0.476906727775214
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,37541,0.00344512102909859,0.00485150031623064,-0.00606381959071347,0.0129540616489106,0.477645746783878
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DOCK9,Dedicator of cytokinesis protein 9,37541,-0.00829102956580674,0.0117191494949523,-0.0312605625759131,0.0146785034442997,0.47928265249808
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",37562,0.00464519973570392,0.00656895260684096,-0.00822994737370436,0.0175203468451122,0.479489155953741
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PPM1B,Protein phosphatase 1B,37598,-0.0043661284040921,0.00619747883427035,-0.016513186919262,0.00778093011107779,0.481133471390016
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FRMD7,FERM domain-containing protein 7,37572,0.00229658217171452,0.00326005437156822,-0.00409312439655919,0.00868628873998823,0.481158040492993
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GAGE2A,G antigen 2A,37482,-0.00429275862924196,0.0060941251900308,-0.0162372440017023,0.00765172674321841,0.481190487756508
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NCLN,Nicalin,40044,-0.00365361304017305,0.00520962908733403,-0.0138644860513477,0.00655725997100166,0.483114284551606
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NAAA,N-acylethanolamine-hydrolyzing acid amidase,40159,0.00401986317775365,0.00576306228994804,-0.00727573891054451,0.0153154652660518,0.485486452606589
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TPSD1,Tryptase delta,37959,-0.00260089655461395,0.00373341728787897,-0.00991839443885674,0.00471660132962884,0.486031933753406
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCN3A,Sodium channel protein type 3 subunit alpha,37572,0.00263815149282422,0.00380037171953166,-0.00481057707745783,0.0100868800631063,0.48758006486778
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",37572,0.00285570605628756,0.00413991249463791,-0.00525852243320274,0.0109699345457779,0.490333017172803
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,40471,0.00316955979399585,0.00461405741814172,-0.00587399274556193,0.0122131123335536,0.492133325086298
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ESR1,Estrogen receptor,37598,0.00390686496091949,0.00568914010303387,-0.0072438496410269,0.0150575795628659,0.492269235661389
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GH2,Growth hormone variant,39980,0.0112929549003107,0.0164511879004422,-0.020951373384556,0.0435372831851774,0.492438217317599
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PPT1,Palmitoyl-protein thioesterase 1,37572,-0.00524554437148658,0.00764835528928263,-0.0202363207384805,0.00974523199550738,0.492826426394969
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,THSD1,Thrombospondin type-1 domain-containing protein 1,37500,0.00230158961093277,0.00337100355890942,-0.0043055773645297,0.00890875658639524,0.494770026761564
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MEGF11,Multiple epidermal growth factor-like domains protein 11,37562,0.00216274989079226,0.00317559455912205,-0.00406141544508696,0.00838691522667149,0.495849647231403
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTTG1,Securin,37714,-0.00275120567381999,0.00404554981899331,-0.0106804833190469,0.00517807197140689,0.496480052753058
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MYOM2,Myomesin-2,37562,0.00308796424079,0.00458986390099758,-0.00590816900516526,0.0120840974867453,0.501099730593823
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HNF1A,Hepatocyte nuclear factor 1-alpha,37572,-0.0047802252923908,0.00712361749570793,-0.0187425155839783,0.00918206499919673,0.502207486340577
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RBP1,Retinol-binding protein 1,37572,-0.00452451034804424,0.00674922760238905,-0.0177529964487268,0.0087039757526383,0.502630860059977
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TTN,Titin,37562,0.00425597448767142,0.00641667634185737,-0.00832071114236903,0.0168326601177119,0.507170748543742
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SEMA6C,Semaphorin-6C,37598,0.00171071608223563,0.00260054426946069,-0.00338635068590733,0.00680778285037859,0.510658882033587
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ARHGAP30,Rho GTPase-activating protein 30,37714,0.00241555972762033,0.00368854006462591,-0.00481397879904646,0.00964509825428711,0.512554872737723
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ISM2,Isthmin-2,37998,0.00284552981200495,0.00434984020375995,-0.00568015698736455,0.0113712166113745,0.513014155875
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD163,Scavenger receptor cysteine-rich type 1 protein M130,40403,-0.00271211616397123,0.00415116869114536,-0.0108484067986161,0.00542417447067368,0.513547830004484
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD5L,CD5 antigen-like,37934,0.00297762822954105,0.00455819651701376,-0.00595643694380591,0.011911693402888,0.513608190156258
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,37959,-0.00149826584621831,0.00230910108455323,-0.00602410397194264,0.00302757227950602,0.516444797341183
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,37457,0.00325945301055785,0.00502769789488279,-0.00659483486341241,0.0131137408845281,0.516802834606915
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CHIT1,Chitotriosidase-1,40398,-0.00941855193446127,0.014530073021172,-0.0378974950559584,0.0190603911870359,0.516857876380276
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OSTN,Osteocrin,37572,0.00271071181954242,0.00421569831145163,-0.00555205687090277,0.0109734805099876,0.520232596454673
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RNF4,E3 ubiquitin-protein ligase RNF4,37714,0.00418406099753649,0.00657911063224032,-0.00871099584165454,0.0170791178367275,0.524812497207524
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNN,Tenascin-N,37998,-0.00270279853127763,0.0042689301034202,-0.0110699015339812,0.00566430447142597,0.526657786900183
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SUMF1,Formylglycine-generating enzyme,37598,-0.00411409451611762,0.00655645232760708,-0.0169647410782275,0.00873655204599226,0.530350362453782
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",37598,0.00296147386424299,0.00474246950548607,-0.0063337663665097,0.0122567140949957,0.5323375652259
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DHODH,Dihydroorotate dehydrogenase,37562,-0.00295018263149053,0.00472597013229551,-0.0122130840907897,0.00631271882780867,0.532474864151852
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KLK12,Kallikrein-12,39980,0.00869673400091382,0.0139555641919523,-0.0186561718153127,0.0360496398171404,0.533179844428277
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CILP,Cartilage intermediate layer protein 1,37998,-0.00325510825336931,0.00524788942910953,-0.013540971534424,0.00703075502768536,0.535090492266018
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BTN1A1,Butyrophilin subfamily 1 member A1,37883,-0.00253234005706546,0.0041095375457194,-0.0105870336466755,0.00552235353254456,0.537766063146975
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CNGB3,Cyclic nucleotide-gated cation channel beta-3,37541,-0.00331248643093354,0.0053801002702888,-0.0138574829606996,0.00723251009883252,0.538108310804809
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SHD,SH2 domain-containing adapter protein D,37531,0.00527495988186857,0.00858210780076571,-0.0115459714076322,0.0220958911713694,0.538799094086665
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CASP4,Caspase-4,37714,-0.0102544993959259,0.0167218632207741,-0.043029351308643,0.0225203525167913,0.539728809063272
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CA12,Carbonic anhydrase 12,40305,-0.0019213176139358,0.003146153441647,-0.00808777835956392,0.00424514313169233,0.541415020183081
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CTAG1A_CTAG1B,Cancer/testis antigen 1,37687,0.00300585382334638,0.00495153161209004,-0.00669914813635009,0.0127108557830429,0.543824584980927
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TRPV3,Transient receptor potential cation channel subfamily V member 3,37562,0.00302209276513946,0.00498798423453806,-0.00675435633455515,0.0127985418648341,0.544608541390942
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,UPK3BL1,Uroplakin-3b-like protein 1,37692,-0.00328883913617389,0.00545370480372004,-0.0139781005514652,0.00740042227911738,0.546487896937443
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LMNB1,Lamin-B1,37874,0.00334193436718768,0.00555996605965439,-0.00755559910973492,0.0142394678441103,0.547802847225479
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PFDN4,Prefoldin subunit 4,37482,-0.00317811677721539,0.00531798272164279,-0.0136013629116353,0.00724512935720448,0.550105916752441
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",37959,0.00248791621984936,0.00416495879303745,-0.00567540301450405,0.0106512354542028,0.550287254283834
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPRING1,SREBP regulating gene protein,37482,-0.00336146703111381,0.00563570769666755,-0.0144074541165822,0.00768452005435459,0.550879181037718
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CHGB,Secretogranin-1,40406,0.00232957258136663,0.00392117239400577,-0.00535592531088467,0.0100150704736179,0.552452961823279
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EVI2B,Protein EVI2B,37482,0.00244000351833123,0.00412315254779533,-0.00564137547534761,0.0105213825120101,0.554007485556133
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EFNB2,Ephrin-B2,37572,-0.00335214368657593,0.00567232479537187,-0.0144699002855048,0.00776561291235295,0.554554257515482
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,37901,0.00998818940986106,0.0169370250623972,-0.0232083797124375,0.0431847585321596,0.555384847268759
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL2RB,Interleukin-2 receptor subunit beta,40044,0.00220677110946993,0.0037869998261622,-0.00521574854980798,0.00962929076874784,0.560088354701792
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TPPP3,Tubulin polymerization-promoting protein family member 3,39961,-0.00225089843086461,0.00386359637761571,-0.00982354733099139,0.00532175046926218,0.560176794716571
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KEL,Kell blood group glycoprotein,39961,-0.00202065392290102,0.00347393432691243,-0.00882956520364938,0.00478825735784735,0.560803149120788
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HIF1A,Hypoxia-inducible factor 1-alpha,37598,-0.00387597446751815,0.00667117913433103,-0.016951485570807,0.00919953663577067,0.561248454898205
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IZUMO1,Izumo sperm-egg fusion protein 1,37482,0.00279852564826384,0.00482621532606232,-0.00666085639081831,0.012257907687346,0.5620195568808
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HIP1,Huntingtin-interacting protein 1,37562,0.00192599863093433,0.0033275488475684,-0.00459599711029975,0.0084479943721684,0.562731365705265
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDC123,Cell division cycle protein 123 homolog,37482,-0.00362483473814433,0.00627309088294715,-0.0159200928687207,0.00867042339243209,0.563383003560761
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL13,Interleukin-13,40044,-0.00269183977837261,0.00467885048801585,-0.0118623867348837,0.00647870717813846,0.565082691709775
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDAN1,Codanin-1,37942,0.00130074905953623,0.00226744011275166,-0.00314343356145704,0.00574493168052949,0.566204669384833
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FGF16,Fibroblast growth factor 16,37598,-0.0027356591975376,0.00479848564261668,-0.0121406910570663,0.00666937266199109,0.568613606495041
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PMCH,Pro-MCH,37562,0.00472383372447645,0.00830667136703954,-0.011557242154921,0.0210049096038739,0.569583402925961
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HEBP1,Heme-binding protein 1,40042,-0.00299819017564372,0.00531556864200123,-0.0134167047139661,0.00742032436267868,0.572735428440979
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,THRAP3,Thyroid hormone receptor-associated protein 3,37562,-0.00658211986853961,0.0116813853283534,-0.0294776351121124,0.0163133953750331,0.573123956005762
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ACTA2,"Actin, aortic smooth muscle",40042,-0.00237915405611317,0.00425841874939814,-0.0107256548049335,0.00596734669270719,0.576378430584842
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,39980,0.00657310439417968,0.011807066277333,-0.0165687455093931,0.0297149542977524,0.577734038941146
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CRHR1,Corticotropin-releasing factor receptor 1,40042,-0.00344324328346078,0.00619559982883812,-0.0155866189479835,0.00870013238106193,0.578385477397666
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL17RA,Interleukin-17 receptor A,40332,-0.00236794133428991,0.00427096890914362,-0.0107390403962114,0.00600315772763159,0.579294322999055
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRR5,Proline-rich protein 5,37598,-0.00259987892343183,0.00471436608677319,-0.0118400364535073,0.00664027860664363,0.581314000807356
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ZPR1,Zinc finger protein ZPR1,37541,-0.00525296142226773,0.00953472870843467,-0.0239410296907997,0.0134351068462642,0.581691543573971
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LTB,Lymphotoxin-beta,37900,-0.00190311970086573,0.00345782430918871,-0.00868045534687561,0.00487421594514414,0.58206743748844
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CR2,Complement receptor type 2,40403,0.00249421644068056,0.0045326272380886,-0.00638973294597309,0.0113781658273342,0.582134693630286
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,37990,-0.00178935724587571,0.00325912469500266,-0.00817724164808092,0.0045985271563295,0.582993913871402
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FGF12,Fibroblast growth factor 12,37598,0.00257626312625721,0.00471107230073074,-0.00665743858317505,0.0118099648356895,0.584489140144969
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TEX101,Testis-expressed protein 101,37572,0.00210355442359213,0.00384813896192128,-0.00543879794177357,0.00964590678895784,0.58463399649891
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCN2A,Sodium channel protein type 2 subunit alpha,37541,0.0026438782458352,0.00488688147097683,-0.00693440943727939,0.0122221659289498,0.588506159257494
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TSC1,Hamartin,37598,-0.00401802952269696,0.00744959331785564,-0.018619232425694,0.0105831733803001,0.589646047950488
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,40357,-0.00155187530707685,0.00288797382388914,-0.00721230400189956,0.00410855338774587,0.591027993442071
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LY9,T-lymphocyte surface antigen Ly-9,40182,-0.00149934985157975,0.00279645500146019,-0.00698040165444172,0.00398170195128221,0.59185493003687
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,40379,-0.00138458349414661,0.00259601942369483,-0.00647278156458849,0.00370361457629527,0.59379968827497
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GGA1,ADP-ribosylation factor-binding protein GGA1,39961,-0.00360436981172704,0.00676132027402243,-0.016856557548811,0.00964781792535692,0.593981214080001
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EPGN,Epigen,37900,-0.0025722747274533,0.0048308734038964,-0.0120407865990902,0.00689623714418366,0.594412240538747
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ROBO1,Roundabout homolog 1,40379,-0.00124819131056252,0.00234546719626102,-0.00584530701523411,0.00334892439410908,0.594614491409258
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OSBPL2,Oxysterol-binding protein-related protein 2,37942,-0.00206701391558252,0.00389453758067796,-0.00970030757371132,0.00556627974254628,0.595602888300819
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CA11,Carbonic anhydrase-related protein 11,39980,0.00171140164244645,0.00322516919467015,-0.00460992997910704,0.00803273326399993,0.595676319650495
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SCGB1A1,Uteroglobin,40384,-0.00292596249164648,0.00552582858941827,-0.0137565865269063,0.00790466154361332,0.596461472320235
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DEFB104A_DEFB104B,Beta-defensin 104,37541,0.00294148600526093,0.00556159663733938,-0.00795924340392426,0.0138422154144461,0.596889086194787
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MORN4,MORN repeat-containing protein 4,37482,-0.00406537051455535,0.00772011502611024,-0.0191967959657314,0.0110660549366207,0.598484139636599
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ERCC1,DNA excision repair protein ERCC-1,37482,0.0017122920128272,0.00328684727919572,-0.00472992865439641,0.00815451268005081,0.602408564494572
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PCARE,Photoreceptor cilium actin regulator,37541,-0.00438980987243233,0.00844990119809177,-0.0209516162206922,0.0121719964758275,0.603413785530084
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PPM1A,Protein phosphatase 1A,39980,-0.00156870694612113,0.00302362334652478,-0.00749500870530969,0.00435759481306743,0.603895812379014
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TCN2,Transcobalamin-2,40497,-0.00150645732814836,0.00290887885260194,-0.00720785987924816,0.00419494522295143,0.604547422717415
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,40305,-0.00194329581117212,0.00375386115195203,-0.0093008636689981,0.00541427204665386,0.604689341429595
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLAMF7,SLAM family member 7,40341,-0.00290478842453879,0.00561655751750329,-0.0139132411588452,0.00810366430976766,0.605035572726317
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,37900,0.00228226509588371,0.00441664457085322,-0.00637435826298861,0.010938888454756,0.60534487363301
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FOLH1,Glutamate carboxypeptidase 2,37598,-0.00541731356976124,0.0105169668860746,-0.0260305686664675,0.015195941526945,0.606490213911221
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GAD2,Glutamate decarboxylase 2,37598,0.00236957829624547,0.00462983593645242,-0.00670490013920128,0.0114440567316922,0.608795314403812
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ZNF830,Zinc finger protein 830,37900,-0.00403552152950176,0.00788741520862637,-0.0194948553384094,0.0114238122794059,0.608910994534511
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LYPLA2,Acyl-protein thioesterase 2,37541,-0.00541236844300755,0.0106103562694085,-0.0262086667310482,0.0153839298450331,0.609988309008116
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",37562,0.00203697163231855,0.00402379489511258,-0.0058496663621021,0.00992360962673921,0.612702672875108
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTPRR,Receptor-type tyrosine-protein phosphatase R,37942,0.00174288887133598,0.00348070374657278,-0.00507929047194668,0.00856506821461863,0.616570117036237
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SNAP25,Synaptosomal-associated protein 25,37541,-0.00228721266191607,0.00457833507310098,-0.011260749405194,0.00668632408136186,0.617384159088726
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLEC14A,C-type lectin domain family 14 member A,40332,-0.00151673460476092,0.00306191228999065,-0.00751808269314259,0.00448461348362074,0.620356167576771
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HSP90B1,Endoplasmin,39878,0.00336806886951376,0.0068445618923002,-0.0100472724393946,0.0167834101784222,0.622670117628566
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BRD3,Bromodomain-containing protein 3,37562,-0.00230297817891818,0.00473080956160946,-0.0115753649196727,0.00696940856183636,0.626405199708998
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,STOML2,"Stomatin-like protein 2, mitochondrial",37482,0.00428252396560334,0.00886498825075111,-0.0130928530058688,0.0216579009370755,0.629045013100845
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL1A,Interleukin-1 alpha,40044,-0.00253587939104673,0.00525408846738285,-0.0128338927871171,0.00776213400502365,0.629351912733016
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CEP152,Centrosomal protein of 152 kDa,37482,-0.00195871812329138,0.00406337359423592,-0.00992293036799379,0.00600549412141103,0.629783964203353
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TMED1,Transmembrane emp24 domain-containing protein 1,37714,-0.00255875555834891,0.00532454925403034,-0.0129948720962484,0.00787736097955056,0.630838489527038
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LHB,Lutropin subunit beta,39980,-0.00394524599792862,0.00826894424940069,-0.020152376726754,0.0122618847308967,0.633286202666571
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLC34A3,Sodium-dependent phosphate transport protein 2C,37482,-0.00234833763826819,0.00493420316433273,-0.0120193758403603,0.00732270056382395,0.634131891854703
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BATF,Basic leucine zipper transcriptional factor ATF-like,37572,0.00396908546921699,0.00848752026814107,-0.0126664542563395,0.0206046251947735,0.64005138178067
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PSCA,Prostate stem cell antigen,37901,-0.0118528905759524,0.0253909069776144,-0.0616190682520765,0.0379132871001717,0.640638837357509
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SKIV2L,Helicase SKI2W,37562,0.00184718362966964,0.00396773287966344,-0.0059295728144707,0.00962394007380999,0.641544364756132
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SOX9,Transcription factor SOX-9,37572,0.0012373675356895,0.00265823060599097,-0.00397276445205281,0.0064474995234318,0.641591616544038
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ZP3,Zona pellucida sperm-binding protein 3,37628,-0.0119156218807773,0.0256805200959244,-0.0622494412687891,0.0384181975072345,0.642659301348064
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MAG,Myelin-associated glycoprotein,37572,0.00209832668215911,0.00456630248002965,-0.00685162617869901,0.0110482795430172,0.645865362049781
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MAPRE3,Microtubule-associated protein RP/EB family member 3,37482,0.00635465380258346,0.0138479786510645,-0.020787384353503,0.0334966919586699,0.646323154395774
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,37900,-0.00424666023083476,0.00926188552725034,-0.0223999558642454,0.0139066354025759,0.646594024447356
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KCNIP4,Kv channel-interacting protein 4,39961,0.00226599987928006,0.00500854370857,-0.00755074578951713,0.0120827455480773,0.65096780324236
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLC28A1,Sodium/nucleoside cotransporter 1,37482,-0.00261776908308718,0.00581279147386218,-0.0140108403718571,0.00877530220568269,0.652468257884599
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DAND5,DAN domain family member 5,37598,0.0023756891627549,0.00532082642055231,-0.00805313062152762,0.0128045089470374,0.65525158823344
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,INSL3,Insulin-like 3,37942,0.00259735162342052,0.00582770363395931,-0.00882494749913974,0.0140196507459808,0.655828045048738
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RPGR,X-linked retinitis pigmentosa GTPase regulator,37572,-0.0018142952377018,0.00420150133293743,-0.0100492378502592,0.00642064737485556,0.665878831018093
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPINT3,Kunitz-type protease inhibitor 3,37901,-0.00542487938533832,0.0125748467025009,-0.03007157892224,0.0192218201515634,0.666179231705119
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TDO2,"Tryptophan 2,3-dioxygenase",37572,-0.00162402820671862,0.00379925998413642,-0.009070577775626,0.00582252136218877,0.669051993246257
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GHRHR,Growth hormone-releasing hormone receptor,39961,0.00232531111084777,0.00545798592887333,-0.00837234130974395,0.0130229635314395,0.670085841852976
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",37598,0.00115478842292484,0.00275324526332092,-0.00424157229318417,0.00655114913903385,0.674910146640727
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SHC1,SHC-transforming protein 1,37482,0.00472021142599186,0.0114282275065607,-0.0176791144868671,0.0271195373388508,0.679590749707919
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,40536,-0.000920270154418113,0.00222945468429399,-0.00529000133563433,0.00344946102679811,0.679774671971568
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NEB,Nebulin,37562,-0.00146945900955794,0.0035600473394227,-0.00844715179482644,0.00550823377571056,0.679786355751875
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HK2,Hexokinase-2,40042,-0.001111223363517,0.0026990990394402,-0.00640145748081979,0.00417901075378579,0.680563820007142
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CAPN3,Calpain-3,37900,-0.00148136633871863,0.0036249043340512,-0.00858617883345898,0.00562344615602172,0.682793080574566
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ARNT,Aryl hydrocarbon receptor nuclear translocator,40044,0.00147874653850813,0.00365988888958231,-0.0056946356850732,0.00865212876208946,0.686187835652484
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",37562,-0.00344776192839415,0.00866975776175487,-0.0204404871414337,0.0135449632846454,0.690874881279149
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NECTIN1,Nectin-1,37598,-0.00123848676087588,0.0031179461678545,-0.00734966124987071,0.00487268772811894,0.691217315833823
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KIAA2013,Uncharacterized protein KIAA2013,37900,-0.00222645166829719,0.00561538837560777,-0.0132326128844884,0.00877970954789404,0.691749043028479
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RNF168,E3 ubiquitin-protein ligase RNF168,37598,0.00158179779608241,0.00401004691183853,-0.00627789415112112,0.00944148974328593,0.693248829572304
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AOC1,Amiloride-sensitive amine oxidase [copper-containing],40044,-0.00220576848864765,0.0055930467572656,-0.0131681401328882,0.00875660315559293,0.693308183432066
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TMED4,Transmembrane emp24 domain-containing protein 4,37562,0.00221917388368273,0.00566954435506473,-0.00889313305224414,0.0133314808196096,0.695493064308287
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,37959,-0.0011258046977332,0.00287738143915413,-0.00676547231847529,0.0045138629230089,0.695611121994541
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KHDC3L,KH domain-containing protein 3,37482,0.00259995751197049,0.00667522508171689,-0.0104834836481946,0.0156833986721356,0.69691740245664
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CYTH3,Cytohesin-3,37482,-0.00279891950714725,0.00721863651737297,-0.0169474470811983,0.0113496080669038,0.698218333963447
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TMEM25,Transmembrane protein 25,37959,0.00165454119651029,0.00428064239824734,-0.00673551790405449,0.0100446002970751,0.699119879376196
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BTNL10,Butyrophilin-like protein 10,37482,0.00158256602285336,0.00409561396988532,-0.00644483735812186,0.00960996940382859,0.699203001613787
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SAP18,Histone deacetylase complex subunit SAP18,37714,-0.00280505681295535,0.00731137902445917,-0.0171353597008953,0.0115252460749846,0.701239336929788
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BCL7B,B-cell CLL/lymphoma 7 protein family member B,37900,-0.00164509071437382,0.0042980963358622,-0.0100693595326637,0.0067791781039161,0.701912162926811
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SDK2,Protein sidekick-2,37671,-0.00142280427285593,0.00373259552036575,-0.0087386914927728,0.00589308294706094,0.703073128553867
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLC44A4,Choline transporter-like protein 4,37572,-0.00260942169321926,0.00686375483813651,-0.0160623811759668,0.0108435377895283,0.703822351302864
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PNMA2,Paraneoplastic antigen Ma2,37541,-0.00161794556655103,0.00426120594877666,-0.00996990922615327,0.00673401809305122,0.704180261623702
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CASQ2,Calsequestrin-2,37562,0.00185505696588745,0.00490248836405573,-0.00775382022766178,0.0114639341594367,0.705146356938146
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CDC25A,M-phase inducer phosphatase 1,37482,0.00150643771406166,0.00400819806677725,-0.00634963049682175,0.00936250592494507,0.707042606464823
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MAGEA3,Melanoma-associated antigen 3,37714,-0.00310724121706977,0.00827610737936096,-0.0193284116806172,0.0131139292464777,0.707333923122013
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PCDH12,Protocadherin-12,37959,-0.000933927545336823,0.00250174821321246,-0.00583735404323325,0.0039694989525596,0.708923616955522
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SIGLEC9,Sialic acid-binding Ig-like lectin 9,40470,-0.00105374963270419,0.0028607577075622,-0.00666083473952611,0.00455333547411773,0.712619870606268
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,37482,-0.00307638724701577,0.00842235940453202,-0.0195842116798985,0.013431437185867,0.714920050117831
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FGFBP2,Fibroblast growth factor-binding protein 2,37998,-0.00176974814150331,0.00485429739931677,-0.0112841710441642,0.00774467476115756,0.715435498053499
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MYL6B,Myosin light chain 6B,37572,-0.00328797963717111,0.00906353365578131,-0.0210525056025025,0.0144765463281603,0.716782421325411
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HLA_DRA,,40288,0.00127156401368532,0.00350969462104352,-0.00560743744355999,0.00815056547093062,0.717132340956609
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PAM,Peptidyl-glycine alpha-amidating monooxygenase,40432,0.000982624385319319,0.00272151214284385,-0.00435153941465463,0.00631678818529327,0.718060682823417
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,QSOX1,Sulfhydryl oxidase 1,37761,-0.00157731700561172,0.00438559689084667,-0.0101730869116712,0.00701845290044776,0.719108269636868
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DUSP13,Dual specificity protein phosphatase 13 isoform A,37900,0.00143319734356977,0.00400660737247412,-0.00641975310647951,0.00928614779361904,0.720567116849472
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PFDN6,Prefoldin subunit 6,37572,0.00229320525861868,0.00647854144369742,-0.0104047359710283,0.0149911464882656,0.723367523403038
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RANGAP1,Ran GTPase-activating protein 1,39980,0.00170742418162555,0.00485454676795674,-0.00780748748356966,0.0112223358468208,0.725055660102637
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SEMA3G,Semaphorin-3G,37671,0.00147397622466114,0.00422894861104109,-0.00681476305297939,0.00976271550230168,0.727436949345552
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NPPB,Natriuretic peptides B,40042,0.00433792126236135,0.0125146844417085,-0.0201908602433872,0.0288667027681099,0.728876613145849
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NGF,Beta-nerve growth factor,40228,-0.000400600586604932,0.0011873409060547,-0.00272778876247215,0.00192658758926228,0.735825101058088
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GNLY,Granulysin,40332,-0.00164474054286944,0.00494158548765189,-0.0113302480986671,0.00804076701292826,0.73926201806951
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,37541,0.00236017533001029,0.00716330658242238,-0.0116799055715376,0.0164002562315581,0.741797222986121
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDCL2,Phosducin-like protein 2,37482,-0.0017376283956983,0.00527712973360508,-0.0120808026735643,0.00860554588216765,0.741952915770058
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,40516,-0.00111115178282951,0.00339533225933751,-0.00776600301113104,0.00554369944547201,0.743476544057126
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,37900,-0.00248201331790476,0.0075947335851378,-0.0173676911447748,0.0124036645089653,0.743818829382135
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD3E,T-cell surface glycoprotein CD3 epsilon chain,37714,-0.00115067389816048,0.0035326400046486,-0.00807464830727173,0.00577330051095077,0.744636552879832
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,37628,0.00128956955090237,0.00397729632156792,-0.00650593123937076,0.0090850703411755,0.745767008951157
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CCNE1,G1/S-specific cyclin-E1,37598,-0.00291446608172029,0.00915335538118528,-0.0208550426288434,0.0150261104654029,0.750183470156108
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,38013,0.000589228093656653,0.00185785107182378,-0.00305216000711795,0.00423061619443125,0.751130329797534
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL17F,Interleukin-17F,40044,-0.00244627032445258,0.00775906932928822,-0.0176540462098575,0.0127615055609523,0.752554174098096
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ADGRE1,Adhesion G protein-coupled receptor E1,37901,-0.00166697955147311,0.00539607084546677,-0.012243278408588,0.00890931930564176,0.757383594721526
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GART,Trifunctional purine biosynthetic protein adenosine-3,37959,0.000808431546678441,0.0026260491820919,-0.00433862485022168,0.00595548794357856,0.758200551994978
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RSPO1,R-spondin-1,40228,-0.00105287632294116,0.0034472727501793,-0.00780953091329259,0.00570377826741028,0.76004804997303
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SFTPA1,Pulmonary surfactant-associated protein A1,39980,-0.0017299909206529,0.00571548611283154,-0.0129323437018027,0.00947236186049692,0.762134117024059
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL34,Interleukin-34,39934,-0.00104332830028653,0.00350073157785515,-0.00790476219288262,0.00581810559230957,0.765683117488459
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MEPE,Matrix extracellular phosphoglycoprotein,40357,0.000769362733127268,0.00259136635262587,-0.00430971531801944,0.00584844078427398,0.766550839317276
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KLK15,Kallikrein-15,37880,0.00147859647067423,0.00500077629151949,-0.00832292506070397,0.0112801180020524,0.767484093815296
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CHEK2,Serine/threonine-protein kinase Chk2,40042,0.000972589417420073,0.00329114732562724,-0.00547805934080931,0.00742323817564946,0.7676030349366
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,37998,0.003924323860602,0.0134370768166869,-0.0224123467001042,0.0302609944213082,0.770251412257028
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TP53BP1,TP53-binding protein 1,37598,0.00253353133494371,0.00868710206152363,-0.0144931887056426,0.01956025137553,0.770564299488241
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CALCB,Calcitonin gene-related peptide 2,37942,0.0011274777396197,0.00389520328307874,-0.00650712069521463,0.00876207617445402,0.772239295323646
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ARID3A,AT-rich interactive domain-containing protein 3A,37541,0.00111302074894891,0.00394136902277982,-0.00661206253569954,0.00883810403359736,0.777645533007656
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LTO1,Protein LTO1 homolog,40044,-0.00110876991158266,0.00401452731861311,-0.00897724345606435,0.00675970363289903,0.78240625496049
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DCC,Netrin receptor DCC,37572,-0.000630037022544775,0.00228728815255534,-0.00511312180155323,0.00385304775646368,0.782973696735856
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SMC3,Structural maintenance of chromosomes protein 3,37482,0.00150428563755379,0.00546163659846388,-0.00920052209543541,0.012209093370543,0.782992084500567
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DDX4,Probable ATP-dependent RNA helicase DDX4,37598,0.00147535726546241,0.00536626218192317,-0.009042516611107,0.0119932311420318,0.783372792040438
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FABP9,Fatty acid-binding protein 9,40341,-0.00148532500419502,0.00543872175552579,-0.0121452196450256,0.00917456963663552,0.784778469628092
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRC1,Protein regulator of cytokinesis 1,37900,0.00123677846964803,0.0045553238227525,-0.00769165622294687,0.0101652131622429,0.786009307903376
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",37598,0.000955957252237942,0.00354617478822206,-0.00599454533267729,0.00790645983715317,0.787492077702353
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FGF3,Fibroblast growth factor 3,37598,0.000793103203447996,0.00297789220501982,-0.00504356551839084,0.00662977192528684,0.789988944294256
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",37482,-0.00143589776376987,0.00549386240379132,-0.0122038680752009,0.00933207254766113,0.793815959669097
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,VSIG10,V-set and immunoglobulin domain-containing protein 10,37900,-0.000907407063772457,0.00347766685982138,-0.00772363410902237,0.00590881998147745,0.794155041689498
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NLGN1,Neuroligin-1,37572,-0.00177174514229353,0.00682809981843657,-0.0151548207864292,0.0116113305018421,0.79527013487347
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CHP1,Calcineurin B homologous protein 1,37541,-0.00185338855591652,0.00716102768933052,-0.0158890028270043,0.0121822257151713,0.795781280539993
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TPPP2,Tubulin polymerization-promoting protein family member 2,37714,-0.00204548691340244,0.00807124618027632,-0.017865129426744,0.0137741555999391,0.799940738014596
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,40451,0.000847380387832445,0.00337033466402746,-0.00575847555366138,0.00745323632932627,0.801490147650606
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DDX39A,ATP-dependent RNA helicase DDX39A,37598,-0.000544709166391851,0.00218606697968029,-0.00482940044656523,0.00373998211378152,0.803230750791678
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EXTL1,Exostosin-like 1,37562,-0.00116173678506223,0.00466383438045371,-0.0103028521707515,0.00797937860062703,0.803291371674317
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",37482,0.00118572704329724,0.00494971292114565,-0.00851571028214823,0.0108871643687427,0.810679246640873
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LRP2BP,LRP2-binding protein,37572,-0.00200636754532576,0.00851012018337299,-0.0186862031047368,0.0146734680140853,0.81362061792216
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RAP1A,Ras-related protein Rap-1A,37598,0.00149141449169146,0.00681257437597276,-0.0118612312852152,0.0148440602685981,0.826715112298348
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PALM3,Paralemmin-3,37562,0.00152290249445911,0.00708722457615578,-0.0123680576748062,0.0154138626637244,0.829864256139202
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DIPK1C,Divergent protein kinase domain 1C,37572,-0.000897853807603007,0.00420458432857178,-0.0091388390916037,0.00734313147639769,0.830907836804234
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BTLA,B- and T-lymphocyte attenuator,37482,-0.00182324483478248,0.00869356911302504,-0.0188626402963116,0.0152161506267466,0.833886843343303
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PCDHB15,Protocadherin beta-15,37900,0.000818876994198566,0.00393242271390811,-0.00688867152506134,0.00852642551345847,0.835046857925633
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TEF,Thyrotroph embryonic factor,37562,0.000874003564077072,0.00420937698738331,-0.00737637533119422,0.00912438245934837,0.835519133125552
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OFD1,Oral-facial-digital syndrome 1 protein,37714,-0.0013749012675611,0.00665331429352816,-0.0144153972828763,0.0116655947477541,0.836287100770186
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ZNF174,Zinc finger protein 174,37598,0.000766488696227466,0.00379393028278827,-0.00666961465803754,0.00820259205049247,0.83989619920697
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MSTN,Growth/differentiation factor 8,40042,0.00100015861695744,0.00498382832964489,-0.00876814490914654,0.0107684621430614,0.840950797654968
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OMP,Olfactory marker protein,37541,0.000993391189959094,0.00496835684260534,-0.00874458822154736,0.0107313706014656,0.841527791330358
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TBR1,T-box brain protein 1,37572,-0.000948653737376075,0.00477902001535562,-0.0103155329674731,0.00841822549272095,0.842653970568429
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,37714,0.00122297970044452,0.00617635167005566,-0.0108826695728646,0.0133286289737536,0.84304023586343
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRND,Prion-like protein doppel,37942,-0.00102087192728992,0.00524230050102349,-0.011295780909296,0.00925403705471611,0.84560147026811
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AMIGO1,Amphoterin-induced protein 1,37572,0.000938444185302483,0.00489304871746216,-0.00865193130092334,0.0105288196715283,0.847908652372298
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TXK,Tyrosine-protein kinase TXK,37714,0.00139604091325699,0.00742786014636181,-0.0131625649736122,0.0159546468001261,0.85092140301057
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CSRP3,Cysteine and glycine-rich protein 3,37562,0.00176957767320855,0.009447786000553,-0.0167480828878753,0.0202872382342924,0.851427711090997
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NXPH1,Neurexophilin-1,39961,-0.000679598153958237,0.00367673976575135,-0.00788600809483089,0.00652681178691441,0.853359173663385
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TEK,Angiopoietin-1 receptor,40411,-0.000386714955544788,0.00209376915189076,-0.00449050249325068,0.0037170725821611,0.853468269071838
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DPT,Dermatopontin,40536,0.000469601186157136,0.00257920621948622,-0.00458564300403586,0.00552484537635014,0.855528531508235
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ATF2,Cyclic AMP-dependent transcription factor ATF-2,39961,-0.00120156713670633,0.00660477352837581,-0.0141469232523229,0.0117437889789103,0.855644709387767
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LMOD2,Leiomodin-2,37541,0.0011243585529237,0.00637721452809519,-0.0113749819221429,0.0136236990279903,0.860054136670484
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,39980,0.0021158239097784,0.0123342222633198,-0.0220592517263285,0.0262908995458853,0.863800688246912
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",40044,-0.00198808216701559,0.011714463149897,-0.0249484299408138,0.0209722656067826,0.86523902626544
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DCUN1D2,DCN1-like protein 2,37482,0.00132075511459135,0.0079149651120592,-0.0141925765050447,0.0168340867342274,0.867476430492005
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPRR1B,Cornifin-B,37714,0.00135842690307132,0.00834269508682466,-0.014993255467105,0.0177101092732477,0.870656102097159
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GUCY2C,Heat-stable enterotoxin receptor,37714,-0.00135224406285149,0.00831013396964916,-0.0176401066433638,0.0149356185176609,0.870739572095572
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,37714,0.00101010690065533,0.00624562088897409,-0.0112313100417339,0.0132515238430446,0.871520610524284
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CNTNAP4,Contactin-associated protein-like 4,37572,-0.00158903696265873,0.00994582203814969,-0.0210828481574321,0.0179047742321147,0.87306527282279
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PAPPA,Pappalysin-1,40044,-0.000714607165787196,0.00458582173300744,-0.00970281776248178,0.00827360343090739,0.876169286846927
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CD14,Monocyte differentiation antigen CD14,40048,0.000626840364309648,0.00405050914981776,-0.00731215756933315,0.00856583829795245,0.877015727403508
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,COL15A1,Collagen alpha-1(XV) chain,37998,0.000382785166892798,0.00252677542432425,-0.00456969466478273,0.00533526499856833,0.879590219046205
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DSG3,Desmoglein-3,40419,-0.000469064886551085,0.00325792077416738,-0.00685458960391915,0.00591645983081698,0.885520636027883
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,INHBB,Inhibin beta B chain,37671,-0.000720919485085571,0.00503971114455467,-0.0105987533284127,0.00915691435824159,0.886254627416635
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,UNG,Uracil-DNA glycosylase,37900,0.000472648446860915,0.00330831719262659,-0.0060116532506872,0.00695695014440902,0.886397577909424
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,STX1B,Syntaxin-1B,37572,-0.00059905451755022,0.00420779449421759,-0.00884633172621669,0.00764822269111625,0.88679166762238
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,37541,0.000792794425939902,0.00561204870869221,-0.0102068210430968,0.0117924098949766,0.887661594746128
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,LYPD1,Ly6/PLAUR domain-containing protein 1,39961,-0.000890736466775651,0.00640102272809716,-0.0134367410138461,0.0116552680802948,0.889329208775524
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,39961,-0.000674843386850836,0.00485319497963206,-0.0101871055469297,0.008837418773228,0.889411365267379
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PRRT3,Proline-rich transmembrane protein 3,37628,-0.000503226769720842,0.00367503647531159,-0.00770629826133157,0.00669984472188988,0.891087352000037
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,BGLAP,Osteocalcin,37998,-0.00117913057687934,0.00889163982045429,-0.0186067446249697,0.0162484834712111,0.894502884024166
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GIPR,Gastric inhibitory polypeptide receptor,37598,-0.000621056296280657,0.00478156771386585,-0.00999292901545773,0.00875081642289641,0.89665900645853
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,HDAC8,Histone deacetylase 8,37598,-0.000789890487394882,0.00611294746998172,-0.0127712675285591,0.0111914865537693,0.897188730185253
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ZCCHC8,Zinc finger CCHC domain-containing protein 8,37562,-0.000747218876240667,0.00586336481937192,-0.0122394139222096,0.0107449761697283,0.898595238665554
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DUOX2,Dual oxidase 2,40042,-0.000873617947865114,0.00707338310432371,-0.0147374488323396,0.0129902129366093,0.901706594480821
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",37541,-0.000545682628484665,0.0045027754157708,-0.00937112244339543,0.0082797571864261,0.903543939428922
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CA8,Carbonic anhydrase-related protein,37598,0.000322136173955471,0.0027183524125926,-0.00500583455472603,0.00565010690263697,0.90566997920144
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TPBGL,Trophoblast glycoprotein-like,37572,0.00048173369566388,0.00409093953328601,-0.0075365077895767,0.00849997518090446,0.90626259884094
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CAPS,Calcyphosin,37942,-0.00108943083798079,0.00926521257750684,-0.0192492474898942,0.0170703858139326,0.90639988186258
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,37959,-0.00126526414595517,0.0111282429136376,-0.0230766202566848,0.0205460919647745,0.909478518606137
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NOP56,Nucleolar protein 56,37562,0.00116474894864762,0.0108160994466369,-0.0200348059667608,0.022364303864056,0.914245949129423
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,37482,-0.000628178676634056,0.00593253143830411,-0.0122559402957101,0.010999582942442,0.915673542230905
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,40286,0.00178122792879578,0.0175068300616153,-0.0325321589919701,0.0360946148495617,0.918960574783379
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",37541,-0.000324387977536508,0.00319136549647857,-0.00657946435063451,0.00593068839556149,0.919039610694647
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,XG,Glycoprotein Xg,40458,0.000288444954003616,0.00291662529269672,-0.00542814061968196,0.0060050305276892,0.921221435678003
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,37482,-0.000532626739349997,0.00552407138046759,-0.0113598066450665,0.0102945531663665,0.923189098421587
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MANSC4,MANSC domain-containing protein 4,37562,0.000618551683442673,0.00642254376793711,-0.0119696341017141,0.0132067374685994,0.923276274905166
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,37901,-0.000305516147802377,0.00321280556580849,-0.00660261505678702,0.00599158276118226,0.924242170049213
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GPR158,Probable G-protein coupled receptor 158,37959,0.000301245746797906,0.00360445407214616,-0.00676348423460857,0.00736597572820438,0.933394811456336
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DDX53,Probable ATP-dependent RNA helicase DDX53,37572,-0.000283001899562218,0.00346359285320389,-0.00707164389184185,0.00650564009271741,0.934880471789678
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AIF1L,Allograft inflammatory factor 1-like,37628,-0.000456095011546002,0.00566718776255539,-0.0115637830261546,0.0106515930030626,0.935856761046913
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MED21,Mediator of RNA polymerase II transcription subunit 21,37562,0.000372699688273748,0.00475467829296673,-0.00894646976594104,0.00969186914248854,0.937522293667001
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FGL1,Fibrinogen-like protein 1,37987,-0.000442568900868239,0.00613460775999722,-0.0124664001104628,0.0115812623087263,0.942489186102517
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DUSP29,Dual specificity phosphatase 29,37572,-0.000459329819959567,0.00652933124588204,-0.0132568190618884,0.0123381594219692,0.943917211357291
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TNFSF11,Tumor necrosis factor ligand superfamily member 11,40341,0.000400198683552183,0.00591011552152483,-0.0111836277386365,0.0119840251057409,0.946014005516621
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TAGLN3,Transgelin-3,37482,-0.000387935055911948,0.00596931370712343,-0.0120877899218739,0.01131191981005,0.948184378674642
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,CLEC2L,C-type lectin domain family 2 member L,37572,0.000313032123918678,0.00486168158172846,-0.0092158637762691,0.00984192802410645,0.948662565423362
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MYO6,Unconventional myosin-VI,37959,-0.000220966334861883,0.00365961665587505,-0.00739381498037698,0.00695188231065321,0.95185416758729
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,KLK3,Prostate-specific antigen,37998,-0.000319826334012713,0.00558077136374932,-0.0112581382069614,0.010618485538936,0.954300195058573
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,37564,-0.000188227027495426,0.00373167892025603,-0.00750231771119725,0.0071258636562064,0.959772285829021
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MFAP3L,Microfibrillar-associated protein 3-like,37572,-0.000331657581013623,0.00657805490223589,-0.013224645189396,0.0125613300273687,0.959789429196646
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,GSAP,Gamma-secretase-activating protein,39980,-0.000423857876316601,0.00870917789869271,-0.0174938465577543,0.0166461308051211,0.961184539883357
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SERPINA1,Alpha-1-antitrypsin,37779,3.8460874198546e-05,0.000794058058553029,-0.00151789292056539,0.00159481466896248,0.961369617283678
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RUVBL1,RuvB-like 1,39980,-0.000471403128544302,0.0104712266124227,-0.0209950072888929,0.0200522010318043,0.964092821205559
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IL2,Interleukin-2,40044,-0.000131344160332795,0.00305585191870282,-0.00612081392099033,0.00585812560032474,0.965717076377537
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EPB41L5,Band 4.1-like protein 5,37572,-0.000263771875688031,0.00623954244154899,-0.0124932750611241,0.011965731309748,0.966280728692558
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,AIDA,"Axin interactor, dorsalization-associated protein",37572,0.000346062421154421,0.00819064095946065,-0.0157075938593885,0.0163997187016973,0.966299283709571
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SOX2,Transcription factor SOX-2,37937,-9.51873623490671e-05,0.00227860649374758,-0.00456125609009432,0.00437088136539619,0.96667918135501
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MMP15,Matrix metalloproteinase-15,37990,-0.000190393205897721,0.00487230819540375,-0.00974011726888908,0.00935933085709364,0.968829898729394
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PGLYRP4,Peptidoglycan recognition protein 4,37562,0.000224173223087467,0.00615287283549637,-0.0118354575344854,0.0122838039806604,0.97093692953024
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ALCAM,CD166 antigen,40536,-6.36491144182194e-05,0.00188928017190764,-0.00376663825135719,0.00363934002252076,0.973125081388497
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,RBM19,Probable RNA-binding protein 19,37562,-0.000151807538136682,0.00467877422961785,-0.00932220502818767,0.0090185899519143,0.974116867988275
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,40536,8.87777925288856e-05,0.00286021723992031,-0.00551724799771492,0.00569480358277269,0.975238958994538
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ITGAX,Integrin alpha-X,37714,-0.000157311046228021,0.00540723583852542,-0.0107554932897378,0.0104408711972818,0.976791102117684
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TPT1,Translationally-controlled tumor protein,40044,-0.000181484535833217,0.0064873981009742,-0.0128967848137426,0.0125338157420762,0.977682500854713
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PYDC1,Pyrin domain-containing protein 1,37628,0.000111028751836302,0.00417406677372322,-0.00807014212466121,0.00829219962833381,0.978779448262006
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",37482,0.000142305627175557,0.00566769124704135,-0.0109663692170255,0.0112509804713766,0.979969029752849
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,EBI3_IL27,Interleukin-27,40453,-7.57035745521208e-05,0.00303185562620717,-0.00601814060191818,0.00586673345281393,0.980079693495847
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,IKZF2,Zinc finger protein Helios,39980,0.000219854152497132,0.00913118508405856,-0.0176772686122577,0.0181169769172519,0.980791270797694
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DCTPP1,dCTP pyrophosphatase 1,40359,6.47561503119376e-05,0.00308842460526638,-0.00598855607601018,0.00611806837663405,0.983271945603834
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,TCP11,T-complex protein 11 homolog,37714,0.000107675998784908,0.00594995317136416,-0.0115542322170888,0.0117695842146587,0.985561784175493
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,COL24A1,Collagen alpha-1(XXIV) chain,37901,-9.66400371870206e-05,0.00536643699930474,-0.0106148565558243,0.0104215764814503,0.985632554212704
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NENF,Neudesin,37900,-0.000164028429958716,0.0105687820190996,-0.020878841187394,0.0205507843274766,0.987617488523498
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,FGF7,Fibroblast growth factor 7,37482,0.000104980109881263,0.00792979820274932,-0.0154374243675074,0.0156473845872699,0.989437567913288
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,ACHE,Acetylcholinesterase,37671,3.88717899827618e-05,0.00312428990120157,-0.00608473641637232,0.00616247999633784,0.990073323766734
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,MYOM1,Myomesin-1,37541,-4.67315006936811e-05,0.00458994858390249,-0.00904303072514256,0.0089495677237552,0.991876818255629
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,DEFB118,Beta-defensin 118,37541,5.09826774039264e-05,0.00571576224446254,-0.0111519113217426,0.0112538766765505,0.992883368296361
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,PGM2,Phosphoglucomutase-2,37572,3.30592560192297e-05,0.00587645053885524,-0.011484783800137,0.0115509023121755,0.995511435340514
NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,NFKB2,Nuclear factor NF-kappa-B p100 subunit,37714,2.94441364294484e-05,0.00549872420953243,-0.0107480553142541,0.010806943587113,0.995727651390856
